Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3001122	p-ferrit	ug/l (ug/l)	133084	405958	0.02%
3001122	s-ferrit	ug/l (ug/l)	84493	182335	0.00%
3001122	p-ferrit	— (—)	35229	70786	100.00%	Distribution not available
3001122	s-ferrit	µg/l (ug/l)	25426	44852	0.00%
3001122	p-ferritiini	ug/l______ (ug/l)	3846	6535	0.00%
3001122	p-ferrit	ug/l______ (ug/l)	3487	8755	0.00%
3001122	p-ferritiini	ug/l (ug/l)	2481	3628	0.00%
3001122	s-ferrit	ug/l______ (ug/l)	576	1014	0.00%
3001122	s-ferritiini	ug/l (ug/l)	416	653	0.00%
3001122	ferritiini	ug/l (ug/l)	364	434	0.00%
3001122	s-ferritiini(pi)	ug/l (ug/l)	147	267	0.00%
3001122	p-ferrit	µg/l (ug/l)	125	133	0.00%
3001122	s-ferritiini(ko)	ug/l (ug/l)	74	97	0.00%
3001122	ferritiini(ferrit)	ug/l (ug/l)	73	94	0.00%
3001122	ferritiini	— (—)	67	88	100.00%	Distribution not available
3001122	s-ferrit	µg/L (ug/l)	53	73	0.00%
3001122	s-ferrit	UG/L (ug/l)	41	46	0.00%
3001122	p-ferrit	UG/L (ug/l)	31	48	0.00%
3001122	p-ferritiini	— (—)	30	32	100.00%	Distribution not available
3001122	s-ferritiini	µg/l (ug/l)	16	17	0.00%
3001122	s-ferritiini	— (—)	12	14	100.00%	Distribution not available
3001122	p-ferritiini	µg/l (ug/l)	8	8	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Arthropathies

30704

128818

1.40

323.31

3.5

3.1

109.46

108.73

ug/l

0.19

29059

121648

Diseases of the musculoskeletal system and connective tissue

18953

74549

1.53

323.01

3.4

2.9

105.07

101.21

ug/l

1.25

17970

70593

Calcific aortic valvular stenosis, operated

7776

51897

1.94

322.70

4.3

3.1

156.42

163.15

ug/l

1.14

7193

47014

Calcific aortic valvular stenosis

7776

51897

1.94

322.70

4.3

3.1

156.42

163.15

ug/l

1.14

7193

47014

Calcific aortic valvular stenosis, diagnosis (helper)

7762

51798

1.93

322.13

4.3

3.1

156.53

163.35

ug/l

1.16

7181

46920

Operations 2 for CAVS

7762

51798

1.93

322.13

4.3

3.1

156.53

163.35

ug/l

1.16

7181

46920

Shoulder lesions

22896

110680

1.47

322.01

3.4

3.0

127.29

130.59

ug/l

0.87

21472

103804

Insulin, intermediate and long-acting

15709

118141

1.59

320.98

4.7

3.0

137.96

139.24

ug/l

0.22

14659

110021

Hypothyroidism, drug reimbursement

4760

20586

2.46

320.97

4.0

2.4

98.01

73.92

ug/l

11.87

4516

19792

Diseases of the eye and adnexa

26997

110888

1.43

320.82

3.5

3.0

109.05

108.55

ug/l

0.11

25615

105445

Calcific aortic valvular stenosis, including rheumatic fever

7782

51933

1.93

320.72

4.3

3.1

156.87

163.27

ug/l

1.05

7200

47046

Preparatory care for dialysis

1491

6748

11.60

317.63

15.6

3.0

293.59

151.09

ug/l

53.89

1486

6275

Gout, strict definition

4851

30767

2.38

315.89

5.3

3.0

207.98

173.31

ug/l

6.61

4575

28167

Secondary hypertension

2391

12010

3.61

315.25

9.0

2.5

221.35

129.95

ug/l

33.52

2320

11169

Symptoms and signs involving the skin and subcutaneous tissue

23042

178608

1.47

314.78

3.7

3.2

118.51

116.89

ug/l

0.36

21756

167622

Other diseases of intestine

4455

27683

2.48

314.38

4.7

2.8

134.96

150.52

ug/l

1.83

4215

25641

Dysphagia

7359

51101

1.98

313.77

3.8

2.9

129.56

136.50

ug/l

0.84

6790

47303

Nerve, nerve root and plexus disorders

33997

172276

1.37

313.05

3.6

3.1

121.44

120.96

ug/l

0.11

31896

161770

Non-selective monoamine reuptake inhibitors

10385

73156

1.74

312.24

3.6

3.0

110.91

134.13

ug/l

15.78

9502

68396

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

5657

38070

2.36

311.92

4.5

3.1

95.96

115.00

ug/l

8.39

5468

36082

Other gastritis (incl. Duodenitis)

6246

42006

2.11

311.79

4.6

2.9

125.08

145.02

ug/l

7.82

5906

38876

Any reimbursement code in KELA

20829

83770

1.51

309.71

3.6

2.7

106.22

81.38

ug/l

39.71

19887

79732

Cardiomyopathy (excluding other)

3361

19200

2.77

309.45

4.5

2.7

178.23

162.91

ug/l

1.04

3219

17660

Conjunctivitis (acute, non atopic), including avohilmo

32611

165931

1.38

308.53

3.4

3.1

104.74

121.74

ug/l

36.42

30741

155858

Asthma (only as main-diagnosis)

24652

103706

1.69

307.65

3.7

2.8

104.52

104.39

ug/l

0.03

23399

97581

Renal failure

16547

79753

3.13

307.65

6.6

2.7

217.23

146.44

ug/l

105.70

15785

72834

Crohn disease

4341

27101

3.01

307.65

5.3

3.1

102.28

108.75

ug/l

1.20

4215

25662

Dentofacial anomalies [including malocclusion]

24178

150921

1.59

307.65

3.5

3.2

86.87

105.63

ug/l

23.09

22916

142963

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

40747

166036

2.91

307.65

5.3

2.7

152.80

110.44

ug/l

77.94

38667

155548

Persons encountering health services for examination and investigation

21193

80935

1.58

307.65

3.4

2.7

118.21

120.77

ug/l

0.64

19970

75877

Asthma

26746

103706

1.69

307.65

3.6

2.8

106.40

104.39

ug/l

0.65

25434

97581

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

33067

168193

1.51

307.65

4.2

3.0

134.62

109.80

ug/l

43.66

30883

158792

Implicit bacterial Sepsis, including avohilmo

14633

78763

2.26

307.65

5.0

2.9

193.59

139.22

ug/l

43.14

13709

72397

Anxiety disorders

32117

165585

1.76

307.65

3.7

3.1

100.25

113.91

ug/l

13.39

30273

156357

Asthma-related infections

19252

147610

1.58

307.65

3.9

3.1

112.37

117.74

ug/l

1.84

18253

138123

Heart failure, not strict

23910

102795

2.32

307.65

5.0

2.7

172.07

137.25

ug/l

42.02

22538

95117

Asthma (mode)

26480

104327

1.70

307.65

3.6

2.8

104.51

104.49

ug/l

0.00

25197

98155

Implicit viral Sepsis

6644

41993

2.52

307.65

5.5

2.9

176.32

126.45

ug/l

23.34

6283

38787

Non-rheumatic valve diseases

13547

64309

2.05

307.65

4.1

2.8

155.91

142.91

ug/l

1.79

12563

59345

Cardiomyopathies, Primary/intrinsic

3279

18283

2.90

307.65

4.5

2.7

178.79

164.32

ug/l

0.93

3146

16843

Condition for Implicit Sepsis (Organ dysfunction codes)

27632

147258

1.62

307.65

4.2

2.9

159.37

114.80

ug/l

70.30

25862

137913

Bacterial Sepsis

14976

81850

2.15

307.65

5.0

2.9

198.71

137.32

ug/l

54.60

14011

75370

Complications of surgical and medical care, not elsewhere classified

34075

176691

1.62

307.65

4.1

3.1

133.04

116.77

ug/l

18.91

32019

165871

Nutritional anaemias

20576

107283

4.10

307.65

6.3

2.9

103.86

128.49

ug/l

28.45

19480

99306

Explicit Sepsis

13984

88528

1.99

307.65

5.1

2.9

203.74

126.77

ug/l

70.86

13101

81911

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

30050

156467

1.62

307.65

4.1

2.9

150.87

109.99

ug/l

64.92

28204

146961

Certain infectious and parasitic diseases

33132

134117

1.47

307.65

3.7

2.9

130.11

100.81

ug/l

49.24

31279

126158

Conduction disorders

8340

43805

2.09

307.65

4.0

2.8

143.43

145.83

ug/l

0.38

7693

40184

Hyperlipidaemia, other/unspecified

10534

67335

1.83

307.65

4.0

2.8

152.97

154.41

ug/l

0.19

9681

61562

Ischemic heart diseases

23560

110104

1.53

307.65

3.9

2.9

143.66

136.77

ug/l

2.33

22124

102601

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

35521

176750

1.62

307.65

3.9

3.0

116.78

116.29

ug/l

0.09

33683

165711

Cardiomyopathy

4807

28084

2.64

307.65

4.4

2.7

169.18

158.31

ug/l

0.98

4588

25852

Bacterial infection, other or unspecified, including avohilmo

19034

107790

2.01

307.65

4.6

2.9

227.29

120.83

ug/l

143.04

17916

99803

Atrial fibrillation and flutter

8881

37232

2.08

307.65

3.9

2.4

158.91

128.41

ug/l

14.46

8376

34909

Diarrhoea and gastroenteritis of presumed infectious origin

23209

167882

1.49

307.65

4.2

3.1

127.94

112.24

ug/l

11.75

21934

157758

Erysipelas, including avohilmo

21842

126344

1.55

307.65

3.9

2.9

151.15

120.16

ug/l

42.21

20397

117724

Percutaneous Coronary Intervention

23131

104662

1.70

307.65

3.9

2.8

144.03

139.95

ug/l

0.98

21706

97353

Major coronary heart disease event

23781

110977

1.54

307.65

3.9

2.9

144.20

139.92

ug/l

1.13

22309

103162

Atrial fibrillation and flutter with reimbursement

7208

26908

2.43

307.65

3.8

2.3

155.01

141.00

ug/l

3.10

6757

24952

AV-block

5026

25205

2.49

307.65

4.1

2.7

147.40

160.36

ug/l

3.07

4647

22780

Heart failure, strict

17667

77966

2.32

307.65

4.7

2.9

172.71

156.92

ug/l

6.47

16617

71066

Erysipelas

15934

104399

1.62

307.65

4.1

2.9

158.01

128.68

ug/l

24.86

14849

96660

Hypertension, essential

23581

104344

1.55

307.65

3.9

2.8

137.31

117.13

ug/l

23.98

22355

98319

Disorders of conjunctiva

27833

179000

1.44

307.65

3.5

3.2

100.48

111.52

ug/l

13.08

26340

168555

Continuous positive airway pressure

5199

25407

2.47

307.65

4.1

2.4

160.23

146.39

ug/l

1.77

4726

23790

Any mental disorder

36374

146022

1.50

307.65

3.5

3.0

117.50

120.59

ug/l

1.14

33948

137646

Hypothyroidism and >3 levothyroxin purchases

10397

33974

2.90

307.65

4.0

2.5

89.41

71.05

ug/l

28.46

9923

32671

General symptoms and signs

38436

143350

1.73

307.65

3.8

2.9

132.56

105.32

ug/l

48.40

36329

134958

Other anxiety disorders

17713

109836

1.98

307.65

3.9

3.1

83.19

96.28

ug/l

11.31

16771

104736

All anxiety disorders

23560

132553

1.97

307.65

3.8

3.1

85.82

103.68

ug/l

28.04

22256

126114

Mood [affective] disorders

36816

175709

1.78

307.65

3.7

3.1

102.23

118.85

ug/l

27.84

34491

165538

Septicaemia

13031

81128

2.03

307.65

5.2

2.9

212.85

127.07

ug/l

78.38

12189

74708

Spinal stenosis

14345

76324

1.77

307.65

3.5

3.0

133.92

152.59

ug/l

13.42

13238

70422

Acute renal failure

6941

39730

3.04

307.65

6.0

2.7

247.87

149.21

ug/l

57.57

6619

36283

Hypertensive diseases

23774

107861

1.47

307.65

4.0

2.8

135.97

115.34

ug/l

25.79

22565

101714

Anaemias

11312

32627

7.51

307.65

6.9

2.5

121.89

70.41

ug/l

40.64

10951

31366

General examination and investigation of persons without complaint and reported diagnosis

21406

80806

1.75

307.65

3.7

2.7

119.20

120.75

ug/l

0.35

20294

75775

Abnormalities of breathing

32776

136250

1.83

307.65

3.8

3.0

120.29

109.52

ug/l

8.78

30911

128685

Non-invasive ventilation

7931

44609

2.19

307.65

3.8

2.6

115.53

112.35

ug/l

0.41

7757

42273

Heart failure and coronary heart disease

12527

53782

2.47

307.65

4.8

2.9

167.18

169.32

ug/l

0.25

11802

48760

Diverticular disease of intestine

22312

96974

1.89

307.65

3.8

2.8

135.01

143.61

ug/l

4.12

20804

90136

Other CVD (FINNGEN)

3403

13541

3.24

307.65

4.4

2.4

157.63

144.22

ug/l

1.48

3109

12368

Use of hypnotics and sedatives

34181

160793

1.43

307.65

3.6

3.1

128.10

121.15

ug/l

3.73

31977

151418

Sleep disorders

33818

167191

1.96

307.65

3.5

3.1

96.11

117.68

ug/l

60.09

32159

157099

Acute upper respiratory infections of multiple and unspecified sites

25752

153438

1.47

307.65

3.8

3.1

115.64

111.40

ug/l

1.22

24340

144518

Other disorders of urethra and urinary system

23945

130517

1.60

307.65

3.8

3.1

112.92

111.57

ug/l

0.36

22361

122394

Low back pain

27257

140753

1.67

307.65

3.7

3.1

114.63

114.48

ug/l

0.03

25575

132520

Dyspnoea

30930

167758

1.74

307.65

4.0

3.1

132.77

119.12

ug/l

10.79

28921

157414

Pain in limb

29958

140936

1.80

307.65

3.8

3.1

115.19

113.88

ug/l

0.36

28039

132780

Malaise and fatigue

19078

96646

2.35

307.65

4.2

2.9

146.69

113.59

ug/l

34.54

17774

90131

37721

160754

1.37

307.65

3.7

3.0

125.10

114.04

ug/l

5.28

35306

150820

Heart failure,strict

16116

67318

2.58

307.65

4.7

2.6

174.19

155.23

ug/l

7.89

15189

61343

Mood disorders, excluding more controls

33417

144078

1.81

307.65

3.7

3.0

105.65

120.05

ug/l

17.86

31261

135893

Other nutritional deficiencies

24621

163171

2.00

307.65

4.5

3.1

105.73

110.46

ug/l

2.80

23373

154000

Fever of other and unknown origin

19610

119696

1.94

307.65

4.5

2.9

187.27

108.28

ug/l

98.80

18542

112231

Presence of other functional implants

16434

85410

1.61

307.65

3.7

2.9

151.58

142.88

ug/l

3.14

14560

79056

Other heart diseases, wide

30673

145726

1.57

307.65

3.9

3.0

132.50

107.46

ug/l

21.50

29024

137698

Liquid cancers

8272

53741

2.01

307.65

4.1

3.1

288.35

126.63

ug/l

43.39

7818

49555

Other specific joint derangements/joint disorders

26127

126026

1.65

307.65

3.7

3.1

105.15

108.13

ug/l

1.09

24709

119135

IBD patients in KELA-register

7900

51069

2.64

307.65

4.7

3.1

96.70

114.18

ug/l

8.68

7653

48417

Certain infectious and parasitic diseases, including avohilmo

24050

93586

1.55

307.65

3.5

2.8

129.84

103.98

ug/l

15.46

22671

87796

Inflammatory bowel disease

10637

71761

2.32

307.65

4.6

3.1

102.81

118.38

ug/l

9.06

10259

67776

Antihypertensive medication - note that there are other indications

21864

90792

1.55

307.65

3.9

2.9

100.28

83.62

ug/l

18.13

20904

86630

Neurotic, stress-related and somatoform disorders

31873

164700

1.77

307.65

3.7

3.1

100.00

113.49

ug/l

13.04

30047

155556

Hypertensive heart and/or renal disease

6871

31897

2.12

307.65

5.0

2.6

174.04

167.16

ug/l

0.80

6367

28851

Implicit bacterial Sepsis

13123

72333

2.28

307.65

5.1

2.9

202.45

141.68

ug/l

44.50

12288

66363

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

17735

137742

1.64

307.65

4.1

3.1

126.66

124.03

ug/l

0.65

16668

128601

Medical observation and evaluation for suspected diseases and conditions

22477

80923

1.85

307.65

3.8

2.7

125.41

120.76

ug/l

1.25

21057

75868

Care involving dialysis

2849

12582

8.73

307.65

15.5

2.8

323.11

136.12

ug/l

173.79

2829

11718

Symptoms and signs involving the urinary system

23021

137325

1.53

307.65

3.8

3.1

139.15

129.53

ug/l

4.89

21214

128286

Persons encountering health services for specific procedures and health care

36705

173133

1.52

307.65

4.2

3.0

153.60

103.92

ug/l

123.89

34713

162750

ILD differential diagnosis

26248

104327

1.52

307.65

3.5

2.8

125.47

104.49

ug/l

12.22

24732

98155

Unspecified kidney failure

3170

16864

3.54

307.65

7.0

2.7

210.94

146.91

ug/l

24.09

3032

15280

Implicit Sepsis

24825

131963

1.84

307.65

4.4

2.9

164.15

120.87

ug/l

62.02

23153

123008

Symptoms and signs involving the digestive system and abdomen

33813

131768

1.56

307.65

3.6

2.9

124.44

119.93

ug/l

2.07

31778

123837

Hypertensive diseases (excluding secondary)

16448

72971

1.64

307.65

4.2

2.7

130.96

98.32

ug/l

49.07

15735

69510

Complications of medical and surgical care

24111

167934

1.65

307.65

4.2

3.1

131.40

119.67

ug/l

8.75

22652

157285

Depression

34872

170970

1.85

307.65

3.7

3.1

100.01

117.65

ug/l

29.52

32739

161286

Other antidepressants

37514

133687

1.96

307.65

3.5

3.0

115.99

124.67

ug/l

6.95

34983

126012

Colectomy operation

4779

30367

2.54

307.65

4.4

3.1

107.00

145.90

ug/l

18.90

4515

28008

Insomnia

33467

167409

1.97

307.65

3.5

3.1

94.56

115.66

ug/l

58.75

31852

157413

Neurological diseases, wide definition

10913

37982

1.93

307.65

3.5

2.7

93.55

86.20

ug/l

2.75

10360

36323

Opioids

34686

137901

1.62

307.65

3.7

3.0

123.63

104.26

ug/l

27.54

32673

130119

Other obstetric conditions, not elsewhere classified

13228

66357

2.00

307.65

4.3

3.3

51.83

59.71

ug/l

19.48

12691

64018

Other and unspecified iron deficiency

15040

75897

6.40

307.65

6.9

2.9

86.65

123.73

ug/l

65.01

14292

70376

Nephropathy related operations

3994

20571

4.95

307.65

13.0

2.9

305.92

145.94

ug/l

128.50

3943

19204

Glomerular disorders in diseases classified elsewhere

3489

20448

3.22

307.65

9.8

3.0

224.75

142.80

ug/l

67.29

3381

19071

Other diseases of liver

5610

36464

2.50

307.65

4.2

3.1

175.58

123.11

ug/l

17.21

5281

34238

Other intervertebral disc disorders

26299

126581

1.47

307.65

3.4

3.1

117.79

122.43

ug/l

2.17

24793

118971

Covid-19 confirmed case

13196

84890

2.65

307.65

4.5

3.1

179.77

123.46

ug/l

61.35

12485

78877

Coronary atherosclerosis

16778

80990

1.58

307.65

4.0

2.8

149.73

154.33

ug/l

0.94

15611

74583

Hypertension

23754

107778

1.47

307.65

4.0

2.8

136.00

115.39

ug/l

25.73

22545

101636

Pain (limb, back, neck, head abdominally)

24252

90880

1.64

307.65

3.4

2.8

121.18

122.29

ug/l

0.22

22826

85291

COPD differential diagnosis

26260

104366

1.52

307.65

3.5

2.8

125.43

104.49

ug/l

12.18

24744

98191

29330

140699

1.44

307.65

4.0

3.0

158.87

104.15

ug/l

75.47

27629

132245

Inflammatory bowel disease, strict (require KELA)

7900

51591

2.59

307.65

4.7

3.1

96.70

114.54

ug/l

9.04

7653

48911

Genitourinary diseases

17659

64759

1.67

307.65

3.5

2.6

133.66

128.68

ug/l

1.21

16690

61087

Diseases of liver

10700

72284

2.20

307.65

4.3

3.1

203.36

132.19

ug/l

33.66

10107

67525

Diseases of the skin and subcutaneous tissue

33337

135070

1.47

307.65

3.6

3.0

123.16

114.72

ug/l

5.14

31334

127019

Nonorganic sleeping disorders, excluding more controls

7256

49514

2.31

307.65

4.0

3.0

88.76

98.60

ug/l

6.59

6915

47210

Other extrapyramidal and movement disorders in other diseases

7988

51570

2.62

307.65

3.9

3.2

109.63

128.83

ug/l

13.86

7375

48028

L04AX Other immunosuppressants

17658

136803

1.66

307.65

4.0

3.1

135.88

116.85

ug/l

14.49

16849

128483

Sleep apnoea

31123

147914

1.71

307.65

3.6

3.1

129.85

127.02

ug/l

1.05

28815

139249

Ulcer of lower limb, not elsewhere classified

4250

25460

2.82

307.65

5.9

3.0

167.56

153.12

ug/l

2.55

3963

23375

Other diseases of hard tissues of teeth

17176

68031

1.59

307.65

3.3

2.9

126.76

134.65

ug/l

2.93

15914

63642

Gastrointestinal diseases

21429

79563

1.71

307.65

3.6

2.6

106.38

96.00

ug/l

6.98

20321

75120

Ulcerative colitis

7911

53555

2.27

307.65

4.5

3.1

102.88

119.83

ug/l

7.66

7615

50514

Mood disorders

36885

175786

1.78

307.65

3.7

3.1

102.33

118.84

ug/l

27.53

34554

165608

Constipation

29558

152666

1.67

307.65

3.7

3.1

128.24

123.93

ug/l

1.43

27309

143304

Other arrhythmias

20408

116303

1.65

307.65

3.7

2.9

120.00

114.40

ug/l

2.69

19065

109309

Coronary revascularization (ANGIO or CABG)

22982

104721

1.67

307.65

3.9

2.8

143.83

139.93

ug/l

0.92

21576

97409

ILD medications

40594

166511

1.67

307.65

4.1

2.9

143.19

106.34

ug/l

54.40

38485

156306

Caries of dentine

6879

43698

2.19

307.65

5.7

2.9

180.33

134.61

ug/l

17.39

6549

41264

Asthma (diagnoses ohter than nonallergic)

29224

191308

1.50

307.65

3.7

3.2

106.54

116.22

ug/l

8.62

27721

179484

Dental caries

7800

49154

2.13

307.65

5.7

2.9

176.28

133.08

ug/l

18.71

7435

46414

GI-bleeding

9463

63693

2.09

307.65

5.0

3.0

134.74

148.37

ug/l

4.11

8847

58587

Autoimmune diseases related-to ILD

29438

187305

1.70

307.65

4.0

3.1

120.69

115.93

ug/l

2.15

27906

175854

ILD medications: prednisolone, methylprednisolone, prednisone

38793

163194

1.69

307.65

4.2

2.9

144.78

107.24

ug/l

52.99

36721

153143

Heart failure and antihypertensive medication

7700

25375

3.36

307.65

5.1

2.4

180.09

143.22

ug/l

9.44

7335

23682

Inflammatory bowel disease treatment related agents

41018

172631

1.69

307.65

4.0

3.0

136.19

110.48

ug/l

29.52

38873

162045

Asthma, including avohilmo

40389

180902

1.47

307.65

3.5

3.1

106.11

119.16

ug/l

17.43

38273

169747

All-cause Heart Failure

17334

76818

2.30

307.65

4.7

2.9

172.62

157.27

ug/l

5.99

16296

69985

Cardiovascular diseases

22103

92761

1.58

307.65

3.9

2.9

101.53

81.86

ug/l

27.53

21193

88557

ILD medications: azathioprine

4862

30202

2.83

307.65

5.7

2.9

127.40

104.30

ug/l

7.07

4732

28485

Infections, IBD-co-morbidities

5038

19917

2.73

307.65

5.4

2.5

178.48

112.55

ug/l

22.93

4790

18961

ILD medications: immunosuppressive drugs

22835

146344

2.00

307.65

4.7

2.9

149.04

108.89

ug/l

70.75

21897

137542

Emergency coronary revascularization (for ACS)

25021

112746

1.67

307.65

3.9

2.9

144.49

141.78

ug/l

0.59

23430

104630

All chronic kidney diseases

18949

95987

2.42

307.65

6.1

2.8

187.01

128.00

ug/l

114.51

18055

88701

Hypothyroidism, levothyroxine purchases

10397

33974

2.90

307.65

4.0

2.5

89.41

71.05

ug/l

28.46

9923

32671

Dental operations

18424

73046

1.56

307.65

3.2

2.9

133.33

135.88

ug/l

0.53

17102

68340

Acute tubulo-interstitial nephritis

19877

133475

1.55

307.65

4.1

3.0

140.70

108.06

ug/l

42.63

18552

124334

Hypothyreosis and Thyroxine purchase for inclusion criteria

32435

163548

1.69

307.65

3.8

3.1

102.60

113.69

ug/l

15.32

30424

153767

Hypothyroidism (congenital or acquired)

10454

34044

2.91

307.65

4.0

2.5

89.85

71.10

ug/l

29.48

9973

32740

Other diseases of anus and rectum

9230

62577

2.05

307.65

4.1

2.9

118.88

136.53

ug/l

9.05

8558

57864

Irritable bowel syndrome

9457

65646

2.18

307.65

3.9

3.0

101.44

104.84

ug/l

0.62

8890

61762

Other diseases of the digestive system

9543

63880

2.13

307.65

5.0

3.0

134.70

147.41

ug/l

3.67

8915

58775

Diaphragmatic hernia

11081

73259

2.30

307.65

4.4

3.0

110.16

141.45

ug/l

25.02

10389

67596

Sciatica+with lumbago

16524

112417

1.65

307.65

3.5

3.0

115.21

122.34

ug/l

3.38

15625

105735

Spondylosis

16083

93686

1.70

307.65

3.4

3.0

128.82

140.43

ug/l

4.73

14877

87340

Cystitis

30203

136407

1.72

307.65

3.6

3.1

100.71

112.17

ug/l

13.38

28516

128047

GASTRO-related operations

29069

105371

1.79

307.65

3.7

2.7

121.35

89.23

ug/l

58.59

27415

99686

Chronic kidney disease

11375

56985

3.92

307.65

7.9

2.7

215.50

148.18

ug/l

93.22

10934

51862

Glomerular diseases

5252

33654

2.52

307.65

8.7

3.0

207.05

138.75

ug/l

60.07

5071

31398

Psychiatric diseases

32567

125793

1.59

307.65

3.4

3.0

118.13

123.92

ug/l

2.99

30436

118485

Used for control exclusion in common control thyroid runs

37627

142857

1.69

307.65

3.8

2.9

120.12

115.60

ug/l

2.23

35556

134323

Gout, FINNGEN

7854

52281

2.06

307.65

5.1

3.0

210.07

166.58

ug/l

17.04

7406

47744

Use of pramipexole

6922

42390

2.94

307.65

4.2

3.1

117.67

135.88

ug/l

8.95

6360

39301

Obesity and other hyperalimentation

22629

159342

1.85

307.65

4.3

3.1

107.82

110.03

ug/l

0.80

21416

150511

Chronic gastritis

7818

50805

2.26

307.65

4.4

2.9

119.18

148.04

ug/l

14.89

7246

46620

Neurological diseases

29853

116523

1.58

307.65

3.5

3.0

108.46

110.03

ug/l

0.44

28121

110309

Gout, idiopatic and unspecified

6644

44361

2.13

307.65

5.1

3.0

204.00

170.45

ug/l

8.70

6254

40636

Any gastric operation

29069

105371

1.79

307.65

3.7

2.7

121.35

89.23

ug/l

58.59

27415

99686

Dialysis, with operation codes

4214

21011

5.16

307.65

12.7

2.7

303.21

143.13

ug/l

137.29

4161

19523

Hypothyroidism, strict autoimmune, 3 medication purchases required

29111

153994

1.62

307.65

3.8

3.1

102.69

110.47

ug/l

7.25

27186

144833

Aplastic and other anaemias

18455

86589

4.50

307.65

6.0

2.8

198.20

134.79

ug/l

50.09

17520

79377

Endocrine, nutritional and metabolic diseases

28622

106838

1.73

307.65

3.8

2.7

113.37

104.82

ug/l

5.59

27146

101157

Hypothyroidism, other/unspecified

31381

157722

1.71

307.65

3.8

3.1

102.86

113.88

ug/l

14.48

29453

148333

Other anaemias

17319

81654

4.74

307.65

5.9

2.8

194.03

135.95

ug/l

38.79

16443

74754

Dipeptidyl peptidase 4 (DPP-4) inhibitors

15890

88969

1.86

307.65

4.2

2.9

135.41

156.23

ug/l

15.82

14664

82184

Presence of cardiac and vascular implants and grafts

12443

60445

2.08

307.65

4.2

2.8

153.84

162.74

ug/l

2.43

11604

55588

Obesity

22536

158911

1.85

307.65

4.3

3.1

107.67

109.94

ug/l

0.83

21331

150114

All kidney diseases

33761

176782

1.60

307.65

4.6

2.9

157.04

106.05

ug/l

137.44

31875

166090

Persons encountering health services for other counselling and medical advice, not elsewhere classified

39479

157574

1.72

307.65

3.8

3.0

118.69

119.18

ug/l

0.13

37535

147858

Persons encountering health services in other circumstances, wide

40465

158197

1.66

307.65

3.8

2.9

122.95

119.24

ug/l

1.46

38147

148361

Codeine or tramadol medication

40001

167228

1.65

307.65

3.6

3.1

119.55

116.12

ug/l

1.62

37516

157340

Follow-up examination after treatment for conditions other than malignant neoplasms

14440

71666

1.71

307.65

3.6

2.8

101.02

114.31

ug/l

7.48

13662

67204

Explicit Sepsis, including avohilmo

14323

90309

1.99

307.65

5.1

2.9

202.07

126.19

ug/l

71.81

13424

83579

Other disorders of fluid, electrolyte and acid-base balance

9728

58075

2.37

307.65

4.8

2.9

181.60

142.81

ug/l

16.47

9038

53178

Persons encountering health services in other circumstances

13689

101559

1.77

307.65

3.9

3.0

121.91

111.87

ug/l

2.67

12578

95421

Examination and observation for other reasons

21700

80393

2.18

307.65

4.1

2.8

112.32

120.52

ug/l

4.28

20674

75416

Care involving use of rehabilitation procedures

19877

140662

1.56

307.65

4.0

2.9

122.58

112.47

ug/l

6.42

18907

131611

Other special examinations and investigations of persons without complaint or reported diagnosis

22036

80935

1.74

307.65

3.6

2.7

120.93

120.77

ug/l

0.03

20822

75877

Pure hypercholesterolaemia

22519

107268

1.66

307.65

3.6

2.8

137.46

136.79

ug/l

0.14

21189

99677

Adjustment and management of implanted device

5309

31617

2.70

307.65

4.7

2.8

142.78

143.21

ug/l

0.04

4951

28731

Viral Sepsis

6656

42071

2.52

307.65

5.4

2.9

176.49

126.38

ug/l

23.55

6295

38862

Implicit viral Sepsis, including avohilmo

10035

65012

2.40

307.65

4.9

2.9

158.89

124.61

ug/l

20.17

9452

60151

Extracorporeal dialysis

1996

9542

7.12

307.65

17.0

2.9

358.76

149.41

ug/l

129.59

1980

8888

Acute upper respiratory infections

34547

172471

1.40

307.65

3.6

3.1

118.15

116.20

ug/l

0.37

32481

161715

Other dorsopathies, not elsewhere classified

35202

143916

1.56

307.65

3.5

3.1

112.66

114.15

ug/l

0.46

33230

135505

Other joint disorders

30273

128634

1.46

307.65

3.5

3.1

106.09

108.77

ug/l

1.03

28583

121471

Behavioural syndromes associated with physiological disturbances and physical factors

34853

170005

1.94

307.65

3.5

3.1

97.06

118.41

ug/l

58.01

33128

159718

Non-ischemic cardiomyopathy

8927

44650

2.34

307.65

4.3

2.8

174.66

158.45

ug/l

2.95

8343

40547

Valvular heart disease excluding rheumatic fever

13632

64744

2.05

307.65

4.1

2.8

155.66

142.44

ug/l

1.86

12643

59759

Excluding asthma or asthma-COPD overlap

26360

104598

1.52

307.65

3.5

2.8

125.74

104.34

ug/l

12.76

24835

98420

Dorsalgia

34557

143613

1.57

307.65

3.5

3.1

114.19

114.24

ug/l

0.01

32528

135212

Factors influencing health status and contact with health services

8702

28454

1.90

307.65

3.2

2.3

141.58

131.12

ug/l

1.93

8143

26712

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

29939

192795

1.44

307.65

3.6

3.2

118.48

115.25

ug/l

1.02

28246

181269

Polyarthropathies

22029

108082

1.64

307.65

4.1

3.0

151.87

118.06

ug/l

39.78

20855

101766

Disorders of other endocrine glands

14101

107471

1.68

307.65

4.7

3.1

120.78

108.99

ug/l

7.47

13259

100821

Lower back pain or/and sciatica

37029

184533

1.53

307.65

3.6

3.1

116.09

116.75

ug/l

0.18

34812

173434

Bronchitis

36342

183270

1.38

307.65

3.8

3.1

121.72

114.22

ug/l

4.03

34153

172159

Noninfective enteritis and colitis

15930

111307

2.08

307.65

4.5

3.1

112.92

117.66

ug/l

1.34

15233

104576

Dermatitis and eczema

38368

182470

1.51

307.65

3.6

3.1

115.81

117.73

ug/l

0.62

36164

171365

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

19301

146006

1.66

307.65

4.2

3.1

130.78

122.58

ug/l

3.86

18138

136425

Other bacterial diseases, including avohilmo

32979

166269

1.48

307.65

4.2

3.0

178.68

105.41

ug/l

172.73

31032

156215

Other soft tissue disorders, not elsewhere classified

34337

143351

1.82

307.65

3.8

3.1

114.85

113.90

ug/l

0.25

32221

135063

Heart failure and bmi 25plus

9569

39912

2.34

307.65

4.7

2.9

174.63

159.46

ug/l

3.02

8943

36063

Renal tubulo-interstitial diseases

30299

165241

1.79

307.65

4.9

2.9

166.11

108.60

ug/l

160.88

28587

154709

Metabolic disorders

30916

142382

1.62

307.65

4.0

2.9

143.96

119.23

ug/l

36.85

29113

133548

Migraine, single triptan purchase ok & required. ICD-code if available is included

26130

139264

1.62

307.65

3.4

3.1

84.22

106.21

ug/l

57.46

24972

131697

Episodal and paroxysmal disorders

38536

151513

1.60

307.65

3.6

3.0

109.15

114.61

ug/l

3.92

36164

142726

Soft tissue disorders

35419

144361

1.52

307.65

3.6

3.1

112.74

113.84

ug/l

0.32

33328

135998

Hypothyroidism, strict autoimmune

26671

128533

1.84

307.65

3.8

2.9

102.93

110.53

ug/l

6.10

25002

120581

Other heart diseases

15629

74221

1.80

307.65

4.1

2.7

136.01

97.06

ug/l

17.56

14912

70648

Cardiac arrhythmias

20300

100023

1.65

307.65

3.8

2.8

119.44

99.49

ug/l

25.30

19260

95093

Hard cardiovascular diseases

23757

112215

1.48

307.65

3.9

2.9

145.35

132.86

ug/l

3.74

22339

104887

Exposure to unspecified factor

33553

191594

1.39

307.65

3.6

3.1

120.04

115.42

ug/l

2.32

31146

180544

Intestinal infectious diseases, including avohilmo, including avohilmo

39989

174499

1.58

307.65

3.8

3.0

123.34

116.86

ug/l

2.80

37832

163532

COPD/asthma/ILD related infections

33670

140699

1.40

307.65

3.7

3.0

129.85

104.15

ug/l

25.72

31678

132245

Other bacterial diseases

30208

155556

1.59

307.65

4.3

2.9

196.21

111.73

ug/l

172.98

28363

145730

Other diseases of intestines

38227

160707

1.70

307.65

3.9

3.0

116.62

112.51

ug/l

1.92

36099

151461

Disorders of eyelid, lacrimal system and orbit

27629

167725

1.43

307.65

3.5

3.2

116.70

120.92

ug/l

1.82

25783

157314

Autoimmune diseases

39643

152451

1.67

307.65

3.9

2.9

120.26

115.23

ug/l

2.89

37469

143307

Autoimmune diseases excluding thyroid diseases

35892

151492

1.58

307.65

4.0

2.9

129.94

115.44

ug/l

13.54

34039

142404

Bacterial infection, other or unspecified

17170

98821

2.05

307.65

4.7

2.9

238.82

124.07

ug/l

137.63

16132

91256

Diseases of oesophagus, stomach and duodenum

37761

165557

1.77

307.65

4.0

3.0

119.00

119.44

ug/l

0.10

35450

155769

Diseases of oral cavity, salivary glands and jaws

17503

68660

1.58

307.65

3.3

2.9

130.26

134.82

ug/l

1.21

16267

64170

Osteopathies and chondropathies

17058

122311

1.59

307.65

4.0

3.1

132.47

123.67

ug/l

3.88

15893

114105

Asthma, hospital admission 2, infections

19252

147610

1.58

307.65

3.9

3.1

112.37

117.74

ug/l

1.84

18253

138123

Asthma (only as main-diagnosis), excluding more controls

23962

97883

1.74

307.65

3.6

2.8

104.03

101.37

ug/l

0.85

22771

92187

Gastro-oesophageal reflux disease

22932

139409

1.88

307.65

3.9

2.9

117.66

127.69

ug/l

5.56

21282

130698

Systemic connective tissue disorders

10671

78644

1.87

307.65

4.1

3.1

135.95

118.02

ug/l

6.78

10042

73036

Benign neoplasms

33009

148549

1.41

307.65

3.6

3.1

114.45

116.07

ug/l

0.48

31209

140026

Triptan medication for migraine, single purchase ok

26130

139264

1.62

307.65

3.4

3.1

84.22

106.21

ug/l

57.46

24972

131697

Asthma, excluding more controls

25836

97883

1.75

307.65

3.6

2.8

105.12

101.37

ug/l

1.60

24588

92187

Anxiety disorders, excluding more controls

29317

137350

1.83

307.65

3.7

3.0

103.56

116.79

ug/l

10.49

27584

129816

Other diseases of upper respiratory tract

35674

156127

1.37

307.65

3.4

3.1

114.22

121.07

ug/l

4.19

33472

146285

Diseases of the digestive system

14645

100351

2.05

307.65

4.7

3.1

127.28

135.38

ug/l

2.80

13744

92971

Intestinal infectious diseases

31722

191311

1.48

307.65

4.1

3.1

128.00

114.19

ug/l

11.93

30003

179611

Disorders of the thyroid gland

33292

165837

1.68

307.65

3.8

3.1

104.99

116.90

ug/l

17.35

31250

155933

Autoimmune diseases excluding thyroid diseases, strict definition

34875

147774

1.58

307.65

3.9

2.9

130.32

115.79

ug/l

13.01

33080

138913

Other diseases of urinary system

34187

148589

1.62

307.65

3.6

3.1

111.90

118.44

ug/l

4.52

32094

139652

Other septicaemia, including avohilmo

11834

75237

2.06

307.65

5.3

2.9

214.95

128.21

ug/l

70.35

11087

69167

Abnormal findings on examination of blood, without diagnosis

13689

90603

1.80

307.65

4.0

3.1

175.12

144.87

ug/l

16.59

13007

84045

Spondylopathies

24304

111014

1.58

307.65

3.5

3.0

130.84

131.41

ug/l

0.10

22624

103905

Dorsopathies

34830

144392

1.44

307.65

3.5

3.1

112.16

114.03

ug/l

0.59

32832

135964

Triptan medication for migraine, min. 3 purchases

20279

121581

1.63

307.65

3.6

3.2

73.21

88.59

ug/l

44.08

19544

115686

Provisional assignment of new diseases of uncertain etiology

19022

134942

2.05

307.65

4.3

3.2

153.63

111.56

ug/l

64.04

18145

126439

Codes for special purposes

19041

135056

2.05

307.65

4.3

3.2

153.57

111.56

ug/l

63.96

18160

126549

Transplanted organ and tissue status

3262

16428

5.16

307.65

10.2

2.8

272.95

133.16

ug/l

50.93

3217

15506

Disorders of thyroid, IBD co-morbidities

6321

28280

2.24

307.65

3.9

2.7

98.29

89.54

ug/l

2.99

5960

27014

Other functional intestinal disorders

15189

96749

1.95

307.65

3.9

2.9

124.46

122.63

ug/l

0.27

14153

90033

Depression medications

11478

35178

2.51

307.65

3.5

2.5

89.98

72.12

ug/l

19.96

10935

33837

Restless leg syndrome

5237

29131

4.87

307.65

4.2

3.2

99.01

118.43

ug/l

10.43

4853

27287

Sleep apnoea, including avohilmo

33707

153814

1.72

307.65

3.6

3.1

124.56

123.45

ug/l

0.32

31303

144935

Extrapyramidal and movement disorders

11462

82793

1.89

307.65

3.7

3.2

116.71

137.56

ug/l

17.14

10537

76653

Asthma, unspecified (mode), excluding more controls

17778

91896

1.83

307.65

3.8

2.8

114.12

102.39

ug/l

6.87

16817

86429

Other systemic involvement of connective tissue (FG)

8096

54846

2.11

307.65

3.9

3.0

124.26

116.00

ug/l

1.39

7581

50900

Liquid cancers, including Hilmo

9963

63031

1.83

307.65

4.0

3.1

287.70

125.87

ug/l

57.17

9424

58230

Complications of procedures, not elsewhere classified

27182

169711

1.64

307.65

4.1

3.1

126.92

117.74

ug/l

5.78

25614

159214

Mycoses, including avohilmo

30505

191894

1.44

307.65

3.5

3.2

111.10

116.79

ug/l

3.00

28598

180617

Other septicaemia

11555

73703

2.07

307.65

5.3

2.9

216.68

128.23

ug/l

70.26

10820

67738

First line medication for Crohn's disease

39544

162552

1.66

307.65

4.0

2.9

146.52

103.30

ug/l

68.64

37529

152577

Hernia of abdominal wall, postoperative

5797

33858

2.66

307.65

4.5

2.5

134.92

117.19

ug/l

5.71

5448

31659

Syncope and collapse

13932

85068

1.75

307.65

3.7

2.9

134.62

118.94

ug/l

8.17

12829

79008

Obesity related asthma

11105

78194

2.07

307.65

4.1

3.1

113.07

127.95

ug/l

9.54

10499

73358

Pain in joint

21229

88533

2.06

307.65

3.7

2.8

107.27

121.33

ug/l

10.87

20016

83259

Asthma, unspecified (mode)

18317

97494

1.76

307.65

3.7

2.8

114.81

105.40

ug/l

4.80

17300

91602

Pain in throat and chest

29523

131586

1.68

307.65

3.6

2.9

118.56

111.87

ug/l

4.32

27668

124233

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

12719

43641

1.88

307.65

3.3

2.6

112.74

94.12

ug/l

10.85

12047

41472

Headache

24356

135813

1.89

307.65

3.8

2.9

95.46

101.89

ug/l

5.04

23059

128010

Symptoms and signs involving the circulatory and respiratory systems

35964

136499

1.67

307.65

3.7

3.0

112.52

109.53

ug/l

1.21

33974

128927

Haemorrhage from respiratory passages

10350

60480

2.08

307.65

4.2

2.9

146.27

146.35

ug/l

0.01

9592

55855

Symptoms and signs involving cognition, perception, emotional state and behaviour

31664

172638

1.46

307.65

3.6

3.1

120.16

118.94

ug/l

0.32

29561

162367

Pain, not elsewhere classified

9376

65699

2.03

307.65

4.0

2.9

113.36

104.39

ug/l

2.88

8878

61726

Abnormalities of heart beat

11973

80965

2.00

307.65

3.9

2.9

113.30

116.95

ug/l

1.00

11169

75744

Nausea and vomiting

8726

60135

1.95

307.65

4.7

3.0

132.27

112.72

ug/l

8.80

8176

56030

Abdominal and pelvic pain

33673

131759

1.56

307.65

3.6

2.9

120.20

119.94

ug/l

0.06

31633

123829

Depression or dysthymia

23101

82092

2.16

307.65

3.5

2.9

115.37

134.94

ug/l

16.58

21476

77317

L04AD Calcineurin inhibitors

3610

19960

4.45

307.65

9.6

3.0

228.95

121.98

ug/l

64.12

3561

18918

Migraine

19485

110836

1.98

307.65

3.8

3.1

76.99

92.89

ug/l

28.06

18683

105334

Oxycodone

11346

68274

1.85

307.65

4.0

2.8

245.83

139.13

ug/l

63.41

10508

63162

Diseases of arteries, arterioles and capillaries (FINNGEN)

6702

28205

2.32

307.65

4.8

2.4

160.00

136.61

ug/l

8.99

6313

26261

Other headache syndromes

14035

105065

1.79

307.65

3.7

3.0

95.86

107.07

ug/l

7.93

13270

99222

Selective serotonin reuptake inhibitors

34630

134137

1.70

307.65

3.4

3.0

110.30

124.46

ug/l

17.15

32280

126438

L04AA Selective immunosuppressants

6923

47316

2.30

307.65

6.4

3.1

167.04

117.14

ug/l

37.18

6698

44569

Budesonide

4982

30273

3.17

307.65

5.0

3.0

102.35

107.91

ug/l

0.83

4807

28492

Implicit Sepsis, including avohilmo

27225

144448

1.74

307.65

4.3

2.9

157.85

116.47

ug/l

64.55

25434

135117

Other disorders of skin and subcutaneous tissue

22896

151901

1.58

307.65

4.1

3.1

130.24

125.20

ug/l

1.95

21361

141871

Iron deficiency anaemia secondary to blood loss (chronic)

5264

29872

3.35

307.65

6.8

2.8

123.64

134.71

ug/l

1.94

4985

27500

Iron deficiency anaemia

18299

94948

4.88

307.65

6.5

2.9

96.90

125.93

ug/l

42.00

17350

87926

Other and unspecified anaemias

17192

81075

4.79

307.65

5.9

2.8

194.08

136.11

ug/l

38.22

16321

74215

Bleeding

24602

135810

1.53

307.65

4.3

3.0

145.70

133.04

ug/l

6.94

22902

126533

Azathioprine

4862

30455

2.79

307.65

5.7

3.0

127.40

107.39

ug/l

5.47

4732

28729

Parasetamol

26103

94984

1.78

307.65

3.5

2.8

116.34

108.45

ug/l

4.75

24653

90101

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

13026

65100

2.03

307.65

4.3

3.3

51.36

59.12

ug/l

18.93

12503

62797

Other arthrosis

15380

78375

1.62

307.65

3.4

2.9

123.91

138.83

ug/l

9.82

14344

73272

Tramadol

27163

118096

1.82

307.65

4.0

2.9

131.54

113.38

ug/l

18.62

25398

111158

Codeine

33684

135739

1.75

307.65

3.7

3.0

117.57

104.97

ug/l

14.16

31689

128079

Oral corticosteroids

37411

166391

1.69

307.65

3.9

3.0

142.10

112.35

ug/l

32.45

35335

156107

Gout

7854

41161

2.37

307.65

5.1

2.9

210.07

172.73

ug/l

11.63

7406

37732

Oedema, not elsewhere classified

10552

68299

2.21

307.65

4.2

2.9

140.77

120.37

ug/l

11.84

9835

63347

Second line medication for Crohn's disease

18533

141770

1.71

307.65

4.1

3.1

134.23

116.12

ug/l

13.48

17706

133231

Benzodiazepine use

33604

185523

1.46

307.65

3.6

3.1

118.63

117.40

ug/l

0.29

30974

174937

Sleep disorders (combined)

40480

153197

1.86

307.65

3.5

3.1

111.62

118.88

ug/l

6.51

37894

143974

Dizziness and giddiness

23835

148249

1.52

307.65

3.6

3.1

119.57

123.16

ug/l

1.29

22212

138896

Cough

12922

89165

1.76

307.65

3.7

2.9

119.44

119.13

ug/l

0.04

12082

83557

5-aminosalicylic acid

7202

46376

2.55

307.65

4.4

3.0

99.66

110.67

ug/l

2.72

6943

43799

Type 2 diabetes, wide definition

23246

114112

1.56

307.65

4.3

2.8

139.22

135.83

ug/l

0.97

21752

106541

Anxiety (asthma-related co-morbidities)

22905

124112

2.02

307.65

3.8

3.0

86.84

104.84

ug/l

26.63

21625

118207

Kidney transplant status

1789

8429

8.32

307.65

13.3

2.9

259.86

135.69

ug/l

54.02

1779

7951

Other pulmonary diagnosis

26455

104598

1.53

307.65

3.5

2.8

125.35

104.34

ug/l

12.92

24941

98420

Benign neoplasm: Colon

16108

106667

1.94

307.65

4.2

3.0

130.43

150.04

ug/l

14.72

15069

98279

Benign neoplasm of colon, rectum, anus and anal canal

19342

115846

1.91

307.65

4.1

3.0

130.85

146.81

ug/l

10.80

18106

106949

Hypo-osmolality and hyponatraemia

5095

31355

2.47

307.65

4.3

2.9

184.55

142.79

ug/l

7.96

4670

28621

Disorders of lipoprotein metabolism and other lipidaemias

25083

116077

1.62

307.65

3.7

2.8

139.25

132.93

ug/l

3.12

23551

108141

Obesity due to excess calories

16639

123864

1.91

307.65

4.4

3.1

109.71

107.02

ug/l

0.84

15735

117319

COPD/asthma related infections

33670

140699

1.40

307.65

3.7

3.0

129.85

104.15

ug/l

25.72

31678

132245

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

29330

140699

1.44

307.65

4.0

3.0

158.87

104.15

ug/l

75.47

27629

132245

Pacemaker

10350

63834

2.16

307.65

4.3

3.1

150.05

159.13

ug/l

3.13

9633

58160

Obesity, other/unspecified

11907

85859

2.09

307.65

4.7

3.1

96.06

101.56

ug/l

2.08

11399

81519

Recurrent or chronic depression

15502

62108

2.96

307.65

3.7

2.9

91.80

117.51

ug/l

30.49

14659

59073

Polyarthrosis

5779

34276

2.15

307.40

3.6

2.9

122.96

140.67

ug/l

5.75

5335

31517

Finngen Rheumatological endpoints

31533

150069

1.38

307.04

3.6

3.1

125.45

109.62

ug/l

18.58

29813

141534

Mucosal proctocolitis

4148

26219

2.82

305.67

4.7

3.1

94.95

113.18

ug/l

5.23

4019

24854

Other symptoms and signs involving cognitive functions and awareness

13331

90310

1.62

305.06

3.5

3.1

123.11

144.09

ug/l

21.13

12337

83422

Cardiovascular diseases (excluding rheumatic etc)

22014

102406

1.49

304.50

4.0

2.9

112.07

84.59

ug/l

48.85

21115

97688

Ulcerative colitis (strict definition, require KELA)

5298

35436

2.42

302.23

4.5

3.1

94.73

113.72

ug/l

7.82

5120

33605

Gout, unspecified

5397

35410

2.21

301.29

5.2

3.0

202.88

170.26

ug/l

9.76

5073

32418

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

5156

34374

2.45

299.69

4.5

3.1

94.42

113.45

ug/l

7.64

4985

32611

14472

112537

1.62

299.66

4.0

3.2

104.19

111.54

ug/l

2.41

13718

105820

Symptoms and signs involving the nervous and musculoskeletal systems

17729

142245

1.53

299.26

3.6

3.2

119.23

122.46

ug/l

0.81

16721

132915

Diseases of arteries, arterioles and capillaries

18041

104941

1.50

298.92

4.6

3.0

153.29

146.43

ug/l

2.41

16825

96819

Gastroduodenal ulcer

6843

46591

1.93

298.28

4.7

2.9

144.57

161.96

ug/l

3.63

6386

42684

Chronic lower respiratory diseases

39565

178536

1.33

297.45

3.6

3.1

111.12

116.74

ug/l

3.61

37416

167791

Asthma, hospital admissions , main diagnosis only

26429

191732

1.41

297.14

3.6

3.2

104.03

115.15

ug/l

10.28

25047

180055

Dental caries, including avohilmo

22471

93080

1.45

295.15

3.3

3.0

129.82

130.31

ug/l

0.08

20827

87332

Hypertensive Heart Disease

6006

29864

2.00

293.76

4.4

2.6

166.43

169.03

ug/l

0.21

5535

26964

Pneumonia, organism unspecified

28878

165916

1.39

292.85

4.1

3.0

165.37

108.35

ug/l

102.03

27102

155923

Conjunctivitis

25223

169366

1.43

290.21

3.5

3.2

96.72

107.12

ug/l

11.28

23923

159746

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

19056

133595

1.48

289.31

3.8

3.1

158.67

132.67

ug/l

15.62

17717

124169

Atopic dermatitis

20379

132809

1.50

289.27

3.5

3.1

85.31

100.27

ug/l

29.52

19389

126125

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

2767

10127

2.79

289.04

3.8

2.4

193.34

150.91

ug/l

6.11

2574

9494

Dermatitis

19609

156008

1.49

289.04

3.8

3.1

131.78

118.72

ug/l

5.99

18399

146234

Paralytic ileus and intestinal obstruction

7060

48952

1.90

287.84

4.3

2.8

142.37

148.40

ug/l

0.75

6594

45026

Urinary track infection

21577

89027

1.52

286.17

3.7

3.1

83.37

77.32

ug/l

4.45

20511

84142

Diseases of pulp and periapical tissues and dental caries

20286

83430

1.47

286.10

3.3

3.0

127.45

129.01

ug/l

0.31

18809

78238

Other cataract

11749

65580

1.63

285.77

3.9

2.9

145.84

148.94

ug/l

0.59

10759

61045

Haemorrhoids and perianal venous thrombosis

9746

71385

1.72

284.97

3.7

2.9

111.95

137.06

ug/l

25.38

9071

66065

Chronic rhinitis, nasopharyngitis and pharyngitis

10168

76665

1.77

283.49

3.7

3.1

103.56

115.17

ug/l

5.67

9609

72314

Other medical care

13879

90401

1.58

283.30

3.5

2.9

243.40

123.87

ug/l

108.45

13011

83368

Pain and other conditions associated with female genital organs and menstrual cycle

7812

48168

2.10

283.17

3.9

3.1

66.24

71.79

ug/l

3.22

7427

45771

Unspecified haematuria

11368

69563

1.65

282.98

3.9

3.1

156.92

154.06

ug/l

0.41

10452

64466

Other noninfective gastroenteritis and colitis

7509

53900

1.95

281.32

4.5

3.1

125.77

115.04

ug/l

2.25

7113

50403

Other disorders of lacrimal gland

11197

85893

1.71

279.72

3.8

3.1

110.26

116.96

ug/l

2.64

10444

80259

Influenza and pneumonia

34283

180524

1.34

279.55

4.0

3.0

160.72

103.78

ug/l

87.45

32322

169942

Pneumonias (Asthma/COPD co-morbidities)

32411

179965

1.35

278.09

4.0

3.0

166.74

105.32

ug/l

92.66

30550

169339

Other and unspecified dermatitis

16391

131535

1.53

277.28

3.8

3.1

131.63

117.10

ug/l

5.82

15412

123319

Caries of dentine, including avohilmo

24460

102880

1.41

277.05

3.4

3.0

126.31

127.01

ug/l

0.13

22691

96743

Myalgia

7858

57364

1.93

276.01

3.9

3.1

102.31

107.03

ug/l

0.78

7350

54149

Concussion

16350

100617

1.51

275.15

3.4

3.0

115.81

108.39

ug/l

2.84

15202

95435

Functional dyspepsia

8202

60012

1.87

275.05

3.9

2.9

107.64

117.89

ug/l

3.87

7684

56196

Other/unspecified dorsalgia

11561

87414

1.65

274.90

3.7

3.1

112.73

117.93

ug/l

0.92

10784

81934

Gastric ulcer

4735

30576

2.19

273.70

4.8

2.9

137.03

158.33

ug/l

4.36

4426

28037

All pneumoniae

32571

180266

1.35

272.60

4.0

3.0

166.42

105.39

ug/l

92.20

30711

169630

Gonarthrosis

18280

82273

1.47

272.32

3.3

2.9

134.19

136.48

ug/l

0.49

17053

76940

Ischaemic heart disease, wide definition

20191

100548

1.44

270.73

3.9

2.9

147.07

147.36

ug/l

0.04

18825

93180

Other systemic involvement of connective tissue

8228

60690

1.88

270.00

3.9

3.2

124.57

115.63

ug/l

1.73

7707

56385

Disorders of lacrimal system

13438

104113

1.61

269.13

3.7

3.1

109.67

116.93

ug/l

3.67

12533

97274

Nonorganic sleeping disorders

7256

53065

2.04

268.81

4.0

3.2

88.76

98.83

ug/l

7.02

6915

50362

Other bacterial intestinal infections, including avohilmo

7049

50343

1.94

268.54

4.6

3.0

151.52

123.01

ug/l

8.32

6677

46862

Valvular operations

3589

21579

2.41

268.36

4.0

2.7

149.65

167.12

ug/l

3.15

3361

19716

Disorders of gallbladder, biliary tract and pancreas

30461

160612

1.35

267.44

3.8

3.1

137.04

120.84

ug/l

16.44

28490

150673

Asthma-related pneumonia

10598

80113

1.67

265.84

4.1

3.1

130.75

132.08

ug/l

0.15

10063

74048

Asthma, hospital admissions 3, pneumonia

10619

80314

1.67

265.38

4.1

3.1

130.65

132.01

ug/l

0.15

10083

74238

Asthma-related pneumonia or sepsis

10619

80314

1.67

265.38

4.1

3.1

130.65

132.01

ug/l

0.15

10083

74238

Rotator cuff syndrome

17772

98244

1.47

264.21

3.4

3.0

129.65

137.87

ug/l

2.94

16661

91879

Angina pectoris

14045

72323

1.54

263.28

3.8

2.8

141.07

158.28

ug/l

9.15

13092

66297

Coxarthrosis

13632

67892

1.54

262.33

3.3

2.9

141.02

147.33

ug/l

1.73

12569

63030

Ulcerative colitis, NAS

4333

28564

2.47

262.22

4.8

3.1

101.76

114.57

ug/l

2.70

4175

26990

Special screening examination for infectious and parasitic diseases

8847

47673

1.79

261.17

3.3

2.8

82.68

97.14

ug/l

9.99

8397

45615

Hypotension

4818

31867

2.19

261.02

4.1

3.1

156.34

151.14

ug/l

0.59

4354

28996

Disorders of lens

17779

88222

1.46

260.19

3.9

2.9

151.39

144.38

ug/l

2.38

16436

82666

Other specified/unspecified arthritis

8069

59114

1.82

260.12

3.8

3.0

141.00

122.71

ug/l

4.99

7613

55405

Malignant neoplasm of colon, including Hilmo

4942

32612

2.13

260.03

3.4

3.1

115.62

134.40

ug/l

6.53

4634

29915

Gonarthrosis [arthrosis of knee](FG)

21391

100410

1.42

259.93

3.3

2.9

134.84

134.03

ug/l

0.15

19903

93797

Excessive, frequent and irregular menstruation

13300

56040

1.66

259.84

4.0

3.1

73.99

78.95

ug/l

2.55

12581

52846

Colorectal cancer, including Hilmo

7036

46413

1.86

259.72

3.3

3.1

127.37

134.65

ug/l

1.12

6559

42587

Symptoms and signs concerning food and fluid intake

3337

20423

2.72

259.25

4.1

2.9

132.71

114.53

ug/l

4.94

3099

18947

Nonalcoholic fatty liver disease

3128

19207

3.05

258.97

4.1

3.1

165.67

122.46

ug/l

18.36

2970

18188

Other CVD

5503

37535

2.06

257.37

4.1

3.1

155.62

150.06

ug/l

0.66

4988

34314

Osteoporosis

7263

47971

1.87

256.88

4.1

3.0

137.70

130.63

ug/l

1.06

6642

43796

Diseases of the respiratory system

21078

86273

1.43

256.79

3.4

2.8

117.68

103.03

ug/l

12.00

19826

80957

Lumbar disc prolapse

19504

118027

1.45

256.47

3.4

3.0

116.97

124.65

ug/l

4.25

18447

111024

Temporomandibular joint disorders, including avohilmo

15648

123627

1.58

255.48

3.6

3.2

81.27

89.42

ug/l

4.91

14903

117437

Insulin medication

17207

115013

1.47

255.26

4.7

3.0

140.75

134.74

ug/l

1.82

16057

107466

Coxibs

8520

32068

1.74

254.67

3.2

3.3

120.22

126.37

ug/l

1.12

7964

30014

Disease of hard tissues of teeth, NOS

15961

66128

1.51

254.63

3.3

2.9

119.31

134.15

ug/l

6.95

14785

61989

Other external causes of accidental injury

26645

111722

1.37

254.49

3.4

3.1

116.63

112.41

ug/l

1.44

24913

105805

Other retinal disorders

17765

109001

1.46

252.99

4.0

3.1

144.63

141.27

ug/l

0.84

16157

101031

Gingivitis and periodontal diseases

31322

137608

1.34

252.67

3.4

3.1

119.68

122.80

ug/l

1.19

29215

129441

Personality disorders, excluding more controls

8418

62877

1.82

251.64

3.9

3.0

90.00

96.30

ug/l

1.45

7864

60210

Senile cataract

15891

76446

1.48

251.60

3.8

2.9

153.94

151.07

ug/l

0.54

14590

71273

Coxarthrosis [arthrosis of hip](FG)

14829

80258

1.50

250.92

3.3

2.9

140.60

144.42

ug/l

0.91

13660

74319

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

31430

179012

1.34

250.64

4.0

3.0

163.95

107.56

ug/l

75.58

29582

168426

Other arthritis (FG)

9193

69172

1.72

250.21

3.8

3.0

139.65

120.71

ug/l

6.40

8686

64757

Diseases of the ear and mastoid process

37568

162769

1.30

246.82

3.4

3.1

112.73

114.75

ug/l

0.69

35171

153868

Arthrosis

20916

93732

1.41

246.80

3.3

2.9

129.81

129.16

ug/l

0.13

19608

88014

Falls/tendency to fall

35162

151541

1.31

245.75

3.4

3.1

118.09

111.86

ug/l

3.51

32954

143442

Caries of enamel

30507

170907

1.34

245.30

3.5

3.1

97.96

119.20

ug/l

48.58

28823

161151

Chronic sinusitis

12978

102610

1.57

244.62

3.6

3.1

110.38

118.57

ug/l

3.28

12225

96580

Paroxysmal tachycardia

6521

38231

1.88

243.97

4.0

2.7

123.34

107.84

ug/l

6.15

6169

35907

Missing teeth due to accident, extraction or parodontitis

17305

125940

1.46

242.46

3.7

3.1

134.09

138.17

ug/l

0.97

15669

117421

Myocardial infarction, without ST-elevation

10000

68161

1.62

240.57

4.2

3.1

158.91

165.74

ug/l

1.42

9228

62200

Irregular menses

17422

108844

1.55

240.00

3.9

3.2

70.92

76.71

ug/l

5.56

16624

103577

Fibrosis and cirrhosis of liver

2276

12948

3.50

239.77

5.3

3.1

177.73

137.80

ug/l

6.46

2198

12025

Neoplasms

25687

113405

1.37

236.52

3.5

3.0

121.51

94.77

ug/l

27.44

24466

107564

Polyneuropathies and other disorders of the peripheral nervous system

5758

40396

1.97

236.39

4.5

3.1

164.25

151.92

ug/l

1.24

5385

37372

Vascular disorders of the intestines

1953

10335

3.39

234.25

7.2

2.8

126.76

156.45

ug/l

3.73

1864

9386

Visual disturbances and blindness

15724

127821

1.49

234.16

3.7

3.2

114.88

120.94

ug/l

2.17

14659

119449

Fall on same level

37274

172570

1.29

233.03

3.5

3.1

123.54

112.45

ug/l

11.90

34765

163162

Intracranial trauma

18529

102343

1.43

232.93

3.4

3.0

121.82

107.48

ug/l

9.03

17240

97096

Hernia

28005

158211

1.34

232.84

3.8

3.0

126.87

124.25

ug/l

0.72

26238

148453

Accidents

26450

111722

1.36

232.34

3.4

3.1

116.68

112.41

ug/l

1.44

24764

105805

Type 2 diabetes

30635

151883

1.32

231.83

3.9

3.0

130.04

116.97

ug/l

12.84

28681

142991

Fibromyalgia

3228

20899

2.98

231.12

4.2

3.0

81.49

87.77

ug/l

2.13

3059

19818

Retention of urine

8951

53990

1.66

231.08

3.8

3.1

160.07

159.51

ug/l

0.05

8183

49839

Other Crohn's disease

2309

13618

3.73

230.87

5.6

3.0

102.90

108.08

ug/l

0.51

2256

12942

Migraine with aura

8847

68346

1.80

229.19

3.8

3.1

74.01

81.88

ug/l

7.10

8486

65171

Candidiasis, including avohilmo

9795

76463

1.72

229.05

4.0

3.2

109.23

102.07

ug/l

1.11

9158

71968

Other and unspecified polyneuropathies, also in other diseases

5027

34577

2.05

229.00

4.6

3.1

156.97

154.79

ug/l

0.21

4709

31942

Disorders of choroid and retina

22679

132623

1.37

228.55

3.9

3.0

141.88

136.42

ug/l

2.28

20755

123642

Malignant neoplasm of digestive organs, including Hilmo

11135

63057

1.57

228.37

3.4

3.1

149.92

132.37

ug/l

5.82

10402

58134

Ulcerative colitis (strict definition, all Crohn cases excluded)

4372

29759

2.28

227.06

4.2

3.1

93.76

114.03

ug/l

7.47

4221

28190

Polyuria

6086

43460

1.90

226.21

3.7

3.1

133.26

147.43

ug/l

2.56

5604

40339

Colorectal cancer

6203

42222

1.84

225.61

3.3

3.1

126.93

136.05

ug/l

1.38

5785

38712

Female infertility, cervical, vaginal, other or unspecified origin

9088

44820

1.80

225.52

3.7

3.1

66.95

77.27

ug/l

6.63

8722

42535

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

15310

119807

1.47

223.50

3.5

3.1

123.91

127.85

ug/l

0.68

14390

112688

Generalized anxiety disorder

6019

44288

2.09

222.96

4.0

3.2

73.02

79.18

ug/l

2.58

5690

42356

Female infertility

9863

46106

1.75

222.82

3.7

3.1

67.73

76.58

ug/l

5.59

9452

43753

Malignant neoplasm of colon

4057

26646

2.17

222.52

3.4

3.1

112.62

134.25

ug/l

7.07

3800

24441

All influenza

7478

55329

1.75

222.02

4.4

3.0

144.82

121.20

ug/l

7.90

6984

51557

Insulin, combination of fast acting with intermediate-acting or long-acting

17232

128032

1.43

221.63

4.7

3.0

140.67

136.32

ug/l

1.14

16077

119275

Vocal cord dysfunction

4045

23132

2.13

221.62

3.7

2.5

119.08

109.09

ug/l

1.27

3784

22033

Other diseases of blood and blood-forming organs, wide

6102

44116

1.92

220.91

4.6

3.1

249.84

128.11

ug/l

27.34

5757

41138

Disorders resulting from impaired renal tubular function

1193

5690

7.66

219.87

14.1

3.1

279.32

142.66

ug/l

37.57

1177

5303

Disorders of mineral metabolism

2533

15155

2.96

219.34

7.1

2.9

234.86

127.54

ug/l

20.82

2406

14075

STROKE

14829

79958

1.46

219.15

3.7

2.7

143.38

135.48

ug/l

1.07

13845

74590

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

3795

24789

2.26

219.01

4.8

3.1

233.63

161.90

ug/l

14.33

3602

23057

Visual disturbances

14576

118677

1.50

218.10

3.7

3.2

112.66

119.90

ug/l

2.75

13653

111073

Nonischemic cardiomyopathy

2656

15812

2.67

217.97

4.2

2.9

188.48

160.03

ug/l

1.86

2520

14543

Cardiodefibrillation

8584

64671

1.66

217.45

3.8

3.1

162.93

167.24

ug/l

0.59

7918

59243

Degeneration of macula and posterior pole

12294

74591

1.52

217.36

3.5

3.1

142.04

154.90

ug/l

5.27

11049

68141

Hyperkalaemia

1700

8850

3.59

216.17

7.2

2.9

217.50

156.04

ug/l

10.23

1615

8074

Intestinal stricture

8221

61949

1.69

215.46

4.4

3.1

142.88

143.07

ug/l

0.02

7706

57202

Diabetes mellitus

32247

161094

1.30

214.82

4.0

3.0

128.52

113.63

ug/l

16.09

30223

151860

Viral pneumonia

3812

25216

2.28

214.24

4.6

3.0

237.57

120.65

ug/l

12.28

3634

23522

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

13511

67964

1.51

214.12

3.7

2.7

124.68

97.35

ug/l

25.73

12872

64640

Menorrhagia

10708

46830

1.65

213.09

4.0

3.1

82.45

86.89

ug/l

1.44

10050

44096

Other bacterial intestinal infections

5134

36003

1.98

212.46

5.0

3.0

172.74

127.96

ug/l

11.83

4852

33379

Other reaction to severe stress, and adjustment disorders

11999

96367

1.57

211.69

4.0

3.1

108.96

95.13

ug/l

3.89

11332

91913

Diabetes, varying definitions

32028

160828

1.30

209.88

4.0

3.0

128.90

113.78

ug/l

16.43

30014

151598

Reimbursement for rheumatic diseases

16661

136924

1.44

209.82

3.7

3.2

130.20

117.42

ug/l

7.24

15783

128123

Oter anti-inflammatory and antirheumatic agents, non-steroids

5754

21730

1.81

209.18

3.3

3.4

138.50

158.66

ug/l

4.11

5315

20152

Soft tissue disorders related to use, overuse and pressure

7672

57446

1.70

208.77

3.6

2.9

121.47

135.86

ug/l

5.59

7192

53631

Disturbances of skin sensation

8758

68050

1.72

208.20

3.7

3.2

99.02

104.30

ug/l

1.57

8299

64448

Major coronary heart disease event excluding revascularizations

14654

77539

1.44

207.86

4.0

2.8

153.82

158.71

ug/l

1.09

13618

71115

Benign neoplasm: Colon, unspecified

6452

47194

1.80

206.82

4.3

3.1

138.57

154.36

ug/l

3.89

5926

43497

Type 2 diabetes, definitions combined

28861

144360

1.31

206.61

3.7

2.9

128.79

119.68

ug/l

6.04

26990

135737

Crohn's disease of small intestine

2255

13640

3.43

205.52

5.8

3.1

100.33

108.33

ug/l

0.92

2202

12925

Type 2 diabetes, strict (exclude DM1)

28941

144872

1.31

205.23

3.7

2.9

128.79

120.24

ug/l

5.39

27062

136220

Artrosis, including avohilmo

24630

114179

1.34

204.77

3.3

3.1

125.30

128.62

ug/l

1.17

23156

107671

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

28784

156619

1.31

204.72

3.6

3.1

132.53

125.17

ug/l

4.20

26933

147019

Rheumatoid arthritis

8884

60176

1.62

202.81

3.5

2.9

133.93

127.64

ug/l

1.29

8361

56020

Paracetamol or NSAID medication

5271

17892

1.83

202.62

3.2

3.0

112.70

104.35

ug/l

0.95

4946

16835

Chronic diseases of tonsils and adenoids

24773

133462

1.34

202.24

3.3

3.1

96.76

113.66

ug/l

24.21

23625

126012

Myocardial infarction

11675

63960

1.50

202.13

4.1

2.8

159.21

164.18

ug/l

0.89

10827

58522

Undetermined asthma, excluding more controls

3905

26149

2.16

201.55

3.8

2.7

111.86

105.55

ug/l

0.98

3692

24416

Infections of the skin and subcutaneous tissue

17848

146557

1.41

201.41

4.1

3.1

132.68

118.97

ug/l

8.05

16880

138109

Hyperkinetic disorders, excluding more controls

4849

32525

2.17

201.16

4.0

3.2

65.31

65.27

ug/l

0.01

4646

31372

Colorectal adenocarcinoma

5122

35388

1.88

201.02

3.2

3.1

128.00

139.23

ug/l

1.49

4767

32452

Benign neoplasm of other and ill-defined parts of digestive system

4833

34152

2.03

200.76

4.8

3.1

108.90

134.42

ug/l

14.16

4558

31677

4579

32389

2.15

200.17

4.6

3.0

107.57

96.22

ug/l

1.11

4347

30676

Colon adenocarcinoma

3197

20389

2.30

199.44

3.4

3.1

110.77

136.54

ug/l

7.14

2990

18625

Migraine without aura

7290

56150

1.85

198.97

4.0

3.1

71.12

75.54

ug/l

1.62

7049

53776

Insulin, fast-acting

10057

78967

1.58

198.43

5.1

3.1

140.95

131.62

ug/l

2.55

9424

73901

Cerebrovascular diseases (FINNGEN)

8276

43602

1.62

196.69

3.8

2.5

152.98

116.26

ug/l

5.64

7814

41072

Other or unspecified ileus, impaction or obstruction

4763

32908

1.90

196.40

4.4

2.8

148.74

152.62

ug/l

0.35

4447

30238

Iron deficiency

1381

8030

30.96

196.17

9.4

3.3

47.35

62.55

ug/l

7.47

1363

7649

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

17836

143686

1.42

196.02

3.5

3.2

92.63

99.18

ug/l

3.82

16950

135792

Disorders of synovium and tendon

16453

115639

1.42

194.25

3.5

3.0

111.99

118.05

ug/l

2.32

15440

109011

Diseases of pulp and periapical tissues, including avohilmo

33672

152169

1.28

194.07

3.4

3.1

115.19

115.18

ug/l

0.00

31369

143430

Noninflammatory disorders of female genital tract

13719

56216

1.53

193.96

3.5

3.1

70.89

78.84

ug/l

7.50

12988

53013

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

2231

13729

3.38

193.91

5.3

3.2

97.96

104.75

ug/l

0.84

2176

13041

Laparoscopic right hemicolectomy

1642

9105

4.04

193.57

3.7

3.1

86.64

148.72

ug/l

21.98

1534

8344

Crohn disease (strict definition, require KELA, min 2 HDR)

2090

12677

3.59

193.15

5.4

3.2

98.13

103.78

ug/l

0.61

2044

12043

Cirrhosis of liver, NAS

1573

8532

3.98

192.75

5.7

3.1

195.21

151.61

ug/l

4.68

1527

7892

Crohn disease (strict definition, require KELA)

2112

12849

3.54

192.54

5.4

3.2

97.81

104.07

ug/l

0.70

2064

12206

Oxicams

6412

26077

1.72

192.33

3.2

3.4

133.18

142.49

ug/l

1.26

5971

24297

Deforming dorsopathies

8143

62541

1.66

192.12

3.6

3.0

104.45

117.41

ug/l

6.26

7659

58539

Injuries to the head

35766

186536

1.27

191.10

3.4

3.2

125.21

114.01

ug/l

10.48

33172

175875

Dilated cardiomyopathy

2955

18855

2.39

190.39

4.5

3.1

183.20

169.80

ug/l

0.69

2841

17431

Other menopausal disorders

7707

32550

1.72

189.46

3.3

3.0

84.72

101.21

ug/l

13.12

7267

30598

Bacterial intestinal infections, IBD co-morbidities

5097

36504

1.91

189.22

5.0

3.1

172.70

130.27

ug/l

10.73

4810

33855

Other disorders of kidney and ureter

3481

23255

2.26

189.02

7.8

3.0

196.79

142.62

ug/l

22.37

3331

21620

Vitamin B12 deficiency anaemia

2723

16899

2.41

188.85

5.1

2.8

128.50

144.71

ug/l

1.29

2559

15443

Volume depletion

2609

15979

2.44

188.63

4.8

2.9

190.99

143.03

ug/l

10.10

2401

14576

Type 2 diabetes, definitions combined, including avohilmo

28916

144751

1.29

188.26

3.7

2.9

128.80

119.03

ug/l

6.92

27052

136226

Gonarthrosis,primary

24356

125374

1.32

186.91

3.3

3.1

136.18

141.59

ug/l

2.27

22519

116913

10387

73720

1.53

186.77

3.5

3.1

146.91

151.67

ug/l

0.69

9473

67188

Sequelae of external causes of morbidity and mortality

7131

54117

1.72

186.66

4.2

3.1

145.62

129.37

ug/l

3.44

6689

50396

Other disorders of veins

11814

94018

1.51

186.64

3.5

3.1

111.73

120.09

ug/l

3.80

10954

87953

Allergic conjunctivitis

18514

150999

1.40

186.61

3.5

3.2

92.67

99.10

ug/l

3.89

17589

142721

Injuries to the abdomen, lower back, lumbar spine and pelvis

11889

94533

1.50

186.56

3.7

3.2

128.13

123.60

ug/l

0.76

10988

88172

Intracranial injury

17653

137690

1.38

186.48

3.5

3.2

122.38

121.85

ug/l

0.08

16293

129156

Acetic acid derivatives and related substances

8116

31388

1.61

184.60

3.3

117.62

127.74

ug/l

2.46

7544

29355

Crohn's disease NAS

2029

12217

3.32

184.20

5.8

3.1

104.67

110.77

ug/l

0.70

1970

11572

Skin changes due to chronic exposure to nonionizing radiation

9751

69281

1.54

183.13

3.5

3.1

147.61

153.76

ug/l

0.92

8877

62996

Other diseases of lip and oral mucosa

12204

99366

1.50

183.12

3.6

3.2

110.39

119.69

ug/l

4.69

11425

93147

Peripheral artery disease

10571

65748

1.50

182.49

4.9

2.9

160.69

162.28

ug/l

0.22

9797

59954

External causes of morbidity and mortality

21523

91248

1.34

181.25

3.4

3.0

111.99

109.05

ug/l

0.80

20208

86436

Symptoms and signs involving speech and voice

9405

74480

1.58

180.58

3.7

3.2

117.64

123.14

ug/l

0.76

8798

69437

Undetermined asthma

3905

26823

2.07

179.87

3.8

2.8

111.86

107.19

ug/l

0.64

3692

25097

Coagulation defects, purpura and other haemorrhagic conditions

5593

41390

1.86

179.58

4.6

3.2

204.62

118.14

ug/l

18.13

5341

38763

Implicit fungal Sepsis, including avohilmo

2132

12970

2.99

178.94

5.3

2.9

169.74

119.52

ug/l

6.64

2000

12015

Malignant neoplasm of digestive organs

9823

58820

1.52

177.51

3.3

3.1

148.61

133.50

ug/l

3.89

9170

54151

Actinic keratosis

9427

67277

1.54

177.45

3.5

3.1

147.82

154.99

ug/l

1.14

8567

61115

Sequelae with surgical and medical care as external cause

5546

40944

1.84

176.80

4.3

3.1

150.16

132.44

ug/l

3.02

5195

38066

Asthma/COPD (KELA code 203)

30491

178358

1.28

176.64

3.5

3.1

106.43

116.73

ug/l

9.62

28831

167627

Rheumatism, unspecified

3766

26074

2.11

173.58

3.9

2.9

98.33

113.06

ug/l

5.19

3505

24336

Biological medication for rheuma

5391

40110

1.89

173.10

4.3

3.2

107.22

102.95

ug/l

0.48

5239

38151

Cervicalgia

5902

43880

1.75

172.67

3.6

3.0

109.73

124.12

ug/l

5.50

5535

41004

Complications of internal orthopaedic prosthetic devices, implants and grafts

5744

42367

1.75

172.26

3.7

3.0

146.02

141.15

ug/l

0.70

5281

38836

Glucagon-like peptide-1 (GLP-1) analogues

8322

64995

1.60

172.19

4.0

2.9

120.19

138.31

ug/l

9.83

7791

61359

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

8322

64995

1.60

172.19

4.0

2.9

120.19

138.31

ug/l

9.83

7791

61359

Cholelithiasis, broad definition with cholecystitis

25989

150033

1.30

171.34

3.7

3.1

128.41

119.96

ug/l

5.06

24225

140517

Cardiomyopathy, other and unspecified

2000

11756

2.70

171.02

4.6

2.7

174.54

152.09

ug/l

0.92

1911

10831

Hypokalaemia

3314

22221

2.15

170.40

4.4

2.9

162.01

129.18

ug/l

7.66

3120

20489

Noninfectious colitis NAS

3969

27917

2.06

170.04

4.6

3.1

123.25

114.34

ug/l

1.51

3768

26151

Cholelithiasis

25015

147872

1.30

169.16

3.7

3.1

125.96

119.68

ug/l

3.00

23292

138458

Peripheral arterial reconstruction

4074

28264

1.92

168.66

5.2

3.1

167.63

168.92

ug/l

0.09

3779

25649

Unspecified fall

14913

121969

1.40

168.58

3.5

3.2

125.79

124.48

ug/l

0.21

13750

113986

Zoster [herpes zoster], including avohilmo

14661

117881

1.41

167.89

3.6

3.1

135.75

127.01

ug/l

2.10

13672

109511

Fissure and fistula of anal and rectal regions

6615

50109

1.67

166.82

3.7

2.9

127.59

129.47

ug/l

0.19

6171

46946

Insulin, fast-acting or short human

10096

80932

1.51

166.32

5.1

3.1

140.88

131.69

ug/l

2.52

9461

75700

Voice disturbances

7555

59023

1.65

165.98

3.6

3.2

110.73

118.04

ug/l

1.15

7134

55195

Other disorders of eyelid

11692

89602

1.45

165.77

3.4

3.1

127.53

140.30

ug/l

4.82

10805

82577

Other symptoms and signs involving the nervous and musculoskeletal systems

12209

100492

1.46

164.23

3.6

3.2

114.25

117.50

ug/l

0.63

11595

94266

Other neurological diseases

19876

131312

1.33

164.15

3.6

3.1

126.97

134.92

ug/l

4.13

18504

121996

Primary_lymphoid and hematopoietic malignant neoplasms

6008

45047

1.70

162.86

4.0

3.1

325.62

141.07

ug/l

33.82

5696

41488

Open wound of head

15247

119353

1.37

162.46

3.4

3.1

141.90

136.73

ug/l

1.17

13936

111622

Benign neoplasm: Stomach

2589

16881

2.48

162.04

5.0

3.1

101.95

133.44

ug/l

10.69

2435

15603

Abnormal serum enzyme levels

7344

54514

1.60

161.88

3.5

3.1

184.14

168.44

ug/l

2.41

6997

50349

Sulfasalazine

8063

63260

1.58

161.08

3.6

3.0

125.05

114.25

ug/l

3.00

7641

59315

Injuries to the ankle and foot

22953

170236

1.31

160.80

3.5

3.2

101.13

110.50

ug/l

9.64

21616

161253

Subjective visual disturbances

7423

58128

1.65

160.64

3.7

3.2

102.82

115.65

ug/l

5.13

6966

54446

Colon adenocarcinoma, helper endpoint

3197

21498

2.11

160.62

3.4

3.1

110.77

155.44

ug/l

18.51

2990

19599

Hernia of abdominal wall

12231

100443

1.44

160.62

3.9

3.1

134.35

139.25

ug/l

1.12

11467

93815

Primary gonarthrosis, bilateral

13284

91563

1.41

160.61

3.4

3.1

134.58

148.86

ug/l

7.06

12170

84557

7324

48145

1.58

160.27

3.6

3.1

139.85

158.58

ug/l

7.31

6507

43583

Cholecystectomy

20636

150718

1.32

160.08

3.7

3.2

121.05

121.17

ug/l

0.02

19300

140909

Mouth breathing

10260

82657

1.49

159.72

3.5

3.1

125.89

139.90

ug/l

7.54

9656

77753

Chronic apical periodontitis

35403

176554

1.24

158.80

3.5

3.1

123.12

114.58

ug/l

5.57

32873

166543

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1337

7248

3.65

158.71

5.3

3.0

181.71

136.85

ug/l

5.91

1266

6634

Endometriosis

10718

50757

1.54

158.47

3.6

3.1

82.79

82.98

ug/l

0.03

10111

47866

Excessive attrition of teeth

18990

161639

1.35

157.89

3.6

3.2

99.33

110.23

ug/l

8.85

17861

152987

Abnormal findings on diagnostic imaging of lung

12321

95604

1.42

157.58

3.7

3.1

171.93

146.63

ug/l

8.86

11390

88130

Anaemia in chronic diseases classified elsewhere

768

3423

7.38

157.45

12.8

2.8

377.03

146.37

ug/l

26.58

755

3142

Atherosclerosis, excluding cerebral and coronary sclerosis

9764

60853

1.48

157.45

4.9

2.9

161.27

164.23

ug/l

0.44

9045

55335

Myocardial infarction, strict

10611

59967

1.45

157.17

4.0

2.8

160.24

166.89

ug/l

1.20

9838

54812

Diseases of male genital organs

11480

45870

1.42

156.84

3.2

2.9

176.02

190.81

ug/l

4.04

10749

43155

Migraine without aura and triptan purchases

5867

45668

1.88

156.43

4.1

3.3

67.60

73.61

ug/l

2.17

5676

43690

Somatoform disorder

4869

36163

1.88

156.33

4.1

3.1

98.85

105.91

ug/l

1.09

4569

34198

Acute sinusitis

16623

128332

1.37

156.17

3.8

3.1

113.44

104.79

ug/l

1.58

15696

121572

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

9683

78408

1.53

155.68

3.8

3.2

106.64

113.47

ug/l

2.84

9136

73584

Myeloproliferative diseases

2193

13823

2.61

155.42

4.4

3.1

152.16

139.48

ug/l

0.64

2070

12762

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

8833

69960

1.56

155.30

3.8

3.1

90.38

93.70

ug/l

0.62

8248

66962

Heartburn

3313

22829

2.10

154.26

3.9

2.9

99.57

115.33

ug/l

5.68

3100

21438

Gonarthrosis, primary, with knee surgery

14682

95257

1.38

153.90

3.3

3.1

136.70

151.02

ug/l

7.67

13404

87910

Fitting and adjustment of other devices

9349

65377

1.48

153.55

3.3

2.9

148.61

133.88

ug/l

4.63

8603

59691

Injuries to the knee and lower leg

37899

183150

1.23

153.35

3.4

3.2

115.96

115.36

ug/l

0.14

35557

172246

Migraine with aura and triptan purchases

5643

43833

1.90

153.29

4.0

3.3

70.12

74.33

ug/l

1.70

5429

41887

Crohn disease (strict definition, all UC cases excluded)

1636

9858

3.57

153.26

5.2

3.1

99.08

107.82

ug/l

0.86

1599

9359

Inflammatory diseases of female pelvic organs

21172

126463

1.35

152.52

3.7

3.2

80.96

82.52

ug/l

0.68

19977

119433

Exposure to other specified factors

25114

188944

1.28

152.23

3.5

3.2

111.69

115.14

ug/l

1.48

23541

178219

Polycystic ovarian syndrome, consortium definition

24474

123460

1.32

152.01

3.7

3.2

81.22

82.05

ug/l

0.30

22977

116676

Vasomotor and allergic rhinitis

11930

96593

1.45

151.79

3.5

3.1

95.10

101.46

ug/l

1.21

11317

91648

Benign neoplasm: Sigmoid colon

4701

34447

1.80

150.35

4.1

3.1

122.77

153.49

ug/l

11.85

4429

31804

Hyperplasia of prostate

7908

34056

1.52

150.19

3.3

3.0

180.67

207.08

ug/l

7.76

7268

31747

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

27487

142787

1.26

149.87

4.0

2.9

131.37

122.11

ug/l

5.72

25596

134262

Personality disorders

8418

67847

1.59

149.63

3.9

3.2

90.00

96.38

ug/l

1.50

7864

64737

Injuries to the hip and thigh

13321

99133

1.39

149.13

3.6

3.1

144.07

134.57

ug/l

2.34

12255

91857

Mycoses

7862

62373

1.58

148.73

4.1

3.2

137.47

122.11

ug/l

2.94

7395

58431

Unstable angina pectoris

8437

51926

1.50

148.41

3.8

2.9

141.94

168.73

ug/l

14.68

7838

47159

Carpal tunnel syndrome

17654

130754

1.34

148.09

3.5

3.1

117.17

123.70

ug/l

2.98

16517

122594

Disorders of skin appendages

15542

131594

1.38

148.03

3.7

3.2

107.70

104.91

ug/l

0.69

14726

124421

Persistent mood disorders

5473

41376

1.73

147.65

3.9

3.1

97.61

113.43

ug/l

7.98

5079

38978

Trochanteric bursitis

4072

29349

1.90

147.32

3.6

2.9

105.16

118.42

ug/l

3.14

3794

27317

Injury, poisoning and certain other consequences of external causes

17648

74884

1.34

147.13

3.3

3.0

107.93

107.97

ug/l

0.01

16611

70846

Crohn's disease of large intestine

1579

9475

3.39

145.97

5.5

3.1

98.70

111.42

ug/l

2.29

1530

8961

Fenamates

4291

20903

1.84

145.72

3.5

3.4

96.09

121.30

ug/l

8.02

4056

19640

Superficial injury of head

6883

53535

1.60

145.44

3.4

3.2

122.99

122.76

ug/l

0.02

6384

50114

Myeloproliferative diseases (CML excluded)

1990

12466

2.66

145.23

4.4

3.1

142.60

139.65

ug/l

0.10

1872

11507

Weight loss

2838

19367

2.25

144.91

3.9

3.2

136.82

124.54

ug/l

2.23

2621

17994

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

20155

159363

1.32

144.53

3.8

3.2

101.76

106.01

ug/l

2.09

19118

150975

Collagenous colitis

2620

17650

2.36

144.49

4.7

3.1

133.79

116.49

ug/l

1.44

2484

16498

Cervical disc disorders

9314

74857

1.47

143.74

3.4

3.0

125.71

140.45

ug/l

6.92

8700

69914

Transient ischemic attack

13027

85995

1.38

143.67

3.5

3.1

134.17

150.67

ug/l

9.42

12071

79046

Endometriosis of pelvic peritoneum

5014

34540

1.83

143.23

3.6

3.0

74.94

82.92

ug/l

3.94

4759

32769

Polymyalgia rheumatica

3325

23074

1.99

143.06

3.7

3.1

161.25

146.99

ug/l

1.14

3055

20983

KRA_PSY_EATING, excluding more controls

3231

23407

2.50

142.83

4.5

3.2

53.16

56.53

ug/l

1.21

3081

22477

Other symptoms and signs involving the digestive system and abdomen

4837

35997

1.77

142.49

3.9

2.9

121.58

106.82

ug/l

2.29

4459

33660

Other maternal disorders predominantly related to pregnancy

18391

99901

1.37

142.17

3.6

3.2

73.55

81.16

ug/l

6.96

17487

94893

Disorders of parathyroid gland

5260

39041

1.70

141.88

5.8

3.0

151.96

127.40

ug/l

9.05

4865

35884

Abnormal weight loss

2584

17358

2.32

141.87

3.8

3.2

137.27

127.76

ug/l

1.44

2381

16108

Pain in thoracic spine

4468

32956

1.82

141.74

3.6

3.0

105.44

114.12

ug/l

1.67

4273

31022

Postmenopausal bleeding

6659

26645

1.62

141.32

3.2

2.9

104.84

117.57

ug/l

4.33

6117

24694

Tumor necrosis factor alpha inhibitors

4780

36036

1.84

141.17

4.1

3.2

105.62

101.45

ug/l

0.41

4641

34316

Other disorders of ear

26789

152201

1.26

140.99

3.3

3.1

130.01

124.50

ug/l

2.27

24646

143168

Hypertensive Renal Disease

999

4931

3.61

140.52

9.0

2.5

228.89

176.76

ug/l

6.63

961

4419

Cervicobrachial syndrome

6224

48100

1.63

140.50

3.5

3.0

107.09

118.38

ug/l

1.52

5969

45254

Disorders of iron metabolism

592

2565

16.65

140.36

13.0

2.8

237.59

133.70

ug/l

8.67

576

2423

Ventral hernia

6215

47886

1.62

140.16

4.1

3.0

127.56

138.36

ug/l

2.48

5805

44467

Dermatophytosis, including avohilmo

19477

165283

1.31

140.14

3.3

3.2

111.09

121.90

ug/l

10.28

18253

155549

Injuries to the thorax

12378

102787

1.39

140.01

3.6

3.1

142.66

139.68

ug/l

0.51

11428

95786

Postmenopausal atrophic vaginitis

6646

27858

1.62

139.46

3.1

2.9

96.13

113.83

ug/l

11.47

6233

25942

Benign neoplasm: Ascending colon

3507

24844

1.96

139.40

4.3

3.1

130.26

151.37

ug/l

4.67

3314

22884

Venous thromboembolism

14172

114811

1.36

139.17

3.9

3.1

161.19

136.38

ug/l

10.77

13203

106220

Other inflammation of eyelid, including avohilmo

14357

122204

1.39

138.90

3.4

3.2

90.86

101.46

ug/l

11.59

13585

115756

Disorders of adult personality and behaviour

8899

72722

1.54

138.89

3.8

3.2

89.66

95.60

ug/l

1.43

8308

69448

Coxarthrosis, primary

15032

105312

1.34

138.04

3.3

3.1

139.60

149.56

ug/l

4.92

13828

96956

Persons with potential health hazards related to communicable diseases

12121

101203

1.44

137.98

4.0

3.3

103.40

89.30

ug/l

6.62

11473

96700

Certain disorders involving the immune mechanism

4946

37232

1.75

137.63

5.4

3.1

167.36

126.36

ug/l

7.47

4723

34955

Diabetic nephropathy, excluding more controls

3920

23182

1.93

137.63

8.2

3.3

198.37

140.87

ug/l

30.76

3772

21396

Dental pulpitis, including avohilmo

28908

164457

1.25

137.59

3.5

3.2

99.59

113.85

ug/l

16.99

27240

155866

Bipolar affective disorders

5727

44341

1.71

137.48

3.6

3.1

96.67

97.44

ug/l

0.12

5359

42340

Disturbance of activity and attention

4778

35848

1.92

137.42

4.0

3.3

64.40

66.14

ug/l

0.55

4574

34414

Fracture of lumbar spine and pelvis

5863

44791

1.63

137.27

3.8

3.1

146.63

135.37

ug/l

1.47

5376

41239

Allergic asthma (mode), excluding more controls

7392

57187

1.56

136.68

3.6

2.9

87.44

85.15

ug/l

0.50

7119

54313

Other hearing loss

7124

53933

1.53

135.45

3.5

3.2

144.07

147.69

ug/l

0.28

6376

49622

Meniscus derangement

14739

82211

1.34

134.87

3.2

2.9

137.24

136.66

ug/l

0.08

13689

76955

Streptococcal septicaemia, including avohilmo

2409

15843

2.22

134.85

5.1

2.9

201.99

128.71

ug/l

16.23

2252

14621

Purpura and other haemorrhagic conditions

3646

26329

1.93

133.91

4.5

3.2

253.80

122.09

ug/l

18.99

3486

24612

Ovarian cyst

11093

52747

1.47

133.77

3.6

3.1

81.47

81.33

ug/l

0.03

10404

49754

Any operation in hilmo

1226

3025

2.67

133.53

2.9

2.0

114.45

78.89

ug/l

5.20

1173

2951

Hyperkinetic disorders

4936

37323

1.87

132.09

4.0

3.4

64.57

66.61

ug/l

0.68

4729

35828

Viral infections characterized by skin and mucous membrane lesions

11986

100287

1.40

131.94

4.1

3.2

138.33

119.59

ug/l

6.30

11311

94183

6-mercaptopurine

1209

6987

4.12

131.82

4.8

3.0

112.07

94.65

ug/l

0.88

1186

6632

Osteoporosis with pathological fracture (FG)

1870

11670

2.47

131.04

4.3

2.9

123.20

125.75

ug/l

0.13

1710

10537

Idiopathic gout

2261

14720

2.23

130.72

4.9

3.0

216.33

174.39

ug/l

3.16

2130

13514

Spondylolisthesis/Spondylolysis

4757

35638

1.71

130.56

3.5

3.0

114.76

133.60

ug/l

6.01

4465

33259

Explicit bacterial Sepsis, including avohilmo

2867

19653

2.02

130.05

5.0

2.9

192.11

131.18

ug/l

14.62

2684

18190

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

2046

13170

2.40

129.62

4.9

3.1

207.54

131.88

ug/l

13.93

1925

12091

Other sleep disorders

3175

22419

1.99

129.41

4.1

3.0

107.33

126.38

ug/l

6.97

3024

21126

Non-allergic asthma (mode), excluding more controls

5112

38177

1.65

129.30

3.6

2.7

103.68

107.02

ug/l

0.59

4851

35534

Procreative management

9454

63595

1.46

129.06

3.7

3.0

102.80

109.56

ug/l

1.83

9066

60527

Other diseases of blood and blood-forming organs

1848

11713

2.59

128.79

4.5

3.1

147.77

133.68

ug/l

0.89

1723

10899

Streptococcal septicaemia

2337

15417

2.20

128.75

5.1

2.9

204.18

129.40

ug/l

16.04

2182

14220

Benign neoplasm: Rectum, anus and anal canal

4892

36909

1.69

128.35

3.9

3.1

135.24

151.76

ug/l

2.72

4581

34054

Seropositive rheumatoid arthritis

6390

49613

1.56

127.74

3.4

3.0

131.90

126.36

ug/l

0.86

6039

45909

Enterocolitis due to Clostridium difficile

2796

19204

2.04

127.59

5.7

3.1

220.52

133.05

ug/l

15.29

2630

17727

Exclusions for E4_PCOS_BROAD

4836

36855

1.74

126.99

4.2

3.2

119.91

111.08

ug/l

1.88

4591

34827

Panic disorder

4923

38073

1.79

126.95

3.9

3.1

77.90

83.16

ug/l

2.07

4617

36392

Viral pneumonia (unknown virus, not influenza)

1926

12430

2.52

125.76

4.7

3.1

281.90

120.78

ug/l

38.39

1863

11691

Persons encountering health services for specific procedures, not carried out

2580

17794

2.19

124.93

4.5

2.9

107.62

102.79

ug/l

0.62

2404

16769

Other (not insulin) diabetes medications

29111

152114

1.23

124.60

3.7

3.0

123.88

121.65

ug/l

0.69

27127

143015

Amiodarone users

2351

15672

2.16

124.17

4.5

3.1

156.89

166.56

ug/l

1.19

2239

14411

Ulcerative rectosigmoiditis

2335

15823

2.30

124.00

4.4

3.1

101.86

116.58

ug/l

1.75

2256

14987

Specific personality disorders

7282

59058

1.58

123.96

3.9

3.2

89.01

94.14

ug/l

0.90

6812

56355

Chronic pancreatitis

2992

20881

1.94

123.45

4.3

3.0

176.79

156.53

ug/l

2.63

2826

19438

Oesophageal varices

1112

6172

3.47

123.31

5.9

3.0

157.47

157.96

ug/l

0.01

1064

5739

Other diseases of stomach and duodenum

1688

10439

2.53

123.15

5.3

2.8

120.21

141.06

ug/l

2.23

1604

9678

Explicit bacterial Sepsis

2783

19177

1.99

122.80

5.1

2.9

193.84

130.93

ug/l

14.82

2603

17746

Benign neoplasm: Caecum

2671

18469

2.09

122.67

4.1

3.1

127.25

147.39

ug/l

3.39

2515

16991

Allergic asthma (mode)

7393

57978

1.52

122.64

3.6

2.9

87.43

86.71

ug/l

0.12

7120

55087

Monoamine oxidase A inhibitors

2945

20558

1.95

122.44

3.7

3.0

102.39

132.67

ug/l

17.89

2735

19349

Faecal incontinence

2481

16887

2.13

121.73

3.8

2.8

108.24

114.28

ug/l

0.51

2256

15606

Diabetes medication

31912

167133

1.22

121.58

3.9

3.0

125.04

115.94

ug/l

6.97

29827

157495

Diabetes, insulin treatment (Kela reimbursement)

29172

154672

1.22

121.52

4.0

3.0

132.37

124.79

ug/l

4.24

27137

145366

5207

36936

1.61

121.32

3.5

3.1

141.63

154.30

ug/l

2.56

4595

33343

Other enthesopathies

8228

66715

1.47

121.27

3.4

3.0

107.87

122.94

ug/l

9.54

7719

62839

Barrett oesophagus

1295

7512

2.97

120.98

4.3

2.8

115.00

164.36

ug/l

11.44

1211

6954

Uterine polyps

7865

36998

1.52

120.85

3.5

3.0

89.82

98.29

ug/l

3.20

7350

34717

Benign neoplasm: Rectum

4345

32552

1.72

120.76

4.0

3.1

131.58

153.52

ug/l

5.25

4078

30038

Propionic acid derivatives

8333

33298

1.45

120.14

3.2

3.4

116.28

123.54

ug/l

1.44

7826

31199

Disorders of tooth development and eruption

4934

30560

1.67

119.90

3.7

2.9

88.15

107.24

ug/l

8.05

4720

29061

Disorders of vestibular function (Vertigo)

12568

103723

1.36

119.33

3.4

3.2

118.61

129.13

ug/l

3.80

11586

96335

Intestinal adhesions without obstruction

2163

14219

2.17

119.12

4.6

2.8

133.19

141.04

ug/l

0.56

2036

13106

Hyperparathyroidism

4539

33828

1.68

118.74

6.0

3.0

156.06

128.27

ug/l

12.10

4199

31047

Fracture of rib(s), sternum and thoracic spine

7758

62471

1.47

118.72

3.6

3.1

151.98

149.68

ug/l

0.23

7126

57961

Cutaneous abscess, furuncle and carbuncle

7368

59457

1.51

118.68

4.4

3.1

136.15

119.29

ug/l

5.35

6964

56110

Herpesviral [herpes simplex] infections, including avohilmo

7980

65601

1.52

118.60

3.6

3.2

102.49

94.52

ug/l

2.47

7576

62176

Other acute lower respiratory infections

15488

126860

1.31

118.21

4.0

3.1

130.93

120.35

ug/l

3.83

14493

118727

Coronary artery bypass grafting

5585

31572

1.56

118.20

4.0

2.8

159.34

188.12

ug/l

7.06

5178

28492

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

7585

54321

1.57

118.16

3.9

3.3

65.97

69.28

ug/l

1.78

7228

52151

Sensorineural hearing loss

19867

115266

1.27

118.01

3.2

3.1

144.14

139.64

ug/l

1.05

18001

107468

Coeliac disease

3421

25169

1.93

117.72

4.0

3.1

101.89

105.39

ug/l

0.51

3250

23667

Internal derangement of knee

10275

84471

1.39

116.40

3.3

3.0

121.44

125.70

ug/l

0.97

9558

79426

L01XX Other antineoplastic agents

1476

9041

2.75

116.32

4.4

3.1

170.05

149.52

ug/l

1.42

1399

8276

Cellulitis

5959

46918

1.57

115.86

4.4

3.1

145.10

129.61

ug/l

3.77

5618

44014

Acute bronchitis

11447

94330

1.37

115.77

4.1

3.1

132.80

122.18

ug/l

2.66

10662

87919

Enlarged lymph nodes

4271

32043

1.70

115.67

3.8

2.9

183.35

114.53

ug/l

19.31

4060

30003

Biguanides

28050

151149

1.22

115.21

3.6

3.0

122.24

124.50

ug/l

0.69

26069

142023

DVT of lower extremities and pulmonary embolism

10511

87201

1.38

115.01

3.8

3.1

168.49

140.42

ug/l

8.88

9790

80454

Benign neoplasm: Transverse colon

2653

18522

2.03

114.75

4.4

3.1

126.74

152.52

ug/l

5.96

2529

17092

Pruritus

3392

25003

1.91

114.68

4.5

3.1

103.06

104.07

ug/l

0.12

3210

23407

Disorders of vitreous body

12913

104501

1.34

114.55

3.7

3.1

130.96

138.08

ug/l

1.62

11980

96947

Other hammer toe(s) (acquired)

4082

27484

1.69

114.33

3.3

2.9

115.47

140.04

ug/l

10.76

3711

25154

Amputation

2395

16148

2.01

113.93

6.6

3.0

188.59

163.48

ug/l

4.35

2242

14738

Rheumatoid arthritis, including avohilmo

9990

83384

1.41

113.84

3.5

3.1

130.52

123.23

ug/l

1.99

9404

77415

Disorders of vitreous body and globe

13254

106885

1.34

113.73

3.7

3.1

131.00

138.55

ug/l

1.83

12297

99164

Other ulcerative colitis

1678

10837

2.66

113.52

5.2

3.0

107.42

114.83

ug/l

0.44

1622

10260

Unspecified/other endometriosis

3189

23255

2.07

113.07

3.9

3.1

67.10

67.50

ug/l

0.07

3062

22194

Phobic anxiety disorders

4374

33644

1.77

112.78

3.8

3.1

86.16

82.43

ug/l

0.38

4112

32232

Polyp of the female genital tract

8444

39095

1.47

111.96

3.5

3.0

89.66

95.62

ug/l

1.97

7892

36710

Combinations of oral blood glucose lowering drugs

6554

52125

1.50

111.36

3.8

2.9

114.51

167.85

ug/l

52.69

6099

48422

Candidiasis

4089

31220

1.78

110.70

4.3

3.2

124.68

106.28

ug/l

3.15

3838

29319

Deviated nasal septum

8110

65958

1.43

110.61

3.2

3.1

139.92

151.28

ug/l

2.38

7615

61847

Myelodysplastic syndrome, including Hilmo

824

4242

3.84

110.51

5.9

3.0

436.53

137.92

ug/l

37.32

784

3891

Disorders of sclera, cornea, iris and ciliary body

15608

135412

1.30

110.45

3.6

3.2

121.05

122.01

ug/l

0.17

14670

127218

False labour

10415

55237

1.49

110.43

3.7

3.3

60.18

67.16

ug/l

5.07

9981

53324

Other skin changes

5245

41010

1.61

110.03

4.1

3.1

139.02

131.55

ug/l

0.97

4939

38033

COPD (mode)

7141

44265

1.45

110.01

3.7

2.7

159.44

141.56

ug/l

4.03

6517

40501

Artificial joint operation, meniscal resection

24585

139585

1.23

109.39

3.2

3.1

137.11

137.37

ug/l

0.05

22753

130340

Excessive earwax

17252

136312

1.28

109.27

3.3

3.2

128.63

134.16

ug/l

1.77

15842

127113

Anti-inflammatory and antirheumatic products, non-steroids

8252

33302

1.42

109.09

3.2

3.4

114.08

123.53

ug/l

2.23

7714

31203

Glomerulonephritis

2471

17201

2.05

108.87

7.7

3.1

188.21

132.86

ug/l

22.54

2383

16124

Thrombocytopenia, unspecified

1895

12550

2.33

108.76

4.6

3.1

331.89

130.69

ug/l

14.11

1808

11676

Conductive and sensorineural hearing loss

21130

123338

1.25

108.67

3.2

3.1

142.29

135.93

ug/l

1.88

19227

115254

Pulmonary heart disease, diseases of pulmonary circulation

7799

63468

1.44

107.75

4.0

3.1

174.58

142.23

ug/l

7.48

7307

58415

Congenital malformations, deformations and chromosomal abnormalities

18007

150166

1.28

107.23

3.9

3.2

101.85

104.05

ug/l

0.71

17078

142422

Diseases of inner ear

14473

119515

1.31

107.21

3.3

3.2

122.82

131.13

ug/l

2.66

13350

111198

Tonsillectomy and adenotomy

18253

111860

1.29

106.83

3.5

3.2

82.21

92.88

ug/l

11.14

17554

106990

Urticaria and erythema

10824

92014

1.39

106.70

3.9

3.2

110.01

101.20

ug/l

2.30

10195

87002

Disorder of lipoprotein metabolism, unspecified

3037

21679

1.80

106.64

4.1

2.8

156.89

156.07

ug/l

0.05

2782

19758

Other viral diseases, including avohilmo

11744

99508

1.37

106.49

4.1

3.2

116.30

97.17

ug/l

10.19

11246

94736

Other symptoms and signs involving the urinary system

2607

18296

1.94

106.03

3.8

3.1

134.81

145.14

ug/l

1.19

2485

17045

In situ neoplasms

11147

94799

1.37

105.96

3.5

3.2

118.05

120.00

ug/l

0.41

10306

88065

Non-allergic asthma (mode)

5112

39330

1.57

105.68

3.6

2.8

103.68

108.59

ug/l

1.02

4851

36656

Other necrotizing vasculopathies (FG)

1501

9364

2.48

105.59

4.6

2.9

172.43

138.35

ug/l

4.13

1418

8600

Adenomyosis (Endometriosis of uterus)

3598

26905

1.79

105.42

3.7

3.0

86.89

99.62

ug/l

4.07

3383

25169

Other disorders of skin and subcutaneous tissue, not elsewhere classified

3685

27551

1.74

105.19

4.6

3.1

149.87

130.01

ug/l

2.80

3408

25605

Diabetic nephropathy

3949

29745

1.76

105.06

8.1

3.5

197.91

141.95

ug/l

31.61

3800

27489

Blepharochalasis

7145

58003

1.47

104.96

3.3

3.1

124.81

138.66

ug/l

3.71

6564

53433

Statin medication

19989

98780

1.26

104.74

3.5

3.0

117.39

112.75

ug/l

1.86

18912

93792

Exclusions for E4_PCOS_CONSORTIUM

23251

129804

1.25

104.35

3.6

3.2

92.13

91.72

ug/l

0.11

21812

122919

Tinnitus

6094

48787

1.53

104.03

3.3

3.1

122.01

131.44

ug/l

0.96

5664

45738

Enthesopathies of lower limb, excluding foot

6227

49875

1.51

103.83

3.5

3.0

108.47

121.41

ug/l

4.26

5848

46964

Disorders of calcium metabolism

1699

11035

2.35

103.70

5.3

2.9

232.94

127.30

ug/l

12.81

1600

10216

Female genital prolapse

7695

34786

1.46

103.47

3.2

3.0

89.36

101.68

ug/l

5.06

7188

32528

Fungal Sepsis

1173

7011

2.99

102.96

5.9

2.9

226.48

128.60

ug/l

8.49

1103

6490

Abnormalities of gait and mobility

2994

21732

1.85

102.92

3.8

3.2

134.75

143.99

ug/l

0.92

2774

20032

Left bundle-branch block

1773

11433

2.17

102.87

3.6

2.7

146.02

147.44

ug/l

0.09

1627

10456

Essential (haemorrhagic) thrombocythaemia

1034

5996

3.32

102.58

4.4

3.0

127.33

118.74

ug/l

0.53

971

5547

Cerebrovascular diseases

18585

112839

1.26

102.25

3.7

3.1

149.67

144.77

ug/l

0.70

17158

104526

Pregnancy examination and test

5500

27683

1.72

101.66

3.8

3.2

58.63

64.35

ug/l

1.83

5256

26691

Traumatic subdural haemorrhage

3066

20420

1.73

101.50

3.5

3.0

166.55

171.33

ug/l

0.31

2784

18769

Implicit fungal Sepsis

1097

6481

3.13

101.38

5.9

2.9

215.46

127.45

ug/l

7.61

1032

5994

Thyrotoxicosis, other and/or unspecified

5619

44927

1.57

101.35

3.7

3.1

103.17

105.71

ug/l

0.46

5265

42225

Presence of other devices

6037

47173

1.49

101.24

3.2

2.9

137.15

142.27

ug/l

0.71

5658

43462

Thoracic aortic aneurysm

3256

23830

1.75

101.00

3.6

2.9

173.05

178.95

ug/l

0.42

2994

21997

Infections with a predominantly sexual mode of transmission, including avohilmo

13055

103752

1.35

101.00

3.6

3.3

85.17

84.75

ug/l

0.07

12375

99174

Peripheral artery operations in Hilmo

2878

20431

1.77

100.56

6.0

2.9

179.40

164.30

ug/l

1.88

2687

18598

Fracture of femur

6552

47196

1.45

100.14

3.7

3.1

163.36

145.68

ug/l

4.55

5953

43012

Diseases of salivary glands

9065

76134

1.41

99.87

3.5

3.2

110.01

115.22

ug/l

1.27

8523

71504

Spondyloarthritis

4716

36634

1.59

99.80

3.8

3.1

125.73

119.87

ug/l

0.61

4463

34423

Persons encountering health services in circumstances related to reproduction

15565

90570

1.28

99.40

3.2

3.0

104.67

122.29

ug/l

14.99

14894

85865

Misadventures to patients during surgical and medical care

3813

29024

1.72

99.40

4.4

3.1

133.36

122.71

ug/l

1.63

3606

27119

Benign paroxysmal vertigo

7631

62962

1.45

99.34

3.5

3.2

116.20

127.81

ug/l

3.42

7011

58434

Amputation of toe

1692

10986

2.24

99.16

6.8

3.1

188.81

163.39

ug/l

3.25

1592

10080

Need for other prophylactic measures

1530

9897

2.50

98.76

4.8

3.1

158.63

123.34

ug/l

2.04

1486

9295

Other metabolic disorders

3796

29038

1.74

98.60

4.1

3.0

112.68

99.35

ug/l

3.22

3584

27335

Presbycusis

3280

23585

1.69

98.36

3.4

3.2

153.64

155.89

ug/l

0.08

2779

21314

Endocarditis

907

4952

3.08

98.16

5.6

2.7

205.47

159.81

ug/l

4.77

870

4560

Post-traumatic stress disorder

3065

23357

2.03

97.57

4.1

3.2

69.28

68.34

ug/l

0.12

2911

22397

Substance abuse, excluding more controls

15255

110729

1.27

96.54

3.4

3.0

153.42

128.55

ug/l

13.08

14059

104589

Delirium, not induced by alcohol and other psychoactive substances

2925

21085

1.76

95.50

3.7

3.2

163.83

157.48

ug/l

0.45

2649

19262

Colonic or urogenital fistula

6963

57092

1.46

95.49

3.7

3.2

128.38

128.28

ug/l

0.01

6493

53540

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

18511

128048

1.27

94.76

3.4

3.3

94.35

97.50

ug/l

1.22

17528

121121

Other abnormal findings of blood chemistry

1349

8646

2.71

94.43

4.4

3.1

156.96

118.23

ug/l

4.85

1294

8082

Endometriosis of ovary

4794

35756

1.61

94.39

3.6

3.1

83.47

89.32

ug/l

0.87

4543

33748

Asthma and allergy, excluding more controls

4198

32292

1.66

94.35

3.7

2.9

79.29

76.29

ug/l

0.47

4047

30823

Artificial opening status

1369

8621

2.48

94.28

4.7

2.9

144.54

138.74

ug/l

0.36

1296

8023

Haemolytic anaemias

990

5865

3.36

94.22

7.3

3.1

317.58

122.17

ug/l

7.90

949

5475

Convulsions, not elsewhere classified

6379

50896

1.46

94.06

3.7

2.9

131.43

109.81

ug/l

4.87

5934

47843

Pain associated with micturition

3231

24228

1.78

93.82

3.8

3.1

108.46

116.38

ug/l

1.55

3009

22662

Cervicocranial syndrome

2941

21667

1.82

93.74

3.7

3.0

103.64

114.81

ug/l

2.38

2813

20307

Viral and other specified intestinal infections, including avohilmo

8892

72133

1.40

93.63

4.0

3.1

98.20

89.74

ug/l

4.01

8498

68471

Other diseases of pericardium

1126

6690

2.65

93.36

5.0

2.7

195.51

147.20

ug/l

5.63

1063

6177

Abnormal involuntary movements

3556

27056

1.72

93.30

3.7

3.1

116.95

124.72

ug/l

1.29

3323

25325

Viral hepatitis, IBD co-morbidity

1459

9174

2.24

92.93

3.6

2.6

123.94

106.08

ug/l

2.11

1359

8808

Haemorrhage, not elsewhere classified

1029

6000

2.82

92.44

5.8

2.8

184.15

126.63

ug/l

3.96

961

5501

Eating disorder

3242

25515

2.10

92.05

4.5

3.4

53.13

57.55

ug/l

1.75

3092

24435

Stomatitis and related lesions

5521

44608

1.54

91.86

3.8

3.2

117.11

110.04

ug/l

0.96

5169

41966

Other disorders involving the immune mechanism, not elsewhere classified

899

5211

3.53

91.86

9.0

3.1

218.17

131.04

ug/l

7.25

880

4921

Other malignant neoplasms of skin (=non-melanoma skin cancer)

11167

64288

1.32

91.73

3.4

3.1

147.80

127.77

ug/l

9.54

10222

59259

Abnormal results of function studies

2408

17326

1.97

91.71

4.2

3.1

141.98

116.15

ug/l

3.17

2237

16314

Postpartum care and examination

4938

25213

1.73

91.18

3.8

3.2

54.92

62.52

ug/l

6.17

4645

24312

Maternal care for other known or suspected fetal problems

8622

46446

1.51

91.04

3.9

3.3

54.58

61.63

ug/l

9.01

8245

44941

Chronic ulcer of skin, not elsewhere classified

1700

11315

2.17

90.64

5.4

3.0

155.14

143.17

ug/l

1.31

1606

10451

Seronegative rheumatoid arthritis

2893

21260

1.78

90.63

3.6

2.9

133.30

124.95

ug/l

0.86

2708

19739

Acute pancreatitis

4695

36780

1.54

90.42

3.9

3.0

167.23

144.48

ug/l

3.84

4357

34228

Other disorders of bladder

2815

20509

1.77

90.33

3.7

3.0

139.04

156.79

ug/l

3.35

2492

18953

Superficial injury of lower leg

7595

63348

1.43

90.09

3.7

3.2

102.07

108.40

ug/l

2.04

7103

59627

Other diseases of oesophagus

2272

15925

1.89

90.01

4.1

2.9

128.20

144.78

ug/l

2.50

2080

14742

Injuries to the shoulder and upper arm

24661

171237

1.21

90.00

3.3

3.1

130.68

124.82

ug/l

2.72

22923

160544

Asthma and allergy

4198

32494

1.64

89.96

3.7

2.9

79.29

77.34

ug/l

0.27

4047

31028

Pulmonary embolism

7079

58128

1.42

89.94

3.9

3.1

179.72

141.47

ug/l

8.70

6627

53565

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

11663

67118

1.31

89.73

3.4

3.1

147.39

127.37

ug/l

10.13

10701

61947

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

848

4877

3.67

89.64

9.2

3.1

212.25

131.19

ug/l

8.40

831

4614

Total colectomy operation

1143

7116

2.87

89.19

6.1

3.1

100.86

126.39

ug/l

3.25

1097

6699

Total colectomy

1143

7116

2.87

89.19

6.1

3.1

100.86

126.39

ug/l

3.25

1097

6699

Hypopituitarism

1844

12569

2.10

89.16

3.9

3.0

130.42

128.18

ug/l

0.18

1776

11921

Ascites

1825

12319

2.06

89.10

4.9

2.8

233.10

140.36

ug/l

20.75

1754

11395

Alzheimer disease, excluding more controls

3943

19095

1.57

89.08

2.9

139.65

171.56

ug/l

11.71

3520

17404

Pulmonary heart disease

7079

58192

1.41

89.01

3.9

3.1

179.72

141.30

ug/l

8.77

6627

53637

Urticaria

8850

75250

1.40

88.56

3.9

3.2

107.10

96.76

ug/l

2.46

8336

71274

Ulcerative proctitis

1772

12243

2.28

88.41

4.4

3.1

94.50

108.49

ug/l

2.37

1712

11605

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

4615

35562

1.59

88.17

5.0

3.2

119.79

110.17

ug/l

2.95

4395

33608

Supervision of high-risk pregnancy

6670

33459

1.54

88.12

3.6

3.1

63.29

72.20

ug/l

7.81

6387

32233

Basal cell carcinoma

10803

62530

1.32

87.87

3.3

3.1

146.92

127.82

ug/l

8.33

9871

57592

Basal cell carcinoma, including Hilmo

11252

64908

1.31

87.71

3.3

3.1

146.72

127.41

ug/l

8.86

10305

59838

Seborrhoeic keratosis

6146

50025

1.46

87.56

3.5

3.0

126.32

140.05

ug/l

4.36

5753

46177

Other necrotizing vasculopathies

1752

11908

2.15

87.31

4.9

3.1

179.27

133.99

ug/l

8.06

1657

10992

Other postsurgical states

1689

11406

2.19

87.29

4.6

2.9

108.87

120.96

ug/l

0.71

1615

10726

ILD, hospital admission 2, with pulmonary infections

2305

16269

1.85

87.24

4.0

2.9

204.75

142.83

ug/l

10.93

2155

14887

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

4329

33096

1.61

87.19

5.1

3.2

120.97

109.60

ug/l

3.61

4126

31314

Spondylopathies (FG)

3703

28539

1.66

87.06

3.7

3.0

114.02

112.54

ug/l

0.09

3519

27000

Testicular dysfunction

958

5493

2.71

87.06

3.5

2.7

160.06

190.01

ug/l

2.85

908

5230

Diseases of external ear

9507

80897

1.35

87.02

3.6

3.2

122.98

126.35

ug/l

0.51

8651

75776

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

2828

20345

1.71

86.87

3.8

3.1

164.34

141.57

ug/l

4.11

2588

18411

Glucosamine medication

10844

73924

1.32

86.67

3.2

3.1

132.06

147.00

ug/l

6.07

9767

67564

Other general symptoms and signs

1592

10660

2.34

86.48

4.2

2.9

97.06

84.84

ug/l

1.33

1476

10071

Postprocedural endocrine and metabolic disorders, not elsewhere classified

3498

26979

1.71

86.18

4.1

3.0

110.74

98.67

ug/l

2.51

3304

25410

Recurrent aphthous stomatitis , including avohilmo

3950

30960

1.66

86.16

3.9

3.2

116.68

108.37

ug/l

0.85

3699

29020

Other blood glucose lowering drugs, excl. Insulins

3571

27127

1.62

86.13

4.2

2.9

113.80

159.33

ug/l

25.07

3328

24924

Sicca syndrome [Sjögren]

2216

15992

2.02

85.76

3.9

3.1

115.02

106.62

ug/l

0.73

2052

14925

Adalimumab

2808

21075

1.85

85.74

4.4

3.1

111.80

103.13

ug/l

0.86

2728

20085

Thyroiditis, ILD-related definition

3307

25513

1.77

85.04

4.2

3.1

95.55

93.85

ug/l

0.21

3106

24071

Other diseases of pleura

10683

79236

1.31

84.80

4.1

3.1

194.14

151.16

ug/l

24.01

9826

72871

Cholangitis (primary sclerosing, PSC)

1584

10568

2.18

84.33

4.5

3.1

148.99

132.11

ug/l

1.45

1490

9783

Diabetic maculopathy, excluding more controls

2660

19475

1.77

84.04

6.0

2.9

165.61

138.02

ug/l

7.36

2458

18180

Dysplasia of cervi uteri

7372

43514

1.45

83.95

3.3

3.1

73.11

78.38

ug/l

2.27

7016

41289

Other noninflammatory disorders of vulva and perineum

2868

21681

1.83

83.64

3.8

3.1

80.66

84.60

ug/l

0.61

2713

20467

Supplementary factors related to causes of morbidity and mortality classified elsewhere

8599

72868

1.37

83.60

3.7

3.2

131.44

119.06

ug/l

2.05

8020

68489

Other shoulder lesions

2605

19200

1.82

83.40

3.7

3.0

113.76

116.63

ug/l

0.22

2433

18099

Primary Sclerosing Cholangitis, IBD and UDCA required

666

3647

4.29

82.86

5.6

2.9

113.90

113.29

ug/l

0.02

646

3438

Other diseases of pancreas

2015

14161

1.96

82.56

4.2

3.0

155.66

143.32

ug/l

1.29

1880

13084

Abnormal findings on diagnostic imaging of other body structures

3701

28786

1.64

82.13

3.8

3.1

146.41

122.94

ug/l

3.22

3504

26878

Eating disorders

3620

28951

1.83

82.02

4.4

3.4

63.55

66.13

ug/l

0.39

3452

27640

Hallux valgus (acquired)

8650

52075

1.36

81.76

3.1

2.9

107.56

120.84

ug/l

5.52

8000

48573

Allergic rhinitis

9453

80305

1.36

81.55

3.5

3.2

90.56

90.54

ug/l

0.00

8997

76552

Diabetes mellitus in pregnancy

11614

65120

1.38

81.37

3.9

3.3

59.51

63.93

ug/l

5.13

11109

62886

Other viral diseases, not elsewhere classified, including avohilmo

7905

66523

1.40

81.36

4.1

3.2

108.89

98.36

ug/l

2.87

7592

63255

Erosion of teeth , including avohilmo

7950

67493

1.40

81.23

3.9

3.2

94.03

100.62

ug/l

2.41

7491

64180

Psychotic depression

1607

10795

2.10

81.13

3.7

2.9

101.03

114.46

ug/l

1.92

1500

10208

Parkinson's disease, strict definition, excluding more controls

2685

18075

1.67

81.01

2.9

143.65

173.11

ug/l

6.24

2425

16592

Coxarthrosis, primary, with hip surgery

11001

87793

1.30

80.96

3.2

3.1

142.36

152.01

ug/l

3.50

10091

80479

Maternal care for other conditions predominantly related to pregnancy

7042

58607

1.50

80.79

4.0

3.3

61.42

66.99

ug/l

3.11

6690

56443

Umbilical hernia

6767

56075

1.41

80.71

3.9

3.1

139.06

145.29

ug/l

0.93

6364

52650

Bacterial pneumoniae

10549

79439

1.30

80.04

4.1

3.0

162.16

124.51

ug/l

8.18

10082

73651

Parkinson's disease, excluding more controls

2865

19258

1.63

79.94

2.9

142.31

172.50

ug/l

7.16

2590

17695

Other and unspecified nerve root and plexus disorders, also in other diseases

5391

43841

1.48

79.66

3.4

3.1

113.21

128.44

ug/l

5.92

5058

41284

Multiple myeloma, including Hilmo

1075

6607

2.52

79.60

4.4

3.0

300.31

137.50

ug/l

15.62

1032

6059

Acne, including avohilmo

7902

54761

1.44

79.54

3.7

3.4

63.38

68.08

ug/l

2.21

7556

52388

Later onset COPD, excluding more controls

4616

27643

1.49

79.43

3.7

2.8

162.73

148.24

ug/l

1.82

4208

24797

Other (seronegative) rheumatoid arthritis, wide

4655

37324

1.53

79.27

3.7

3.1

138.70

124.42

ug/l

2.58

4360

34653

Diabetic retinopathy, excluding more controls

6487

29979

1.45

79.19

5.1

3.4

146.93

132.67

ug/l

4.17

5978

27757

Other eating disorders

1820

13395

2.50

79.16

4.6

3.3

53.84

57.31

ug/l

0.72

1742

12773

Radiculopathy

3840

29783

1.56

79.11

3.5

3.0

129.37

141.12

ug/l

0.75

3523

27593

Zoster [herpes zoster]

4606

36787

1.52

79.04

4.1

3.1

161.78

132.07

ug/l

3.98

4284

34021

Maternal care related to the fetus and amniotic cavity and possible delivery problems

14047

73073

1.31

78.93

3.4

3.2

68.24

77.28

ug/l

10.90

13376

69894

Alcoholic liver disease

2234

15985

1.81

78.84

4.0

3.0

277.48

164.05

ug/l

16.42

2084

14905

Squamous cell neoplasms and carcinomas of the skin

2260

16075

1.78

78.83

3.8

3.1

160.88

142.84

ug/l

2.50

2074

14521

IgA nephropathy (IgA glomerulonephritis)

678

3789

3.98

78.81

9.3

3.1

186.04

135.72

ug/l

8.18

667

3576

Maternal care for known or suspected abnormality of pelvic organs

8483

49503

1.44

78.45

3.8

3.3

60.65

68.24

ug/l

4.68

8179

47746

Testicular hypofunction

846

4832

2.73

78.05

3.6

2.7

162.71

192.48

ug/l

2.39

802

4603

Familial hypercholesterolemia

3307

25114

1.60

77.69

3.8

2.8

150.18

158.36

ug/l

0.84

3052

22826

Hydronephrosis

2780

20747

1.70

77.46

4.2

2.8

196.63

126.19

ug/l

18.78

2618

19139

Thyrotoxicosis

6871

57723

1.42

77.26

3.7

3.2

103.71

106.78

ug/l

0.69

6430

54080

Type 1 diabetes, wide definition, subgroup 1

5528

45132

1.46

77.17

5.2

3.0

130.99

113.52

ug/l

7.06

5196

42734

Other and unspecified disorders of vitreous body

10302

86905

1.31

77.13

3.3

3.1

123.95

138.32

ug/l

4.11

9544

80533

Aortic aneurysm

5027

39380

1.44

77.13

3.6

2.9

177.71

177.83

ug/l

0.01

4619

36006

Transport accidents

14163

103824

1.26

76.76

3.3

3.1

107.34

111.35

ug/l

0.80

13384

98521

Type 1 diabetes

6542

54173

1.40

76.75

5.2

3.0

139.46

119.64

ug/l

6.49

6157

51137

Type of accident

7923

67171

1.37

76.62

3.6

3.2

131.54

119.43

ug/l

1.76

7387

63113

Retinal detachments and breaks

8441

71530

1.34

76.42

3.5

3.0

139.39

149.88

ug/l

3.25

7801

66197

Intestinal malabsorption

1268

8385

2.45

76.41

5.1

3.0

135.41

117.24

ug/l

1.26

1198

7860

Alcohol use disorder, Swedish definition

14023

112019

1.25

75.97

3.5

3.1

171.14

138.00

ug/l

19.20

12973

105229

Acute pancreatitis (for exclusion)

4695

37625

1.48

75.66

3.9

3.1

167.23

145.38

ug/l

3.57

4357

35032

Superficial injury of hip and thigh

3887

30503

1.55

75.63

3.8

3.1

141.40

125.48

ug/l

1.18

3569

28288

Other diseases of arteries and capillaries

2212

16035

1.83

75.61

6.6

3.0

134.31

133.31

ug/l

0.08

2107

14880

Elevated blood glucose level

2137

15513

1.88

74.98

4.7

3.1

148.65

123.20

ug/l

2.79

2017

14510

Other and unspecified effects of external causes

7945

67804

1.38

74.85

3.7

3.2

104.84

100.95

ug/l

0.77

7463

64298

Special screening examination for other diseases and disorders

3180

24247

1.62

74.72

4.0

2.8

109.33

121.40

ug/l

2.31

3079

22662

Other viral diseases

8349

71194

1.36

74.69

4.2

3.2

129.15

100.26

ug/l

12.91

7961

67644

Diseases of the myoneural junction and muscle

2912

22061

1.67

74.62

3.7

3.1

158.58

139.78

ug/l

2.93

2646

20524

Obsessive-compulsive disorder

2247

16836

1.98

74.40

3.9

3.1

67.39

73.97

ug/l

2.15

2128

16106

Ulcerative ileocolitis

1104

7132

2.63

74.40

5.4

3.0

99.87

117.22

ug/l

0.95

1051

6768

Bacterial pneumonia, not elsewhere classified

9942

74964

1.30

74.35

4.1

3.0

160.53

124.73

ug/l

6.91

9520

69461

Benign thyroid growths and nodules

8339

66017

1.34

73.36

3.4

3.0

107.55

117.28

ug/l

4.36

7742

61340

Adverse effects, not elsewhere classified

5632

46881

1.47

73.09

3.8

3.3

100.33

97.69

ug/l

0.37

5296

44359

Thiazolidinediones

2474

18280

1.73

73.02

4.4

2.9

121.72

166.11

ug/l

11.56

2276

16849

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

2405

17977

1.82

73.01

4.3

3.1

143.25

110.30

ug/l

4.55

2277

16882

Chronic laryngitis and laryngotracheitis

3489

27229

1.59

72.76

3.8

3.1

117.90

129.63

ug/l

2.63

3169

25439

Decubitus ulcer and pressure area

1470

9870

2.05

72.62

5.4

3.0

190.80

150.95

ug/l

5.65

1357

9019

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2481

18620

1.79

72.47

4.8

3.2

167.73

124.45

ug/l

7.95

2346

17415

Poisoning by drugs, medicaments and biological substances

6729

56789

1.41

72.19

3.7

3.2

105.14

100.62

ug/l

0.54

6253

54034

Redundant prepuce, phimosis and paraphimosis

4266

32918

1.45

72.15

3.3

2.8

168.21

188.97

ug/l

3.80

4005

31112

Primary biliary cholangitis, wide definition

648

3642

3.66

72.08

5.0

2.9

132.95

116.23

ug/l

0.87

619

3406

Ischaemic Stroke, excluding all haemorrhages

13201

85080

1.25

72.00

3.7

3.1

152.23

154.01

ug/l

0.14

12089

78191

Carcinoma in situ of skin of other and unspecified parts of face

1977

14163

1.86

71.68

3.9

3.2

143.83

155.65

ug/l

1.49

1786

12803

Malignant neoplasm of skin

12288

72471

1.26

71.50

3.3

3.1

147.69

124.94

ug/l

11.92

11273

67073

Infliximab

680

3971

3.89

71.42

4.5

3.1

83.48

93.66

ug/l

1.32

670

3800

Osteomyelitis

1531

10481

2.04

71.15

6.4

3.1

170.11

147.55

ug/l

3.19

1443

9733

Acquired haemolytic anaemia

673

3867

3.59

70.86

7.0

3.1

389.73

131.61

ug/l

6.72

647

3594

Cystic kidney disease

867

5358

2.98

70.58

9.6

3.1

194.27

123.89

ug/l

19.57

851

5042

Autoimmune hepatitis, wide definition

1199

7873

2.32

70.57

4.5

2.8

208.05

117.09

ug/l

4.82

1158

7384

Other symptoms and signs involving the circulatory and respiratory systems

1703

11908

1.94

70.36

4.0

2.9

120.71

123.43

ug/l

0.23

1600

11161

Fibroblastic disorders

5490

44915

1.41

70.30

3.5

3.0

139.89

148.89

ug/l

1.35

5107

41735

Emotionally unstable personality disorder

3920

31944

1.64

70.22

4.0

3.3

77.53

77.70

ug/l

0.01

3658

30603

Other degenerative diseases of the nervous system

6942

42101

1.35

70.17

3.0

134.79

139.10

ug/l

0.54

6320

39164

Atopic dermatitis, strict definition with reimbursement

9583

80251

1.33

69.97

3.6

3.2

84.04

85.88

ug/l

0.49

9128

76552

Wet age-related macular degeneration

3922

29818

1.50

69.71

3.6

3.1

141.85

153.46

ug/l

1.74

3479

26862

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

8833

76661

1.35

69.67

3.8

3.3

90.38

92.90

ug/l

0.44

8248

73155

ILD, hospital admissions 3, with pneumonia sepsis

1944

13885

1.82

69.37

4.0

3.0

218.11

144.51

ug/l

11.31

1819

12688

Cystic kidney disease, including avohilmo

930

5873

2.81

69.30

9.2

3.1

188.43

123.80

ug/l

18.37

911

5523

Impingement syndrome of shoulder

5466

44861

1.41

69.26

3.3

2.9

131.18

148.48

ug/l

4.50

5098

41957

Postprocedural disorders of digestive system, not elsewhere classified

868

5333

2.80

69.12

5.8

3.0

137.19

126.73

ug/l

0.46

830

4961

Injuries to the neck

6491

54777

1.40

69.08

3.6

3.2

106.43

109.85

ug/l

0.57

6097

51867

Open wound of lower leg

3949

31529

1.53

68.99

3.9

3.1

125.46

121.96

ug/l

0.37

3677

29485

Myocarditis

1128

7141

2.17

68.97

5.4

2.4

138.07

130.99

ug/l

0.43

1083

6682

Failure and rejection of transplanted organs and tissues

416

2057

5.92

68.91

11.8

2.8

332.43

127.84

ug/l

19.95

411

1937

Other inflammation of eyelid

3690

29319

1.56

68.87

3.6

3.1

106.31

120.91

ug/l

5.96

3450

27440

Organic, including symptomatic, mental disorders

11992

73612

1.26

68.69

3.2

143.42

156.36

ug/l

5.44

10752

67379

Poisoning by medicine

6106

51363

1.42

68.61

3.7

3.2

104.45

99.96

ug/l

0.51

5685

48883

Other complications of surgical and medical care, not elsewhere classified

2583

19676

1.73

68.18

4.2

3.0

139.51

110.37

ug/l

3.47

2445

18488

Other respiratory diseases principally affecting the interstitium

4028

32055

1.49

68.12

4.1

3.1

197.87

152.74

ug/l

10.78

3748

29343

Adhesive capsulitis of shoulder

3969

31576

1.50

68.03

3.6

2.9

121.81

137.63

ug/l

4.20

3693

29495

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

6068

51761

1.47

67.93

3.8

3.3

70.87

71.92

ug/l

0.26

5775

49250

Congenital malformations of the urinary system

1538

10861

2.13

67.90

7.4

3.2

154.11

107.69

ug/l

17.27

1493

10226

Other abnormal uterine and vaginal bleeding

6159

36948

1.41

67.80

3.6

3.0

94.42

94.72

ug/l

0.04

5603

34560

Oesophagitis

1294

8624

2.13

67.79

4.2

2.9

134.31

145.43

ug/l

0.90

1225

8034

Other and unspecified myopathies

2035

14778

1.80

67.68

3.6

3.1

170.41

146.56

ug/l

2.97

1822

13674

Fracture of shoulder and upper arm

9242

79652

1.30

67.41

3.5

3.1

132.97

128.37

ug/l

0.69

8538

74057

Inflammatory diseases of prostate (prostatitis)

2578

19146

1.62

67.38

3.0

168.13

204.29

ug/l

7.84

2383

17876

Chronic hepatitis, not elsewhere classified

921

5835

2.74

67.10

4.3

3.0

193.01

110.99

ug/l

6.12

880

5477

Gestational diabetes (for exclusion)

12851

79458

1.31

66.90

3.8

3.4

59.39

64.80

ug/l

8.31

12220

76620

Primary hyperparathyroidism

2617

19981

1.70

66.84

3.9

3.1

128.41

124.73

ug/l

0.35

2410

18494

Primary coxarthrosis, bilateral

6528

54765

1.36

66.65

3.3

3.1

142.36

153.38

ug/l

2.93

5961

50113

Ulcer of oesophagus

1490

10180

1.96

66.61

4.4

2.9

134.39

165.04

ug/l

4.34

1396

9399

Benign neoplasm: Descending colon

1634

11530

1.97

66.55

4.3

3.1

128.01

150.11

ug/l

4.02

1567

10667

Congenital malformations of the urinary system, including avohilmo

1632

11688

2.06

66.52

7.2

3.2

150.77

107.39

ug/l

16.65

1581

10997

Neuromuscular dysfunction of bladder

2185

16145

1.76

66.41

4.0

3.0

124.82

136.63

ug/l

1.63

2042

15068

Social phobias

2674

20731

1.75

66.28

3.6

3.1

79.67

79.70

ug/l

0.00

2505

19836

Diseases of tongue

1539

10704

1.98

66.08

3.5

2.9

113.88

122.24

ug/l

0.94

1429

9998

Fall on same level involving ice and snow

16219

145617

1.22

66.07

3.3

3.2

118.83

120.55

ug/l

0.35

15098

136601

Diseases of peritoneum

2389

17933

1.72

65.95

6.8

3.1

177.66

131.19

ug/l

14.17

2274

16720

Malignant neoplasm of skin, including Hilmo

12998

76579

1.24

65.90

3.4

3.1

148.12

123.58

ug/l

14.42

11958

71012

Other enthesopathy of foot (+metatarsalgia)

2777

21405

1.66

65.82

3.5

3.0

97.35

111.20

ug/l

4.08

2583

20122

ILD, hospital admissions

3364

26377

1.55

65.36

3.8

3.2

193.19

153.84

ug/l

7.81

3123

24205

Viral warts, including avohilmo

6187

52297

1.40

65.06

3.9

3.2

100.96

104.53

ug/l

0.73

5916

49481

Psoriatic and enteropathic arthropathies

2895

22361

1.62

64.97

3.9

2.9

127.62

120.96

ug/l

0.87

2751

21054

Phlebitis and thrombophlebitis (not including DVT)

5606

46677

1.40

64.85

3.9

3.1

141.73

129.42

ug/l

1.88

5221

43577

Alcohol use disorder, ICD-based

10130

88192

1.27

64.36

3.4

3.1

165.89

142.92

ug/l

7.25

9347

82959

Amenorrhoea

2297

17803

1.91

64.27

4.2

3.1

65.47

61.15

ug/l

0.98

2205

17005

Cytomegalovirus infection, IBD co-morbidity

628

3640

3.50

64.21

9.1

3.0

332.98

125.97

ug/l

14.30

619

3420

Adrenocortical insufficiency

987

6453

2.60

63.99

5.3

3.0

133.95

112.13

ug/l

2.07

940

6045

Alzheimer’s disease (Late onset), excluding more controls

3171

15670

1.52

63.91

2.9

3.0

134.70

172.21

ug/l

14.05

2825

14192

Polycystic kidney disease

712

4301

3.21

63.71

10.1

3.1

198.68

124.07

ug/l

19.50

702

4043

Other and unspecified drugs and medicaments

2210

16680

1.80

63.70

4.3

3.2

145.61

113.84

ug/l

3.94

2093

15656

Other disorders of the musculoskeletal system and connective tissue

3519

27983

1.54

63.64

3.6

3.1

123.77

133.51

ug/l

1.94

3301

26087

Nephrotic syndrome

807

4992

2.82

63.58

10.1

3.1

204.30

131.59

ug/l

11.56

780

4670

Contraceptive management

11073

67906

1.27

63.32

3.2

3.0

93.65

114.31

ug/l

22.02

10659

64744

Disorders of ocular muscles, binocular movement, accommodation and refraction

14151

125664

1.24

63.25

3.6

3.2

102.02

105.47

ug/l

0.94

13356

118953

Polycythaemia vera

805

4893

2.62

63.12

4.0

3.0

110.62

130.30

ug/l

1.35

767

4501

Non-Hodgkin lymphoma, all, including Hilmo

2862

22018

1.58

62.69

3.6

3.1

345.74

133.61

ug/l

30.29

2691

20273

Acute gastritis

1720

12258

1.84

62.67

4.4

2.9

123.41

137.33

ug/l

1.05

1626

11402

Hypertrophy of breast in women and men

5428

45684

1.44

62.63

3.6

3.2

92.91

94.96

ug/l

0.32

5121

43212

Other disorders of glucose regulation and pancreatic internal secretion

2088

15515

1.77

62.46

5.4

3.2

134.47

121.35

ug/l

1.80

1962

14538

Other interstitial pulmonary diseases

3398

26817

1.52

62.38

3.8

3.2

194.17

153.59

ug/l

8.26

3154

24589

Ankylosing spondylitis

2142

15929

1.73

62.18

3.7

3.0

114.82

127.84

ug/l

2.43

2036

15064

All influenza (not pneumonia)

3669

29249

1.50

62.18

4.2

3.0

137.13

117.32

ug/l

2.88

3428

27481

Interstitial lung disease

3398

26833

1.52

62.10

3.8

3.2

194.17

153.82

ug/l

8.17

3154

24607

Interstitial lung disease endpoints

3398

26833

1.52

62.10

3.8

3.2

194.17

153.82

ug/l

8.17

3154

24607

Acute posthaemorrhagic anaemia

844

5174

2.46

62.01

6.0

2.8

160.85

130.49

ug/l

2.03

779

4732

Contact with and exposure to communicable diseases

9634

84527

1.31

62.00

3.6

3.3

87.59

81.76

ug/l

2.24

9071

81001

Left ventricular outflow tract obstruction (LVOTO), broad definition

2309

17404

1.70

61.93

4.1

3.1

131.96

140.28

ug/l

0.79

2194

16518

Other inflammatory liver diseases

1610

11534

1.95

61.80

4.5

3.1

209.73

121.14

ug/l

6.87

1545

10787

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

8736

75780

1.34

61.70

3.9

3.3

86.11

80.53

ug/l

0.99

8308

72478

Mental and behavioural disorders due to alcohol, excluding acute intoxication

10888

94663

1.25

61.50

3.4

3.1

166.85

143.37

ug/l

8.22

10041

88993

Keratitis

9578

83704

1.28

61.46

3.6

3.2

117.33

120.62

ug/l

0.73

8992

78672

Stroke, excluding SAH

14033

89935

1.22

61.45

3.7

3.1

155.53

152.88

ug/l

0.23

12866

82789

Metatarsalgia

2550

19616

1.67

61.44

3.6

3.0

98.05

111.11

ug/l

3.35

2370

18421

Seropositive rheumatoid arthritis, wide

6387

54112

1.36

61.37

3.4

3.1

131.92

126.12

ug/l

0.96

6038

50138

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

6233

52733

1.37

61.27

3.4

3.1

132.32

125.96

ug/l

1.07

5888

48893

L04AC Interleukin inhibitors

1732

12663

1.93

61.23

4.8

3.1

124.06

113.19

ug/l

0.75

1687

12061

Acute peritonitis

1477

10339

1.95

61.17

8.6

3.1

215.55

142.17

ug/l

17.81

1421

9606

Female infertility, associated with anovulation

2762

22123

1.79

61.12

3.9

3.2

54.97

57.02

ug/l

0.60

2652

21245

Other bursopathies

3060

23874

1.55

61.05

3.6

3.0

134.02

144.68

ug/l

1.39

2837

22207

Other and unspecified mood [affective] disorders

2194

16784

1.82

60.98

3.7

3.1

84.66

82.55

ug/l

0.30

2081

16066

Trigger finger

3629

29030

1.50

60.88

3.6

2.9

113.40

126.94

ug/l

3.34

3362

27244

Early onset COPD, excluding more controls

4393

35465

1.41

60.79

3.8

2.7

145.75

141.65

ug/l

0.38

4048

32919

Familial hypercholesterolemia, with ischemic heart disease

1933

14076

1.74

60.75

4.0

2.9

145.05

173.37

ug/l

5.98

1766

12719

Duodenal ulcer

2260

16730

1.63

60.53

4.4

2.9

165.63

168.75

ug/l

0.13

2098

15298

Alzheimer’s disease (Atypical or mixed), excluding more controls

1916

10167

1.69

60.44

2.9

3.0

153.25

174.15

ug/l

2.40

1677

9177

Follow-up examination after treatment for malignant neoplasms

2246

16662

1.64

60.34

3.2

2.7

137.76

150.42

ug/l

1.34

2080

15209

Other disorders of eye and adnexa

3856

31428

1.52

60.23

3.8

3.2

104.52

103.27

ug/l

0.10

3651

29589

Papulosquamous disorders

9994

87637

1.27

60.20

3.5

3.1

132.68

128.71

ug/l

0.71

9351

82001

Cytomegaloviral disease

645

3838

3.25

60.19

8.9

3.0

325.94

125.76

ug/l

14.10

636

3604

Other/unspecified seropositive rheumatoid arthritis

6309

53500

1.36

60.00

3.4

3.1

132.30

126.14

ug/l

1.03

5961

49577

Chronic nephritic syndrome

941

6082

2.42

59.89

9.0

3.0

216.41

140.10

ug/l

15.33

916

5677

Cytomegaloviral disease, including avohilmo

654

3913

3.21

59.89

8.8

3.0

322.80

124.77

ug/l

14.13

644

3675

Multiple myeloma and malignant plasma cell neoplasms

1097

7293

2.20

59.68

4.4

3.0

298.70

153.14

ug/l

14.98

1052

6666

Disorders of muscles

2600

20034

1.63

59.53

3.7

3.0

133.97

123.36

ug/l

1.00

2477

18821

Other specified/unspecified bacterial intestinal infections

1613

11620

1.91

59.49

4.4

3.1

115.71

125.26

ug/l

0.91

1528

10852

Extreme obesity with alveolar hypoventilation

1018

6736

2.35

59.46

4.8

3.0

121.43

134.93

ug/l

1.29

921

6295

Aortic valve malfunction, age under 60 years

2121

15878

1.72

59.38

4.1

3.1

135.33

145.78

ug/l

0.99

2015

15042

Arthropathies in other diseases classified elsewhere

902

5767

2.43

59.18

7.3

2.9

141.26

132.09

ug/l

0.68

848

5408

ILD, hospital admissions 1, main diag only

2983

23353

1.56

59.06

3.8

3.2

193.51

153.18

ug/l

7.17

2768

21433

Osteonecrosis

1487

10557

1.95

59.00

4.3

3.0

182.97

137.64

ug/l

6.78

1416

9805

Unspecified privation

2663

20728

1.63

58.88

4.4

3.2

121.62

121.37

ug/l

0.02

2524

19449

Other and unspecified diseases of blood and blood-forming organs

694

4218

2.97

58.86

5.5

3.0

163.62

131.60

ug/l

0.93

661

3924

Superficial injury of abdomen, lower back and pelvis

4263

35058

1.46

58.56

3.7

3.2

111.90

109.83

ug/l

0.15

3945

33034

Pleural effusion

3398

26948

1.49

58.41

4.4

3.1

227.71

155.96

ug/l

21.08

3151

24676

Varicose veins

15608

105887

1.20

58.18

3.3

3.0

127.06

132.17

ug/l

1.50

14471

98382

Flat foot [pes planus] (acquired)

2388

18260

1.65

57.95

3.5

2.9

107.17

117.65

ug/l

1.59

2198

17040

Glaucoma

13705

103874

1.22

57.57

3.3

3.1

135.20

143.91

ug/l

3.36

12468

95801

Methotrexate

3462

27783

1.51

57.50

3.7

3.0

122.30

112.17

ug/l

1.39

3251

25917

Diseases of middle ear and mastoid

17460

129600

1.20

57.39

3.6

3.2

97.12

103.63

ug/l

2.82

16476

122801

Anosmia

544

2792

2.75

57.16

3.7

2.0

107.69

107.19

ug/l

0.02

509

2615

Primary biliary cholangitis (PBC)

590

3454

3.23

56.97

4.5

2.9

121.04

106.56

ug/l

0.86

562

3222

Supervision of normal pregnancy

7007

34710

1.39

56.71

3.4

3.1

60.49

71.26

ug/l

8.74

6711

33431

Conjunctivitis (acute, non atopic)

7864

68064

1.31

56.70

3.7

3.2

102.76

107.28

ug/l

1.21

7428

64282

conjunctival haemorrhage

1782

13116

1.80

56.60

3.9

3.1

133.55

137.85

ug/l

0.33

1658

12129

Cholangitis (primary sclerosing, PSC), with reimbursement 202

536

3095

3.67

56.54

5.6

3.1

107.40

112.61

ug/l

0.25

521

2913

Vitamin deficiency

1242

8627

2.08

56.53

4.9

3.0

126.34

116.68

ug/l

0.79

1176

8069

Vitamin deficiency, wide

1242

8627

2.08

56.53

4.9

3.0

126.34

116.68

ug/l

0.79

1176

8069

Scoliosis

2426

18923

1.70

56.44

3.8

3.1

85.05

89.16

ug/l

0.53

2293

17749

Enteropathic arthropathies

663

4055

3.07

56.37

5.5

2.9

98.81

111.16

ug/l

0.82

649

3836

Covid-19 suspected case

6187

53038

1.37

56.34

3.8

3.2

107.06

94.07

ug/l

4.84

6008

50318

Speech therapy

6296

53688

1.35

56.20

3.7

3.1

129.03

128.95

ug/l

0.01

6103

49905

14949

119957

1.20

56.14

3.5

3.1

168.86

133.87

ug/l

22.79

13803

112803

Other disorders of white blood cells

1329

9387

2.04

56.13

4.7

3.1

189.76

123.94

ug/l

2.99

1250

8766

Fracture of foot, except ankle

6803

58525

1.34

56.11

3.6

3.2

107.69

109.49

ug/l

0.32

6394

55435

Inflammatory disease of uterus

4327

36466

1.52

56.08

4.0

3.3

72.39

73.76

ug/l

0.26

4116

34707

Immunodeficiencies

1219

8540

2.16

56.02

5.5

3.1

162.81

108.05

ug/l

4.22

1172

8047

Other coagulation defects

2014

15360

1.80

55.81

4.9

3.2

109.91

101.64

ug/l

0.77

1914

14489

Gout due to impairment of renal function

314

1492

5.83

55.67

11.0

3.0

267.20

163.54

ug/l

8.43

307

1379

Type 1 diabetes, wide definition

5644

47568

1.36

55.57

5.2

3.0

131.40

115.09

ug/l

6.40

5308

44958

Acute myeloid leukaemia and myelodysplastic syndromes

581

3320

2.88

55.53

5.3

3.0

612.40

133.67

ug/l

16.46

548

3052

Mixed and other personality disorders

2151

16555

1.75

55.52

4.1

3.1

90.68

102.03

ug/l

3.24

1990

15826

Diagnoses used for exclusion with ILD

5856

49402

1.34

55.52

4.0

3.1

155.73

142.92

ug/l

1.51

5426

45816

Hepatic failure, not elsewhere classified

903

5870

2.35

55.37

5.0

3.0

357.74

137.73

ug/l

6.72

868

5449

Melanocytic naevi

8656

75994

1.30

55.32

3.8

3.2

105.11

108.01

ug/l

0.49

8297

71696

Malignant neoplasm, including Hilmo

24523

131327

1.16

55.32

3.3

3.1

169.33

105.78

ug/l

57.93

23120

123893

Pericarditis

818

5093

2.31

55.24

4.9

2.8

188.73

149.95

ug/l

3.41

773

4711

Injuries to the wrist and hand

30737

189515

1.14

54.88

3.3

3.2

113.03

116.08

ug/l

1.35

28735

178529

Hypogonadotropic hypogonadism

707

4258

2.50

54.85

3.3

2.9

148.53

179.37

ug/l

2.74

675

4070

Postmenopausal osteoporosis with pathological fracture

1511

10918

1.90

54.83

4.1

3.0

118.27

116.54

ug/l

0.08

1364

9842

Sleep disorders, other/unspecified

1078

7467

2.33

54.80

4.3

3.2

78.94

89.85

ug/l

2.37

1023

7084

Abnormal findings in secretions and smears from cervix uteri vagina vulva

15900

106781

1.23

54.67

3.4

3.3

75.09

78.83

ug/l

2.75

15260

101462

Other and unspecified injuries of head

1863

13898

1.76

54.63

3.6

3.1

112.57

124.88

ug/l

1.96

1725

12976

Other disorders of adrenal gland

1212

8548

2.16

54.51

5.1

3.0

130.63

105.51

ug/l

3.28

1157

8022

Injuries to the elbow and forearm

20881

164157

1.17

54.37

3.4

3.2

109.99

113.55

ug/l

1.57

19403

154379

Vitreous haemorrhage

2321

17829

1.63

54.12

5.5

3.1

175.68

140.72

ug/l

6.20

2166

16588

Leisure time condition

4672

39039

1.41

53.97

3.5

3.2

131.29

117.21

ug/l

1.32

4280

36624

Macular pucker

3432

27651

1.48

53.94

3.4

3.1

147.01

157.35

ug/l

1.34

3126

25374

Diplopia

3189

25597

1.52

53.92

3.6

3.1

127.86

126.93

ug/l

0.06

2973

23921

Artificial joint re-operation

1551

11261

1.85

53.81

3.7

3.1

139.77

139.61

ug/l

0.01

1434

10313

Localized swelling, mass and lump of skin and subcutaneous tissue

8289

72385

1.29

53.77

3.6

3.1

127.14

123.02

ug/l

0.52

7822

67700

Hallux rigidus

3040

24030

1.50

53.77

3.2

2.9

116.39

145.49

ug/l

9.93

2766

22190

Ptosis of eyelid

2575

20114

1.59

53.58

3.6

3.1

134.23

138.87

ug/l

0.25

2415

18596

Bacterial pneumonia (organism specified)

11220

90035

1.23

53.45

4.1

3.1

167.24

134.08

ug/l

6.99

10707

83245

Other and unspecified local infections of skin and subcutaneous tissue

2437

18971

1.62

53.42

4.8

3.1

125.76

122.32

ug/l

0.31

2313

17793

DVT of lower extremities

4357

35952

1.40

53.29

3.8

3.1

155.03

140.98

ug/l

1.65

4029

33335

Drug-induced adrenocortical insufficiency

531

3147

3.71

53.17

5.7

3.1

136.48

108.95

ug/l

1.56

510

2957

Diabetic retinopathy

8110

43912

1.31

53.16

5.0

3.7

148.16

136.93

ug/l

3.54

7429

40862

Other local infections of skin and subcutaneous tissue

2562

20068

1.60

53.10

4.7

3.1

126.95

124.42

ug/l

0.21

2430

18833

Any death

12445

97279

0.83

52.95

3.7

3.1

316.92

129.69

ug/l

102.89

11573

89906

Hypertrophy of breast

4866

41335

1.44

52.89

3.6

3.2

82.53

84.85

ug/l

0.41

4587

39148

Other and unspecified urticaria

5390

45929

1.39

52.83

3.9

3.2

111.08

98.86

ug/l

1.90

5062

43428

Malignant neoplasm, wide definition

24497

131363

1.16

52.82

3.3

3.1

169.22

106.15

ug/l

56.97

23092

123918

Myelodysplastic syndrome

343

1678

4.25

52.80

5.9

2.9

520.62

140.07

ug/l

20.35

320

1535

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

11677

103334

1.24

52.70

3.4

3.2

93.00

96.22

ug/l

1.00

11009

98532

Charcot foot

461

2526

3.40

52.50

8.3

2.6

180.48

161.25

ug/l

0.91

441

2361

Other disorders of patella

4540

37940

1.41

52.04

3.4

3.0

100.45

108.74

ug/l

1.96

4259

36008

Disorders of breast

14941

119777

1.22

51.99

3.4

3.2

84.39

86.43

ug/l

0.72

14144

112870

Other disorders of conjunctiva

3263

26286

1.49

51.89

3.6

3.1

131.00

140.41

ug/l

1.39

3024

24367

Unspecified urinary incontinence

2170

16718

1.67

51.86

3.5

3.1

119.66

114.02

ug/l

0.34

1866

15492

15776

124173

1.19

51.84

3.4

3.1

166.19

132.02

ug/l

23.91

14580

116859

Antenatal screening

7291

35734

1.36

51.79

3.4

3.1

61.34

71.26

ug/l

7.28

7005

34416

Other noninflammatory disorders of vagina

2117

16334

1.70

51.76

3.6

3.0

89.23

89.82

ug/l

0.06

1994

15351

Substance abuse

15255

128149

1.19

51.65

3.4

3.1

153.42

130.22

ug/l

11.62

14059

120747

Stroke, including SAH

14793

95548

1.19

51.18

3.7

3.1

153.97

150.95

ug/l

0.28

13565

88142

Abscess of anal and rectal regions

2018

15253

1.65

51.15

3.9

2.8

141.44

132.72

ug/l

0.70

1902

14404

Thyrotoxicosis with diffuse goitre

3746

30940

1.47

51.12

3.6

3.1

97.20

99.49

ug/l

0.31

3523

29261

Periodontitis

28474

168606

1.14

51.07

3.5

3.1

135.60

122.01

ug/l

11.90

26263

158791

Carcinoma in situ of other and unspecified digestive organs

1012

6872

2.15

50.95

4.0

3.1

124.52

153.34

ug/l

3.45

954

6346

Chronic periodontitis, including avohilmo

28413

168442

1.14

50.92

3.5

3.1

135.82

122.09

ug/l

12.07

26208

158625

Mental and behavioural disorders due to psychoactive substance use

15809

131270

1.19

50.87

3.4

3.1

153.42

129.22

ug/l

13.25

14551

123706

Ulcerative enterocolitis

832

5500

2.48

50.87

5.7

3.0

98.60

116.68

ug/l

1.61

794

5201

Outcome of delivery

5297

27960

1.44

50.82

3.5

3.2

55.92

67.67

ug/l

7.39

5144

26978

Pollen allergy

5679

48243

1.38

50.46

3.6

3.3

84.26

81.08

ug/l

0.22

5390

46121

Progressive vascular leukoencephalopathy

931

6193

2.18

50.38

3.6

3.1

118.53

147.32

ug/l

3.70

894

5567

Other benign neoplasms of skin

9389

82983

1.25

50.36

3.5

3.2

122.93

127.70

ug/l

0.97

8699

77163

Status post-ami

5252

33253

1.33

50.34

4.1

2.8

163.71

181.82

ug/l

3.17

4828

30058

Medical treatment for female infertility

6969

61169

1.38

50.31

3.8

3.4

61.19

63.70

ug/l

0.68

6750

58985

Hypoglycaemia, other or unspecified

1662

12349

1.77

50.22

5.5

3.2

135.71

119.69

ug/l

2.07

1567

11590

Carbimazole or st.post thyroidectomy, condition for graves disease

5540

47490

1.37

50.13

3.6

3.2

98.98

103.67

ug/l

1.11

5203

44694

Small fibre neuropathy

736

4718

2.54

49.70

4.6

3.1

157.92

142.54

ug/l

0.98

685

4392

Malignant neoplasm of prostate, including Hilmo

5656

27926

1.32

49.58

3.0

3.1

237.47

176.02

ug/l

16.16

5127

25807

malignant neoplasm of male genital organs, including Hilmo

5835

29408

1.31

49.53

3.0

236.34

174.40

ug/l

17.26

5297

27225

Other and unspecified coagulation defects

1400

10374

2.00

49.48

5.1

3.2

105.51

97.72

ug/l

0.50

1344

9831

Other noninflammatory disorders of uterus, except cervix

4974

27810

1.37

49.37

3.3

3.0

107.12

111.93

ug/l

0.80

4600

25807

Reactive arthropathies

2086

15983

1.63

49.35

3.5

3.0

138.63

123.56

ug/l

1.01

1988

15045

Other diseases of biliary tract

1991

15132

1.64

49.28

4.1

3.0

185.45

133.52

ug/l

7.57

1873

13933

Viral and other specified intestinal infections

6216

52307

1.33

49.21

4.2

3.1

99.32

87.58

ug/l

4.88

5924

49612

Spontaneous rupture of synovium and tendon

1881

14170

1.66

49.02

3.5

2.9

134.10

140.94

ug/l

0.41

1706

13162

Iridocyclitis

5594

47783

1.34

48.99

3.7

3.2

130.22

125.59

ug/l

0.45

5272

44828

Bulimia nervosa (incl. atypical)

1193

8950

2.51

48.94

4.4

3.3

50.98

54.79

ug/l

1.13

1137

8541

Malignant neoplasm of stomach, including Hilmo

1257

8753

1.82

48.91

3.8

3.1

107.03

140.98

ug/l

5.39

1177

8018

Other viral diseases, not elsewhere classified

4827

40713

1.38

48.84

4.3

3.2

124.18

105.04

ug/l

3.87

4607

38590

Pyogenic arthritis

1467

10567

1.75

48.72

4.5

2.9

187.39

144.52

ug/l

3.06

1371

9848

Ganglion

5712

48948

1.34

48.68

3.3

3.0

106.70

108.26

ug/l

0.16

5414

46295

Colitis, primary sclerosing

410

2289

4.08

48.48

5.7

3.1

106.74

112.16

ug/l

0.23

398

2167

Atrophic disorders of skin

4063

33940

1.43

48.38

3.6

3.1

98.27

105.56

ug/l

1.34

3776

31743

Amputation of foot

610

3704

2.64

48.35

7.6

3.1

198.13

169.43

ug/l

1.88

576

3405

Immunodeficiency with predominantly antibody defects

707

4592

2.72

48.33

5.8

3.1

174.54

108.24

ug/l

3.86

687

4325

Retinal vascular occlusion

2559

20085

1.52

48.30

4.0

3.1

142.36

154.83

ug/l

1.75

2340

18338

Malignant neoplasm of prostate

5540

27458

1.31

48.15

3.0

3.1

239.16

176.18

ug/l

16.38

5013

25356

Benign neoplasm: Small intestine

914

6169

2.21

48.07

5.2

3.1

106.29

141.51

ug/l

7.08

860

5690

Agranulocytosis

2617

20856

1.55

47.88

4.0

3.1

311.55

119.72

ug/l

29.75

2486

19474

Malignant neoplasm of urinary organs, including Hilmo

2370

18378

1.53

47.76

4.0

3.1

199.57

141.12

ug/l

17.56

2187

16869

Malignant neoplasm

23614

127752

1.15

47.61

3.3

3.1

173.43

107.12

ug/l

58.79

22247

120436

Unspecified misadventure during surgical and medical care

1383

10135

1.88

47.47

4.2

3.1

148.95

127.64

ug/l

1.43

1307

9489

Sequelae of injuries, of poisoning and of other consequences of external causes

5756

49339

1.32

47.36

3.5

3.1

119.03

129.21

ug/l

2.28

5399

46560

Chronic lymphocytic leukaemia

663

4096

2.41

47.30

4.2

3.0

366.66

141.74

ug/l

1.70

621

3760

Chronic lymphocytic leukaemia, helper endpoint

663

4096

2.41

47.30

4.2

3.0

366.66

141.74

ug/l

1.70

621

3760

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

663

4096

2.41

47.30

4.2

3.0

366.66

141.74

ug/l

1.70

621

3760

Dislocation, sprain and strain of joints and ligaments at neck level

4340

36723

1.42

47.24

3.6

3.2

92.47

95.77

ug/l

0.56

4088

34973

Chronic periodontitis, complicated

14013

123678

1.19

47.23

3.6

3.1

150.20

138.52

ug/l

3.73

12863

115534

UC patients in KELA-register (code 208), prior to 1994

976

6678

2.11

47.20

4.8

3.0

123.73

144.37

ug/l

2.28

927

6247

Other and unspecified visual disturbances

2665

21372

1.55

47.10

3.9

3.2

106.52

114.65

ug/l

1.03

2503

20013

malignant neoplasm of male genital organs

5699

28867

1.30

47.10

3.0

238.23

174.71

ug/l

17.43

5165

26705

Alcohol abuse, main dg, excluding more controls

3514

28707

1.42

47.06

3.4

3.0

140.04

133.02

ug/l

0.47

3283

27262

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

640

3932

2.46

46.99

4.2

3.0

315.46

137.48

ug/l

10.18

608

3598

Multiple myeloma

640

3932

2.46

46.99

4.2

3.0

315.46

137.48

ug/l

10.18

608

3598

Otitis externa

5946

51324

1.33

46.86

3.7

3.2

111.36

117.99

ug/l

1.27

5490

48331

Bronchiectasis

1724

12941

1.69

46.85

3.7

3.0

135.03

146.46

ug/l

0.81

1586

11846

SLE (Finngen)

902

6150

2.25

46.75

4.6

2.9

159.07

97.40

ug/l

8.11

863

5790

Problems related to lifestyle

2746

22023

1.52

46.71

3.7

2.9

125.38

110.55

ug/l

1.27

2546

20888

Other specified/unspecified inflammatory spondylopathies

1281

9320

1.94

46.68

3.7

3.0

108.05

99.98

ug/l

0.56

1219

8857

Personal history of other diseases and conditions

3414

28386

1.52

46.41

4.2

3.2

77.26

71.25

ug/l

1.51

3216

27111

Atopic dermatitis, strict definition

9076

79289

1.27

46.41

3.6

3.3

82.72

83.60

ug/l

0.20

8658

75744

Disorders of oesophagus in diseases classified elsewhere

531

3161

2.86

46.37

5.3

2.8

166.96

150.64

ug/l

0.62

500

2901

Brachial plexus disorders

2521

20244

1.59

46.31

3.6

3.1

98.33

101.37

ug/l

0.30

2410

19318

Malignant neoplasm

23595

127794

1.15

46.30

3.3

3.1

173.64

107.23

ug/l

58.83

22229

120468

Other specified and unspecified personality disorders

2378

18964

1.61

46.18

4.1

3.2

94.72

101.99

ug/l

0.90

2241

18061

Cyst of kidney

1578

11745

1.74

46.18

4.6

3.0

150.04

148.37

ug/l

0.10

1487

10851

Giant cell arteritis

947

6462

2.10

46.05

3.9

3.1

173.86

138.81

ug/l

2.54

878

5898

Other abnormal products of conception

10888

64759

1.27

46.00

3.6

3.3

62.65

68.98

ug/l

5.78

10499

62395

Single delivery by caesarean section

5969

29841

1.40

45.85

3.7

3.4

62.69

67.18

ug/l

1.28

5753

28750

Other and unspecified disorders of white blood cells

972

6732

2.13

45.78

4.6

3.1

206.98

125.23

ug/l

2.63

913

6263

Mental and behavioural disorders due to alcohol

12920

110967

1.19

45.78

3.4

3.1

161.53

136.44

ug/l

11.43

11905

104457

Abrasion of teeth

9501

84760

1.25

45.77

3.3

3.2

97.17

116.27

ug/l

18.95

8914

79767

Disorders of continuity of bone

2556

20461

1.55

45.70

3.9

3.1

118.60

109.42

ug/l

1.28

2419

19325

Other/unspecified enthesopathies of lower limb, excluding foot

1859

14257

1.67

45.66

3.6

3.0

102.28

110.42

ug/l

1.03

1756

13463

Fracture of lower leg, including ankle

14759

131798

1.18

45.60

3.4

3.1

128.40

123.56

ug/l

0.99

13770

123584

Benign neoplasm of other and unspecified endocrine glands

3119

25479

1.48

45.52

3.7

3.1

131.31

126.96

ug/l

0.33

2935

23845

Other disorders of nervous system

1520

11282

1.75

45.51

3.9

3.1

136.51

142.10

ug/l

0.43

1393

10532

Retinal vascular disorders

2580

20407

1.50

45.41

4.0

3.1

143.52

154.88

ug/l

1.51

2359

18622

Injuries to unspecified part of trunk, limb or body region

2536

20276

1.55

45.23

4.1

3.2

119.76

119.39

ug/l

0.03

2381

18996

Other disorders of penis

1917

14439

1.57

45.16

3.6

3.0

168.73

194.33

ug/l

2.31

1770

13559

Laparoscopic left hemicolectomy

451

2629

3.39

45.13

2.8

3.0

86.26

146.01

ug/l

6.37

436

2427

Sequelae of cerebrovascular disease

8165

61107

1.25

45.10

3.8

3.1

144.99

156.63

ug/l

3.66

7446

55945

Cardiac arrest

1313

7811

1.71

45.07

4.6

2.3

181.30

163.09

ug/l

1.22

1244

7097

Crystal arthropathies, rheuma endpoint

473

2721

2.91

45.06

4.2

2.9

167.67

161.35

ug/l

0.15

435

2467

Hypercalcemia

1023

7157

2.05

45.02

4.6

3.1

254.37

130.01

ug/l

7.90

955

6604

Herpesviral [herpes simplex] infections

3026

24763

1.50

45.01

4.0

3.2

138.20

107.62

ug/l

5.88

2847

23336

Infections with a predominantly sexual mode of transmission

9164

81948

1.26

44.51

3.6

3.3

90.40

85.40

ug/l

1.51

8668

78294

Lichen simplex chronicus and prurigo

1495

11134

1.76

44.43

4.3

3.0

118.81

128.79

ug/l

0.94

1399

10391

Disorders of refraction and accommodation

7987

70485

1.27

44.32

3.6

3.2

98.24

101.11

ug/l

0.47

7546

66897

Ocular pain

2304

18441

1.61

44.21

4.0

3.2

95.02

98.88

ug/l

0.33

2178

17401

Other crystal arthropathies

473

2740

2.88

44.13

4.2

3.0

167.67

158.62

ug/l

0.23

435

2505

Other embolism and thrombosis

2937

23777

1.46

44.08

4.2

3.1

141.71

132.56

ug/l

1.21

2732

22109

Appendectomy

18512

162460

1.16

43.95

3.3

3.2

110.42

111.56

ug/l

0.29

17522

153582

Malignant neoplasm of bladder, including Hilmo

2316

17759

1.49

43.79

3.5

3.1

167.50

154.58

ug/l

1.43

2113

16213

Nontoxic multinodular goitre

4479

37884

1.36

43.65

3.4

3.0

103.70

120.92

ug/l

7.56

4154

35024

Rash and other nonspecific skin eruption

2357

18788

1.56

43.47

3.9

3.1

119.13

114.70

ug/l

0.25

2231

17573

Anorexia (incl.atypical)

1829

14430

1.78

43.36

4.4

3.3

68.27

70.81

ug/l

0.19

1754

13691

Haemorrhage in early pregnancy

8235

71587

1.29

43.36

3.6

3.2

76.09

77.47

ug/l

0.23

7821

68314

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4483

38274

1.38

43.24

3.7

3.2

102.55

96.41

ug/l

0.72

4146

36544

Malignant neoplasm of stomach

1092

7581

1.83

43.22

3.9

3.0

102.37

141.14

ug/l

6.70

1026

6955

Dermatophytosis

3175

26017

1.44

43.15

3.7

3.1

135.94

138.49

ug/l

0.23

2985

24321

Folate deficiency anaemia

289

1458

4.45

42.92

4.7

2.8

291.16

145.44

ug/l

5.90

275

1353

Malignant neoplasm of bronchus and lung

2598

27359

0.72

42.91

2.9

3.1

225.51

142.44

ug/l

24.78

2379

24976

940

13695

0.59

42.86

3.1

317.95

178.20

ug/l

7.79

865

12690

Vascular diseases of the intestine

868

5830

2.04

42.86

5.8

2.9

162.94

144.15

ug/l

0.64

826

5309

Other mental disorders due to brain damage and dysfunction and to physical disease

2593

20726

1.49

42.81

3.6

3.2

124.08

149.59

ug/l

7.14

2379

19042

Ankylosing spondylitis, ICD10

2067

16228

1.60

42.73

3.7

3.1

114.37

124.86

ug/l

1.66

1967

15370

Maternal care for known or suspected fetal abnormality and damage

5293

39357

1.41

42.71

3.7

3.4

51.65

63.43

ug/l

20.81

5070

38106

Malignant neoplasm of rectum, including Hilmo

2510

19906

1.48

42.67

3.0

3.1

148.41

138.81

ug/l

0.54

2320

18321

Memory loss

1945

15056

1.60

42.66

3.4

3.2

106.12

147.33

ug/l

22.00

1832

13828

Acidosis

508

3034

2.71

42.63

5.5

2.8

200.73

156.95

ug/l

1.81

478

2794

Attention to artificial openings

909

6172

1.99

42.60

4.2

2.8

152.28

138.39

ug/l

0.82

850

5671

Paralytic ileus

822

5440

2.05

42.58

4.2

2.8

142.13

151.98

ug/l

0.54

764

5006

Unspecified acute lower respiratory infection

3695

30726

1.39

42.53

3.9

3.1

145.77

129.79

ug/l

2.73

3512

28896

Substance use, excluding alcohol

4980

42611

1.33

42.37

3.5

3.1

116.86

116.00

ug/l

0.07

4541

40470

Injury of muscle and tendon at shoulder and upper arm level

8075

71273

1.24

42.26

3.2

3.1

143.58

157.08

ug/l

3.81

7530

66495

Malnutrition

557

3479

2.73

42.25

4.4

3.2

199.95

116.88

ug/l

1.26

513

3225

Necrosis of pulp, including avohilmo

16607

150959

1.17

42.15

3.5

3.2

106.42

115.26

ug/l

5.53

15507

143229

Lymphoid leukaemia

1208

8737

1.83

42.07

4.3

3.2

303.17

144.40

ug/l

2.54

1146

8069

Plantar fascial fibromatosis

2445

19584

1.52

41.97

3.5

3.0

106.60

116.06

ug/l

1.45

2295

18428

Special screening examination for neoplasms

1431

10482

1.67

41.82

3.6

2.7

155.77

160.73

ug/l

0.15

1323

9738

Excessive vomiting in pregnancy

2478

20461

1.64

41.77

4.1

3.3

67.34

69.37

ug/l

0.35

2330

19581

Seborrhoeic dermatitis

2326

18489

1.53

41.69

3.8

3.1

145.01

135.62

ug/l

0.73

2189

17308

Childhood asthma (age<16), excluding more controls

4352

28927

1.38

41.58

3.5

3.0

69.18

64.68

ug/l

1.15

4174

27770

Fracture of skull and facial bones

5203

44591

1.31

41.54

3.4

3.1

137.39

130.85

ug/l

0.83

4851

42064

Otalgia

2176

17380

1.60

41.42

3.8

3.3

96.83

100.12

ug/l

0.32

2028

16392

Cholecystitis

3153

25790

1.41

41.30

3.8

3.1

155.62

137.82

ug/l

2.11

2927

23748

Other/unspecified synovitis and tenosynovitis

2793

22685

1.46

41.30

3.6

3.0

115.32

122.15

ug/l

1.00

2595

21256

Heart failure and hypertrophic cardiomyopathy

443

2596

3.00

41.27

5.7

3.0

171.62

163.12

ug/l

0.31

424

2377

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

2048

15902

1.53

41.15

4.0

3.1

201.68

139.84

ug/l

16.46

1897

14617

Maternal care for known or suspected malpresentation of fetus

6373

40428

1.36

41.13

3.7

3.4

56.13

62.42

ug/l

4.49

6129

39167

Striking against or struck by other objects

8873

79003

1.23

41.12

3.4

3.2

115.85

120.02

ug/l

0.79

8262

74882

Other specified/unspecified systemic involvement of connective tissue

1420

10743

1.80

41.11

4.0

3.1

115.61

101.55

ug/l

1.73

1352

10107

Impotence

1124

7937

1.79

41.07

3.9

3.0

183.83

210.78

ug/l

1.09

1061

7432

Superficial injury of thorax

3669

30648

1.39

40.84

3.7

3.1

128.54

128.63

ug/l

0.01

3404

28730

Sarcoidosis

2984

24479

1.45

40.81

4.4

3.0

154.27

130.50

ug/l

1.76

2823

22969

Hypocalcemia

602

3895

2.63

40.76

6.4

3.1

207.89

122.57

ug/l

7.21

577

3631

Other infectious diseases, including avohilmo

2105

16598

1.56

40.75

4.8

3.2

168.50

129.37

ug/l

5.47

2000

15492

Nonalcoholic steatohepatitis

282

1489

5.39

40.74

4.7

2.9

196.64

114.32

ug/l

5.09

270

1409

Viral pneumonia (known virus, not influenza)

700

4645

2.32

40.34

5.1

3.1

268.87

132.82

ug/l

1.06

668

4300

Sequelae of other external causes

1371

10231

1.75

40.34

4.2

3.1

136.11

120.96

ug/l

1.31

1296

9573

Nasal polyp

4267

36034

1.34

40.29

3.2

3.1

124.61

150.21

ug/l

9.68

3989

33679

Childhood asthma (age<16)

4354

29035

1.37

40.15

3.6

3.0

69.18

65.24

ug/l

0.95

4176

27881

Endometriosis ASRM stages 1,2

5104

44655

1.37

40.12

3.6

3.3

75.54

77.03

ug/l

0.35

4843

42526

Reactive arthropathies, FINNGEN

1685

12945

1.64

40.11

3.6

3.0

140.99

117.17

ug/l

1.54

1621

12199

Rosacea

3363

28185

1.44

40.07

3.6

3.2

113.22

104.57

ug/l

0.81

3164

26562

Fall on and from stairs and steps

6651

58430

1.27

40.03

3.5

3.2

122.62

122.39

ug/l

0.02

6182

54674

Colitis, primary sclerosing, strict definition

315

1724

4.41

39.99

5.6

3.0

91.42

106.00

ug/l

1.37

308

1636

Secondary right heart disease

917

6361

1.97

39.85

5.5

3.1

131.43

139.51

ug/l

0.42

872

5806

Synovial cyst of popliteal space [Baker]

1659

12660

1.63

39.85

3.6

2.9

131.09

132.25

ug/l

0.07

1529

11729

Spontaneous abortion

13998

86176

1.20

39.77

3.5

3.3

74.77

81.06

ug/l

4.62

13232

81825

Chronic myeloproliferative disease

353

1979

3.64

39.73

6.3

3.0

352.30

144.78

ug/l

3.57

340

1821

Psoriatic arthropathies

2320

18502

1.50

39.52

3.5

2.9

135.64

133.77

ug/l

0.12

2190

17400

Superficial injury of shoulder and upper arm

3014

24867

1.44

39.38

3.3

3.1

112.47

118.25

ug/l

0.81

2771

23400

Raynaud syndrome

2352

19152

1.57

39.38

3.7

3.3

88.69

99.96

ug/l

1.41

2234

18122

Non-follicular lymphoma

1971

15413

1.55

39.37

3.6

3.1

371.76

150.22

ug/l

23.33

1850

14191

Carcinoma in situ of skin

1835

14272

1.59

39.31

3.9

3.1

137.00

145.63

ug/l

0.99

1696

13056

Impacted cerumen

2593

21008

1.47

39.27

3.4

3.2

140.05

139.10

ug/l

0.04

2238

19492

Other/unspecified rheumatoid arthritis

2730

22252

1.46

39.25

3.8

3.1

141.74

126.01

ug/l

1.82

2564

20495

Other disorders of bone

4973

42915

1.32

39.17

3.6

3.1

110.35

112.02

ug/l

0.24

4672

40568

Vulvovaginal ulceration/inflammation in other diseases

2144

17559

1.68

39.15

4.0

3.3

70.36

67.29

ug/l

0.47

2038

16719

Other autoimmune haemolytic anaemias

334

1860

3.89

39.15

5.0

3.0

526.22

131.33

ug/l

4.43

318

1718

Other pulmonary heart/vessel disease

999

7054

1.89

39.15

5.4

3.1

131.12

139.07

ug/l

0.44

950

6442

Anankastic personality disorder

1103

8188

2.02

39.13

4.0

3.1

80.39

92.69

ug/l

1.83

1043

7813

Lesion of ulnar nerve

3210

26579

1.40

38.85

3.6

3.0

129.07

138.21

ug/l

1.19

3004

25024

Carcinoma in situ of colon

668

4418

2.31

38.82

4.1

3.0

117.06

155.06

ug/l

4.66

629

4082

Right bundle-branch block

803

5380

1.97

38.72

4.1

2.7

144.29

152.58

ug/l

0.35

739

4927

Carcinoma in situ of skin of trunk

740

4976

2.16

38.64

4.2

3.1

158.62

155.40

ug/l

0.10

677

4504

Bullous disorders

1296

9643

1.75

38.60

3.9

3.1

144.02

132.74

ug/l

0.79

1218

8914

Emotional disorders starting during childhood or adolecense, excluding more controls

1415

10564

1.82

38.41

4.2

3.1

73.32

52.51

ug/l

0.56

1324

10100

Acute and subacute iridocyclitis

4563

39110

1.33

38.41

3.7

3.1

130.27

126.17

ug/l

0.32

4306

36736

Psoriasis

6903

60880

1.26

38.36

3.5

3.1

137.43

128.68

ug/l

1.58

6472

57143

Anterior Iridocyclitis

4826

41564

1.32

38.29

3.7

3.2

128.49

125.66

ug/l

0.22

4551

39014

Postpartum haemorrhage

8178

60971

1.28

38.20

3.7

3.3

63.68

68.38

ug/l

2.95

7765

58646

Speech and linguistic disorders, excluding more controls

2195

16455

1.53

38.18

4.0

3.0

86.96

81.27

ug/l

0.76

2086

15676

IBD (strict) with PSC

292

1580

4.48

38.16

5.9

3.1

85.15

108.92

ug/l

2.42

286

1505

Any prescribed medicine buy

118

170

5.08

38.05

3.0

2.4

143.05

74.52

ug/l

2.34

112

161

Lichen ruber planus, wide definition including periferal and oral lichen planus

5272

45726

1.30

38.01

3.3

3.1

116.19

126.58

ug/l

2.80

4915

42611

Other problems related to primary support group, including family circumstances

3262

26820

1.46

37.92

4.4

3.3

84.72

76.39

ug/l

1.49

3113

25626

Temporal arteritis

811

5585

2.06

37.84

3.8

3.0

164.41

136.25

ug/l

1.58

750

5086

Infection of intervertebral disc (pyogenic)

344

1912

3.30

37.74

5.1

2.9

194.67

160.57

ug/l

1.14

319

1767

Cardiac murmurs and other cardiac sounds

2528

20358

1.48

37.70

3.8

3.0

91.18

94.19

ug/l

0.34

2380

19176

Ethmoidectomy

3092

25733

1.42

37.62

3.5

3.1

114.93

121.03

ug/l

0.91

2853

24318

Drug-induced osteoporosis with pathological fracture

423

2553

3.10

37.61

5.2

3.0

138.14

119.52

ug/l

0.83

402

2346

Other respiratory disorders and diseases

4377

37181

1.32

37.59

4.2

3.1

163.72

148.96

ug/l

1.98

4029

34136

Other diseases of the respiratory system

4377

37181

1.32

37.59

4.2

3.1

163.72

148.96

ug/l

1.98

4029

34136

Degenerative macular diseases

2533

20491

1.45

37.38

3.7

3.1

141.46

147.00

ug/l

0.52

2285

18761

Neuralgia and neuritis, unspecified

1258

9376

1.76

37.38

3.9

3.0

114.39

120.16

ug/l

0.44

1193

8795

Convalescence

1302

9789

1.75

37.31

4.0

2.9

108.87

102.94

ug/l

0.61

1199

9181

Anogenital herpesviral [herpes simplex] infection, including avohilmo

3476

29763

1.45

37.10

3.6

3.3

72.72

75.29

ug/l

0.56

3316

28478

Diseases of spleen

465

2877

2.84

37.07

6.8

3.1

280.77

128.51

ug/l

3.07

447

2688

Other follicular disorders

1985

15909

1.59

37.04

4.1

3.2

122.28

104.20

ug/l

2.28

1883

15124

D07AA Corticosteroids, weak (group I)

4188

35949

1.36

36.66

3.7

3.3

95.83

93.37

ug/l

0.22

3978

34100

Right hemicolectomy

1227

9079

1.73

36.49

4.4

3.1

136.21

144.28

ug/l

0.33

1156

8341

Endometriosis of rectovaginal septum and vagina

1910

15219

1.58

36.31

3.5

3.1

89.58

92.24

ug/l

0.17

1782

14275

Suicide or other Intentional self-harm

6396

56532

1.27

36.23

3.6

3.2

107.44

107.12

ug/l

0.03

5904

53716

COPD

9917

72338

1.19

36.07

3.7

3.0

155.97

161.45

ug/l

0.80

9072

66338

Alcohol-induced chronic pancreatitis

1285

9564

1.68

36.04

3.9

3.0

188.61

169.05

ug/l

1.24

1207

8979

Deficiency of other B group vitamins

527

3348

2.47

35.93

5.5

3.0

116.95

125.85

ug/l

0.48

496

3089

Abnormal findings on examination of urine, without diagnosis

1036

7571

1.87

35.87

5.9

3.2

153.29

125.63

ug/l

3.07

1002

7076

Olecranon bursitis

1256

9263

1.67

35.86

3.8

2.9

163.61

185.37

ug/l

1.58

1169

8635

Postviral fatigue syndrome

302

1785

6.23

35.78

6.0

3.3

82.79

69.02

ug/l

1.19

296

1719

Hydrocele

2187

17259

1.44

35.64

3.8

3.0

173.87

199.34

ug/l

2.88

2036

16014

Benign neoplasm: Duodenum

595

3922

2.36

35.62

5.4

3.1

103.55

148.43

ug/l

6.30

553

3617

Suggestive for eosinophilic asthma

2039

16261

1.52

35.62

3.5

3.0

113.54

138.53

ug/l

6.62

1920

15183

Lateral epicondylitis

3154

26302

1.39

35.60

3.2

2.9

110.47

125.77

ug/l

3.56

2979

24905

Malignant neoplasm of urinary organs

1969

15492

1.49

35.53

4.0

3.1

205.05

141.81

ug/l

16.07

1817

14219

Postprocedural musculoskeletal disorders, not elsewhere classified

1566

12121

1.62

35.53

3.8

3.1

129.19

138.02

ug/l

0.92

1476

11243

Carcinoma in situ of skin of scalp and neck

619

4084

2.24

35.41

4.4

3.2

153.96

165.83

ug/l

0.69

567

3712

Hypermobility syndrome

1606

12896

1.78

35.39

4.2

3.3

69.18

68.73

ug/l

0.05

1563

12331

Cervical polyps

2276

18417

1.48

35.39

3.3

3.0

88.55

104.13

ug/l

4.55

2135

17282

Asthma and opportunity respiratory infection

1019

7407

1.85

35.38

3.8

3.0

134.72

137.43

ug/l

0.04

963

6791

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

7345

65264

1.23

35.31

3.3

3.1

126.80

131.49

ug/l

0.77

6903

61429

Tongue abnormality

1395

10698

1.69

35.18

3.5

3.1

111.79

123.25

ug/l

1.53

1290

9951

Hyperhidrosis

920

6690

2.01

35.13

3.7

2.9

95.13

81.90

ug/l

1.35

858

6311

Other specified/unspecified hearing loss

1971

15623

1.51

35.12

3.5

3.1

138.93

137.76

ug/l

0.05

1885

14512

Premature rupture of membranes

7091

45471

1.30

35.07

3.5

3.3

61.18

64.97

ug/l

1.42

6676

43886

Other abnormalities of plasma proteins

405

2446

2.95

35.04

5.1

3.1

241.99

133.00

ug/l

4.16

383

2257

Cramp and spasm

1169

8785

1.81

35.03

3.8

3.1

121.98

115.28

ug/l

0.35

1105

8274

Giant cell arteritis with polymyalgia rheumatica

811

5678

2.01

35.02

3.8

3.1

164.41

137.28

ug/l

1.50

750

5169

Nonsuppurative otitis media, including avohilmo

9582

75145

1.22

34.87

3.7

3.2

88.30

90.45

ug/l

0.52

9142

71360

Orchitis and epididymitis

1728

13294

1.50

34.70

3.4

3.0

178.85

197.99

ug/l

1.39

1616

12420

Malignant neoplasm of respiratory system and intrathoracic organs

3119

31230

0.76

34.69

2.9

3.1

230.48

141.77

ug/l

27.42

2873

28581

Adenocarcinoma and papilloma adenocarcinoma of rectum

1987

15713

1.49

34.66

2.9

3.1

154.56

140.01

ug/l

0.71

1834

14437

Discitis, unspecified

408

2437

2.72

34.53

4.8

2.9

171.09

145.90

ug/l

1.54

387

2248

Malignant neoplasm of kidney, except renal pelvis

1800

14069

1.51

34.46

4.1

3.1

204.60

140.98

ug/l

14.81

1663

12939

FESS (DNB20)

2973

24878

1.41

34.23

3.5

3.1

115.01

120.74

ug/l

0.80

2739

23527

Congenital malformations of the circulatory system

3471

28592

1.37

34.21

3.9

3.2

105.33

110.59

ug/l

0.85

3266

27090

Vasculitis limited to skin, not elsewhere classified

629

4225

2.24

34.20

4.3

3.0

163.42

129.79

ug/l

1.29

596

3907

Secondary polycythaemia

555

3600

2.30

33.99

3.7

3.0

148.58

148.91

ug/l

0.01

521

3350

Secondary and unspecified malignant neoplasm of lymph nodes

1795

14127

1.53

33.85

3.4

3.1

328.95

126.57

ug/l

19.01

1683

13078

Atypical facial pain

1270

9702

1.74

33.85

3.9

3.1

110.84

109.57

ug/l

0.03

1194

9106

Unknown and unspecified causes of morbidity

1633

12701

1.56

33.81

3.9

2.8

124.47

109.95

ug/l

2.07

1578

11883

Other specified/unspecified soft tissue disorders

1118

8260

1.74

33.77

4.0

2.9

115.93

120.37

ug/l

0.20

1030

7647

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

2057

16391

1.47

33.67

2.9

3.1

152.76

140.95

ug/l

0.56

1903

15058

Schizophrenia or delusion, excluding more controls

7476

65756

1.22

33.65

3.2

3.0

110.23

115.99

ug/l

0.82

6942

62472

Sulfonylureas

6948

48665

1.22

33.45

4.4

3.0

132.17

173.71

ug/l

30.93

6308

44203

Superficial injury of wrist and hand

5762

50892

1.27

33.42

3.4

3.2

93.65

103.01

ug/l

3.41

5405

48313

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

6197

55314

1.28

33.36

3.5

3.3

85.84

79.97

ug/l

1.65

5881

52965

Agoraphobia

958

7136

1.98

33.15

3.9

3.1

78.01

77.35

ug/l

0.05

885

6835

Fall involving bed

755

5240

1.98

33.10

4.1

3.2

162.11

137.69

ug/l

0.98

696

4778

Other and unspecified vascular occlusions

1928

15316

1.49

33.09

3.9

3.1

140.23

153.42

ug/l

1.45

1752

13994

Chronic tubulo-interstitial nephritis

855

6071

1.89

33.05

6.4

2.8

181.31

107.33

ug/l

12.16

815

5625

Dementia, including avohilmo

10132

62379

1.18

32.97

3.0

3.2

142.18

160.94

ug/l

9.80

8947

56773

Lichen sclerosus et atrophicus

2713

22595

1.42

32.88

3.4

3.0

98.50

109.81

ug/l

2.03

2505

21043

Glaucoma suspect

8377

75310

1.21

32.66

3.4

3.1

126.29

139.49

ug/l

5.77

7682

69573

Mental and behavioural disorders due to sedatives or hypnotics

1606

12632

1.58

32.55

3.6

3.1

113.90

117.35

ug/l

0.12

1469

11996

Autoimmune hyperthyroidism

1571

12382

1.61

32.52

3.7

2.9

102.13

95.91

ug/l

0.56

1495

11724

Malignant neoplasm of bronchus and lung, including Hilmo

3107

31092

0.76

32.46

3.0

3.1

217.79

141.89

ug/l

24.21

2855

28418

Open wound of forearm

2330

19091

1.45

32.45

3.9

3.1

114.32

122.19

ug/l

1.30

2134

17919

Systemic lupus erythematosus

902

6628

1.96

32.45

4.6

3.1

159.07

94.85

ug/l

8.94

863

6231

Other infectious diseases

1679

13224

1.55

32.42

5.1

3.1

179.23

131.57

ug/l

5.43

1591

12307

Malignant neoplasm of small intestine, including Hilmo

667

4538

2.06

32.31

4.1

3.0

137.96

132.21

ug/l

0.27

629

4183

Malignant neoplasm of small intestine

518

3348

2.32

32.26

4.1

3.0

137.72

132.46

ug/l

0.21

487

3089

Oesophageal obstruction

745

5142

1.93

32.22

3.9

2.8

119.47

161.59

ug/l

5.63

689

4732

Diabetic neuropathy

2420

19917

1.45

31.83

5.7

3.8

153.45

150.84

ug/l

0.22

2276

18455

Open wound of ankle and foot

2498

20677

1.43

31.60

4.3

3.1

130.73

121.40

ug/l

1.17

2333

19489

Dermatographic urticaria

1829

14880

1.58

31.56

3.9

3.2

95.03

90.41

ug/l

0.37

1712

14125

Any dementia, excluding more controls

7759

47477

1.21

31.46

3.0

3.1

141.70

162.22

ug/l

8.83

6934

43033

Nail disorders

2020

16400

1.49

31.46

4.3

3.1

111.52

115.37

ug/l

0.47

1906

15425

Other pleural conditions

2090

16829

1.44

31.44

4.6

3.1

225.95

152.97

ug/l

14.63

1941

15403

Retinal breaks without detachment

3538

30143

1.34

31.43

3.2

3.0

130.53

142.96

ug/l

2.01

3275

28137

Gluteal tendinitis

1067

7996

1.76

31.32

3.7

2.9

91.77

110.94

ug/l

5.61

977

7496

Dronedarone medication

587

3887

2.09

31.24

3.5

2.7

129.36

158.09

ug/l

2.81

521

3518

Epilepsy

7442

66322

1.21

31.02

3.4

3.0

139.41

128.56

ug/l

1.82

6920

62188

Injury of unspecified body region

1820

14654

1.52

30.81

4.2

3.2

118.57

117.57

ug/l

0.08

1705

13702

SLE, strict definition

853

6285

1.99

30.79

4.5

3.1

155.24

93.37

ug/l

8.90

817

5907

SLE, ICD10

853

6285

1.99

30.79

4.5

3.1

155.24

93.37

ug/l

8.90

817

5907

Abnormal findings on antenatal screening of mother

2894

25158

1.52

30.68

4.2

3.4

45.85

54.17

ug/l

8.47

2805

24280

Unspecified mental disorder

10553

96463

1.18

30.66

3.4

3.2

102.21

113.47

ug/l

4.90

9827

91333

Postprocedural disorders of nervous system

1983

16359

1.55

30.58

3.8

3.2

78.58

84.80

ug/l

1.33

1912

15621

Hypertrophic cardiomyopathy

885

6427

1.82

30.38

4.7

3.1

149.64

149.37

ug/l

0.01

843

5956

Other disorders of breast

3708

32220

1.36

30.37

3.4

3.2

82.73

85.62

ug/l

0.40

3526

30360

Hypoparathyroidism

840

6115

1.91

30.33

4.5

3.0

124.23

108.83

ug/l

0.62

775

5658

Acute appendicitis, no complications

15338

141640

1.15

30.32

3.3

3.2

110.42

114.36

ug/l

1.55

14584

134296

Nummular dermatitis

1846

14824

1.49

30.30

3.7

3.1

142.38

138.63

ug/l

0.22

1718

13812

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

1333

10392

1.65

30.27

3.4

3.1

109.03

113.37

ug/l

0.36

1233

9655

Lichen planus, including avohilmo

4335

37689

1.29

30.23

3.3

3.1

120.48

128.31

ug/l

1.38

4036

35072

Benign neoplasm: Adrenal gland

1686

13460

1.54

30.22

3.7

3.1

141.99

136.63

ug/l

0.23

1583

12542

Solid cancers, including Hilmo

23504

128595

1.12

30.16

3.2

3.1

158.07

106.91

ug/l

70.82

22106

121243

Nontoxic goitre/thyroid nodule

6943

62282

1.23

30.14

3.4

3.2

105.04

116.92

ug/l

5.86

6457

57680

Mixed hyperlipidaemia

835

5955

1.80

30.10

4.4

2.8

166.94

156.63

ug/l

0.41

769

5473

Urethral stricture

1122

8358

1.63

29.95

3.5

3.0

168.78

186.98

ug/l

1.16

1016

7730

Acute pharyngitis

4287

37027

1.31

29.93

3.7

3.1

98.05

92.82

ug/l

0.89

4096

35353

severe traumatic brain injury, does not include concussion

4798

41797

1.26

29.84

3.5

3.1

160.74

154.33

ug/l

0.64

4378

38475

Acne

3333

28674

1.39

29.81

3.9

3.3

70.65

69.80

ug/l

0.15

3194

27391

Viral warts

2519

21117

1.43

29.71

4.7

3.2

113.33

103.46

ug/l

1.81

2428

19953

Allergic contact dermatitis

3551

30661

1.35

29.67

3.4

3.1

98.34

96.36

ug/l

0.16

3347

28976

Other disorders starting during childhood or adolecense, excluding more controls

1349

10093

1.65

29.65

4.1

3.1

60.44

61.85

ug/l

0.20

1287

9681

Malignant neoplasm of rectum

1981

15949

1.44

29.64

3.0

3.1

155.29

140.23

ug/l

0.74

1825

14655

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

7987

72283

1.21

29.62

3.4

3.2

102.53

108.63

ug/l

1.94

7542

68713

Congenital malformations of heart and great arteries

3024

24899

1.37

29.52

3.9

3.2

105.06

110.83

ug/l

0.91

2843

23597

Other chronic obstructive pulmonary disease

9413

69749

1.18

29.48

3.7

3.0

153.91

162.76

ug/l

1.59

8605

63889

728

5401

2.30

29.46

4.1

3.0

78.04

66.30

ug/l

1.50

676

5158

Sacrococcygeal disorders, not elsewhere classified

808

5896

1.94

29.44

3.7

3.0

94.70

98.99

ug/l

0.32

777

5581

Renal tubulo-interstitial disorders in diseases classified elsewhere

258

1447

3.71

29.41

7.9

2.8

184.56

124.37

ug/l

4.93

247

1332

Isolated proteinuria

671

4727

2.06

29.29

7.1

3.1

165.57

125.83

ug/l

4.27

649

4444

Tubulo-interstitial nephritis, not specified as acute or chronic

1560

12314

1.53

29.28

4.4

2.9

135.24

110.34

ug/l

3.59

1466

11409

Other and unspecified abdominal hernia

906

6654

1.79

29.27

4.4

3.0

112.23

133.85

ug/l

2.83

851

6172

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

1798

14570

1.52

29.26

4.5

3.2

122.70

115.18

ug/l

0.98

1704

13630

Any event in hilmo or specialist outpatient

137

271

3.93

29.11

3.0

1.8

105.63

69.29

ug/l

1.64

132

261

Visual impairment including blindness (binocular or monocular)

1541

12153

1.53

29.04

4.2

3.1

140.07

122.38

ug/l

1.41

1365

11242

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

3261

27705

1.33

28.93

3.1

308.36

128.99

ug/l

31.65

3074

25674

Any event in cancer register

26518

146265

1.11

28.86

3.3

3.2

158.54

101.26

ug/l

55.83

24958

138227

Prurigo nodularis

577

3945

2.15

28.83

4.8

3.0

116.70

139.01

ug/l

1.25

535

3658

Corns and callosities

1471

11589

1.56

28.82

4.5

3.0

141.67

127.93

ug/l

0.96

1382

10789

Other and unspecified vasculitis limited to skin

558

3789

2.18

28.80

4.3

2.9

167.45

130.93

ug/l

1.29

526

3504

Benign lipomatous neoplasm

6783

60802

1.22

28.69

3.2

3.1

123.91

133.06

ug/l

2.06

6327

56775

Superficial injury of forearm

2649

22360

1.40

28.56

3.4

3.2

98.19

101.30

ug/l

0.44

2474

21150

Other and unspecified aplastic anaemias

288

1669

3.13

28.35

6.6

2.8

418.68

119.50

ug/l

10.19

279

1540

Benign neoplasm: Rectosigmoid junction

868

6375

1.80

28.27

3.7

3.1

125.47

147.35

ug/l

1.85

824

5879

Diabetic retinopathy, strict definition

3739

28826

1.33

28.20

6.1

3.7

161.70

136.54

ug/l

8.11

3438

26932

Hypotension due to drugs

345

2090

2.69

28.14

3.9

3.1

146.13

149.11

ug/l

0.09

314

1911

Other symptoms and signs involving general sensations and perceptions

973

7278

1.73

28.13

3.5

3.1

137.12

120.60

ug/l

0.44

899

6762

Primary open-angle glaucoma

6772

58227

1.21

28.07

3.2

144.93

153.18

ug/l

1.38

6041

53039

Volvulus

613

4195

1.97

28.02

4.5

2.8

123.33

133.06

ug/l

0.59

574

3867

Endometriosis diagnosis and infertility diagnosis occurring together

3091

26897

1.42

27.88

3.8

3.4

68.79

71.15

ug/l

0.30

2974

25769

Other/unspecified enthesopathies, not elsewhere classified

1850

14949

1.45

27.85

3.5

2.9

119.09

131.39

ug/l

1.66

1736

13929

Other and unspecified immunodeficiencies with predominantly antibody defects

334

2082

3.13

27.82

5.9

3.0

192.89

99.45

ug/l

2.40

326

1947

Urolithiasis

7182

64555

1.20

27.81

3.6

3.2

149.86

150.87

ug/l

0.08

6652

60080

Trigeminal neuralgia

1394

11009

1.58

27.78

3.4

3.0

102.07

112.51

ug/l

1.31

1311

10315

Fracture of forearm

15135

126525

1.14

27.74

3.3

3.1

112.58

113.19

ug/l

0.12

14048

118512

Arthropathy in ulcerative colitis

361

2302

2.99

27.72

5.2

3.1

91.38

95.69

ug/l

0.27

353

2189

Pneumonia due to other infectious organisms, not elsewhere classified

751

5394

1.87

27.70

4.9

3.0

283.33

126.15

ug/l

5.20

716

5021

Vasomotor rhinitis (mode)

1675

13553

1.52

27.58

3.6

3.1

100.28

116.02

ug/l

4.21

1555

12725

Overexertion and strenuous or repetitive movements

2285

19026

1.42

27.57

3.4

3.1

114.48

122.46

ug/l

1.02

2183

17989

Achilles tendinitis

2321

19237

1.39

27.55

3.5

3.0

127.23

137.67

ug/l

0.89

2175

18083

Traumatic subarachnoid haemorrhage

769

5454

1.76

27.50

3.6

2.9

168.15

161.43

ug/l

0.15

690

5068

Anomalies of dental arch relationship, including avohilmo

5526

44639

1.26

27.49

3.5

3.2

78.10

90.64

ug/l

7.51

5217

42392

Suppurative and unspecified otitis media

10715

87425

1.17

27.45

3.7

3.2

88.90

91.94

ug/l

0.87

10131

83257

Alcohol dependence

5750

50978

1.22

27.41

3.4

3.1

164.24

153.41

ug/l

1.30

5314

47904

Palmar fascial fibromatosis [Dupuytren]

2945

24767

1.32

27.26

3.4

3.0

162.44

176.87

ug/l

1.58

2711

22731

Systemic lupus erythematosus, unspecified

742

5467

2.00

27.13

4.5

3.1

154.01

91.54

ug/l

7.59

707

5139

Wide developmental disorders, excluding more controls

878

6369

1.79

27.10

3.6

3.1

64.07

71.30

ug/l

1.01

813

6123

Invasive ventilation

1569

12542

1.51

27.00

4.7

3.1

182.85

137.66

ug/l

4.46

1448

11691

Abnormal blood-pressure reading, without diagnosis

1084

8264

1.65

26.95

3.6

2.9

108.97

114.71

ug/l

0.40

1012

7759

Gingival hyperplasia

859

6404

1.82

26.92

6.6

3.2

133.87

120.64

ug/l

0.95

822

6006

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

200

1050

4.01

26.85

5.3

2.9

223.92

137.16

ug/l

2.49

195

961

Disorders of magnesium metabolism

214

1163

3.98

26.80

5.3

2.8

322.59

138.88

ug/l

2.63

207

1089

Other and unspecified rosacea

2219

18577

1.43

26.61

3.8

3.1

121.84

109.16

ug/l

0.99

2094

17502

Other or ill-defined heart diseases

1103

8317

1.58

26.60

4.7

2.8

151.01

138.81

ug/l

0.77

1046

7743

Amyloidosis

496

3297

2.11

26.53

4.7

2.9

175.45

146.43

ug/l

2.27

462

3001

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

13547

109749

1.16

26.49

3.7

3.3

78.32

79.64

ug/l

0.42

12946

104198

Pneumocystosis, including avohilmo

436

2870

2.37

26.47

5.3

3.0

339.89

147.93

ug/l

3.41

421

2640

Pneumocystosis

436

2870

2.37

26.47

5.3

3.0

339.89

147.93

ug/l

3.41

421

2640

Injury of muscle and tendon at hip and thigh level

2345

19644

1.39

26.08

3.3

3.1

118.18

127.61

ug/l

1.55

2219

18577

Speech disturbances, not elsewhere classified

1943

15932

1.43

26.02

3.8

3.1

149.89

137.97

ug/l

0.52

1752

14737

Dementia

9420

58625

1.17

25.99

3.0

3.2

141.78

160.03

ug/l

9.58

8323

53252

Other peripheral vascular diseases

1907

15708

1.45

25.97

4.0

3.1

99.98

112.80

ug/l

1.24

1807

14705

Benign neoplasm: Skin of eyelid, including canthus

3406

29419

1.31

25.96

3.4

3.1

115.68

130.94

ug/l

3.70

3165

27316

Other and/or unspecified nontoxic goitre

1785

14570

1.46

25.90

3.3

3.0

100.91

116.10

ug/l

3.48

1693

13578

Dislocation, sprain and strain of joints and ligaments of knee

17525

148648

1.12

25.83

3.2

112.17

111.21

ug/l

0.17

16656

140942

Single delivery by forceps and vacuum extractor

4844

25980

1.32

25.79

3.5

53.96

62.77

ug/l

8.04

4635

25082

Polycystic ovarian syndrome, broad definition

3799

33972

1.38

25.75

3.9

3.5

55.08

55.80

ug/l

0.21

3656

32629

Dissociative [conversion] disorders

1100

8682

1.74

25.71

4.0

3.1

66.95

74.93

ug/l

0.94

1031

8262

Polycystic ovarian syndrome

1971

16915

1.61

25.70

3.9

3.4

53.86

51.82

ug/l

0.71

1905

16189

Autism spe, excluding more controls

680

4897

1.93

25.68

3.5

3.0

65.46

71.75

ug/l

0.71

624

4715

Disorder of the sleep-wake schedule

486

3333

2.30

25.66

4.2

3.1

94.27

93.90

ug/l

0.02

458

3145

Intussusception

526

3615

2.12

25.66

3.6

2.8

114.93

107.63

ug/l

0.11

501

3366

Cluster headache, wide

952

7228

1.71

25.65

4.3

3.0

100.68

111.41

ug/l

0.71

914

6879

Diseases of appendix

20776

175105

1.11

25.60

3.3

3.2

117.30

117.61

ug/l

0.07

19700

165129

Appendicitis, broad definition

20613

174354

1.11

25.42

3.3

3.2

117.12

117.57

ug/l

0.10

19551

164448

Amyloidosis, other/unspecified

416

2699

2.27

25.32

4.7

2.9

181.47

148.65

ug/l

2.35

390

2456

Idiopathic thrombocytopenic purpura

707

5159

1.90

25.25

4.7

3.2

174.11

116.86

ug/l

2.08

684

4811

Nonhereditary hypogammaglobulinemia

292

1796

3.15

25.25

5.2

3.0

190.34

102.45

ug/l

3.32

284

1683

Thyroiditis

1759

14528

1.50

25.24

3.8

3.2

104.32

96.39

ug/l

0.68

1641

13718

Arterial embolism and thrombosis

1143

8753

1.55

25.19

5.1

3.0

156.26

157.66

ug/l

0.07

1077

7997

Need for immunization against other single viral diseases

444

2960

2.27

25.15

10.0

3.0

195.75

139.28

ug/l

3.46

432

2783

Cardiomyopathy, Hypertrophic obstructive

392

2490

2.25

25.05

4.9

2.7

151.42

148.46

ug/l

0.08

371

2285

Heterophoria

2066

17343

1.44

24.99

3.8

3.2

91.55

93.47

ug/l

0.12

1936

16424

Clear cell adenocarcinoma of kidney

939

7070

1.66

24.91

3.7

3.0

200.95

142.33

ug/l

7.82

865

6526

Other secondary gonarthrosis

1111

8591

1.60

24.88

3.6

3.1

139.45

140.49

ug/l

0.05

1041

8011

Complications of other internal prosthetic devices, implants and grafts

938

7108

1.69

24.87

4.0

3.0

135.50

120.73

ug/l

0.77

879

6585

Myeloid leukaemia

583

4081

1.96

24.84

4.6

3.1

475.48

141.93

ug/l

9.55

564

3773

COPD related to multimorbidity

8363

64220

1.17

24.80

3.9

3.1

151.52

163.77

ug/l

2.42

7648

58827

Other superficial mycoses, including avohilmo

2859

24620

1.35

24.80

3.6

3.2

91.21

97.52

ug/l

1.50

2702

23400

Other and unspecified acquired haemolytic anaemias

243

1401

3.25

24.73

7.9

3.1

408.74

125.05

ug/l

6.57

234

1303

Female infertility, tubal origin

1258

10010

1.60

24.73

3.6

3.0

75.80

82.54

ug/l

1.37

1216

9547

Other aneurysm

1082

8277

1.58

24.71

4.5

2.9

171.69

161.79

ug/l

0.46

1016

7601

Delivery, wide proxy

9456

46234

1.19

24.62

3.4

3.3

74.86

85.90

ug/l

8.12

8848

43305

Other epidermal thickening

1031

7948

1.64

24.50

4.3

3.1

133.14

123.36

ug/l

0.77

985

7401

Pregnancy, childbirth and the puerperium

8367

40026

1.20

24.47

3.4

3.3

73.84

84.66

ug/l

8.56

7759

37457

Other and unspecified follicular disorders

987

7603

1.68

24.46

4.3

3.1

142.01

121.10

ug/l

1.12

933

7163

Cluster headache, strict

896

6805

1.73

24.42

4.4

3.0

96.79

109.84

ug/l

0.99

861

6497

Other complications of labour and delivery, not elsewhere classified

4157

33200

1.35

24.41

3.7

3.5

46.38

54.34

ug/l

13.54

3995

32010

Etanercept

1620

13296

1.50

24.40

3.5

3.2

116.66

101.98

ug/l

0.66

1556

12637

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

3692

35073

0.81

24.40

3.0

3.1

222.48

140.31

ug/l

28.32

3409

32091

Other condition

3450

30018

1.30

24.38

3.8

3.2

130.31

117.76

ug/l

1.29

3298

28298

Calcific tendinitis of shoulder

1298

10283

1.54

24.35

3.3

2.9

109.26

121.53

ug/l

1.51

1221

9699

Panniculitis affecting regions of neck and back

828

6167

1.73

24.35

3.8

3.0

116.99

119.12

ug/l

0.11

791

5790

Viral hepatitis, including avohilmo

1760

14469

1.45

24.33

3.5

3.1

132.36

114.50

ug/l

1.56

1638

13788

Sacroiliitis, not elsewhere classified

1270

10159

1.59

24.25

3.7

3.1

103.42

86.59

ug/l

0.67

1217

9696

Carcinoma in situ of skin of upper limb, including shoulder

553

3868

2.01

24.21

4.4

3.2

159.30

154.95

ug/l

0.16

512

3507

Cardiomyopathy in other diseases

145

685

4.34

24.20

4.4

2.5

142.48

178.04

ug/l

1.40

135

621

therapeutic use

689

5021

1.86

24.19

4.0

3.0

148.26

132.47

ug/l

0.90

616

4617

Ovarian dysfunction

2549

22293

1.47

24.15

3.9

3.4

58.85

56.89

ug/l

0.53

2452

21342

Other viral hepatitis

1448

11675

1.51

24.14

3.5

3.1

130.98

112.93

ug/l

1.44

1352

11162

Entropion and trichiasis of eyelid

1697

13754

1.42

24.13

3.6

3.1

145.36

155.44

ug/l

0.75

1555

12510

Congenital iodine-deficiency syndrome/hypothyroidism

673

4901

1.89

24.10

3.9

3.0

105.68

106.61

ug/l

0.05

630

4566

Biomechanical lesions, not elsewhere classified

1140

8950

1.60

24.07

3.9

3.1

106.10

125.67

ug/l

3.54

1064

8366

Dermatitis due to substances taken internally

1304

10413

1.55

23.99

4.1

3.1

147.22

107.31

ug/l

2.25

1226

9776

Psoriasis vulgaris

4223

37209

1.26

23.98

3.6

3.1

145.30

132.66

ug/l

1.73

3956

34960

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

1885

15591

1.42

23.95

3.4

3.0

103.72

109.11

ug/l

0.64

1789

14841

Complications predominantly related to the puerperium

7620

70133

1.21

23.88

3.7

3.3

72.50

74.34

ug/l

0.40

7241

66848

Viral hepatitis

1658

13576

1.46

23.84

3.5

3.1

134.49

115.77

ug/l

1.54

1543

12942

COPD-related respiratory insufficiency

2288

19116

1.35

23.83

4.4

3.1

154.47

166.09

ug/l

0.68

2098

17442

Primary open-angle glaucoma, strict

5496

48923

1.21

23.82

3.2

145.81

152.73

ug/l

0.94

4895

44530

Malignant immunoproliferative diseases

243

1412

3.11

23.82

5.4

3.0

253.58

151.04

ug/l

2.55

235

1293

Arthropathy in Crohn disease

291

1833

3.16

23.80

6.0

3.1

89.29

102.74

ug/l

0.96

285

1732

Other noninfective disorders of lymphatic vessels and lymph nodes

851

6432

1.73

23.79

4.2

3.0

133.59

115.52

ug/l

1.41

815

6037

Calculus of kidney and ureter

6616

59736

1.19

23.77

3.6

3.2

147.93

149.51

ug/l

0.12

6152

55633

Postzoster neuralgia

378

2452

2.34

23.72

4.0

2.9

253.30

128.42

ug/l

1.21

351

2250

Other viral hepatitis, including avohilmo

1541

12540

1.48

23.65

3.5

3.1

128.52

111.80

ug/l

1.40

1437

11987

Scleritis and episcleritis

1483

12079

1.52

23.64

3.7

3.1

108.73

105.70

ug/l

0.26

1411

11463

Other and unspecified disorders of skin and subcutaneous tissue

1395

11212

1.51

23.64

4.0

3.0

165.50

121.23

ug/l

2.51

1241

10455

Carcinoma in situ of skin of ear and external auricular canal

339

2121

2.38

23.62

4.4

3.3

157.16

176.01

ug/l

0.80

307

1936

Other chronic obstructive pulmonary disease, including avohilmo

11992

91111

1.14

23.58

3.6

3.1

150.94

155.47

ug/l

0.76

10938

84004

Lesion of lateral popliteal nerve

1067

8282

1.60

23.49

3.8

3.0

129.37

137.52

ug/l

0.52

1013

7756

Inguinal or femoral hernia, bilateral

2050

16965

1.37

23.46

3.5

3.1

161.52

185.59

ug/l

2.02

1901

15683

Myositis

565

3967

1.93

23.44

3.8

2.9

157.85

134.84

ug/l

1.08

540

3689

Other juvenile arthritis

1109

8840

1.67

23.37

4.3

3.2

83.48

73.15

ug/l

0.55

1077

8401

Long labour

7449

58125

1.22

23.36

3.4

3.3

66.34

69.28

ug/l

0.95

7172

55837

Other chondrocalcinosis

297

1825

2.65

23.35

4.3

3.0

176.95

150.10

ug/l

0.68

274

1654

Drug-induced cataract

540

3815

2.04

23.28

6.9

3.0

172.02

129.04

ug/l

2.68

509

3577

Inguinal hernia, bilateral

2012

16634

1.37

23.27

3.5

3.1

161.97

186.73

ug/l

2.06

1866

15380

Lichen planus

2804

24066

1.32

23.22

3.3

3.1

126.38

129.83

ug/l

0.31

2597

22337

Seropositive rheumatoid arthritis, strict definition

3376

29445

1.29

23.19

3.2

3.1

132.04

120.70

ug/l

1.72

3208

27449

Cerebral palsy and other paralytic syndromes

2505

21295

1.34

23.18

3.8

3.2

127.10

119.67

ug/l

0.59

2333

19992

Complications of cardiac and vascular prosthetic devices, implants and grafts

447

2995

2.08

23.15

8.0

2.9

193.28

151.69

ug/l

2.76

421

2750

Corneal ulcer

4467

39634

1.25

23.14

3.6

3.2

114.63

118.69

ug/l

0.70

4210

37361

Pregnancy hypertension

12329

103186

1.16

23.09

3.7

3.3

77.50

77.41

ug/l

0.02

11799

98242

Monoarthritis, not elsewhere classified

947

7247

1.63

23.07

3.5

3.0

135.83

120.84

ug/l

0.82

896

6807

Acute appendicitis

19307

169121

1.11

23.05

3.3

3.2

116.31

117.26

ug/l

0.24

18325

159652

Chondrocostal junction syndrome [Tietze]

917

7092

1.72

23.04

3.6

3.1

103.36

102.88

ug/l

0.02

845

6652

Examination and encounter for administrative purposes

1657

13441

1.41

23.01

3.4

2.8

132.55

160.89

ug/l

5.73

1585

12377

Diffuse large B-cell lymphoma, helper endpoint

963

7353

1.61

23.00

3.5

3.1

449.04

136.04

ug/l

15.04

895

6770

Diffuse large B-cell lymphoma, including Hilmo

963

7353

1.61

23.00

3.5

3.1

449.04

136.04

ug/l

15.04

895

6770

Diffuse large B-cell lymphoma

963

7353

1.61

23.00

3.5

3.1

449.04

136.04

ug/l

15.04

895

6770

Oligomenorrhoea

1004

7941

1.72

22.98

4.1

3.1

68.95

69.57

ug/l

0.05

950

7535

Hepatocellular carcinoma, including Hilmo

559

3867

1.84

22.93

4.4

3.0

169.78

152.41

ug/l

0.89

529

3554

Endometriosis ASRM stages 3,4

6118

55736

1.23

22.81

3.6

3.3

85.43

83.75

ug/l

0.20

5770

52662

Other/unspecified reactive arthropathies

1489

12144

1.49

22.80

3.6

3.1

141.93

115.70

ug/l

1.53

1437

11446

Other female pelvic inflammatory diseases

3961

35162

1.28

22.68

3.7

3.2

92.42

90.42

ug/l

0.32

3647

33008

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

880

6743

1.70

22.58

6.6

3.0

150.61

113.25

ug/l

6.67

830

6515

Other diseases of gallbladder

966

7432

1.61

22.50

3.6

3.0

126.05

123.95

ug/l

0.07

913

6847

Benign neoplasm of mouth and pharynx

2330

19759

1.35

22.44

3.6

3.1

132.74

129.34

ug/l

0.25

2150

18459

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

829

6296

1.71

22.39

4.0

3.1

136.41

121.80

ug/l

0.59

786

5848

Strabismus

6734

61149

1.20

22.38

3.6

3.2

105.91

108.64

ug/l

0.38

6346

57701

Suppurative and necrotic conditions of lower respiratory tract

1112

8684

1.54

22.33

4.3

3.1

195.60

157.50

ug/l

3.09

1049

8038

Respiratory insufficiency

1566

12568

1.40

22.31

4.1

2.8

146.30

143.14

ug/l

0.19

1435

11442

Sudden idiopathic hearing loss

2136

17967

1.37

22.23

3.6

3.1

136.39

137.45

ug/l

0.05

1952

16777

Inguinal hernia

13837

85528

1.12

22.22

3.2

3.0

151.64

152.25

ug/l

0.07

12890

79919

Mixed conductive and sensorineural hearing loss

2537

21610

1.32

22.20

3.3

3.1

141.05

142.32

ug/l

0.06

2316

20068

Premenstrual syndrome

475

3426

2.41

22.20

4.2

3.1

54.60

61.00

ug/l

1.74

463

3282

Graves disease, strict definition

2623

22714

1.36

22.19

3.5

3.2

95.07

91.73

ug/l

0.37

2465

21553

Erythema intertrigo

576

4130

1.91

22.13

4.2

3.0

130.45

134.27

ug/l

0.17

535

3825

Fracture at wrist and hand level

8733

79985

1.16

22.09

3.2

3.1

122.88

124.60

ug/l

0.27

8141

75597

Acne vulgaris

2522

21816

1.38

22.08

3.9

3.3

69.60

68.18

ug/l

0.25

2415

20829

Disorders of psychological development

3274

26580

1.30

22.07

3.8

3.2

82.41

79.06

ug/l

0.53

3092

25302

Other peripheral vertigo

2006

16844

1.39

22.03

3.4

3.1

114.44

124.73

ug/l

0.91

1841

15671

Prolonged pregnancy

5137

39919

1.27

22.02

3.5

3.4

55.87

61.79

ug/l

1.28

4917

38614

Complications associated with artificial fertilization

561

4173

2.22

22.00

4.2

3.2

53.48

59.85

ug/l

1.45

552

3997

Hepatomegaly and splenomegaly, not elsewhere classified

246

1469

2.92

21.99

6.0

2.9

191.56

121.00

ug/l

1.68

240

1372

Other strabismus

5634

50746

1.22

21.95

3.6

3.2

94.75

100.88

ug/l

1.42

5318

48050

Melanocytic naevi of trunk

2988

26020

1.31

21.88

4.0

3.2

110.96

111.66

ug/l

0.07

2855

24563

Use of disulfiram, acamprosate or naltrexone

1813

15018

1.39

21.87

3.2

3.0

155.18

144.38

ug/l

0.44

1665

14313

Kyphosis

316

2001

2.45

21.87

4.1

2.9

113.17

122.91

ug/l

0.39

296

1840

Small cell lung cancer, helper endpoint

198

3571

0.46

21.85

2.7

3.0

281.54

160.30

ug/l

4.43

182

3247

Spermatocele

1351

10719

1.44

21.81

3.1

3.0

185.38

207.60

ug/l

1.09

1256

9959

Protozoal diseases

651

4790

1.84

21.79

4.8

3.1

269.30

139.52

ug/l

3.33

622

4469

Other bursitis of hip

492

3442

2.01

21.61

3.8

2.9

110.39

115.16

ug/l

0.23

460

3190

Use of levodopa decarboxylase inhibitor

2728

23378

1.30

21.57

3.1

3.2

145.72

159.23

ug/l

1.52

2457

21312

Vascular dementia

1832

14473

1.35

21.53

3.3

132.43

160.04

ug/l

6.52

1664

13016

Other predominantly sexually transmitted diseases, not elsewhere classified

4809

43395

1.25

21.39

3.5

3.3

90.65

83.84

ug/l

1.49

4564

41552

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

2903

25189

1.32

21.37

3.9

3.3

83.18

86.05

ug/l

0.42

2768

23953

Solid cancers

22475

124836

1.10

21.35

3.1

161.04

108.00

ug/l

71.18

21111

117633

Dislocation, sprain and strain of joint and ligaments of hip

809

6126

1.67

21.31

3.5

3.1

130.90

126.39

ug/l

0.20

761

5685

Early lumbar disc prolapse, operated

2511

21573

1.33

21.23

3.2

3.1

98.82

98.27

ug/l

0.04

2407

20789

Protozoal diseases, including avohilmo

679

5052

1.79

21.22

4.7

3.1

261.70

137.05

ug/l

3.32

647

4717

Left ventricular outflow tract obstruction, narrow definition

1055

8302

1.57

21.19

3.7

3.2

119.75

130.00

ug/l

0.87

1005

7858

Habitual aborter

654

5004

2.03

21.17

4.3

3.2

64.55

59.73

ug/l

0.15

636

4805

Embedded and impacted teeth

8468

63581

1.18

21.08

3.6

3.3

71.45

75.34

ug/l

1.55

8170

60802

Labour and delivery complicated by fetal stress [distress]

8186

49534

1.21

20.93

3.7

3.4

52.52

60.32

ug/l

13.56

7890

47822

Other bullous disorders

613

4499

1.85

20.91

3.8

3.1

138.64

127.11

ug/l

0.42

584

4215

Ingrowing nail

1220

9802

1.51

20.91

4.4

3.1

117.00

116.21

ug/l

0.05

1148

9235

Meralgia paraesthetica

778

5916

1.71

20.89

3.8

3.0

116.97

123.53

ug/l

0.23

730

5557

Ehlers-Danlos syndrome, including avohilmo

399

2871

2.80

20.88

5.1

3.3

68.98

60.91

ug/l

0.57

376

2754

Lactose intolerance

762

5800

1.74

20.86

3.8

3.0

102.51

95.26

ug/l

0.27

719

5465

Drug-induced osteoporosis

320

2087

2.50

20.85

5.8

3.0

193.13

114.99

ug/l

1.48

304

1928

Polyarthritis, unspecified

798

6056

1.66

20.76

3.7

2.9

151.01

125.07

ug/l

1.67

760

5663

Eosinophilic disease (BM)

359

2371

2.24

20.76

4.9

2.8

153.13

125.46

ug/l

1.03

338

2211

Other and unspecified injuries of lower leg

1967

16665

1.39

20.65

3.6

3.2

96.69

101.24

ug/l

0.64

1840

15782

Other nonscarring hair loss

338

2326

2.86

20.64

4.2

3.2

89.90

72.37

ug/l

1.67

327

2194

Disturbances of smell and taste

934

7286

1.61

20.60

3.7

3.0

103.51

124.79

ug/l

3.74

882

6829

Otitis externa, unspecified

2793

24301

1.31

20.58

3.8

3.2

110.35

108.58

ug/l

0.16

2607

22984

Systemic sclerosis (FG)

543

3922

1.91

20.45

4.4

2.9

104.61

105.82

ug/l

0.04

513

3678

Emotional disorders and disorders of social functioning with onset specific to childhood

1530

12587

1.51

20.45

4.2

3.3

55.45

54.31

ug/l

0.18

1433

12025

Other otitis externa (chronic)

1549

12826

1.44

20.44

3.9

3.1

118.78

116.57

ug/l

0.11

1387

12058

Neuroendocrine tumor and carcinoma of small intestine

316

2034

2.36

20.44

3.7

2.9

137.31

134.99

ug/l

0.07

296

1864

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1659

13870

1.43

20.41

3.9

3.2

92.61

99.46

ug/l

0.98

1575

13127

Mental disorders, not otherwise specified

2133

18286

1.38

20.39

3.9

3.2

82.47

92.17

ug/l

2.54

2030

17436

Bell's palsy

2653

22906

1.31

20.38

3.5

3.1

119.13

125.96

ug/l

0.89

2459

21447

Oral lichen planus, including avohilmo , including avohilmo

1556

12890

1.44

20.37

3.4

3.1

99.03

118.12

ug/l

4.53

1459

12083

Superficial injury of ankle and foot

3325

29337

1.28

20.34

3.7

3.2

89.47

95.87

ug/l

1.60

3146

27895

Pregnancy with abortive outcome

20371

100899

1.11

20.29

3.4

3.3

80.71

83.40

ug/l

1.02

19069

95280

Gangrene, not elsewhere classified

179

972

3.11

20.27

6.8

2.8

168.13

156.16

ug/l

0.31

170

885

Other congenital malformations, including avohilmo

3323

29377

1.29

20.16

3.7

3.3

98.73

91.70

ug/l

1.05

3178

27891

Rare circulating lymphoid malignancy, including Hilmo

602

4374

1.77

20.12

4.3

3.2

328.92

120.35

ug/l

15.28

573

4075

Other disorders of amniotic fluid and membranes

4300

37649

1.28

20.11

3.6

3.4

58.71

64.02

ug/l

3.92

4090

36410

Late syphilis, including avohilmo

379

2565

2.18

20.01

6.6

2.9

144.99

139.80

ug/l

0.19

355

2417

Isolated proteinuria with specified morphological lesion

276

1751

2.62

19.98

7.9

2.9

209.38

129.16

ug/l

4.37

268

1635

Golimumab

872

6825

1.66

19.95

3.7

3.1

92.50

99.99

ug/l

0.82

842

6521

Other specified disorders of kidney and ureter

703

5293

1.73

19.94

5.7

3.0

168.61

127.05

ug/l

2.72

664

4905

Episcleritis

1262

10302

1.51

19.88

3.7

3.1

104.37

104.83

ug/l

0.03

1203

9789

Corticotropin deficiency

233

1448

3.17

19.86

4.9

3.1

97.84

107.88

ug/l

0.54

223

1367

Cluster headache, wide,, including avohilmo

1284

10521

1.51

19.73

4.1

3.2

96.74

103.33

ug/l

0.52

1238

10014

Acute laryngitis and tracheitis

3293

28573

1.27

19.65

3.7

3.1

85.75

84.78

ug/l

0.13

3128

27301

Protein-energy malnutrition of moderate and mild degree

236

1450

2.88

19.63

4.3

3.4

253.03

116.45

ug/l

0.73

209

1343

Periapical abscess

11659

108924

1.13

19.63

3.4

3.1

122.59

127.69

ug/l

1.43

10832

102740

Pre-eclampsia or poor fetal growth

9151

85135

1.17

19.61

3.8

3.3

71.76

71.47

ug/l

0.06

8704

81414

Other renal tubulo-interstitial diseases

574

4224

1.86

19.56

5.6

2.9

147.27

95.86

ug/l

7.18

550

3957

Malignant neoplasm of bladder

1206

9527

1.43

19.53

3.4

3.1

174.78

156.61

ug/l

1.32

1120

8649

Alcohol abuse, main dg

3514

31017

1.25

19.45

3.4

3.1

140.04

130.77

ug/l

0.68

3283

29363

Other nutritional anaemias

220

1277

2.59

19.45

5.3

2.7

221.48

130.96

ug/l

2.93

201

1170

Vitamin D deficiency

481

3461

2.01

19.40

4.6

3.0

121.86

96.70

ug/l

1.88

454

3262

Congenital malformations of aortic and mitral valves

888

6914

1.59

19.34

3.6

3.2

122.46

136.31

ug/l

1.12

846

6534

Cluster headache, strict, including avohilmo

1228

10049

1.52

19.32

4.1

3.2

93.74

102.28

ug/l

0.78

1185

9577

Other infective otitis externa

1380

11359

1.46

19.23

3.6

3.2

107.16

117.65

ug/l

1.33

1285

10684

Ankylosing spondylitis, strict definition

977

7739

1.57

19.20

3.6

3.1

104.02

121.12

ug/l

2.64

944

7383

Kela-code for severe mental illness

9035

83713

1.15

19.16

3.3

3.2

106.28

117.08

ug/l

3.60

8376

79179

Car occupant injured in other and unspecified transport accidents

4864

43967

1.22

19.16

3.6

3.2

106.76

103.45

ug/l

0.40

4593

41656

Chronic conjunctivitis

697

5302

1.73

19.12

3.4

3.0

114.23

108.29

ug/l

0.18

670

4974

Osteonecrosis due to drugs

339

2276

2.28

19.08

4.4

3.0

279.68

135.57

ug/l

7.67

322

2104

Complications of labour and delivery

18071

95318

1.11

19.04

3.3

3.2

79.51

83.74

ug/l

2.76

17100

89992

Arthropathic psoriasis

2469

21338

1.31

19.02

3.5

3.1

137.01

126.07

ug/l

1.34

2332

20127

Acute suppurative otitis media

7737

66652

1.17

19.01

3.8

3.2

84.96

84.76

ug/l

0.03

7315

63747

Sequelae of injuries of lower limb

2075

17695

1.34

18.96

3.6

3.1

107.80

121.21

ug/l

2.71

1971

16725

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

523

3954

2.14

18.75

5.1

3.3

67.34

68.45

ug/l

0.07

498

3785

Other disorders of cornea

2131

18212

1.33

18.74

3.5

3.1

111.10

127.83

ug/l

4.33

1976

17017

Hypersomnia

353

2421

2.29

18.72

4.0

3.0

114.21

109.69

ug/l

0.11

338

2276

Chondropathies

3620

32217

1.25

18.58

3.4

3.2

106.04

110.95

ug/l

0.80

3396

30472

Recurrent dislocation and subluxation of joint

1630

13642

1.39

18.55

3.3

3.0

105.01

107.69

ug/l

0.23

1550

13014

Bruxism

509

3797

2.05

18.49

4.2

3.1

72.92

82.13

ug/l

1.52

484

3627

Other and unspecified psoriasis

1436

11865

1.42

18.48

3.7

3.1

145.55

129.70

ug/l

1.44

1345

11132

Sequelae of injuries of upper limb

2145

18367

1.33

18.46

3.5

3.1

117.18

126.29

ug/l

1.43

2025

17349

Vascular dementia (mixed)

400

2712

1.92

18.46

3.3

128.55

159.90

ug/l

2.38

370

2453

Ectropion of eyelid

780

5922

1.57

18.45

3.6

3.1

155.11

159.07

ug/l

0.13

707

5362

Chronic Coagulation defects

613

4676

1.87

18.44

5.1

3.2

89.78

90.88

ug/l

0.06

588

4444

Dependence on enabling machines and devices, not elsewhere classified

263

1651

2.43

18.38

14.5

3.0

249.29

118.27

ug/l

8.93

263

1545

Late syphilis

305

2002

2.29

18.33

7.1

2.8

156.80

149.71

ug/l

0.23

289

1878

Other orthopaedic follow-up care

1229

9983

1.45

18.31

3.5

2.8

115.31

112.82

ug/l

0.14

1155

9309

Varicose veins of other sites

1269

10288

1.43

18.30

3.8

3.0

143.22

149.45

ug/l

0.31

1182

9651

Polyhydramnios

1417

12069

1.55

18.30

4.0

3.4

57.23

61.31

ug/l

1.00

1366

11646

Anogenital herpesviral [herpes simplex] infection

1800

15470

1.42

18.30

3.8

3.3

75.76

77.50

ug/l

0.21

1709

14803

Other and unspecified glaucoma

1386

11361

1.41

18.29

3.7

3.1

151.12

145.22

ug/l

0.23

1243

10393

Toxic liver disease

363

2492

2.16

18.27

4.9

3.0

287.50

117.66

ug/l

2.21

343

2337

Juvenile arthritis (FINNGEN)

1226

10138

1.52

18.21

4.2

3.2

86.56

76.17

ug/l

0.62

1191

9651

Other protozoal intestinal diseases, including avohilmo

576

4331

1.86

18.20

4.1

3.0

83.19

96.54

ug/l

1.20

551

4115

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

905

7013

1.51

18.20

4.0

3.1

205.78

143.84

ug/l

6.53

847

6434

Use of antiglaucoma preparations and miotics

1547

12805

1.37

18.18

3.6

3.2

147.82

142.99

ug/l

0.28

1395

11649

Postpartum hemorraghe, parous women as controls

8178

63938

1.18

18.16

3.7

3.4

63.68

66.61

ug/l

1.42

7765

61498

Other specified/unspecified dorsopathies

755

5792

1.62

18.12

3.6

2.9

108.77

121.97

ug/l

0.71

709

5418

Acquired absence of limb

225

1359

2.56

18.12

7.3

2.9

216.10

148.27

ug/l

2.56

215

1261

Other endocrine disorders

1246

9833

1.49

18.10

4.6

3.3

99.17

85.65

ug/l

1.60

1154

9284

Portal vein thrombosis

355

2404

2.09

18.06

5.8

3.0

201.29

142.72

ug/l

1.97

337

2235

Amputation of ankle bones

441

3083

1.87

18.05

9.0

3.0

229.19

161.62

ug/l

5.88

418

2845

Emotional disorders starting during childhood or adolescence

1430

11994

1.50

17.96

4.2

3.4

72.82

54.12

ug/l

0.49

1337

11458

Pyothorax

846

6568

1.56

17.95

4.1

3.1

198.67

159.91

ug/l

2.47

802

6094

Stenosis and insufficiency of lacrimal passages

2066

17700

1.33

17.85

3.3

3.1

101.69

118.53

ug/l

5.48

1924

16440

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

2950

25951

1.27

17.77

3.2

3.1

119.87

126.01

ug/l

0.57

2785

24352

Alopecia areata

696

5416

1.75

17.66

3.5

3.2

91.37

90.13

ug/l

0.08

657

5110

591

4443

1.77

17.63

3.8

3.0

112.76

111.49

ug/l

0.06

536

4229

Pure hyperglyceridaemia

477

3412

1.82

17.54

4.3

2.8

172.36

151.55

ug/l

0.71

444

3168

Psoriatic arthropathies, ICD10

2269

19622

1.31

17.52

3.5

3.1

136.68

125.48

ug/l

1.55

2145

18513

Bicipital tendinitis

988

7855

1.50

17.51

3.3

2.9

129.98

143.97

ug/l

0.87

935

7395

Lung diseases due to external agents

2732

23739

1.26

17.46

3.6

3.1

160.46

152.49

ug/l

0.78

2472

21813

Unspecified jaundice

968

7625

1.48

17.45

3.7

2.9

277.79

137.63

ug/l

7.46

911

7033

Astigmatism

1526

12824

1.41

17.42

3.8

3.2

107.38

99.20

ug/l

0.51

1426

12108

Unspecific neurodegenerative disorder

8876

56166

1.14

17.42

2.9

3.2

140.20

160.78

ug/l

12.28

7811

50860

Xerosis cutis

393

2754

2.01

17.38

4.3

3.0

144.40

134.99

ug/l

0.34

375

2544

Brain glioblastoma, helper endpoint

110

2136

0.39

17.37

2.3

3.0

202.83

152.85

ug/l

0.82

1982

Alcohol withdrawal state with delirium

1258

10245

1.41

17.33

3.4

3.0

206.72

172.51

ug/l

2.35

1145

9600

Other psoriatic arthropathies

2210

19090

1.31

17.33

3.5

3.1

137.91

125.38

ug/l

1.80

2087

18008

Other specified/unspecified spondylopathies

501

3612

1.77

17.31

3.9

2.9

133.33

138.67

ug/l

0.20

475

3296

Infective dermatitis

2490

21654

1.29

17.30

3.8

3.1

139.80

128.09

ug/l

1.03

2326

20297

Alcohol-induced acute pancreatitis

691

5243

1.62

17.28

3.7

3.0

215.36

169.45

ug/l

2.26

633

4932

Unspecified nephritic syndrome

469

3380

1.86

17.28

7.2

3.0

189.55

138.93

ug/l

3.49

454

3146

Fracture of neck

1223

9985

1.43

17.18

3.7

3.1

159.49

150.27

ug/l

0.44

1132

9242

Emphysema

1379

11310

1.38

17.17

3.5

3.0

176.61

170.78

ug/l

0.25

1269

10353

Other puerperal infections

2485

22204

1.38

17.14

4.1

3.5

57.17

57.70

ug/l

0.06

2381

21301

Follicular cysts of skin and subcutaneous tissue

4172

37504

1.21

17.11

3.6

3.1

129.32

127.71

ug/l

0.14

3937

35205

Other and unspecified tonsillitis

9756

75714

1.14

17.09

3.6

3.1

103.21

95.11

ug/l

2.05

9284

72534

Macular hole

1132

9193

1.46

17.02

3.3

3.1

138.78

147.13

ug/l

0.65

1039

8419

Radial styloid tenosynovitis [de Quervain]

1410

11805

1.42

16.97

3.7

3.0

82.55

96.89

ug/l

4.01

1313

11195

Use of memantine

5759

42121

1.17

16.96

2.8

3.3

135.24

157.96

ug/l

10.86

5038

37948

Use of other anti-dementia drugs

5759

42121

1.17

16.96

2.8

3.3

135.24

157.96

ug/l

10.86

5038

37948

Medial epicondylitis

838

6595

1.56

16.82

3.2

2.9

111.32

123.28

ug/l

1.06

781

6253

Other localized connective tissue disorders

461

3372

1.92

16.80

4.7

3.0

110.51

98.76

ug/l

0.99

430

3138

Postpartum hemorraghe, all women as controls

8178

74829

1.17

16.72

3.7

3.4

63.68

64.72

ug/l

0.34

7765

72013

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

3518

31403

1.23

16.71

3.4

3.2

119.20

123.22

ug/l

0.46

3422

29443

Other congenital malformations of the digestive system, including avohilmo

1171

9561

1.47

16.70

4.8

3.3

92.04

96.67

ug/l

0.53

1119

8988

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

1198

9705

1.40

16.69

3.8

3.1

202.52

142.47

ug/l

8.70

1125

8884

Pyoderma gangrenosum

212

1338

2.90

16.69

5.6

3.1

159.01

103.60

ug/l

1.38

205

1257

Scar conditions and fibrosis of skin

1013

8257

1.53

16.68

3.9

3.1

93.61

92.99

ug/l

0.04

959

7810

Urethritis and urethral syndrome

509

3753

1.79

16.60

3.9

2.9

114.28

112.87

ug/l

0.05

479

3501

Other congenital malformations

2158

18799

1.33

16.60

3.9

3.3

95.68

86.68

ug/l

1.04

2064

17881

Salpingitis and oophoritis

4082

36876

1.22

16.58

3.4

3.1

104.96

97.40

ug/l

1.35

3826

34601

Other disorders of the genitourinary system

2683

23577

1.27

16.52

3.5

3.1

112.55

119.01

ug/l

0.87

2475

21783

Allergic urticaria

2057

17855

1.34

16.48

3.9

3.2

109.30

93.05

ug/l

1.37

1947

16898

Lesion of plantar nerve

1265

10471

1.43

16.43

3.3

3.0

113.79

122.14

ug/l

0.53

1179

9729

Other protozoal intestinal diseases

367

2602

2.11

16.40

4.2

3.1

87.92

96.75

ug/l

0.45

351

2462

Chronic viral hepatitis

1166

9582

1.45

16.34

3.5

3.1

113.53

115.46

ug/l

0.13

1081

9175

Other specified and unspecified disorders of eye and adnexa

820

6481

1.57

16.34

4.0

3.1

114.88

117.65

ug/l

0.09

781

6062

Oral lichen planus and hypothyroidism or thyroxine medication

439

3209

1.95

16.29

3.5

3.0

110.72

100.97

ug/l

0.37

411

2991

Infarction of spleen

162

946

3.25

16.26

5.0

3.0

262.55

140.48

ug/l

2.99

155

873

Speech and linguistic disorders

2256

18849

1.31

16.25

4.0

3.3

85.94

82.38

ug/l

0.40

2146

17916

Dystonia

1215

10057

1.44

16.25

3.6

3.1

97.07

112.52

ug/l

2.61

1131

9469

Drug-induced hypoglycaemia without coma

358

2481

1.99

16.23

5.4

3.1

149.46

132.79

ug/l

0.63

330

2319

Gastrojejunal ulcer

264

1693

2.17

16.21

5.9

2.9

121.99

149.63

ug/l

1.47

251

1555

Exposure to other and unspecified inanimate mechanical forces

1745

14887

1.35

16.17

3.8

3.1

117.65

116.44

ug/l

0.06

1654

14071

Hypertension, Pulmonary Arterial

205

1262

2.62

16.14

7.1

2.7

109.26

115.99

ug/l

0.17

199

1163

Benign neoplasm: Pituitary gland, craniopharyngeal duct

1173

9700

1.46

16.10

3.5

3.2

112.18

113.91

ug/l

0.14

1110

9137

Moderate visual impairment, binocular

626

4734

1.63

16.09

4.3

3.1

158.22

125.88

ug/l

1.10

516

4312

Non-small cell lung cancer, squamous, helper endpoint

505

6960

0.65

16.07

2.8

3.1

233.23

174.80

ug/l

3.25

465

6303

Sexual dysfunction

414

2951

1.87

16.03

3.5

3.0

119.05

139.02

ug/l

1.28

401

2807

Pleural plaque

1721

14539

1.32

16.03

3.2

185.43

178.57

ug/l

0.33

1503

13153

Symptoms and signs involving emotional state

746

5883

1.62

15.96

4.0

3.1

90.50

98.78

ug/l

0.82

709

5581

Malignant neoplasm of rectosigmoid junction, including Hilmo

548

4058

1.67

15.94

3.1

3.0

138.49

139.23

ug/l

0.02

526

3735

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

1077

8802

1.46

15.91

3.4

3.0

103.77

110.05

ug/l

0.42

1026

8339

Malignant neoplasm of breast

9570

65932

0.89

15.78

2.8

3.1

127.69

87.24

ug/l

40.25

8827

61924

Colitis due to radiation

230

1461

2.40

15.77

4.4

3.0

174.24

153.90

ug/l

0.25

217

1342

Campylobacter enteritis

609

4660

1.68

15.71

4.3

3.1

125.63

123.72

ug/l

0.09

580

4377

Congenital malformations of cardiac septa

1531

12589

1.38

15.66

4.0

3.3

94.08

97.46

ug/l

0.33

1431

11943

Acute generalized exanthematous pustulosis

1009

8239

1.49

15.64

4.2

3.2

157.39

109.69

ug/l

2.03

948

7726

Lactose intolerance, other/unspecified

650

5035

1.66

15.63

3.8

3.0

92.91

98.06

ug/l

0.39

613

4740

Helminthiases, including avohilmo

1076

8936

1.51

15.63

4.3

3.3

75.49

85.53

ug/l

1.76

1037

8467

Gastrointestinal stromal tumor and sarcoma

261

1713

2.25

15.60

3.5

3.0

125.34

132.30

ug/l

0.23

241

1584

Pneumonia derived septicemia

741

5805

1.58

15.60

4.6

3.1

175.93

127.29

ug/l

2.77

689

5408

Pneumonitis due to solids and liquids

1591

13361

1.33

15.59

3.7

3.1

150.81

155.60

ug/l

0.33

1428

12285

Malignant neoplasm of breast, HER2-negative

9558

65839

0.89

15.59

2.8

3.1

127.81

87.31

ug/l

40.24

8814

61831

Pediculosis, acariasis and other infestations, including avohilmo

4558

41535

1.20

15.58

3.5

3.2

104.33

97.45

ug/l

0.81

4317

39509

Sub-endpoint used in defining T1D endpoints

6859

62224

1.15

15.57

5.2

3.1

138.83

121.78

ug/l

5.42

6446

58398

Bicuspidal aortic valve syndrome

761

5973

1.56

15.54

3.4

3.1

131.63

145.13

ug/l

0.88

721

5631

Asthma mixed form (mode), excluding more controls

1128

9205

1.41

15.46

3.4

2.8

108.73

104.24

ug/l

0.21

1078

8603

Carcinoma in situ of other and unspecified sites

754

5898

1.55

15.42

3.5

3.2

157.32

176.57

ug/l

1.23

681

5389

Senility

202

1173

2.14

15.42

3.8

2.8

129.70

130.16

ug/l

0.01

187

1042

Hidradenitis suppurativa

976

8030

1.54

15.41

4.0

3.2

103.11

86.12

ug/l

2.41

933

7670

Any dementia

8328

53365

1.13

15.40

3.0

3.2

141.77

158.37

ug/l

7.42

7445

48283

Ehlers-Danlos syndrome

313

2280

2.66

15.35

5.3

3.3

70.85

60.94

ug/l

0.55

291

2185

Additional codes for the location of defect, injury or illness

1298

10873

1.41

15.35

3.6

3.2

118.66

117.16

ug/l

0.08

1252

10202

Carcinoma in situ of rectum

285

1923

2.18

15.35

3.7

3.0

126.32

158.78

ug/l

1.28

270

1780

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

3946

35608

1.21

15.32

3.4

3.2

118.89

127.65

ug/l

1.40

3832

33389

Benign neoplasm of urinary organs

963

7789

1.48

15.31

3.8

3.1

126.85

134.47

ug/l

0.54

903

7224

Small cell lung cancer, including Hilmo

198

3268

0.52

15.28

2.7

3.0

281.54

144.15

ug/l

5.50

182

2969

Small cell lung cancer

198

3268

0.52

15.28

2.7

3.0

281.54

144.15

ug/l

5.50

182

2969

Tracheo-bronchomalasia

134

750

3.49

15.24

4.1

2.6

88.21

86.86

ug/l

0.06

124

720

Diabetic maculopathy

2615

21855

1.27

15.24

6.0

3.7

164.15

136.42

ug/l

7.47

2417

20452

Perineal laceration during delivery

5741

43144

1.21

15.23

3.5

3.4

52.41

58.82

ug/l

3.18

5499

41515

Other obstructive and reflux uropathy

999

8158

1.48

15.19

4.8

3.0

141.39

95.97

ug/l

8.45

943

7623

Delivery

10958

54421

1.13

15.16

3.3

76.90

88.36

ug/l

10.06

10246

51057

Pemphigoid

555

4187

1.67

15.13

3.7

3.1

143.95

144.34

ug/l

0.01

518

3826

Amputation of thigh

556

4133

1.62

15.12

6.1

3.1

192.85

157.98

ug/l

2.14

515

3743

Adult-onset Still disease

120

665

4.28

15.08

10.0

2.9

219.69

97.46

ug/l

2.72

114

630

Generalized skin eruption due to drugs and medicaments

887

7181

1.53

15.05

4.2

3.2

161.38

109.94

ug/l

1.92

834

6733

Other/unspecified disorders of vestibular function

876

7041

1.51

15.03

3.5

3.1

104.78

124.78

ug/l

3.13

816

6528

Other and unspecified nonscarring hair loss

253

1765

2.86

14.99

4.0

3.2

94.01

68.33

ug/l

2.16

243

1668

Personal history of medical treatment

265

1784

2.27

14.85

4.4

3.1

122.46

103.73

ug/l

0.76

255

1677

Other congenital malformations of the digestive system

998

8121

1.48

14.85

5.0

3.3

89.56

96.63

ug/l

0.87

961

7648

Bronchitis, not specified as acute or chronic

1772

15132

1.31

14.85

3.7

3.0

126.02

135.47

ug/l

0.74

1645

14145

Abnormal findings in nipple discharge synovial fluid wound secretions

357

2563

2.03

14.82

4.9

3.1

131.77

101.59

ug/l

1.49

338

2403

Cerebral cysts

1352

11415

1.39

14.81

4.7

3.2

109.10

108.56

ug/l

0.04

1283

10794

Background retinopathy and retinal vascular changes

441

3219

1.77

14.77

5.7

3.1

157.21

141.60

ug/l

0.50

416

3000

Subacute thyroiditis

843

6805

1.54

14.77

3.7

3.0

102.77

101.85

ug/l

0.03

790

6434

L02BX Other hormone antagonists and related agents

1028

8375

1.43

14.76

2.8

3.2

444.30

191.66

ug/l

17.01

950

7684

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

1830

15750

1.31

14.75

3.4

3.1

123.83

134.74

ug/l

1.40

1692

14685

Marginal zone B-cell lymphoma, including Hilmo

339

2375

1.97

14.73

3.8

3.0

268.26

129.03

ug/l

4.55

320

2188

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

376

2670

1.87

14.73

4.8

3.1

152.28

133.40

ug/l

0.21

354

2460

Secondary parkinsonism, excluding more controls

455

3273

1.67

14.68

3.3

2.8

133.57

161.08

ug/l

2.06

410

3034

Antepartum haemorrhage, not elsewhere classified

2530

22703

1.31

14.66

3.8

3.4

61.75

64.50

ug/l

0.32

2441

21977

Medical abortion

19211

99540

1.10

14.66

3.3

83.38

83.74

ug/l

0.08

17941

94019

Other keratitis

2701

23967

1.25

14.64

3.7

3.2

112.22

111.71

ug/l

0.05

2561

22630

Secondary uncertain malignant neoplasm

2640

23203

1.24

14.62

3.2

3.1

329.33

130.43

ug/l

30.71

2451

21384

Orthopaedic devices associated with adverse incidents

386

2790

1.90

14.62

3.6

3.0

161.29

134.82

ug/l

1.15

330

2555

Myopia

3461

31270

1.23

14.60

3.7

3.2

89.10

90.26

ug/l

0.11

3266

29820

Syphilis, including avohilmo

527

3964

1.68

14.56

5.3

2.9

149.59

147.96

ug/l

0.06

503

3737

Syphilis

527

3964

1.68

14.56

5.3

2.9

149.59

147.96

ug/l

0.06

503

3737

Other disorders of pigmentation

982

8026

1.46

14.55

3.6

3.0

113.23

116.81

ug/l

0.25

920

7474

Abnormality of white blood cells, not elsewhere classified

223

1466

2.52

14.52

5.0

3.0

190.59

112.10

ug/l

2.25

216

1372

Other surgical follow-up care

811

6515

1.54

14.51

4.2

3.0

97.20

96.44

ug/l

0.05

773

6085

Fentanyl

1970

16853

1.27

14.49

3.9

2.8

235.43

140.72

ug/l

10.55

1798

15434

Thyroiditis, unspecified

368

2666

1.99

14.49

3.8

2.9

104.08

91.36

ug/l

0.78

333

2507

Endometriosis of intestine

477

3667

1.92

14.49

3.8

3.1

61.08

63.40

ug/l

0.28

462

3520

Dislocation of lens

298

1995

1.92

14.47

3.9

2.9

170.43

158.28

ug/l

0.40

264

1813

Other and unspecified haemorrhagic conditions

368

2652

1.94

14.42

4.7

3.1

169.55

112.78

ug/l

2.45

349

2492

Dislocation, sprain and strain of joints and ligaments of thorax

792

6336

1.53

14.41

3.6

3.1

117.34

119.77

ug/l

0.13

749

5954

Alzheimer’s disease (undefined)

1106

0.27

14.41

2.9

3.0

128.21

151.35

ug/l

0.44

984

Mental and behavioural disorders due to opioids

876

7091

1.50

14.38

3.7

3.1

95.64

103.86

ug/l

0.75

801

6792

Brain glioblastoma

110

2028

0.43

14.37

2.3

3.0

202.83

136.99

ug/l

1.23

1883

Congenital malformations and deformations of the musculoskeletal system

2225

19510

1.30

14.35

4.0

3.3

79.99

81.88

ug/l

0.23

2120

18585

Retinal haemorrhage

522

3929

1.67

14.35

4.6

3.0

160.08

133.48

ug/l

0.84

482

3602

Normotensive glaucoma

1682

14394

1.32

14.33

3.3

3.2

128.18

144.22

ug/l

2.36

1483

13099

Congenital malformations of the musculoskeletal system, not elsewhere classified

425

3241

2.05

14.31

5.2

3.3

68.15

70.18

ug/l

0.11

401

3107

Parkinson's disease, including avohilmo

3020

26832

1.22

14.29

2.9

3.2

142.92

160.99

ug/l

3.25

2730

24460

Ménière disease

1929

16722

1.30

14.28

3.3

3.1

120.67

126.46

ug/l

0.36

1784

15522

Chronic hepatitis NAS

300

2097

2.13

14.25

4.0

3.0

199.44

116.89

ug/l

1.51

285

1951

Complications of genitourinary prosthetic devices, implants and grafts

590

4577

1.66

14.24

3.9

3.0

123.65

107.20

ug/l

1.19

559

4270

Nonsuppurative otitis media

6681

53864

1.16

14.23

3.7

3.2

87.64

85.05

ug/l

0.49

6346

51123

Spinal instabilities

596

4593

1.62

14.22

3.4

2.9

115.34

123.15

ug/l

0.30

557

4329

Systemic sclerosis

543

4177

1.71

14.21

4.4

3.0

104.61

104.69

ug/l

0.00

513

3908

Visual field defects

1738

14937

1.31

14.20

3.6

3.1

146.05

132.44

ug/l

0.83

1611

13921

Hyperfunction of pituitary gland

1238

10495

1.43

14.14

3.9

3.2

93.85

87.26

ug/l

0.37

1154

9961

Residual foreign body in soft tissue

1120

9265

1.40

14.10

3.1

3.0

119.07

127.70

ug/l

0.78

1049

8748

Anxious personality disorder

507

3902

1.78

14.01

3.6

3.1

78.47

85.71

ug/l

0.57

482

3742

Bullous pemphigoid

434

3191

1.76

13.99

3.7

3.1

142.26

149.75

ug/l

0.29

405

2907

Malignant neoplasm of breast, including Hilmo

9848

67053

0.89

13.98

2.8

3.1

127.29

86.75

ug/l

40.02

9101

63001

Assault

3134

28069

1.22

13.97

3.3

3.1

121.60

110.48

ug/l

1.85

2928

26855

Malignant neoplasm of breast, HER2-negative, including Hilmo

9849

67062

0.89

13.95

2.8

3.1

127.30

86.75

ug/l

40.07

9102

63010

Shock, not elsewhere classified

205

1284

2.26

13.95

4.9

2.7

205.33

138.74

ug/l

2.68

195

1189

Muscle strain

768

6141

1.52

13.89

3.6

3.0

112.83

114.40

ug/l

0.06

733

5806

Vascular dementia (subcortical)

658

5086

1.53

13.88

3.4

3.3

123.22

154.65

ug/l

4.45

621

4604

Retinal detachment with retinal break

2533

22328

1.24

13.83

3.5

3.0

144.50

157.30

ug/l

1.55

2343

20734

Other hereditary haemolytic anaemias

164

1020

3.01

13.77

5.6

3.1

171.86

101.55

ug/l

3.71

157

968

Insulin, fast-acting (human)

3292

29585

1.21

13.76

5.4

3.1

132.33

111.65

ug/l

7.57

3115

28044

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

823

6678

1.52

13.75

3.5

3.1

104.18

106.42

ug/l

0.11

780

6341

Effects of foreign body entering through natural orifice

5455

50165

1.16

13.75

3.3

3.2

130.59

133.54

ug/l

0.29

5090

47375

Other misadventures during surgical and medical care

533

4100

1.69

13.70

4.6

3.1

136.40

128.83

ug/l

0.26

503

3842

Other disorders of male genital organs

689

5335

1.48

13.65

3.2

2.9

157.51

185.13

ug/l

2.36

655

5036

Dermatitis herpetiformis

388

2844

1.86

13.64

3.4

3.1

133.43

128.54

ug/l

0.11

366

2672

Other neurotic disorders

950

7747

1.43

13.63

3.7

2.9

112.18

132.76

ug/l

2.01

879

7227

Infection due to other mycobacteria

327

2292

1.89

13.62

4.1

2.8

130.86

115.69

ug/l

0.60

307

2087

Arterial embolism and thrombosis of lower extremity artery

654

5064

1.52

13.61

4.5

2.9

158.95

149.81

ug/l

0.40

612

4605

Carcinoma in situ, bladder

688

5411

1.53

13.60

3.6

3.2

155.70

179.74

ug/l

1.63

621

4945

Short Achilles tendon (acquired)

618

4825

1.60

13.59

3.4

2.8

105.35

109.86

ug/l

0.19

611

4548

Hypermetropia

1682

14534

1.32

13.57

3.8

3.2

98.77

100.21

ug/l

0.12

1587

13699

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1476

12443

1.37

13.57

4.1

3.3

65.82

69.01

ug/l

0.44

1412

11907

Other arterial embolism and thrombosis

529

3985

1.60

13.53

5.8

2.9

154.53

151.16

ug/l

0.13

499

3639

Personal history of malignant neoplasm

1920

16750

1.29

13.49

3.0

2.9

117.31

100.26

ug/l

1.82

1814

15760

Viral infections of the central nervous system, including avohilmo

1729

14976

1.31

13.49

3.6

3.2

111.53

109.44

ug/l

0.18

1619

14144

Other disorders of optic [2nd] nerve and visual pathways

1403

11970

1.36

13.48

4.0

3.2

118.77

113.58

ug/l

0.42

1308

11240

Injury of muscle and tendon at lower leg level

3185

28546

1.21

13.45

3.3

3.1

142.83

144.60

ug/l

0.09

2989

26905

Brain glioblastoma and astrocytoma

171

2742

0.51

13.45

2.3

3.0

161.98

125.55

ug/l

0.93

153

2558

Carcinoma in situ of skin of lower limb, including hip

446

3333

1.74

13.45

4.1

3.1

126.86

139.29

ug/l

0.79

417

3003

Systemic sclerosis, icd10

539

4181

1.70

13.44

4.4

3.0

104.70

104.08

ug/l

0.02

509

3918

Scabies, including avohilmo

3932

35867

1.20

13.43

3.5

3.2

96.67

92.82

ug/l

0.35

3722

34174

Benign neoplasm of eye and adnexa

2239

19715

1.26

13.43

3.4

3.1

119.90

127.07

ug/l

0.74

2086

18356

Other other unspecified disorders of the circulatory system

731

5818

1.52

13.42

4.0

3.1

150.43

134.42

ug/l

0.80

676

5408

Benign leiomyoma with endometriosis

3431

31063

1.21

13.41

3.4

3.1

102.60

103.37

ug/l

0.06

3164

28915

Procedures for purposes other than remedying health state

576

4505

1.66

13.39

3.5

2.9

95.88

88.28

ug/l

0.42

549

4246

Other specified/unspecified necrotizing vasculopathies

297

2077

2.00

13.30

5.7

3.1

169.35

129.31

ug/l

2.93

281

1918

Impacted teeth

6261

50091

1.16

13.29

3.5

3.3

68.22

70.60

ug/l

0.63

6046

47876

Other prurigo

264

1814

2.13

13.29

4.7

3.0

123.89

122.14

ug/l

0.04

255

1681

Eosinophilia

360

2623

1.90

13.29

4.9

3.1

152.73

126.15

ug/l

1.01

339

2438

Non-Hodgkin lymphoma, all

794

6310

1.45

13.28

3.6

3.1

613.59

143.55

ug/l

15.47

737

5779

Chronic myeloid leukaemia, including Hilmo

203

1308

2.33

13.19

4.6

2.9

242.51

127.75

ug/l

3.47

198

1218

Embolic stroke with flimmer

445

3239

1.62

13.15

4.0

2.9

141.15

160.91

ug/l

1.43

413

2912

Acute myeloid leukaemia, including Hilmo

271

1846

2.00

13.14

4.3

3.0

711.23

125.71

ug/l

7.01

260

1709

Acute myeloid leukaemia, helper endpoint

271

1846

2.00

13.14

4.3

3.0

711.23

125.71

ug/l

7.01

260

1709

Acute myeloid leukaemia

271

1846

2.00

13.14

4.3

3.0

711.23

125.71

ug/l

7.01

260

1709

Unspecified protein-energy malnutrition

143

847

2.87

13.14

4.6

3.1

221.06

121.08

ug/l

2.22

135

772

Carrier of infectious disease

590

4651

1.65

13.12

4.7

3.2

136.42

100.63

ug/l

2.12

555

4399

Parkinson's disease, strict definition

2686

23826

1.22

13.11

2.9

3.2

143.61

160.66

ug/l

2.56

2426

21708

Other inflammation of vagina/vulva

1071

9130

1.50

13.07

3.7

3.3

68.60

66.93

ug/l

0.18

1028

8698

Malignant neoplasm of brain

416

5614

0.64

13.05

2.6

3.0

215.20

119.08

ug/l

2.61

381

5234

Unspecified lump in breast

3773

34424

1.20

13.00

3.3

3.2

92.95

94.54

ug/l

0.21

3595

32227

Collapsed vertebra, not elsewhere classified

171

1048

2.42

12.97

4.8

2.8

137.46

138.87

ug/l

0.03

156

942

Presbyopia

1723

14954

1.30

12.93

3.2

3.0

111.17

121.00

ug/l

0.83

1654

14232

Benign neoplasm: Other and unspecified parts of small intestine

337

2429

1.90

12.92

5.0

3.0

105.68

129.47

ug/l

2.38

324

2230

Other salmonella infections, including avohilmo

940

7734

1.43

12.92

3.6

3.0

144.01

114.59

ug/l

1.71

876

7257

Other abnormal immunological findings in serum

504

3916

1.73

12.90

4.1

3.2

96.21

93.95

ug/l

0.11

481

3687

Other retinal artery occlusion

453

3382

1.67

12.88

4.1

3.1

139.18

149.38

ug/l

0.53

421

3078

Idiopathic urticaria

573

4551

1.69

12.85

3.8

3.1

83.58

82.58

ug/l

0.05

551

4327

Congenital malformations of gallbladder, bile ducts and liver

234

1595

2.28

12.82

6.7

3.2

114.77

99.18

ug/l

0.89

226

1494

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

697

5620

1.57

12.78

3.7

3.0

80.02

81.37

ug/l

0.11

665

5321

Acute nasopharyngitis (common cold)

2411

21091

1.23

12.77

3.3

2.9

141.83

137.82

ug/l

0.28

2297

20075

Other secondary gout

433

4.37

12.72

6.2

2.8

191.73

143.44

ug/l

0.94

394

Hordeolum and other deep inflammation of eyelid

1403

12040

1.35

12.71

3.8

3.1

112.63

108.57

ug/l

0.23

1333

11350

Leiomyoma of uterus

17185

92227

1.09

12.70

3.3

3.2

94.24

93.00

ug/l

0.32

16003

87005

Other and unspecified mononeuropathies of lower limb

584

4571

1.59

12.69

3.3

2.9

107.06

122.83

ug/l

1.22

532

4248

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

3756

34036

1.18

12.64

2.7

3.1

242.07

131.49

ug/l

51.53

3523

31371

Recurrent dislocation of patella

1453

12625

1.37

12.64

3.6

3.2

74.70

72.23

ug/l

0.32

1387

12069

Glaucoma, exfoliation

2043

17827

1.25

12.61

3.0

3.2

141.43

148.55

ug/l

0.51

1838

16077

Fistulae involving female genital tract

365

2678

1.83

12.60

4.3

2.8

109.47

101.26

ug/l

0.36

342

2494

Infections of genitourinary tract in pregnancy

2548

22976

1.27

12.59

3.7

3.3

71.38

73.57

ug/l

0.39

2438

21815

Family history of certain disabilities and chronic diseases leading to disablement

1331

11467

1.38

12.58

3.9

3.1

73.40

79.35

ug/l

1.20

1260

10944

Acquired absence of organs, not elsewhere classified

260

1777

2.01

12.57

6.6

2.9

173.20

135.86

ug/l

1.10

244

1644

Bacterial, viral and other infectious agents, including avohilmo

1976

17329

1.27

12.54

3.9

3.1

140.42

121.91

ug/l

1.44

1885

16449

Open wound of wrist and hand

11642

106535

1.10

12.53

3.3

3.2

120.74

126.05

ug/l

1.36

10835

100869

Malignant neoplasm of eye, brain and central nervous system

553

7138

0.68

12.52

2.8

3.0

195.60

120.10

ug/l

2.74

513

6661

Other disorders starting during childhood or adolescence

1359

11605

1.38

12.52

4.2

3.4

60.53

64.59

ug/l

0.64

1297

11094

Tic and related disorders

318

2275

1.91

12.52

3.6

3.1

74.90

74.04

ug/l

0.04

301

2168

Early onset COPD

4393

40140

1.16

12.46

3.8

3.1

145.75

156.49

ug/l

1.39

4048

37391

Otitis media, unspecified

3032

25249

1.23

12.45

3.8

3.2

77.50

81.67

ug/l

0.66

2896

23955

Other erythematous conditions

759

6146

1.49

12.44

4.1

3.1

122.35

117.07

ug/l

0.23

714

5752

Foreign body in alimentary tract

1150

9691

1.38

12.41

3.5

3.2

126.63

123.24

ug/l

0.13

1064

9074

Necrotizing fasciitis

126

725

2.89

12.39

5.0

2.8

267.09

148.22

ug/l

0.80

118

663

Autism spe

680

5501

1.57

12.31

3.5

3.3

65.46

71.89

ug/l

0.80

624

5267

Focal brain injury

1212

10121

1.32

12.31

3.6

2.9

170.25

155.90

ug/l

0.55

1108

9476

Hepatocellular carcinoma

395

2871

1.66

12.30

4.4

3.0

175.31

156.46

ug/l

0.73

372

2635

Pneumococcal septicemia

697

5591

1.51

12.25

4.5

3.2

178.23

128.61

ug/l

2.60

645

5218

Non-small cell lung cancer, including Hilmo

2230

23823

0.83

12.23

3.0

3.1

214.76

141.22

ug/l

17.53

2058

21748

Respiratory disorders in diseases classified elsewhere

306

2200

1.95

12.22

4.5

3.1

194.98

125.91

ug/l

1.23

292

2054

Other/unspecified soft tissue disorders related to use, overuse and pressure

661

5280

1.53

12.16

3.4

2.9

92.39

112.37

ug/l

3.40

631

4988

Autism

697

5657

1.55

12.13

3.5

3.3

64.93

70.75

ug/l

0.72

640

5416

Wide developmental disorders

879

7267

1.47

12.11

3.5

3.4

64.14

69.72

ug/l

0.77

814

6969

Other and unspecified mononeuropathies, also in other diseases

592

4647

1.55

12.10

4.5

3.0

106.40

132.07

ug/l

3.35

556

4313

Separation of retinal layers (serosa)

815

6619

1.44

12.10

3.8

3.0

160.19

152.54

ug/l

0.22

765

6232

Thalassaemia

113

673

4.08

12.06

9.6

3.1

115.94

85.37

ug/l

1.28

108

637

Lichen simplex chronicus

699

5611

1.50

12.05

4.1

3.0

115.79

133.63

ug/l

1.95

657

5246

Other and unspecified types of non-Hodgkin lymphoma, hilmo

775

6267

1.45

12.05

3.9

3.1

365.26

144.86

ug/l

8.05

727

5759

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

203

1344

2.26

12.00

4.4

3.0

341.28

140.01

ug/l

2.90

197

1241

Benign neoplasm: Pancreas

561

4406

1.59

11.98

4.5

3.1

122.77

141.50

ug/l

1.60

534

4072

Von Willebrand disease

334

2498

2.01

11.97

5.3

3.2

88.70

78.35

ug/l

0.60

321

2366

Asthma mixed form (mode)

1128

9461

1.35

11.96

3.4

2.8

108.73

106.67

ug/l

0.09

1078

8864

Injury of eye and orbit

3222

29111

1.19

11.91

3.4

3.1

125.18

124.11

ug/l

0.07

3029

27610

COPD, hospital admission 2, with asthma infections

6579

52607

1.13

11.89

3.9

3.1

155.01

163.09

ug/l

1.17

6020

48233

Pre-eclampsia or eclampsia

5805

54284

1.16

11.89

3.8

3.3

82.01

78.19

ug/l

0.84

5522

51643

Infection due to other mycobacteria, including avohilmo

350

2550

1.77

11.86

4.0

2.8

128.79

115.44

ug/l

0.53

328

2331

Morphin

417

3079

1.62

11.85

3.8

2.9

183.04

153.74

ug/l

1.39

387

2811

Other and unspecified erythematous conditions

686

5526

1.51

11.85

4.2

3.1

122.42

117.10

ug/l

0.21

645

5156

Malignant melanoma, including Hilmo

3516

31865

1.18

11.85

3.3

3.1

150.66

127.45

ug/l

3.62

3224

29449

Abnormal findings on diagnostic imaging of central nervous system

1140

9679

1.38

11.83

3.8

3.1

121.67

109.41

ug/l

0.99

1076

9137

Early complications of trauma

915

7561

1.41

11.83

4.0

3.1

138.12

134.05

ug/l

0.12

859

7081

!Aliquae complicationes praecoces traumatis

915

7561

1.41

11.83

4.0

3.1

138.12

134.05

ug/l

0.12

859

7081

Desensitization to allergens

1424

12395

1.35

11.81

3.5

3.3

75.50

78.02

ug/l

0.24

1364

11853

Thyrotropin deficiency

282

2046

2.10

11.80

4.4

3.1

90.94

91.59

ug/l

0.03

272

1938

Wegener granulomatosis

326

2375

1.86

11.80

5.2

3.0

183.76

131.25

ug/l

2.34

319

2218

Cachexia

122

697

2.71

11.76

3.7

2.8

208.75

134.01

ug/l

2.23

114

632

Autonomic disorders

541

4247

1.60

11.76

4.0

3.1

116.80

124.47

ug/l

0.26

511

3993

Achalasia of cardia

363

2669

1.75

11.75

3.6

2.9

115.59

139.11

ug/l

1.40

342

2476

Other and unspecified iridocyclitis

1047

8816

1.39

11.73

3.8

3.1

118.66

115.78

ug/l

0.12

992

8290

Left hemicolectomy

434

3277

1.65

11.71

4.0

3.1

150.36

152.26

ug/l

0.05

401

2993

Single ventricle heart

247

12.88

11.71

5.7

4.0

78.65

67.72

ug/l

0.24

235

Benign neoplasm: Anus and anal canal

561

4404

1.56

11.68

3.9

3.1

150.90

133.74

ug/l

0.28

526

4057

Malignant neoplasm of endocrine gland, including Hilmo

1790

15694

1.28

11.67

3.6

3.1

119.52

100.68

ug/l

2.36

1673

14728

Panhypopituitarism

374

2786

1.76

11.66

3.3

3.0

151.76

137.59

ug/l

0.65

359

2614

Melanocytic naevi, other sites/unspecified

1950

17251

1.27

11.64

4.1

3.2

116.09

108.62

ug/l

0.89

1874

16326

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

1947

17013

1.29

11.61

3.9

3.3

81.46

74.53

ug/l

0.89

1873

16233

Injuries involving multiple body regions

844

6972

1.44

11.54

3.6

3.1

101.35

113.74

ug/l

1.55

777

6567

Other immunodeficiencies

270

1940

2.07

11.51

5.1

3.2

104.41

95.02

ug/l

0.46

263

1828

Chalazion

2599

23331

1.22

11.50

3.4

3.1

118.45

115.78

ug/l

0.12

2453

21959

Hypothyroidism due to medicaments and other exogenous substances

274

1956

1.98

11.47

3.9

3.0

122.80

114.93

ug/l

0.28

256

1828

Parkinson's disease

2867

25735

1.20

11.46

2.9

3.2

142.24

161.22

ug/l

3.34

2592

23466

Algoneurodystrophy

775

6404

1.49

11.46

4.0

3.1

85.17

94.08

ug/l

1.08

723

6094

Disorders of porphyrin and bilirubin metabolism

252

1755

1.99

11.41

4.8

2.9

144.57

126.93

ug/l

0.75

243

1635

Endocrine disorders, other/unspecified

433

3331

1.71

11.40

4.5

3.1

130.65

111.25

ug/l

0.96

383

3129

Explicit fungal Sepsis

158

995

2.45

11.39

6.8

2.9

363.27

132.20

ug/l

2.13

150

932

Hypertrophic disorders of skin

1417

12328

1.34

11.38

3.8

3.1

84.21

90.47

ug/l

0.83

1343

11671

Benign neoplasm: Oesophagus

259

1825

2.00

11.38

4.6

3.0

114.46

131.56

ug/l

0.62

243

1687

Other salmonella infections

742

6027

1.45

11.38

3.7

2.9

157.93

121.86

ug/l

1.64

684

5632

Epiphora

483

3754

1.63

11.36

3.4

3.0

124.05

117.32

ug/l

0.30

449

3466

Septal defects

1406

11928

1.33

11.36

4.0

3.4

93.93

96.42

ug/l

0.20

1313

11315

Other and unspecified trigeminal disorders

357

2667

1.80

11.35

3.6

3.0

103.92

109.78

ug/l

0.32

334

2498

Herpesviral keratitis and keratoconjunctivitis

898

7461

1.41

11.34

3.8

3.1

129.65

126.62

ug/l

0.15

839

6953

Abnormality of red blood cells

132

802

2.80

11.34

4.0

2.8

160.11

112.87

ug/l

1.96

122

750

Viral meningitis, including avohilmo

879

7354

1.44

11.27

3.8

3.2

98.25

96.96

ug/l

0.09

825

6998

Contusion of toe(s) without damage to nail

677

5539

1.54

11.24

3.6

3.2

84.05

88.12

ug/l

0.36

650

5260

Explicit fungal Sepsis, including avohilmo

159

1006

2.42

11.23

6.8

2.9

361.18

132.46

ug/l

2.12

151

940

Other deformities of toe(s)

731

5938

1.45

11.21

3.7

3.0

112.54

122.38

ug/l

0.50

663

5515

Dermatopolymyositis (FG)

290

2072

1.85

11.19

4.0

2.9

184.92

126.08

ug/l

1.90

279

1919

Chronic iridocyclitis

1055

8923

1.37

11.18

3.9

3.1

122.34

115.45

ug/l

0.25

990

8370

ILD-related respiratory insufficiency

627

4999

1.49

11.18

4.4

3.1

195.79

153.12

ug/l

2.80

597

4588

Androgenic alopecia

252

1831

2.24

11.16

3.9

3.1

75.85

78.47

ug/l

0.18

244

1722

Other and specified injuries of hip and thigh

486

3771

1.60

11.11

4.1

3.1

133.21

125.68

ug/l

0.31

443

3496

Operations for atrial fibrillation

287

2058

1.87

11.08

3.8

3.0

147.56

172.11

ug/l

1.02

266

1902

Specific development disorders of scholastic skills

1113

9325

1.38

11.06

4.3

3.3

75.74

71.15

ug/l

0.45

1056

8945

Drug-induced obesity

235

1675

2.23

11.05

5.1

3.1

99.64

84.68

ug/l

0.52

219

1586

Sequelae of injuries of neck and trunk

607

4842

1.51

11.04

3.5

3.0

126.90

134.68

ug/l

0.27

564

4552

Alzheimer’s disease (undefined), excluding more controls

943

0.31

11.03

2.9

3.0

128.21

149.91

ug/l

0.41

816

Other diseases of peritoneum

924

7735

1.40

11.01

4.0

3.1

116.85

114.91

ug/l

0.10

865

7231

Inflammatory diseases of the central nervous system

1766

15520

1.27

11.00

3.6

3.2

133.34

120.66

ug/l

1.06

1659

14594

COPD, hospital admissions

9412

74758

1.10

10.96

3.7

3.1

153.00

160.91

ug/l

1.38

8598

68626

Use of ropinirole

659

5322

1.48

10.90

3.4

3.1

129.61

153.40

ug/l

1.63

609

4882

Alzheimer’s disease (Atypical or mixed)

2076

18064

1.22

10.86

2.8

3.3

149.53

157.57

ug/l

0.65

1817

16203

Burns and corrosions of external body surface, specified by site

2413

21625

1.22

10.85

3.4

3.2

121.57

118.31

ug/l

0.25

2257

20470

Failed induction of labour

1905

17233

1.33

10.84

3.8

3.5

50.88

56.75

ug/l

3.00

1801

16597

Other acute skin changes due to ultraviolet radiation

682

5521

1.46

10.84

3.8

3.1

136.37

130.80

ug/l

0.23

639

5121

Alzheimer disease, including avohilmo

7700

49896

1.11

10.83

2.9

3.2

137.44

159.53

ug/l

12.78

6830

44989

Open bite

1440

12653

1.34

10.82

3.8

3.4

76.99

69.27

ug/l

0.23

1384

12085

Prepatellar bursitis

847

6965

1.38

10.79

3.2

2.9

168.87

163.62

ug/l

0.20

797

6523

Benign neoplasm of meninges

2117

18843

1.24

10.77

3.4

3.1

122.06

122.57

ug/l

0.03

1949

17441

Adenocarcinoma and papillary adenocarcinoma of stomach

500

3839

1.51

10.75

3.9

3.0

82.55

143.59

ug/l

12.54

472

3531

Crushed, pushed or stepped on by crowd or human stampede

1761

15521

1.27

10.72

3.3

3.2

101.90

101.71

ug/l

0.01

1685

14765

Anorexia

371

2842

1.80

10.72

4.8

3.2

110.01

85.83

ug/l

1.36

355

2674

Benign neoplasm: Kidney

712

5817

1.46

10.71

3.8

3.1

124.06

130.64

ug/l

0.38

671

5394

Deep endometriosis

2378

21532

1.25

10.71

3.5

3.3

83.20

80.57

ug/l

0.22

2229

20294

Other and unspecified injuries of shoulder and upper arm

712

5821

1.46

10.69

3.5

3.1

118.15

124.50

ug/l

0.38

666

5470

Viral infections of the central nervous system

1559

13633

1.29

10.69

3.6

3.2

113.23

111.10

ug/l

0.17

1453

12858

Bursitis of shoulder

532

4196

1.54

10.66

3.5

2.9

122.88

128.48

ug/l

0.17

507

3929

Localized scleroderma [morphea]

334

2503

1.82

10.65

3.6

3.0

93.05

93.83

ug/l

0.04

310

2320

COPD, early/later onset

9506

75315

1.10

10.64

3.7

3.1

153.96

160.73

ug/l

1.09

8687

69144

Unspecified contracted kidney

133

818

2.61

10.64

8.8

2.9

218.99

128.02

ug/l

3.33

127

758

Pre-eclampsia

5435

50929

1.16

10.63

3.8

3.3

81.84

76.85

ug/l

1.17

5175

48517

Panniculitis, unspecified

235

1641

1.99

10.62

4.0

2.9

126.65

121.70

ug/l

0.13

225

1518

Femoral hernia

837

6911

1.39

10.61

3.5

3.0

117.21

138.38

ug/l

1.68

777

6380

Marginal zone B-cell lymphoma

212

1453

2.08

10.61

3.9

2.9

261.81

124.67

ug/l

2.92

200

1342

Post-traumatic wound infection, not elsewhere classified

579

4625

1.52

10.58

4.0

3.1

120.82

133.39

ug/l

0.86

544

4330

Somnolence, stupor and coma

866

7176

1.38

10.56

4.5

3.1

158.34

131.16

ug/l

0.67

812

6689

Infective bursitis

529

4138

1.51

10.55

3.9

2.9

162.95

168.22

ug/l

0.17

489

3840

Selective deficiency of immunoglobulin G [IgG] subclasses

173

1166

2.47

10.51

5.5

3.1

114.26

90.79

ug/l

0.91

167

1095

Implicit parasitic Sepsis, including avohilmo

149

959

2.55

10.49

4.9

2.9

106.62

105.66

ug/l

0.02

140

897

Mixed connective tissue disease

402

3105

1.71

10.46

4.2

3.1

133.29

102.60

ug/l

0.89

375

2908

Atopic conjunctivitis

1087

9317

1.37

10.46

3.7

3.1

93.50

90.56

ug/l

0.22

1036

8808

Bacterial, viral and other infectious agents

1783

15718

1.25

10.45

3.9

3.1

145.52

125.26

ug/l

1.43

1702

14916

Family history of malignant neoplasm

2830

25750

1.21

10.43

3.3

3.1

103.52

90.18

ug/l

2.27

2698

24467

Malignant neoplasm of oesophagus, including Hilmo

619

4924

1.45

10.42

3.4

3.0

154.69

157.19

ug/l

0.07

576

4531

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

1273

10862

1.29

10.40

3.7

3.1

124.81

147.66

ug/l

3.96

1185

9932

Ankylosing hyperostosis [Forestier]

267

1901

1.83

10.34

3.9

2.9

155.86

160.24

ug/l

0.11

254

1748

Conotruncal defects

299

2214

1.86

10.31

4.5

3.7

86.65

75.99

ug/l

0.76

288

2120

L02BB Anti-androgens

1594

13854

1.25

10.31

2.8

3.3

375.02

187.88

ug/l

17.33

1459

12559

Lesion of radial nerve

746

6120

1.42

10.30

3.8

3.0

126.69

134.70

ug/l

0.53

693

5726

Complex cardiac defects

150

982

2.61

10.28

5.2

3.5

96.19

78.28

ug/l

0.63

142

930

Other and unspecified epidermal thickening

575

4620

1.52

10.28

4.3

3.1

128.54

119.71

ug/l

0.45

552

4309

Acute lymphadenitis

1340

11655

1.31

10.27

3.6

3.2

125.19

103.29

ug/l

2.22

1270

11043

Other disorders of electrolyte and fluid balance, not elsewhere classified

192

1284

2.06

10.26

3.9

2.7

163.28

130.23

ug/l

0.92

185

1165

Other mycoses, not elsewhere classified/unspecified, including avohilmo

408

3155

1.67

10.25

4.4

3.1

140.44

117.07

ug/l

0.91

385

2958

Other disorders of iris and ciliary body

567

4526

1.50

10.23

4.5

3.1

132.73

136.36

ug/l

0.17

528

4196

Alzheimer’s disease (Early onset)

534

6814

0.71

10.17

2.6

3.1

133.09

144.82

ug/l

0.72

467

6173

Idiopathic pulmonary fibrosis

1399

12096

1.28

10.15

3.4

3.1

179.66

161.18

ug/l

1.52

1289

11020

Neuroendocrine tumor and carcinoma of stomach

114

682

2.75

10.09

5.1

3.0

85.08

112.87

ug/l

0.80

104

628

Pneumonia due to Streptococcus pneumoniae

824

6821

1.38

10.09

4.0

3.0

183.07

125.49

ug/l

3.76

770

6367

Burns and corrosions

3083

28086

1.18

10.07

3.4

3.2

120.25

118.07

ug/l

0.18

2886

26582

Malignant melanoma

3102

28185

1.18

10.07

3.3

3.1

151.13

127.47

ug/l

3.48

2828

26064

Acute alcohol intoxication, ICD10

4456

41199

1.15

10.07

3.3

3.1

148.32

133.46

ug/l

1.77

4094

38987

Nontoxic single thyroid nodule

1532

13437

1.28

10.06

3.5

3.0

109.10

110.21

ug/l

0.08

1430

12588

Abnormal spermatozoa

2139

19028

1.21

10.04

3.1

3.2

246.26

200.11

ug/l

4.59

1819

17611

Drug-induced neutropenia

1436

12541

1.29

10.02

3.4

3.1

357.52

126.27

ug/l

20.33

1357

11710

Other specified and unspecified retinal disorders

705

5779

1.43

10.01

4.6

3.0

139.91

134.89

ug/l

0.16

654

5366

Viral meningitis

826

6947

1.42

10.00

3.8

3.2

99.72

98.21

ug/l

0.11

773

6609

Pleural plaque with presence of asbestos

1232

10552

1.29

9.99

3.2

3.3

192.31

190.54

ug/l

0.06

1071

9600

Other fall from one level to another

5394

50303

1.14

9.97

3.3

3.2

120.57

117.99

ug/l

0.23

5047

47431

Assault by bodily force

1781

15770

1.25

9.97

3.4

3.1

126.40

108.31

ug/l

2.06

1649

15090

Obstructed labour due to malposition and malpresentation of fetus

6643

58178

1.14

9.96

3.3

66.92

70.12

ug/l

1.06

6420

56051

Other specified disorders of muscle

583

4668

1.47

9.96

3.7

3.0

137.92

132.33

ug/l

0.18

559

4359

Benign neoplasm: Skin of other and unspecified parts of face

2176

19474

1.22

9.90

3.5

3.2

137.85

127.85

ug/l

0.93

1981

18084

Drug-induced headache, not elsewhere classified

153

1029

2.67

9.89

5.0

3.3

69.07

84.32

ug/l

1.47

147

978

Benign neoplasm: Cerebral meninges

1919

17079

1.24

9.87

3.4

3.1

120.38

121.01

ug/l

0.04

1766

15826

Other noninflammatory disorders of cervix uteri

961

8121

1.35

9.81

3.2

3.0

136.80

111.01

ug/l

0.61

887

7525

Otorrhagia

164

1086

2.26

9.80

5.0

3.2

154.84

120.72

ug/l

0.56

154

1012

Disorders of phosphorus metabolism and phosphatases

122

758

2.70

9.80

6.9

3.0

279.17

111.55

ug/l

1.81

115

710

Dementia due to Parkinsons disease, excluding more controls

396

2979

1.55

9.78

2.6

3.0

159.91

182.03

ug/l

0.85

335

2692

Drug-induced polyneuropathy

192

1319

2.12

9.76

4.5

3.1

218.40

132.40

ug/l

2.00

177

1227

Other specified and unspecified disorders of lens

174

1147

2.08

9.76

3.3

2.9

122.07

138.37

ug/l

0.59

148

1031

Deep bite

2761

22068

1.20

9.76

3.7

3.2

74.80

88.79

ug/l

5.26

2610

20959

Other injuries of lower limb, level unspecified

225

1597

1.99

9.73

4.2

3.0

137.05

109.71

ug/l

1.22

219

1500

Polyarteritis nodosa and related conditions

297

2199

1.78

9.69

4.7

2.9

203.57

110.27

ug/l

2.23

288

2051

Benign neoplasm: Tongue

549

4407

1.50

9.69

3.6

3.0

129.52

131.02

ug/l

0.05

509

4101

Allergic purpura

670

5529

1.46

9.68

4.2

3.1

119.50

107.03

ug/l

0.73

634

5227

Syndrome of inappropriate secretion of antidiuretic hormone

125

777

2.56

9.68

3.9

2.8

141.06

130.60

ug/l

0.18

106

712

Secondary thrombocytopenia

267

1949

1.85

9.68

4.5

3.0

474.73

123.66

ug/l

4.23

257

1827

Use of rotigotine

236

1689

1.95

9.68

5.1

2.9

130.80

125.81

ug/l

0.16

211

1565

Inguinal hernia, unilateral

537

4287

1.50

9.65

3.4

3.0

118.99

135.87

ug/l

0.73

501

3954

Inguinal of femoral hernia, unilateral

537

4287

1.50

9.65

3.4

3.0

118.99

135.87

ug/l

0.73

501

3954

Femoral hernia, unilateral

537

4287

1.50

9.65

3.4

3.0

118.99

135.87

ug/l

0.73

501

3954

Diastasis of muscle

248

1828

2.03

9.62

4.2

3.1

92.00

89.37

ug/l

0.11

234

1745

Intrahepatic Cholestasis of Pregnancy (ICP)

2002

18189

1.28

9.59

3.7

3.4

57.99

65.19

ug/l

4.00

1929

17472

Granulomatous disorders of skin and subcutaneous tissue

609

4997

1.50

9.59

4.2

3.1

96.98

94.28

ug/l

0.14

569

4707

Intentional self-harm by unspecified means

347

2687

1.79

9.59

3.9

3.2

85.09

79.61

ug/l

0.26

327

2571

Mantle cell lymphoma

180

1201

2.04

9.59

3.4

2.9

452.66

158.03

ug/l

7.01

165

1101

Recurrent and persistent haematuria

197

1365

2.07

9.56

5.0

3.0

131.38

114.80

ug/l

0.64

185

1277

Glaucoma secondary to other eye disorders

788

6535

1.38

9.56

4.8

3.1

161.11

139.97

ug/l

1.56

739

6049

Encephalopathy

205

1416

1.97

9.55

4.9

2.9

159.38

152.24

ug/l

0.18

196

1313

Adenocarcinoma and Papillary adenocarcinoma of kidney

220

1533

1.90

9.54

5.9

2.9

187.53

154.19

ug/l

0.78

212

1419

Hypertrophic scar

1282

11224

1.32

9.50

3.8

3.1

82.97

89.12

ug/l

0.77

1214

10629

Poor fetal growth

3858

36105

1.20

9.45

3.9

3.5

54.90

59.44

ug/l

2.89

3676

34775

Shoulder region

316

2374

1.73

9.44

3.9

3.0

119.33

126.81

ug/l

0.34

300

2213

Erectile dysfunction

1317

11385

1.27

9.43

4.2

3.2

176.66

198.92

ug/l

1.56

1217

10475

Specific development disorders of speech and language

1354

11398

1.29

9.42

3.8

3.2

93.33

92.24

ug/l

0.07

1296

10781

Urticaria due to cold and heat

220

1598

2.13

9.42

3.7

3.2

110.66

85.75

ug/l

1.17

209

1518

Malignant neoplasm of endocrine gland

1551

13681

1.27

9.42

3.6

3.1

115.92

100.25

ug/l

1.96

1460

12848

Other congenital malformations of skin, including avohilmo

1918

17202

1.24

9.41

3.5

3.2

100.65

97.06

ug/l

0.31

1836

16289

Nonspecific lymphadenitis

1296

11295

1.29

9.40

3.4

3.1

118.37

108.63

ug/l

0.94

1230

10745

Spasmodic torticollis

688

5713

1.45

9.40

3.6

3.1

93.90

108.14

ug/l

1.52

644

5377

Perioral dermatitis

617

5135

1.53

9.38

3.8

3.2

84.16

74.74

ug/l

0.96

578

4868

Disorders of orbit

926

7870

1.36

9.37

3.7

3.1

126.11

112.79

ug/l

0.60

876

7397

Open wound of abdomen, lower back and pelvis

677

5585

1.43

9.37

3.7

3.1

115.79

119.16

ug/l

0.16

628

5282

Neovascular glaucoma

785

6526

1.37

9.33

4.8

3.1

160.29

139.78

ug/l

1.50

736

6013

Fasciculation

280

2091

1.85

9.32

3.5

3.1

118.99

118.80

ug/l

0.00

272

1986

Malignant neoplasm of brain, including Hilmo

663

8092

0.74

9.30

2.7

3.1

187.38

117.09

ug/l

3.16

611

7567

Carcinoma in situ of skin, other sites/unspecified

307

2293

1.72

9.28

4.3

3.1

149.92

150.11

ug/l

0.01

283

2079

Calculus of lower urinary tract

949

8016

1.33

9.27

3.4

3.2

174.58

171.14

ug/l

0.09

846

7410

Sequelae of injuries of head

1063

9102

1.32

9.27

3.4

3.1

146.26

137.16

ug/l

0.30

964

8600

Other diseases of spinal cord

609

4968

1.45

9.25

3.6

3.1

137.32

135.79

ug/l

0.04

564

4650

Single spontaneous delivery

10734

54136

1.10

9.25

3.3

77.15

88.59

ug/l

10.00

10037

50782

Allergic colitis

567

4653

1.53

9.24

4.2

3.3

62.16

56.69

ug/l

0.60

541

4448

Thyrotoxicosis with toxic multinodular goitre

1204

10439

1.30

9.23

3.6

3.1

114.86

118.78

ug/l

0.27

1126

9630

Other acute viral hepatitis

291

2185

1.80

9.18

3.8

3.1

168.41

111.66

ug/l

1.90

279

2083

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

827

7013

1.40

9.17

3.6

3.2

102.10

101.59

ug/l

0.02

791

6649

Torsion of ovary, ovarian pedicle and fallopian tube

579

4767

1.52

9.17

3.3

3.0

71.42

73.71

ug/l

0.18

562

4520

Other/unspecified crystal arthropathies

143

934

2.34

9.16

4.4

3.0

144.16

127.42

ug/l

0.66

129

851

Striae atrophicae

289

2200

1.88

9.16

4.6

3.1

120.32

82.30

ug/l

0.70

271

2090

Primary adrenocortical insufficiency

255

1882

1.89

9.15

4.9

3.1

122.70

97.74

ug/l

1.42

241

1778

Mantle cell lymphoma, including Hilmo

262

1895

1.75

9.14

3.8

3.0

376.79

145.60

ug/l

8.19

243

1745

Hyperprolactinaemia

878

7542

1.41

9.14

3.8

3.2

86.55

80.10

ug/l

0.26

829

7221

Spinal osteochondrosis

233

1663

1.85

9.13

3.6

2.8

103.45

119.34

ug/l

0.90

222

1570

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

882

7374

1.32

9.12

3.8

3.1

210.32

141.94

ug/l

7.65

827

6749

Perforation of tympanic membrane

2152

19374

1.21

9.12

3.6

3.1

122.09

119.08

ug/l

0.18

2001

18168

Benign neoplasm of middle ear and respiratory system

1484

13013

1.25

9.11

3.5

3.1

142.14

142.79

ug/l

0.02

1406

12118

Atypical mycobacterium lung infection

237

1698

1.83

9.07

3.5

3.0

112.69

129.82

ug/l

0.96

220

1548

Oral lichen planus

558

4544

1.49

9.07

3.6

3.0

99.62

114.44

ug/l

1.77

523

4220

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

766

6449

1.41

9.05

3.2

98.23

104.62

ug/l

0.58

705

6100

Disorders of optic nerve and visual pathways

2169

19604

1.22

9.03

3.7

3.3

113.50

102.43

ug/l

1.74

2044

18509

Disorders of synovium and tendon in diseases classified elsewhere

425

3320

1.55

9.03

3.8

2.9

118.71

147.90

ug/l

2.43

399

3100

Malignant neoplasm of thyroid gland, including Hilmo

1584

14031

1.25

9.02

3.5

3.1

107.57

99.46

ug/l

0.82

1477

13163

Other and unspecified injuries of wrist and hand

909

7760

1.36

9.01

3.6

3.2

97.62

101.73

ug/l

0.33

842

7331

Malignant neoplasm of liver and intrahepatic bile ducts

533

4234

1.44

9.01

4.3

3.1

212.01

147.41

ug/l

4.07

499

3889

Perichondritis of external ear

349

2668

1.64

8.99

3.2

3.0

138.76

137.97

ug/l

0.02

313

2468

Myocardial infarction, with ST-elevation

3165

28862

1.16

8.98

3.9

3.1

168.50

171.48

ug/l

0.19

2948

26371

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

1533

13530

1.25

8.94

3.4

3.1

102.71

107.36

ug/l

0.33

1397

12922

Cerebral aneurysm, nonruptured

1757

15637

1.23

8.94

3.6

3.0

126.85

127.16

ug/l

0.02

1657

14613

Disorders of optic nerve, not elsewhere classified

411

3221

1.57

8.90

3.9

3.1

131.74

136.51

ug/l

0.21

381

2990

Other secondary coxarthrosis

660

5440

1.41

8.90

3.7

3.0

134.33

131.95

ug/l

0.10

613

5060

Glaucoma-related operations

1064

9142

1.31

8.89

3.1

3.2

121.73

139.69

ug/l

2.54

960

8369

Atrial septal defect

812

6831

1.39

8.89

4.2

3.4

101.75

96.46

ug/l

0.34

770

6478

Central retinal artery occlusion

400

3090

1.54

8.88

4.8

3.1

159.68

153.28

ug/l

0.23

371

2807

Erythema nodosum

654

5444

1.45

8.87

4.1

3.0

113.34

97.99

ug/l

0.97

627

5097

Malignant neoplasm of rectosigmoid junction

311

2322

1.65

8.86

3.0

132.40

139.22

ug/l

0.25

298

2135

Spirochaetal infections, other/unspecified

1833

16388

1.23

8.85

3.4

3.2

115.79

127.15

ug/l

1.14

1667

15338

Disorders of speech understanding and production

944

7918

1.34

8.81

3.9

3.3

99.44

91.68

ug/l

0.54

899

7435

Use of rasagiline

470

3749

1.52

8.81

2.9

3.1

120.85

153.70

ug/l

3.53

416

3446

Cystic disease of liver

160

1093

2.25

8.77

6.4

3.1

139.07

112.17

ug/l

1.29

152

1016

Follow-up care involving plastic surgery

842

7154

1.37

8.76

3.2

2.9

121.12

96.78

ug/l

2.88

732

6720

Other acquired deformities of musculoskeletal system and connective tissue

885

7510

1.34

8.74

3.2

3.0

136.97

132.11

ug/l

0.23

829

7072

Leukaemia of unspecified cell type

196

1371

1.95

8.74

4.8

3.1

480.22

131.15

ug/l

8.22

186

1267

Mandibular retrognathia

1581

14070

1.27

8.73

3.6

3.3

77.27

85.23

ug/l

1.06

1520

13435

Manic episode

660

5472

1.42

8.72

3.4

3.0

107.98

108.62

ug/l

0.03

604

5195

Other vitreous opacities

851

7218

1.36

8.70

3.5

3.1

112.01

127.63

ug/l

1.99

783

6712

Complications of the puerperium, not elsewhere classified

1182

10503

1.37

8.69

3.9

3.4

60.76

62.69

ug/l

0.24

1152

10103

Other disorders of Eustachian tube

670

5591

1.43

8.67

3.9

3.1

104.40

111.79

ug/l

0.61

641

5255

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

280

2102

1.77

8.67

5.3

3.1

180.64

111.33

ug/l

2.16

255

1960

Dermatopolymyositis

303

2289

1.70

8.66

4.0

3.0

180.42

118.14

ug/l

2.27

292

2131

Other abnormal findings in urine

327

2495

1.65

8.64

3.6

3.1

139.60

128.10

ug/l

0.31

315

2305

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

2284

20926

1.23

8.63

3.7

3.3

65.78

71.30

ug/l

1.93

2189

19989

Congenital malformations of genital organs

2484

22634

1.21

8.62

3.7

3.4

68.39

71.92

ug/l

0.94

2365

21633

Congenital malformations of the respiratory system, including avohilmo

406

3206

1.59

8.61

3.9

3.3

106.13

110.02

ug/l

0.15

383

3019

Hypoplasia of dental enamel , including avohilmo

918

7634

1.38

8.60

5.5

3.4

67.84

56.22

ug/l

1.67

901

7326

Early lumbar disc prolapse operation

2565

23427

1.19

8.59

3.2

99.32

99.72

ug/l

0.03

2460

22556

Other specified and unspecified disorders of eyelid

299

2260

1.70

8.57

3.4

3.0

108.98

136.92

ug/l

1.73

281

2102

Toxic effects of substances chiefly nonmedicinal as to source

2549

23230

1.19

8.55

3.3

3.2

112.23

112.83

ug/l

0.05

2399

21961

Tooth eruption problems

4347

39322

1.15

8.55

3.7

3.3

69.78

68.00

ug/l

0.33

4187

37567

Injury of other and unspecified intrathoracic organs

1211

10510

1.27

8.55

3.4

3.1

159.65

149.30

ug/l

0.57

1131

9815

Biological medicines for asthma

506

4126

1.52

8.54

3.9

3.1

89.36

104.45

ug/l

1.09

484

3915

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

376

2964

1.64

8.54

5.3

3.2

87.18

81.58

ug/l

0.31

361

2799

Other and unspecified nail disorders

510

4146

1.50

8.50

4.2

3.0

103.10

113.92

ug/l

0.83

482

3874

Ulcer of vagina/vulva

712

6055

1.45

8.49

4.0

3.2

72.11

74.13

ug/l

0.23

679

5683

Nosocomial condition (hospital)

134

877

2.30

8.46

4.4

3.0

134.68

124.67

ug/l

0.27

126

809

Other and unspecified bullous disorders

239

1761

1.84

8.39

4.4

3.0

142.40

120.34

ug/l

0.64

231

1651

Ectopic pregnancy

4357

40797

1.15

8.38

3.5

3.2

81.30

84.17

ug/l

0.52

4128

38791

2933

27329

1.21

8.37

3.6

3.5

57.24

58.05

ug/l

0.08

2826

26365

Other forms of systemic lupus erythematosus

203

1477

2.04

8.35

4.7

3.2

111.80

83.44

ug/l

1.45

196

1388

Dependent personality disorder

429

3435

1.56

8.34

4.2

3.0

112.67

108.59

ug/l

0.10

405

3242

Mental and behavioural disorders due to tobacco

1841

16520

1.22

8.33

3.6

3.1

127.36

125.45

ug/l

0.15

1660

15617

ILD and respiratory illness in diseases classified elsewhere

122

789

2.43

8.32

3.8

3.0

170.64

125.93

ug/l

1.63

116

731

Other disorders of prostate

557

4474

1.39

8.32

3.4

3.0

174.72

210.03

ug/l

1.89

525

4147

Event of undetermined intent

1418

12539

1.26

8.32

3.8

3.1

103.69

113.69

ug/l

0.99

1340

11893

Molar incisor enamel hypoplasia

972

8092

1.36

8.29

5.4

3.5

67.14

55.51

ug/l

1.80

951

7765

Other and unspecified mononeuropathies of upper limb

615

5083

1.42

8.28

3.4

3.0

130.07

128.82

ug/l

0.03

581

4779

Hypoplasia of dental enamel, prenatal

282

5.21

8.27

13.3

4.3

66.89

49.08

ug/l

0.58

271

Hemiplegia

1001

8604

1.30

8.26

3.9

3.1

115.67

123.66

ug/l

0.54

933

8054

Certolizumab pegol

493

4082

1.58

8.26

3.3

104.21

76.73

ug/l

0.42

477

3873

Other abnormal auditory perceptions

280

2137

1.78

8.25

3.3

3.0

95.66

92.58

ug/l

0.17

267

2022

Other and unspecified acute skin changes due to ultraviolet radiation

450

3573

1.48

8.22

3.8

3.0

164.07

147.14

ug/l

0.60

418

3276

Benign lipomatous neoplasm of other sites/unspecified

1639

14576

1.23

8.22

3.2

3.1

132.00

135.39

ug/l

0.22

1487

13495

Benign neoplasm of breast

2700

24810

1.19

8.22

3.3

3.2

91.25

94.26

ug/l

0.37

2512

23186

Other congenital malformations of heart

164

1143

2.17

8.21

4.6

3.4

82.47

78.42

ug/l

0.14

158

1094

Implicit parasitic Sepsis

118

760

2.46

8.20

5.1

3.0

116.15

109.66

ug/l

0.13

110

706

Impaction of intestines

150

1003

2.08

8.19

4.5

2.9

103.34

118.57

ug/l

0.74

138

919

Other spirochaetal diseases, including avohilmo

8041

76424

1.10

8.18

3.1

3.2

109.27

124.58

ug/l

7.75

7453

71635

Ovarian hyperstimulation (induction)

522

4422

1.65

8.18

4.3

3.4

52.59

55.62

ug/l

0.57

515

4260

Other factor of the environment

283

2154

1.73

8.14

5.2

3.1

129.52

117.81

ug/l

0.46

267

2039

Flatulence and related conditions

233

1707

1.80

8.12

4.1

2.9

111.66

109.73

ug/l

0.07

213

1590

Pulmonary oedema

323

2443

1.57

8.11

6.9

3.0

238.47

153.03

ug/l

2.91

310

2227

Restrictive cardiomyopathy

463

2.99

8.10

6.4

3.1

141.63

144.55

ug/l

0.05

422

Smoking dependency

1841

16553

1.22

8.06

3.6

3.1

127.36

125.46

ug/l

0.15

1660

15650

Somnolence

288

2200

1.72

8.05

4.8

3.1

86.97

101.54

ug/l

1.14

275

2082

Fall on and from ladder

1371

12066

1.24

7.98

3.0

3.1

162.62

164.04

ug/l

0.04

1273

11270

Bitten or struck by other mammals

2924

27008

1.18

7.98

3.6

3.3

86.28

94.54

ug/l

2.57

2730

25674

111

708

2.48

7.98

3.8

3.0

173.30

129.04

ug/l

1.57

106

656

Tic disorders

308

2379

1.68

7.95

3.6

3.3

75.96

72.13

ug/l

0.21

291

2265

Haemangioma and lymphangioma, any site

1986

17970

1.21

7.93

3.7

3.2

101.55

113.16

ug/l

2.00

1884

16904

Vestibular neuronitis

1764

15820

1.22

7.92

3.3

3.1

131.79

129.97

ug/l

0.08

1628

14803

Benign neoplasm: Liver/bile ducts

605

5068

1.44

7.90

4.2

3.1

109.20

101.80

ug/l

0.46

580

4794

Localized skin eruption due to drugs and medicaments

268

2044

1.76

7.84

4.1

3.0

115.10

106.22

ug/l

0.24

248

1916

Superficial injuries involving multiple body regions

588

4888

1.43

7.84

3.6

3.1

96.60

109.26

ug/l

1.23

537

4609

Other superficial mycoses

513

4211

1.47

7.82

3.9

3.1

113.54

108.62

ug/l

0.24

484

3998

Alcoholic gastritis

256

1885

1.66

7.81

3.8

2.8

181.58

183.43

ug/l

0.03

239

1760

Atlantoaxial subluxation

144

974

2.13

7.80

4.0

2.9

106.99

121.02

ug/l

0.58

137

903

Symptoms and signs involving appearance and behaviour

200

1455

1.93

7.80

3.9

3.0

97.55

101.45

ug/l

0.13

184

1383

Gestational [pregnancy-induced] hypertension

7494

71453

1.11

7.79

3.7

3.3

72.02

70.50

ug/l

0.44

7200

68339

Malignant melanoma of skin, including Hilmo

2847

26095

1.16

7.77

3.3

3.1

152.48

127.15

ug/l

3.12

2615

24163

Loose body in joint

451

3608

1.46

7.76

2.9

140.20

148.96

ug/l

0.28

419

3373

Malignant neoplasm of anus and anal canal, including Hilmo

246

1822

1.72

7.76

3.4

2.9

170.77

124.89

ug/l

1.66

229

1684

CR(E)ST syndrome

342

2701

1.64

7.75

4.7

3.0

88.99

99.47

ug/l

0.43

324

2523

Paralytic strabismus

1348

11901

1.24

7.71

3.6

3.1

157.26

134.63

ug/l

1.46

1263

11066

Personal history of certain other diseases

537

4526

1.54

7.71

3.9

3.3

81.37

64.10

ug/l

0.63

496

4321

Thyrotoxicosis factitia

561

3.22

7.69

3.8

3.1

82.43

83.45

ug/l

0.04

519

Disorders of eyelid in diseases classified elsewhere

679

5720

1.38

7.68

3.9

3.0

113.96

113.30

ug/l

0.03

636

5356

Iridocyclitis in diseases classified elsewhere

393

3129

1.53

7.64

4.1

3.1

129.30

121.85

ug/l

0.30

368

2939

180

1292

2.00

7.64

3.6

3.0

82.52

91.79

ug/l

0.44

172

1219

Psoriasis (vulgaris), strict definition

681

5718

1.37

7.63

3.3

3.0

141.72

136.45

ug/l

0.27

642

5411

Allergic contact dermatitis due to drugs in contact with skin

466

3801

1.50

7.63

3.5

3.1

113.14

111.09

ug/l

0.08

436

3554

432

3450

1.47

7.60

3.8

3.1

124.42

155.29

ug/l

2.70

395

3140

Hyperkinetic disorders (excl. ADHD)

441

3516

1.50

7.58

4.0

3.5

77.09

78.60

ug/l

0.06

425

3386

Other spirochaetal diseases

7915

75354

1.09

7.58

3.1

3.2

109.66

124.76

ug/l

7.36

7329

70622

Other disorders of choroid

283

2146

1.63

7.57

3.9

3.0

127.48

128.71

ug/l

0.04

263

1998

COPD, hospital admissions 3, with asthma pneumonia sepsis

5351

42986

1.11

7.57

3.9

3.1

159.20

165.63

ug/l

0.72

4898

39273

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

175

1241

1.96

7.57

4.9

3.2

121.40

111.77

ug/l

0.29

164

1174

Other specified congenital malformation syndromes affecting multiple systems

375

3000

1.59

7.56

4.9

3.5

126.37

83.15

ug/l

1.44

359

2872

Pediculosis, acariasis and other infestations

1260

11121

1.26

7.52

3.6

3.1

149.34

121.46

ug/l

2.41

1179

10548

Cutaneous lupus erythematosus

493

4042

1.46

7.52

3.5

3.0

125.04

109.05

ug/l

1.41

462

3765

Other bacterial agents as the cause of diseases classified to other chapters

221

1633

1.80

7.51

5.6

3.0

207.58

113.68

ug/l

2.38

196

1519

Enteritis due to Yersinia enterocolitica

125

833

2.27

7.50

3.9

3.1

119.07

98.82

ug/l

0.34

120

791

Benign neoplasm: Liver

549

4588

1.46

7.50

4.2

3.1

105.70

100.09

ug/l

0.30

524

4340

Cushing syndrome

255

1940

1.75

7.49

4.3

2.9

128.11

100.47

ug/l

1.27

241

1807

Haemangioma, any site

1838

16618

1.21

7.48

3.7

3.2

102.67

114.17

ug/l

1.82

1744

15627

Other and unspecified nonorganic psychotic disorders

4628

43412

1.12

7.48

3.2

107.39

104.92

ug/l

0.17

4308

41374

Other congenital malformations of skin

888

7701

1.33

7.46

3.7

3.2

101.58

97.17

ug/l

0.22

853

7269

Malignant neoplasm of breast, HER-positive

7097

55633

0.91

7.46

2.8

3.1

137.55

91.16

ug/l

28.33

6525

51983

Malignant neoplasm of breast, ER-positive, including Hilmo

7121

55744

0.91

7.44

2.8

3.1

137.36

91.11

ug/l

28.35

6548

52090

Complications following infusion, transfusion and therapeutic injection

307

2379

1.62

7.40

5.5

2.9

195.68

117.36

ug/l

3.83

285

2209

Congenital malformations of great arteries

447

3577

1.50

7.39

4.4

3.6

76.77

80.06

ug/l

0.25

429

3418

Hyphaema and other vascular disorders of iris and ciliary body

407

3251

1.49

7.38

5.0

3.1

144.30

144.50

ug/l

0.01

382

2995

Hyperosmolality and hypernatraemia

260

1943

1.63

7.37

3.5

2.7

151.10

140.54

ug/l

0.33

238

1760

Hyperaldosteronism

553

4587

1.42

7.36

4.4

3.0

142.42

134.83

ug/l

0.41

516

4277

Spirochaetal infections, other/unspecified, including avohilmo

7892

75190

1.09

7.35

3.1

3.2

108.64

124.81

ug/l

8.79

7306

70463

Impetigo

1066

9363

1.29

7.33

3.7

3.2

96.85

96.05

ug/l

0.06

1008

8879

Foreign body in respiratory tract

1089

9562

1.28

7.32

3.5

3.2

122.66

108.29

ug/l

0.46

1010

8997

Benign neoplasm: Skin of ear and external auricular canal

747

6343

1.33

7.32

3.4

3.2

136.03

135.82

ug/l

0.00

678

5862

Other disorders of binocular vision

333

2665

1.67

7.31

3.9

3.2

75.83

80.97

ug/l

0.35

327

2542

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

885

7709

1.34

7.30

4.3

3.3

99.59

79.38

ug/l

1.50

844

7345

Other bursitis of elbow

175

1234

1.86

7.29

4.1

2.9

146.60

163.89

ug/l

0.46

170

1138

Malignant neoplasm of oral cavity, including Hilmo

786

6673

1.31

7.28

3.0

165.01

134.02

ug/l

3.00

736

6173

Benign neoplasm: Appendix

226

1683

1.76

7.28

3.5

3.1

129.27

133.17

ug/l

0.10

218

1559

Benign neoplasm of other and unspecified intrathoracic organs

222

1648

1.77

7.27

3.9

3.0

124.96

126.87

ug/l

0.04

207

1530

Disorders of purine and pyrimidine metabolism

120

787

2.17

7.26

5.5

2.7

209.70

142.23

ug/l

1.54

109

730

Malignant neoplasm of head and neck, including Hilmo

1741

15585

1.19

7.23

3.1

178.14

141.12

ug/l

5.59

1609

14392

Benign neoplasm: Skin of trunk

880

7614

1.31

7.23

4.0

3.1

112.22

119.96

ug/l

0.65

808

7143

Infectious mononucleosis, including avohilmo

2261

20785

1.20

7.20

3.5

3.2

89.04

75.86

ug/l

2.17

2151

19888

Infectious mononucleosis

2261

20785

1.20

7.20

3.5

3.2

89.04

75.86

ug/l

2.17

2151

19888

Transepidermal elimination disorders

200

5.36

7.19

6.1

3.2

156.54

117.22

ug/l

0.70

183

Injury of muscle and tendon at ankle and foot level

533

4420

1.42

7.18

3.2

3.0

118.92

121.09

ug/l

0.08

506

4188

Conductive hearing loss, unspecified

1733

15624

1.21

7.18

3.5

3.2

114.35

118.27

ug/l

0.24

1623

14680

Disorders of parathyroid gland, other and/or unspecified

148

1027

2.04

7.18

5.6

2.8

198.26

117.77

ug/l

2.32

136

939

Liver disorders in diseases classified elsewhere

487

3.16

7.17

5.5

3.1

154.45

92.96

ug/l

0.95

461

Melanocytic naevi of lower limb, including hip

990

8677

1.30

7.15

4.2

3.2

106.32

103.54

ug/l

0.16

934

8188

Eustachian salpingitis and obstruction

1901

17282

1.20

7.14

3.5

3.2

110.40

98.11

ug/l

0.64

1805

16571

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

279

2171

1.69

7.14

4.1

3.0

138.24

101.89

ug/l

1.68

263

2045

Disorders of plasma-protein metabolism, not elsewhere classified

152

1062

2.01

7.10

3.5

2.7

157.94

125.43

ug/l

0.90

145

996

Disorders of myoneural junction and muscle in diseases classified elsewhere

178

1293

1.94

7.08

4.7

3.0

135.02

100.41

ug/l

1.18

159

1208

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

1596

14348

1.22

7.05

3.4

3.1

114.31

125.77

ug/l

1.38

1482

13458

Other and unspecified pemphigoid

185

1337

1.84

7.05

3.9

3.1

142.00

138.26

ug/l

0.10

171

1220

Benign neoplasm: Choroid

1278

11340

1.24

7.04

3.2

3.1

120.96

130.85

ug/l

1.07

1180

10537

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

102

648

2.30

7.04

5.5

2.7

202.47

149.13

ug/l

0.92

601

Lifestyle-related condition

258

1983

1.70

7.02

5.2

3.0

126.55

117.81

ug/l

0.31

242

1881

Henoch-Schönlein purpura nephritis (HSPN)

623

2.67

6.99

6.4

2.9

138.87

107.05

ug/l

1.02

588

Autoimmune thyroiditis

449

3711

1.50

6.97

3.9

3.0

95.63

79.18

ug/l

0.85

421

3514

Corneal degeneration

350

2785

1.54

6.96

3.6

3.0

110.96

123.97

ug/l

0.57

328

2575

Exclusion endpoint for clefts

450

3701

1.49

6.95

4.6

3.5

122.91

85.18

ug/l

1.44

429

3532

Paraplegia, diplegia of upper limbs

424

3434

1.47

6.95

3.8

3.1

178.41

138.79

ug/l

1.02

389

3203

Non-small cell lung cancer, squamous

505

6232

0.76

6.95

2.8

3.1

233.23

155.29

ug/l

5.47

465

5656

Degenerative diseases of the nervous system

7461

50914

1.09

6.93

2.9

3.2

143.04

159.03

ug/l

4.49

6671

46062

Disorders of adrenal gland, other and/or unspecified

125

855

2.24

6.92

5.3

2.9

152.94

105.14

ug/l

1.34

116

804

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

293

2277

1.60

6.89

3.1

2.9

110.16

122.56

ug/l

0.60

283

2117

Lyme disease

7818

74599

1.09

6.88

3.1

3.2

108.58

124.93

ug/l

8.89

7234

69908

Lyme disease, including avohilmo

7818

74599

1.09

6.88

3.1

3.2

108.58

124.93

ug/l

8.89

7234

69908

Other disorders of peripheral nervous system

140

969

2.04

6.86

4.0

3.0

141.50

130.51

ug/l

0.23

132

901

Other disorders of carbohydrate metabolism

101

648

2.31

6.84

4.5

3.1

154.92

121.22

ug/l

0.39

608

Aspergillosis

178

1286

1.84

6.80

4.8

3.0

375.24

146.35

ug/l

1.12

172

1192

Congenital malformations of the respiratory system

358

2868

1.53

6.80

3.9

3.3

110.19

110.68

ug/l

0.01

341

2694

Melanocytic naevi of other and unspecified parts of face

1318

11793

1.24

6.80

3.7

3.2

97.31

101.69

ug/l

0.21

1260

11117

Transient global amnesia

1680

15140

1.20

6.80

2.9

3.1

121.66

143.52

ug/l

3.82

1539

13925

Hereditary corneal dystrophies

664

5637

1.35

6.79

3.5

3.1

111.74

130.67

ug/l

1.98

606

5203

Inflammatory disorders of breast

1767

16198

1.23

6.77

3.9

3.3

65.87

67.57

ug/l

0.30

1690

15356

Non-small cell lung cancer

1468

16317

0.84

6.75

2.9

3.1

239.66

145.22

ug/l

15.53

1353

14840

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

746

6382

1.32

6.75

3.7

3.1

145.21

139.25

ug/l

0.15

705

5931

Acute nephritic syndrome

400

3230

1.47

6.74

6.8

3.0

189.05

140.64

ug/l

3.31

384

3023

Aspergillosis, including avohilmo

183

1331

1.82

6.73

4.9

3.0

365.24

144.91

ug/l

1.11

177

1236

Nonpyogenic thrombosis of intracranial venous system

218

1648

1.77

6.73

4.4

3.2

105.23

97.28

ug/l

0.28

202

1560

Hypersensitivity angiitis

106

692

2.25

6.73

8.1

3.1

185.23

127.47

ug/l

2.44

100

638

Dissection of aorta

551

4561

1.36

6.70

3.7

2.9

196.03

162.42

ug/l

1.31

505

4180

Malignant neoplasm of thyroid gland

1421

12746

1.23

6.70

3.5

3.1

107.55

99.90

ug/l

0.70

1334

11961

Contusion of other and unspecified parts of foot

1290

11551

1.25

6.67

3.8

3.2

82.15

92.59

ug/l

1.93

1218

11000

Other bursitis of knee

279

2150

1.58

6.66

3.3

2.9

116.04

148.04

ug/l

1.85

265

2008

Malignant neoplasm of other connective and soft tissue, including Hilmo

766

6560

1.30

6.66

3.1

229.32

126.06

ug/l

3.00

726

6092

Disorders in reading

392

3206

1.52

6.64

4.7

3.5

76.19

71.81

ug/l

0.31

376

3061

Right ventricular outflow tract obstruction

187

1392

1.89

6.63

4.9

3.8

85.16

68.83

ug/l

0.91

180

1341

Scabies

994

8723

1.27

6.62

3.5

3.1

129.65

115.59

ug/l

1.00

923

8274

Disorder of external ear, unspecified

671

5714

1.34

6.62

3.7

3.1

124.65

131.19

ug/l

0.33

619

5365

Combined immunodeficiencies

219

1649

1.72

6.61

4.7

3.0

152.63

112.82

ug/l

1.43

204

1537

Enterobiasis, including avohilmo

619

5357

1.44

6.60

4.4

3.4

57.73

64.55

ug/l

1.23

599

5126

Unspecified visual impairment (binocular)

320

2532

1.55

6.60

4.1

3.2

126.49

116.26

ug/l

0.27

307

2366

Non-allergic asthma

1738

15722

1.19

6.58

3.4

3.2

106.58

121.47

ug/l

2.99

1639

14704

Infections of breast associated with childbirth

1025

9188

1.33

6.56

3.6

3.3

58.72

61.46

ug/l

0.26

980

8780

Hodgkin lymphoma, hilmo

580

4898

1.38

6.54

3.9

3.2

245.22

120.24

ug/l

6.19

556

4611

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

458

3814

1.47

6.54

4.9

3.3

85.71

82.44

ug/l

0.22

441

3603

Tic and related disorders

318

2540

1.58

6.52

3.6

3.4

74.90

71.49

ug/l

0.19

301

2405

Other and unspecified acne

362

2956

1.56

6.52

4.8

3.2

88.61

78.65

ug/l

0.86

344

2808

Malignant melanoma of skin

2320

21254

1.16

6.52

3.3

3.1

153.26

126.79

ug/l

2.82

2115

19678

All dysplastic lesions of the cervix uteri, vagina or vulva

8780

82419

1.09

6.48

3.4

74.40

71.26

ug/l

1.26

8369

78922

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

1028

11725

0.82

6.48

3.0

3.1

176.95

120.66

ug/l

4.05

957

10937

Placenta praevia

1268

11490

1.28

6.46

3.6

3.4

66.88

63.90

ug/l

0.16

1222

11120

Other articular cartilage disorders

432

3517

1.42

6.44

3.5

2.8

125.98

147.66

ug/l

1.26

413

3278

Other and unspecified disorders of autonomic nervous system

113

783

2.43

6.44

4.8

3.0

123.10

100.78

ug/l

0.20

107

746

Other injuries of upper limb, level unspecified

268

2087

1.62

6.43

4.2

3.1

109.60

112.95

ug/l

0.09

249

1969

Benign neoplasm of bone and articular cartilage

1809

16475

1.19

6.41

3.3

3.1

110.04

112.06

ug/l

0.17

1703

15581

Macular cyst

576

4847

1.36

6.41

3.6

3.0

143.70

144.22

ug/l

0.02

529

4445

Medullary cystic kidney disease, nephronophthisis

259

4.76

6.41

12.3

3.2

250.32

81.00

ug/l

4.74

247

Scleritis

297

2360

1.60

6.40

3.8

3.0

110.50

102.04

ug/l

0.47

282

2226

Other encephalitis

568

4794

1.38

6.38

3.8

3.1

150.13

117.02

ug/l

1.16

529

4506

Abdominal aortic aneurysm (AAA)

1631

14481

1.18

6.37

4.0

3.0

194.32

182.67

ug/l

0.92

1498

12989

Other nonthrombocytopenic purpura

202

1514

1.75

6.36

4.4

3.0

119.22

119.27

ug/l

0.00

195

1401

Melanoma in situ

836

7261

1.29

6.34

3.5

3.1

145.76

142.24

ug/l

0.16

754

6685

Foreign body in ear

441

3658

1.46

6.34

3.5

3.1

109.00

105.20

ug/l

0.15

410

3452

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

2002

18567

1.22

6.32

3.7

3.4

57.99

64.51

ug/l

3.39

1929

17823

Malignant neoplasm of tongue, including Hilmo

461

3787

1.39

6.29

3.0

150.17

137.96

ug/l

0.55

435

3516

Injury of muscle and tendon at wrist and hand level

2775

25683

1.14

6.28

3.1

128.22

139.90

ug/l

1.77

2618

24274

Malignant neoplasm of renal pelvis, including Hilmo

202

1484

1.65

6.27

3.7

2.9

224.40

155.10

ug/l

2.34

183

1344

Vascular dementia (other)

135

925

1.88

6.27

3.1

3.3

119.11

153.40

ug/l

1.34

116

839

Pedestrian injured in transport accident

1471

13252

1.21

6.27

3.4

3.1

98.77

116.40

ug/l

2.90

1382

12449

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

1091

9660

1.25

6.27

3.6

3.1

121.91

120.06

ug/l

0.11

1043

9201

Osteomyelitis of vertebra

450

2.60

6.26

4.8

2.6

150.42

155.25

ug/l

0.09

417

Cauda equina syndrome

284

2243

1.60

6.26

4.0

3.0

103.89

113.97

ug/l

0.50

276

2106

Twin gestation

2436

22687

1.18

6.24

3.6

3.3

72.35

68.92

ug/l

0.30

2337

21935

Injury of nerves and spinal cord at neck level

424

3476

1.43

6.24

3.3

3.1

122.09

148.57

ug/l

2.15

388

3251

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

2284

21243

1.19

6.22

3.7

3.4

65.78

71.44

ug/l

1.99

2189

20265

Pigmented purpuric dermatosis

219

1665

1.69

6.22

3.7

2.9

119.03

127.06

ug/l

0.31

206

1546

Drug-induced systemic lupus erythematosus

154

1127

2.00

6.22

5.8

3.1

179.16

92.14

ug/l

2.11

147

1063

Other and unspecified injuries of ankle and foot

1012

8970

1.27

6.21

3.6

3.1

89.72

95.21

ug/l

0.56

948

8507

Pyogenic granuloma

382

3116

1.48

6.21

4.2

3.1

100.95

106.95

ug/l

0.34

366

2920

Alzheimer disease

6647

45086

1.09

6.20

2.9

3.2

137.61

158.65

ug/l

10.32

5918

40613

Foreign body entering into or through eye or natural orifice

1592

14391

1.19

6.18

3.3

3.1

133.73

131.71

ug/l

0.11

1490

13573

Status epilepticus

680

5798

1.31

6.17

3.8

3.0

187.58

136.61

ug/l

2.74

622

5417

Schizophrenia or delusion

7476

71418

1.08

6.16

3.2

3.1

110.23

116.25

ug/l

0.89

6942

67559

Malignant neoplasm of ureter, including Hilmo

157

1119

1.80

6.16

3.7

3.1

183.10

145.01

ug/l

1.09

143

1021

Other and unspecified paralytic syndromes

296

2347

1.56

6.14

3.6

3.0

116.91

122.17

ug/l

0.17

281

2213

Other intracranial haemorrhages

562

4709

1.34

6.13

3.3

3.1

178.12

157.86

ug/l

0.89

516

4287

Galactorrhea

279

2269

1.74

6.12

3.7

3.3

71.71

64.26

ug/l

0.71

270

2163

Major anomalies of jaw size

561

4759

1.37

6.11

3.7

3.1

105.70

105.31

ug/l

0.02

538

4515

Renal agenesis and other reduction defects of kidney

112

770

2.21

6.10

8.0

3.1

180.55

101.85

ug/l

3.69

106

734

Benign neoplasm: Skin of lower limb, including hip

562

4763

1.37

6.07

3.7

3.1

110.95

116.87

ug/l

0.32

525

4462

Benign neoplasm: Other and unspecified parts of mouth

634

5418

1.33

6.06

3.8

3.0

130.15

134.35

ug/l

0.17

581

5045

Renal agenesis and other reduction defects of kidney, including avohilmo

125

878

2.09

6.04

7.4

3.1

169.69

99.98

ug/l

3.49

117

829

Alcohol abuse counselling and surveillance

323

2582

1.50

6.04

3.2

3.0

166.70

140.51

ug/l

0.62

311

2451

Cardiomyopathy due to drugs and other external agents

312

3.52

6.03

3.3

3.1

204.04

104.17

ug/l

1.49

289

Schizophrenia, schizotypal and delusional disorders

7502

71710

1.08

6.03

3.2

3.1

110.54

116.33

ug/l

0.84

6961

67826

Multiple gestation

2509

23422

1.17

6.03

3.6

3.3

71.92

68.83

ug/l

0.27

2406

22637

Intermittent heterotropia

1396

12617

1.22

6.01

3.6

3.3

78.76

82.30

ug/l

0.48

1319

11989

Papilloedema, unspecified

517

4385

1.40

5.97

4.2

3.2

126.28

98.76

ug/l

1.75

486

4143

Other disorders of optic disc

308

2479

1.56

5.97

4.5

3.1

116.14

105.17

ug/l

0.41

294

2337

Abscess of lung

289

2271

1.52

5.95

4.7

3.0

172.92

160.69

ug/l

0.26

269

2115

Blindness, monocular

190

1414

1.70

5.94

4.4

3.0

151.37

130.58

ug/l

0.71

174

1317

Short stature, not elsewhere classified

527

4166

1.41

5.92

5.1

3.6

59.93

53.39

ug/l

0.52

507

3972

Car occupant injured in noncollision transport accident

789

6894

1.30

5.92

3.7

3.2

142.06

105.44

ug/l

0.50

755

6529

Cardiomyopathies, Secondary/extrinsic

130

896

1.86

5.92

3.8

2.6

211.95

176.48

ug/l

0.63

121

826

Corneal scars and opacities

549

4641

1.36

5.91

4.8

3.0

143.53

129.68

ug/l

0.61

505

4313

Pleural plaque without asbestos

615

5219

1.32

5.91

3.4

3.2

171.82

169.83

ug/l

0.04

538

4734

Behavioural disorders, excluding more controls

459

3810

1.40

5.90

3.5

3.0

73.92

79.43

ug/l

0.41

432

3654

Benign neoplasm of ovary

3697

34765

1.12

5.90

3.4

3.1

98.24

101.56

ug/l

0.46

3448

32313

Effects of other external causes

634

5441

1.33

5.89

3.5

3.1

111.84

107.77

ug/l

0.17

605

5183

Sequelae of other and unspecified infectious and parasitic diseases

1080

9597

1.24

5.88

3.6

3.1

121.81

119.78

ug/l

0.12

1032

9143

Vertigo of central origin

316

2529

1.50

5.88

3.5

3.1

119.72

125.38

ug/l

0.23

287

2338

Encephalitis

600

5125

1.34

5.88

3.7

3.1

148.64

116.36

ug/l

1.20

559

4821

Varicella [chickenpox], including avohilmo

1077

9558

1.24

5.86

4.2

3.1

146.93

118.57

ug/l

1.16

1025

9115

Multifocal fibrosclerosis

131

927

1.97

5.86

3.5

3.0

107.70

122.21

ug/l

0.56

121

854

Varicella [chickenpox]

902

7913

1.26

5.85

4.4

3.1

157.12

127.99

ug/l

0.96

858

7564

Mixed disorders of conduct and emotions, excluding more controls

553

4715

1.37

5.79

3.7

3.1

74.73

60.37

ug/l

1.73

524

4525

Malignant neoplasm of head and neck

1405

12594

1.19

5.79

3.1

187.45

142.93

ug/l

5.71

1292

11641

Peroneal tendinitis

383

3150

1.45

5.79

3.6

2.9

92.40

105.69

ug/l

0.69

366

2986

Congenital malformation of biliary tract

434

2.90

5.79

7.8

3.6

63.31

77.87

ug/l

0.61

413

Polypectomy (DHB20)

1208

10788

1.21

5.76

3.1

126.65

152.03

ug/l

3.31

1145

10070

Granuloma annulare

342

2802

1.51

5.74

3.7

3.1

94.97

94.12

ug/l

0.03

322

2617

522

4506

1.44

5.74

3.9

3.3

61.01

48.25

ug/l

1.72

499

4290

Benign neoplasm: Skin, unspecified

802

7013

1.28

5.72

3.7

3.1

125.52

119.60

ug/l

0.29

752

6569

Medicines for HER+ breast cancer

7891

76586

0.93

5.71

2.9

3.2

133.76

102.55

ug/l

15.60

7281

71230

Exposure to other and unspecified forces of nature

152

1121

1.91

5.71

4.1

3.1

94.67

109.19

ug/l

0.69

144

1064

Other melanin hyperpigmentation

431

3578

1.40

5.70

3.5

2.9

109.64

123.95

ug/l

1.02

395

3281

Spinal enthesopathy

443

3588

1.33

5.70

3.1

2.9

151.01

145.02

ug/l

0.16

406

3192

Papillary adenocarcinoma of thyroid gland

1076

9605

1.24

5.69

3.6

3.1

105.39

99.67

ug/l

0.48

1016

9026

Pyoderma

376

3079

1.44

5.68

3.7

3.0

130.51

122.51

ug/l

0.20

347

2898

Severe visual impairment, binocular

108

729

2.00

5.67

6.1

3.2

169.83

130.49

ug/l

0.92

683

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

126

888

1.95

5.66

5.6

3.0

144.76

125.80

ug/l

0.46

117

835

Routine general health check-up of defined subpopulation

515

4362

1.37

5.65

3.2

2.7

91.94

88.85

ug/l

0.18

507

4157

Diffuse brain injury

680

5824

1.28

5.65

3.3

2.8

152.33

139.45

ug/l

0.31

624

5497

Other and unspecified medical devices associated with adverse incidents

115

804

2.07

5.64

5.3

3.0

147.49

131.77

ug/l

0.26

107

748

Alzheimer’s disease (Late onset)

4633

35921

1.10

5.63

2.9

3.3

129.95

157.36

ug/l

13.58

4157

32227

Abnormal findings in cerebrospinal fluid

502

2.68

5.63

4.0

3.1

116.87

101.74

ug/l

0.28

474

Open wound of shoulder and upper arm

412

3407

1.41

5.62

3.8

3.1

121.28

123.03

ug/l

0.05

377

3203

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

374

3048

1.42

5.61

3.1

2.9

150.62

137.97

ug/l

0.50

353

2820

Other disorders of breast and lactation associated with childbirth

509

4449

1.50

5.56

3.9

3.5

49.40

52.82

ug/l

0.97

497

4255

Follicular lymphoma, hilmo

745

6477

1.28

5.53

3.2

3.1

272.89

144.63

ug/l

3.43

704

5966

Varus deformity, not elsewhere classified

232

1808

1.60

5.53

3.5

2.9

81.02

107.53

ug/l

3.00

227

1688

Family history of other conditions

378

3151

1.48

5.52

4.3

3.1

81.20

75.59

ug/l

0.37

358

3010

Toxic effect of other and unspecified substances

286

2296

1.54

5.52

3.5

3.1

94.88

101.91

ug/l

0.26

272

2201

Defects in the complement system

164

1237

1.86

5.52

5.0

3.3

89.40

84.16

ug/l

0.23

159

1173

Anomalies of pupillary function

474

4017

1.40

5.51

3.2

103.57

94.14

ug/l

0.32

452

3802

Other and unspecified vaccines and biological substances

163

1239

1.91

5.50

5.0

3.4

110.24

78.77

ug/l

0.53

157

1175

Peptic ulcer

186

1388

1.64

5.50

5.6

2.9

137.36

138.68

ug/l

0.03

179

1284

Iliotibial band syndrome

246

1932

1.57

5.49

3.7

2.9

88.50

104.54

ug/l

1.10

233

1806

Arnold-Chiari syndrome

240

1935

1.73

5.49

3.8

3.3

70.93

61.20

ug/l

0.55

231

1844

Erythema multiforme

466

3923

1.38

5.49

3.7

3.1

134.00

112.63

ug/l

0.88

438

3678

Viral agents as the cause of diseases classified to other chapters, including avohilmo

544

4659

1.36

5.48

3.9

3.2

163.68

107.06

ug/l

1.45

520

4411

Crossbite

1692

14275

1.19

5.48

3.8

3.3

73.58

82.71

ug/l

1.64

1606

13604

Ventricular septal defect, a heart condition

498

4235

1.39

5.47

3.9

3.5

79.52

75.07

ug/l

0.32

476

4024

Congenital malformations of the nervous system

523

4486

1.38

5.46

3.7

3.4

76.65

81.00

ug/l

0.31

498

4277

L02BA Anti-estrogens

3232

34413

0.89

5.46

2.7

3.1

147.32

100.06

ug/l

10.16

3049

32171

Unspecified abortion

1112

10008

1.24

5.46

3.5

3.1

83.77

88.18

ug/l

0.62

1060

9583

Other congenital malformations of nervous system

262

2133

1.67

5.44

3.8

3.3

70.63

66.38

ug/l

0.20

253

2033

Sequelae of infectious and parasitic diseases, including avohilmo

1460

13212

1.18

5.44

3.6

3.1

129.41

127.15

ug/l

0.15

1389

12383

Acute alcohol intoxication

5474

51998

1.09

5.43

3.4

3.1

148.21

140.62

ug/l

0.81

5047

48867

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

2027

18869

1.19

5.43

4.1

3.3

70.29

69.50

ug/l

0.13

1961

18149

Migraine without aura, drug-induced

263

2120

1.61

5.41

3.7

3.1

81.30

84.06

ug/l

0.14

257

2010

Pseudomembranous colitis

170

1270

1.73

5.41

4.7

2.9

110.05

103.31

ug/l

0.18

164

1194

Juvenile rheumatoid arthirtis

529

4545

1.38

5.41

4.0

3.1

108.98

78.05

ug/l

0.95

515

4341

Polyarteritis nodosa

135

965

1.83

5.40

5.0

2.9

198.81

117.44

ug/l

2.61

128

896

Personal history of allergy to drugs, medicaments and biological substances

269

2159

1.57

5.39

3.9

3.0

120.99

88.52

ug/l

0.53

254

2051

Congenital malformations of trachea and bronchus

199

1531

1.67

5.37

4.2

3.1

115.57

112.47

ug/l

0.06

186

1422

Exfoliative dermatitis

198

1499

1.61

5.37

3.8

3.0

209.74

163.49

ug/l

0.98

185

1394

Problems related to social environment

616

5307

1.31

5.36

3.7

3.1

130.60

104.12

ug/l

0.35

579

4980

Personal history of risk-factors, not elsewhere classified

322

2637

1.50

5.35

4.3

3.1

98.07

86.70

ug/l

0.59

309

2506

Other and unspecified injuries of abdomen, lower back and pelvis

343

2821

1.47

5.33

3.7

3.1

94.37

107.78

ug/l

0.87

327

2654

Hyposplenism

268

3.91

5.30

20.5

3.1

325.11

80.47

ug/l

1.18

248

Malignant neoplasm of oral cavity

588

5015

1.30

5.29

2.9

3.0

177.74

135.78

ug/l

3.74

548

4640

Serous carcinoma of ovary

980

0.50

5.29

4.1

3.1

109.45

97.88

ug/l

0.25

893

Other lack of coordination

332

2708

1.45

5.29

3.1

138.85

133.19

ug/l

0.13

314

2521

Inflammatory disorders of male genital organs, not elsewhere classified

216

1639

1.52

5.26

3.7

2.9

172.88

203.01

ug/l

0.78

203

1532

Pedestrian injured in collision with pedal cycle

607

5229

1.31

5.25

3.2

3.1

100.15

125.43

ug/l

2.35

585

4900

Malignant neoplasm of anus and anal canal

109

758

1.99

5.24

3.6

3.0

191.85

123.89

ug/l

1.09

102

702

Cerebral atherosclerosis

227

1737

1.52

5.24

3.8

3.0

111.00

156.47

ug/l

4.46

210

1576

Periodontal disease, other/unspecified

568

4885

1.33

5.21

3.6

3.0

117.73

113.99

ug/l

0.12

532

4589

Benign mammary dysplasia

3023

28373

1.13

5.20

3.2

3.1

90.55

100.95

ug/l

3.67

2843

26315

Other disorders of amino-acid metabolism

675

2.04

5.20

6.9

2.8

342.64

123.86

ug/l

1.58

632

Viral conjunctivitis, including avohilmo

897

7997

1.26

5.19

3.7

3.1

99.73

93.32

ug/l

0.39

861

7588

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

544

4762

1.41

5.19

3.6

3.1

59.74

61.10

ug/l

0.17

510

4582

Pulmonary eosinophilia, not elsewhere classified

223

1735

1.57

5.19

3.8

2.9

124.79

130.68

ug/l

0.17

205

1601

Carcinoid syndrome

177

1337

1.68

5.17

3.5

2.9

164.60

143.71

ug/l

0.50

164

1227

Spondylopathies in diseases classified elsewhere

228

1773

1.54

5.17

3.6

2.8

282.55

146.75

ug/l

2.47

220

1623

Congenital malformations of uterus and cervix

581

5125

1.41

5.16

4.0

3.4

61.63

58.93

ug/l

0.33

551

4885

Poisoning by narcotics and psychodysleptics [hallucinogens]

343

2821

1.44

5.15

3.7

3.1

83.83

101.48

ug/l

1.59

310

2695

Other benign neoplasms of connective and other soft tissue

2008

18544

1.16

5.14

3.4

3.1

115.92

120.32

ug/l

0.48

1881

17408

Other acquired deformities of ankle and foot

172

1298

1.69

5.13

3.1

2.9

110.94

112.65

ug/l

0.05

159

1211

Intentional self-harm by sharp object

628

5494

1.33

5.12

4.0

3.2

77.98

80.04

ug/l

0.13

583

5233

Contact with heat and hot substances

1120

10069

1.22

5.12

3.6

3.2

124.30

115.29

ug/l

0.59

1049

9520

Vascular syndromes of brain in cerebrovascular disorders

760

6633

1.25

5.10

3.7

3.2

129.84

152.11

ug/l

2.38

713

6107

Alcohol induced polyneuropathy

188

1430

1.62

5.09

3.6

2.9

264.47

170.97

ug/l

1.59

175

1330

Valgus deformity, not elsewhere classified

165

1243

1.72

5.09

4.2

3.0

93.94

96.69

ug/l

0.10

160

1159

Whooping cough, including avohilmo

421

3577

1.43

5.09

4.4

3.2

89.86

72.51

ug/l

1.85

401

3413

Osteopathy in diseases classified elsewhere

150

1110

1.76

5.08

4.8

2.8

244.58

128.29

ug/l

4.79

143

1026

Coarctation of the aorta

212

1654

1.61

5.07

3.7

3.6

94.10

100.36

ug/l

0.27

203

1580

Congenital malformations of pulmonary and tricuspid valves

167

1275

1.77

5.06

4.9

3.6

74.74

68.53

ug/l

0.31

159

1220

Complications peculiar to reattachment and amputation

131

940

1.79

5.05

6.3

2.7

199.79

148.38

ug/l

1.42

124

871

Gilbert syndrome

155

1152

1.73

5.05

3.6

2.9

148.34

119.71

ug/l

1.19

149

1093

Hereditary deficiency of other clotting factors

216

1717

1.66

5.05

4.9

3.3

89.62

89.57

ug/l

0.00

206

1631

Diabetes insipidus

196

1521

1.65

5.01

3.8

2.9

120.96

106.30

ug/l

0.37

187

1427

Peritonsillar abscess

5154

49104

1.09

5.00

3.4

3.1

105.33

108.39

ug/l

0.42

4901

46695

Changes in corneal membranes

625

2.18

4.99

3.4

3.0

91.93

109.03

ug/l

0.56

584

Intracranial and intraspinal abscess and granuloma

224

1756

1.56

4.99

4.3

2.9

176.55

139.31

ug/l

0.94

209

1636

Patellar tendinitis

364

3013

1.41

4.98

3.2

3.0

101.70

109.43

ug/l

0.32

348

2871

Sequelae of infectious and parasitic diseases

1424

12933

1.18

4.98

3.6

3.1

129.65

127.46

ug/l

0.14

1356

12133

Blood alcohol or alcohol intoxication level

498

4255

1.34

4.97

3.4

3.1

127.13

115.96

ug/l

0.53

463

4040

Distal bite

902

8018

1.26

4.96

3.9

3.3

69.70

68.46

ug/l

0.06

851

7671

Other and unspecified corneal deformities and disorders

637

5536

1.29

4.95

3.7

3.1

104.44

121.28

ug/l

1.78

603

5219

Benign neoplasm: Conjunctiva

640

5574

1.29

4.94

3.7

3.1

112.72

120.10

ug/l

0.26

596

5199

Other conjunctival vascular disorders and cysts

448

3791

1.36

4.94

3.5

3.0

124.28

127.18

ug/l

0.10

415

3517

Abscess of tendon sheath

137

1005

1.79

4.93

4.7

2.7

136.13

122.22

ug/l

0.33

123

939

Other contact dermatitis

1765

16249

1.16

4.92

3.5

3.1

109.24

107.90

ug/l

0.10

1638

15314

Vascular dementia (undefined)

675

5743

1.24

4.89

3.1

3.3

150.07

156.35

ug/l

0.25

591

5139

Cystic fibrosis with pulmonary manifestations

196

4.15

4.89

6.9

3.0

92.75

84.84

ug/l

0.15

185

Dermatopolymyositis, unspecified

115

827

1.95

4.88

4.4

2.9

238.28

116.92

ug/l

1.92

110

774

Benign neoplasm: Bladder

175

1324

1.63

4.88

3.8

3.0

134.36

146.91

ug/l

0.31

165

1224

Guillain-Barre syndrome

308

2514

1.45

4.88

3.4

3.0

279.12

133.72

ug/l

0.89

285

2356

Traction detachment of retina

168

1271

1.67

4.88

6.0

3.1

173.09

129.96

ug/l

1.23

159

1190

Calcaneal spur

263

2114

1.50

4.86

3.1

2.9

86.31

115.18

ug/l

4.13

251

1974

Male infertility

708

6124

1.24

4.84

3.3

2.6

167.87

173.76

ug/l

0.28

683

5877

Viral agents as the cause of diseases classified to other chapters

457

3899

1.37

4.84

4.1

3.2

172.68

110.55

ug/l

1.31

441

3692

Other facial nerve disorders

575

4974

1.31

4.83

3.6

3.0

107.29

116.63

ug/l

0.48

538

4650

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

241

1910

1.51

4.81

4.1

3.0

136.89

146.39

ug/l

0.33

222

1747

Measles

237

1893

1.55

4.81

3.9

3.0

136.68

110.19

ug/l

1.00

229

1827

Dislocation, sprain and strain of joints and ligaments of head

927

8304

1.24

4.81

3.6

3.2

102.47

95.80

ug/l

0.59

879

7901

Other disorders of binocular movement

520

4507

1.35

4.79

3.9

3.2

86.68

87.14

ug/l

0.02

498

4276

Other and unspecified disorders of adult personality and behaviour

142

1075

1.86

4.78

3.6

3.0

80.52

84.81

ug/l

0.20

133

1037

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

4797

44168

1.09

4.78

2.7

3.1

356.99

132.41

ug/l

66.91

4467

40711

Factitial dermatitis

117

851

1.93

4.75

4.8

2.9

95.50

95.11

ug/l

0.01

107

792

Tobacco use

1135

10273

1.21

4.74

3.6

3.2

127.87

118.37

ug/l

0.48

1056

9714

Disorder of pancreatic internal secretion, other and/or unspecified

150

1126

1.73

4.74

4.9

3.0

94.73

111.55

ug/l

1.06

143

1049

Other and unspecified injuries of thorax

364

3029

1.39

4.73

3.5

3.0

120.17

133.22

ug/l

0.61

334

2852

Non-small cell lung cancer, adenocarcinoma, helper endpoint

905

10183

0.83

4.73

3.0

3.1

237.57

157.54

ug/l

6.28

831

9291

All dysplastic lesions of the vulva

947

8532

1.24

4.72

3.8

3.2

102.83

83.77

ug/l

2.53

895

8085

Other specified disorders of external ear

661

5764

1.27

4.72

3.2

3.1

157.02

162.29

ug/l

0.19

606

5372

Other rupture of muscle

144

1073

1.74

4.71

3.5

2.9

124.35

117.96

ug/l

0.12

135

1012

Contracture of joint

237

1874

1.49

4.70

3.4

2.8

96.72

138.00

ug/l

3.45

221

1748

Injury of intra-abdominal organs

497

4255

1.32

4.69

3.6

3.1

146.12

120.57

ug/l

0.93

465

4023

Aphakia

244

1906

1.44

4.69

3.4

2.9

161.18

146.75

ug/l

0.31

220

1751

Measles, including avohilmo

240

1927

1.53

4.69

3.9

3.0

135.18

108.93

ug/l

1.01

232

1860

Acute epiglottitis

313

2575

1.43

4.68

3.7

2.9

139.55

120.13

ug/l

0.54

293

2424

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

295

2475

1.56

4.67

3.8

3.1

57.85

59.45

ug/l

0.13

281

2374

Ductal carcinoma of pancreas

149

1115

1.69

4.63

2.6

2.9

218.87

141.01

ug/l

1.82

144

1031

Mental and behavioural disorders associated with the puerperium

295

2478

1.55

4.62

3.8

3.2

57.85

59.59

ug/l

0.14

281

2364

Myotonic disorders

173

1338

1.67

4.61

3.4

3.1

114.42

118.51

ug/l

0.10

167

1263

Maze procedure for atrial fibrillation

629

2.03

4.60

3.6

2.9

137.87

158.79

ug/l

0.51

585

Disorder of thyroid, unspecified

270

2199

1.48

4.56

4.0

3.0

102.86

105.75

ug/l

0.06

250

2052

Open wound of neck

163

1238

1.64

4.55

3.7

2.9

112.27

131.13

ug/l

0.74

154

1175

Malignant neoplasm of tongue

345

2855

1.38

4.53

3.0

2.9

163.15

137.84

ug/l

1.15

328

2649

Malignant neoplasm of other and unspecified parts of tongue

264

2128

1.45

4.53

3.0

2.9

158.68

136.69

ug/l

0.78

255

1966

Carcinoma in situ of oral cavity, oesophagus and stomach

108

766

1.84

4.52

4.4

3.1

129.81

154.90

ug/l

0.72

101

703

Habit and impulse disorders

342

2849

1.40

4.51

3.3

3.0

93.79

110.73

ug/l

1.21

314

2734

Amblyopia ex anopsia

894

8022

1.23

4.51

3.8

3.3

90.32

92.04

ug/l

0.11

836

7569

Abscess of Bartholin gland

691

6172

1.30

4.48

3.8

3.2

74.02

69.52

ug/l

0.32

652

5869

Motor disorders, excluding more controls

289

2207

1.43

4.47

4.4

3.3

62.37

62.86

ug/l

0.02

279

2111

Metabolic disorder, other/unspecified

437

2.29

4.47

5.6

2.8

142.20

103.25

ug/l

0.69

403

Drug-induced thyroiditis

375

2.49

4.47

5.7

2.9

174.49

129.89

ug/l

0.73

359

Assault by unspecified means

430

3661

1.35

4.46

3.2

3.0

114.49

110.43

ug/l

0.17

391

3507

Schizoid personality disorder

323

2670

1.40

4.46

3.3

2.9

124.49

137.87

ug/l

0.44

297

2536

Benign intracranial hypertension

279

2343

1.56

4.45

4.6

3.4

75.84

61.16

ug/l

1.68

267

2237

Myocardial infarction, unclassifiable

3639

34466

0.92

4.45

4.1

3.1

161.15

163.58

ug/l

0.20

3316

31158

Causalgia

341

2858

1.41

4.44

4.1

3.0

78.62

107.47

ug/l

4.12

326

2710

Pathological resorption of teeth

765

6804

1.25

4.44

3.6

3.2

107.75

120.43

ug/l

1.09

711

6410

Burn and corrosion of trunk

583

5079

1.28

4.43

3.4

3.2

120.34

129.27

ug/l

0.34

555

4770

Open wound of hip and thigh

683

6018

1.26

4.42

3.4

3.1

122.23

119.45

ug/l

0.10

625

5672

Other congenital malformations of intestine, including avohilmo

226

1813

1.53

4.41

4.5

3.0

101.97

109.19

ug/l

0.26

206

1690

Injury of nerves at lower leg level

208

1649

1.55

4.40

3.6

2.9

102.51

123.50

ug/l

0.96

198

1559

Hypertrichosis

610

5443

1.34

4.40

4.0

3.3

74.06

60.17

ug/l

1.27

587

5205

Lung cancer and mesothelioma

3159

28528

0.91

4.40

3.0

2.8

226.58

145.88

ug/l

22.70

2906

25914

Embolic stroke

780

6865

1.22

4.39

3.8

3.1

140.34

162.32

ug/l

2.30

720

6224

Other deformity of hallux (acquired)

159

1215

1.64

4.39

3.6

2.8

101.41

107.46

ug/l

0.23

147

1128

Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]

6.88

4.37

6.2

3.1

199.38

134.94

ug/l

0.64

Benign neoplasm of thyroid gland

643

5661

1.27

4.37

3.3

3.1

122.65

106.76

ug/l

0.97

595

5270

Contusion of ankle

925

8330

1.22

4.37

3.8

3.2

97.31

100.05

ug/l

0.18

865

7891

Effects of heat and light

149

1123

1.65

4.35

3.4

3.1

145.98

136.20

ug/l

0.16

139

1037

Inflammatory disease of cervix uteri

1261

11533

1.19

4.35

3.3

3.1

92.79

95.62

ug/l

0.34

1169

10765

Benign neoplasm: Larynx

536

4625

1.28

4.33

3.4

3.1

158.12

152.81

ug/l

0.10

509

4293

Other and unspecified disorders of pigmentation

160

1235

1.66

4.33

3.7

3.0

122.23

93.41

ug/l

0.95

152

1172

Other congenital malformations of intestine

178

1393

1.61

4.28

4.9

3.0

100.20

104.57

ug/l

0.12

165

1307

Injury of urinary and pelvic organs

386

3254

1.34

4.28

3.5

3.0

121.90

140.55

ug/l

1.20

359

3055

Struck by thrown, projected or falling objec

1071

9698

1.19

4.27

3.3

3.2

112.70

124.94

ug/l

1.01

1025

9167

N06DA Anticholinesterases

7019

51955

1.07

4.26

2.8

3.2

130.76

159.26

ug/l

20.25

6163

46895

Use of anticholinesterases

7019

51955

1.07

4.26

2.8

3.2

130.76

159.26

ug/l

20.25

6163

46895

Congenital malformations of ovaries, fallopian tubes and broad ligaments

1443

13400

1.19

4.25

3.5

3.4

67.62

68.30

ug/l

0.09

1378

12803

Other injuries of spine and trunk, level unspecified

188

1481

1.57

4.24

4.8

3.1

122.41

120.86

ug/l

0.04

176

1398

Other specified/unspecified disorders of bone/cartilage

513

4436

1.29

4.24

3.7

3.0

139.10

140.11

ug/l

0.03

483

4159

Use of rivastigmine

2949

27638

1.11

4.24

2.9

3.2

123.03

153.56

ug/l

11.08

2634

24806

Dermatitis due to ingested food

876

7559

1.24

4.24

3.6

3.4

53.66

58.75

ug/l

0.62

836

7214

Other disorders of bone density and structure

546

4768

1.30

4.24

3.7

3.1

111.73

107.91

ug/l

0.15

502

4503

Benign neoplasm of major salivary glands

1826

16921

1.14

4.23

3.4

3.1

137.34

136.04

ug/l

0.07

1687

15729

Isolated growth hormone deficiency

144

1100

1.71

4.22

4.9

4.0

92.96

64.02

ug/l

0.93

139

1065

Porphyria cutanea tarda

131

4.55

4.22

9.6

2.6

177.28

178.92

ug/l

0.01

118

Chronic thyroiditis

640

2.04

4.22

3.9

2.8

113.93

85.91

ug/l

0.63

585

Congenital deformities of feet, including avohilmo

879

7921

1.23

4.21

3.7

3.2

93.63

93.87

ug/l

0.01

829

7525

Disorders of lacrimal system and orbit in diseases classified elsewhere

509

4430

1.31

4.21

3.9

3.0

92.04

104.51

ug/l

1.16

482

4167

Other osteochondropathies

1401

12868

1.17

4.19

3.3

3.1

109.25

120.13

ug/l

1.51

1322

12215

Retinoschisis and retinal cysts

420

3580

1.33

4.18

3.4

3.0

140.20

148.60

ug/l

0.34

392

3306

Organ-limited amyloidosis

612

1.85

4.17

4.7

2.7

157.54

160.07

ug/l

0.04

547

Pedal cyclist injured in other and unspecified transport accidents

2445

22940

1.12

4.16

3.3

3.2

112.43

116.20

ug/l

0.39

2293

21638

Other sexually transmitted chlamydial diseases, including avohilmo

2932

27808

1.12

4.13

3.3

74.12

66.30

ug/l

0.73

2773

26643

Chorioretinal inflammation

556

4857

1.28

4.12

3.6

3.0

131.30

120.26

ug/l

0.54

515

4560

Benign neoplasm: Parathyroid gland

217

1751

1.51

4.08

5.0

3.0

161.97

128.51

ug/l

1.07

207

1622

Whooping cough

152

1186

1.70

4.08

5.0

3.1

109.03

70.30

ug/l

2.03

143

1133

Other specified and unspecified disorders of conjunctiva

206

1648

1.52

4.07

3.7

2.9

125.87

114.49

ug/l

0.35

195

1538

Benign neoplasm: salivary glands, exclude unknown (D119)

1638

15145

1.15

4.07

3.4

3.1

134.53

135.49

ug/l

0.05

1518

14117

Thyrotoxicosis with toxic single thyroid nodule

192

1540

1.59

4.07

3.4

3.1

87.12

97.22

ug/l

0.57

179

1439

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

1180

10731

1.17

4.07

3.1

238.46

126.01

ug/l

6.09

1114

9924

Fourth [trochlear] nerve palsy

419

3590

1.33

4.07

3.5

3.1

140.99

134.13

ug/l

0.20

399

3337

Embedded teeth, including avohilmo

2472

23337

1.13

4.06

3.7

3.3

76.49

73.53

ug/l

0.45

2382

22237

Malignant neoplasm of other connective and soft tissue

439

3754

1.30

4.06

3.1

282.68

128.46

ug/l

2.41

415

3464

Benign neoplasm: Skin of scalp and neck

513

4467

1.29

4.06

3.5

3.1

136.56

119.24

ug/l

0.43

484

4174

Meningitis

974

8810

1.20

4.05

3.4

3.1

114.51

118.39

ug/l

0.27

922

8302

Patent foramen ovale

436

3754

1.33

4.05

4.2

3.4

79.44

115.33

ug/l

6.73

390

3572

Unspecified multiple injuries

487

2.09

4.05

3.3

132.96

111.24

ug/l

0.43

457

Polymyositis

155

1192

1.61

4.05

3.7

2.9

157.57

118.57

ug/l

1.04

149

1109

Migraine, unspecified, drug-induced

155

1214

1.69

4.04

3.4

3.1

86.28

94.82

ug/l

0.41

145

1144

LeFortI or BSSO operation

941

8550

1.22

4.04

3.1

3.2

78.69

90.58

ug/l

2.72

912

8196

LSIL lesion of the cervix uteri, vagina or vulva

3885

37178

1.11

4.04

3.5

3.3

74.33

72.54

ug/l

0.39

3729

35531

Convergence insufficiency and excess

328

2794

1.43

4.03

3.9

3.2

71.39

77.92

ug/l

0.48

316

2653

Benign neoplasm of brain and other parts of central nervous system

1245

11399

1.17

4.02

3.2

3.1

115.86

124.51

ug/l

0.62

1155

10671

Postdysenteric arthropathy

195

1557

1.54

4.02

3.5

3.0

115.35

122.21

ug/l

0.22

187

1467

Unattended death

1307

0.61

4.01

3.2

3.0

209.90

159.01

ug/l

0.68

1209

Other and unspecified intracranial injuries

571

4989

1.26

4.01

3.4

3.1

116.96

135.35

ug/l

1.62

529

4665

Unspecified chronic bronchitis

591

5139

1.24

4.01

3.7

3.0

138.29

150.18

ug/l

0.51

532

4714

Alopecia universalis

474

2.28

4.00

3.8

3.1

78.22

95.14

ug/l

0.75

452

Perforation of oesophagus

701

1.82

3.99

3.4

2.8

186.50

166.84

ug/l

0.15

642

Hypoplasia of dental enamel, prenatal , including avohilmo

111

835

1.90

3.99

8.8

3.9

53.07

55.96

ug/l

0.12

106

809

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

281

2339

1.43

3.97

4.1

3.1

89.27

99.61

ug/l

0.61

270

2222

Other lesions of median nerve

497

4307

1.28

3.97

3.8

3.0

117.66

130.14

ug/l

0.80

451

3949

Other obstructed labour

1813

16966

1.15

3.97

3.5

3.2

74.53

78.93

ug/l

0.97

1719

16155

Other specific arthropathies, wide

406

3466

1.32

3.97

3.3

2.9

108.04

123.90

ug/l

1.15

392

3245

Congenital malformations of eye, ear, face and neck

1486

13771

1.17

3.96

3.6

3.3

85.98

89.18

ug/l

0.35

1412

13075

Venous complications and haemorrhoids in pregnancy

492

4369

1.37

3.96

3.8

3.3

61.79

60.33

ug/l

0.10

468

4215

Transient synovitis

181

1436

1.56

3.95

4.0

3.0

97.57

87.40

ug/l

0.26

175

1361

Other bursal cyst

294

2441

1.39

3.95

3.4

2.9

134.04

135.51

ug/l

0.05

272

2268

Respiratory conditions due to other external agents

366

3099

1.34

3.94

3.8

3.0

203.80

128.23

ug/l

2.52

342

2844

Typhoid and paratyphoid fevers, including avohilmo

134

1021

1.69

3.93

3.3

3.1

130.53

108.07

ug/l

0.24

126

960

Acanthosis nigricans

557

2.08

3.91

3.7

3.1

133.15

99.24

ug/l

0.77

532

Severe combined immunodeficiency [SCID] with reticular dysgenesis

456

2.22

3.91

4.6

3.0

193.64

110.05

ug/l

1.15

423

Prolapse and hernia of ovary and fallopian tube

603

5219

1.24

3.90

3.3

3.1

113.05

123.02

ug/l

0.49

547

4660

Hypothermia

324

2709

1.35

3.89

3.9

3.0

135.47

156.91

ug/l

1.16

297

2510

Marfan's syndrome

114

854

1.79

3.88

3.7

2.9

201.41

118.70

ug/l

0.75

105

816

Haemophilus septicemia

283

2.55

3.88

6.0

2.9

147.70

119.28

ug/l

0.44

262

Amoebiasis, including avohilmo

173

1368

1.57

3.88

4.0

3.2

98.09

102.78

ug/l

0.12

168

1290

Use of biperiden

957

8652

1.19

3.87

3.1

3.0

137.28

133.59

ug/l

0.07

883

8128

Tibial collateral bursitis [Pellegrini-Stieda]

221

1789

1.47

3.87

3.6

2.9

92.29

118.36

ug/l

2.68

214

1673

Nontoxic diffuse goitre

596

5254

1.26

3.86

3.4

3.0

109.19

109.37

ug/l

0.01

537

4919

Paranoid personality disorder

379

3247

1.35

3.86

3.5

3.1

99.19

110.71

ug/l

0.56

345

3080

Other appendicitis

1745

16231

1.14

3.86

3.4

3.1

124.25

119.26

ug/l

0.24

1645

15328

Tarsal tunnel syndrome

203

1636

1.51

3.85

3.8

2.9

117.26

106.67

ug/l

0.27

198

1520

Pityriasis rubra pilaris

383

2.34

3.85

3.8

3.0

98.46

104.82

ug/l

0.16

362

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

300

2512

1.39

3.84

3.3

3.0

112.35

116.21

ug/l

0.15

287

2379

Hypertrophy of (infrapatellar) fat pad

204

1645

1.50

3.84

3.9

2.8

114.12

111.11

ug/l

0.09

180

1548

Myasthenia gravis

324

2734

1.37

3.83

3.7

3.1

147.85

134.34

ug/l

0.30

309

2539

Malignant neoplasm of corpus uteri, including Hilmo

1733

16106

1.14

3.80

2.9

3.1

149.40

101.92

ug/l

11.66

1561

14732

Dementia in other diseases classified elsewhere

804

7189

1.20

3.80

3.3

3.2

135.59

149.87

ug/l

1.01

691

6600

Disorders of puberty, other/unspecified

101

761

1.98

3.78

4.0

3.2

72.13

54.32

ug/l

0.54

721

Mature T/NK-cell lymphomas, hilmo

235

1912

1.43

3.78

3.8

3.0

544.40

153.69

ug/l

3.29

221

1764

Burn and corrosion of ankle and foot

269

2228

1.40

3.77

3.6

3.0

113.12

130.22

ug/l

0.91

248

2098

Narcolepsy and cataplexy

149

1161

1.62

3.77

4.2

2.9

80.38

93.90

ug/l

0.74

142

1109

Seronegative juvenile rheumatoid arthritis

461

4069

1.35

3.76

3.9

3.4

70.76

61.95

ug/l

0.89

443

3869

Graves ophthalmopathy

501

4398

1.29

3.74

3.9

3.1

92.58

103.67

ug/l

0.96

474

4139

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

622

1.88

3.73

3.6

3.2

115.16

102.08

ug/l

0.40

570

Dacryoadenitis

160

1260

1.58

3.72

4.2

3.1

111.58

111.05

ug/l

0.01

153

1163

Other maltreatment syndromes

584

5146

1.25

3.71

3.2

3.0

115.19

121.61

ug/l

0.31

557

4939

Hirsutism in women

541

4855

1.33

3.71

4.0

3.3

73.65

58.98

ug/l

1.18

519

4641

Mental and behavioural disorders due to cannabinoids

603

5326

1.24

3.70

2.8

3.1

91.06

104.60

ug/l

1.54

548

5127

Other acantholytic disorders

411

2.22

3.69

4.8

3.1

168.36

159.13

ug/l

0.06

380

Crowding of teeth, including avohilmo

2523

19779

1.12

3.68

3.7

3.3

58.94

64.52

ug/l

1.61

2393

18884

Contusion of toe(s) with damage to nail

253

2105

1.44

3.68

3.8

3.2

91.28

96.39

ug/l

0.25

242

1998

Thiamine deficiency

112

835

1.71

3.67

3.8

2.8

223.17

149.67

ug/l

1.27

107

779

Lower leg

146

1144

1.63

3.66

3.4

3.1

100.29

94.02

ug/l

0.20

138

1069

Other obstetric trauma

1480

13862

1.18

3.66

3.7

3.4

60.84

63.64

ug/l

0.47

1436

13345

Bilateral sagittal split ramus osteotomy operation

773

6997

1.23

3.64

3.1

80.72

89.65

ug/l

1.44

752

6692

Pedal cyclist injured in transport accident

5240

50336

1.08

3.64

3.2

103.91

116.83

ug/l

4.78

4960

47535

Traumatic ischaemia of muscle

254

2099

1.40

3.63

4.1

3.0

182.07

131.88

ug/l

0.64

239

1979

Choroidal haemorrhage and rupture

402

2.03

3.61

4.1

3.0

130.00

148.02

ug/l

0.21

367

Other and unspecified hypertrophic disorders of skin

157

1250

1.62

3.61

3.6

3.0

101.83

97.04

ug/l

0.13

150

1183

Necrobiosis lipoidica, not elsewhere classified

139

1099

1.71

3.60

6.3

3.3

100.59

76.26

ug/l

1.07

129

1039

Other hyperalimentation

485

2.03

3.60

4.5

3.0

107.93

102.85

ug/l

0.11

448

Contact with other hot fluids

647

5778

1.24

3.59

3.5

3.2

108.95

106.09

ug/l

0.14

598

5466

Meningitis, viral

107

810

1.81

3.59

3.8

3.3

89.91

86.18

ug/l

0.12

102

771

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

1197

10987

1.16

3.58

3.0

3.1

122.56

141.58

ug/l

2.19

1131

10281

Other corneal oedema

156

1222

1.55

3.58

3.8

3.1

142.08

132.91

ug/l

0.15

144

1119

Disorder of carbohydrate metabolism, other/unspecified

422

2.03

3.58

2.9

125.52

127.13

ug/l

0.03

392

Subarachnoid haemorrhage

1639

17657

0.89

3.57

3.4

3.1

135.15

143.36

ug/l

0.90

1513

16296

Maternal care for known or suspected disproportion

1091

10095

1.20

3.56

3.5

3.3

65.93

69.68

ug/l

0.58

1055

9789

Malignant neoplasm of oesophagus

418

3584

1.27

3.55

3.1

3.0

179.61

155.63

ug/l

0.73

386

3302

Viral conjunctivitis

464

4071

1.29

3.54

3.6

3.1

115.52

96.63

ug/l

0.80

450

3864

Endometriosis of fallopian tube

169

1357

1.56

3.53

4.1

2.9

89.80

80.36

ug/l

0.39

159

1293

Malignant neoplasm of floor of mouth, including Hilmo

145

1120

1.55

3.53

3.1

2.8

222.69

141.28

ug/l

2.30

134

1032

Other/unspecified mastoiditis and related conditions

100

738

1.75

3.53

3.7

3.1

141.68

111.74

ug/l

0.80

686

Peripheral retinal degeneration

588

5213

1.24

3.53

3.3

3.0

133.25

122.73

ug/l

0.35

543

4877

Other congenital malformations of circulatory system

504

4436

1.27

3.51

3.5

3.1

124.66

120.91

ug/l

0.12

474

4178

Childhood allergy (age < 16)

4456

35318

1.09

3.51

3.7

3.4

56.87

ug/l

0.00

4275

33777

Atrial septal defect, secundum type

578

5127

1.26

3.51

4.2

3.4

90.41

89.20

ug/l

0.06

547

4867

Ulcer of oesophagus, drug-induced

578

1.80

3.50

3.9

3.0

151.02

166.62

ug/l

0.30

525

Previous suicide attempt

253

2129

1.44

3.50

4.1

3.1

86.88

87.84

ug/l

0.03

243

2042

Epidural haemorrhage

159

1235

1.48

3.49

3.3

2.8

145.60

169.34

ug/l

0.67

149

1157

Congenital ovarian cysts

1146

10652

1.20

3.48

3.5

3.4

66.44

65.30

ug/l

0.14

1097

10206

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

288

2428

1.37

3.47

3.5

3.0

106.36

114.01

ug/l

0.38

271

2296

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

385

3318

1.31

3.47

3.5

3.1

121.76

122.54

ug/l

0.03

353

3107

Failed attempted abortion

332

2909

1.44

3.47

3.8

3.3

58.80

56.71

ug/l

0.20

318

2814

Nontraumatic intracranial haemmorrhage

3487

36670

0.92

3.47

3.5

3.1

157.40

151.50

ug/l

0.54

3185

33573

Unspecified event, undetermined intent

512

4514

1.26

3.46

4.1

3.1

105.51

114.25

ug/l

0.49

483

4263

Benign neoplasm of other and unspecified sites

612

5447

1.23

3.46

3.3

3.1

118.73

126.88

ug/l

0.36

565

5088

HSIL lesion of the vulva

374

3247

1.34

3.46

3.9

3.1

104.58

84.51

ug/l

1.60

346

3039

Benign neoplasm: Parotid gland

1457

13509

1.14

3.44

3.3

3.1

136.77

136.60

ug/l

0.01

1350

12583

Other specified and unspecified disorders of iris and ciliary body

653

1.85

3.44

3.2

3.0

107.77

100.89

ug/l

0.18

613

Malignant neoplasm of ovary

768

8502

0.84

3.44

2.8

3.1

192.46

92.29

ug/l

12.53

721

7865

Kissing spine

261

2.49

3.44

4.4

2.9

88.10

133.59

ug/l

1.99

245

Melanocytic naevi of upper limb, including shoulder

503

4448

1.28

3.43

3.5

3.2

123.04

106.28

ug/l

0.45

480

4189

Renal cell carcinoma of kidney

515

4498

1.24

3.42

4.0

3.0

223.84

138.37

ug/l

6.31

470

4130

Failure of sterile precautions during surgical operation

485

2.03

3.42

4.0

3.1

142.75

122.09

ug/l

0.36

461

Persistent delusional disorders

1422

13166

1.14

3.41

3.1

108.02

127.47

ug/l

4.03

1296

12323

Dislocation, sprain and strain of joints and ligaments of elbow

1439

13382

1.15

3.41

3.3

3.1

97.92

99.13

ug/l

0.07

1364

12708

Mental and behavioural disorders due to use of other stimulants, including caffeine

592

5269

1.24

3.39

3.2

87.89

104.02

ug/l

2.07

543

5084

All dysplastic lesions of the vagina

598

5367

1.26

3.38

3.5

3.1

91.59

81.76

ug/l

1.01

565

5076

Dissocial personality disorder

270

2253

1.35

3.32

3.0

121.92

156.04

ug/l

2.01

258

2165

All dysplastic lesions of the cervix uteri

7782

74532

1.07

3.29

3.3

3.4

70.91

68.34

ug/l

0.93

7434

71515

Idiopathic peripheral autonomic neuropathy

562

1.88

3.29

4.5

3.1

124.61

122.41

ug/l

0.02

525

Intercostal neuropathy

153

1214

1.53

3.28

3.8

2.9

99.35

130.39

ug/l

1.64

146

1120

Malignant neoplasm of adrenal gland, including Hilmo

143

1125

1.55

3.28

3.8

3.1

184.91

99.98

ug/l

2.38

137

1059

Ophthalmic devices associated with adverse incidents

208

3.07

3.27

3.6

2.9

95.45

144.13

ug/l

1.29

188

Helminthiases

343

2954

1.32

3.27

4.3

3.1

104.65

108.07

ug/l

0.13

320

2757

Other infective (teno)synovitis

655

1.77

3.26

3.5

2.6

193.31

113.16

ug/l

0.47

604

Social disorders starting during childhood or adolecense, excluding more controls

172

1392

1.51

3.26

4.4

3.3

72.95

63.70

ug/l

0.42

166

1330

Viral encephalitis, not elsewhere classified/unspecified

374

3234

1.30

3.25

3.4

3.1

124.12

122.79

ug/l

0.04

342

3030

Alport

240

2.81

3.24

8.9

3.1

224.96

77.50

ug/l

1.11

230

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

114

4.35

3.24

14.4

3.2

292.95

125.09

ug/l

0.86

105

Systemic sclerosis,strict definition

198

1639

1.49

3.24

4.4

3.0

105.33

91.96

ug/l

0.31

191

1536

Hypertrophy of tongue papillae

280

2378

1.37

3.23

3.9

3.0

120.25

115.98

ug/l

0.13

261

2236

Overjet

568

5066

1.26

3.23

4.3

3.5

69.95

65.40

ug/l

0.20

532

4851

Congenital vesicoureteral reflux

163

1345

1.63

3.22

5.3

3.6

50.12

50.56

ug/l

0.03

158

1286

Acne conglobata

117

902

1.64

3.22

3.4

2.9

93.26

82.55

ug/l

0.35

110

861

Vaginal lichen planus

130

1025

1.63

3.21

3.6

2.9

85.76

94.72

ug/l

0.53

124

946

Mild or no visual impairment, binocular

103

781

1.71

3.21

3.7

3.0

113.38

92.48

ug/l

0.50

735

Family history of other specific disorders

312

2691

1.36

3.20

4.0

3.1

76.79

75.07

ug/l

0.10

300

2551

Other specified/unspecified disorders of tympanic membrane

630

1.84

3.20

3.6

3.0

112.26

104.52

ug/l

0.17

588

Benign neoplasm: Mediastinum

516

1.92

3.19

3.6

3.0

113.39

109.84

ug/l

0.09

478

Superficial injury of neck

447

3942

1.28

3.19

3.6

3.2

88.31

97.95

ug/l

0.74

429

3765

Injury of nerves at wrist and hand level

731

6601

1.20

3.18

3.4

3.1

122.82

131.34

ug/l

0.48

686

6241

Tetraplegia

139

1092

1.54

3.18

3.8

2.9

133.89

134.68

ug/l

0.02

120

1018

Lagophthalmos

235

1959

1.39

3.17

4.4

3.0

123.41

135.51

ug/l

0.42

216

1808

Sixth [abducent] nerve palsy

602

5377

1.22

3.17

3.4

3.1

174.81

136.20

ug/l

1.26

558

4971

Benign neoplasm of male genital organs

318

2698

1.30

3.17

3.1

180.67

195.78

ug/l

0.46

290

2495

Evidence of alcohol involvement determined by level of intoxication

225

1880

1.42

3.16

3.5

3.1

110.28

97.05

ug/l

0.56

215

1796

Cutis laxa senilis

155

1247

1.54

3.16

3.4

3.1

133.37

99.08

ug/l

0.40

148

1139

Other infiltrative disorders of skin and subcutaneous tissue

712

1.73

3.15

3.5

2.9

139.29

111.60

ug/l

0.62

664

Graves ophthalmopathy, strict

446

3936

1.28

3.15

3.9

3.1

92.21

104.88

ug/l

1.01

421

3701

Parapsoriasis

384

3346

1.29

3.14

3.4

3.1

116.26

113.58

ug/l

0.09

373

3153

Use of levodopa decarbox-comt-inhibitor

525

4644

1.23

3.14

2.9

3.1

136.46

161.69

ug/l

1.57

470

4235

Other specified/unspecified nutritional deficiencies

138

1087

1.55

3.14

3.9

3.0

118.67

118.81

ug/l

0.00

130

1022

Vitiligo

254

2149

1.39

3.14

3.5

2.9

98.58

107.22

ug/l

0.37

237

2039

Glycosuria

280

2.46

3.13

3.9

3.2

71.62

72.88

ug/l

0.04

265

Other bursitis, not elsewhere classified

180

1456

1.44

3.13

3.1

2.8

115.20

136.49

ug/l

0.88

167

1360

Congenital malformations of breast, including avohilmo

501

4528

1.31

3.12

3.5

3.3

61.78

57.31

ug/l

0.69

477

4322

Dyshidrosis [pompholyx]

358

3122

1.32

3.11

3.3

3.1

153.83

97.67

ug/l

0.73

323

2959

Anuria and oliguria

123

947

1.55

3.11

5.9

3.0

183.77

137.58

ug/l

1.24

116

875

Lesion of femoral nerve

154

1237

1.52

3.10

3.5

2.9

107.67

108.33

ug/l

0.02

143

1153

Malignant neoplasm of corpus uteri

1557

14537

1.13

3.09

2.9

3.1

151.11

102.94

ug/l

11.16

1404

13281

Brain meningioma, including Hilmo

954

8736

1.17

3.09

3.2

3.1

129.74

108.89

ug/l

1.49

879

8098

Toxic effect of carbon monoxide

335

2888

1.31

3.08

3.6

3.0

138.62

134.62

ug/l

0.11

317

2706

Communicating hydrocephalus

274

3235

0.77

3.08

3.2

3.1

109.92

136.02

ug/l

1.91

258

2982

Cerebral palsy

342

2965

1.31

3.07

3.9

3.3

115.12

86.06

ug/l

0.58

314

2840

Anoxic brain damage

160

1995

0.72

3.07

3.6

3.1

156.03

157.85

ug/l

0.03

143

1855

Unspecified threat to breathing

216

1812

1.44

3.06

4.0

3.2

134.30

89.31

ug/l

0.43

206

1723

Injury of cranial nerves

128

1005

1.58

3.06

3.4

2.9

131.99

123.65

ug/l

0.12

120

961

Adenocarcinoma of pancreas

365

4231

0.80

3.06

2.5

3.0

273.69

134.60

ug/l

9.15

342

3886

Bacterial meningitis

628

5641

1.21

3.05

3.2

3.1

116.02

129.92

ug/l

1.10

592

5303

Benign neoplasm: Nasopharynx

166

1342

1.47

3.04

3.4

2.9

119.42

125.58

ug/l

0.13

155

1236

Congenital hypothyroidism without goiter

123

983

1.69

3.03

3.8

3.3

71.33

74.05

ug/l

0.10

117

924

Sequelae of other and unspecified effects of external causes

117

910

1.61

3.02

4.2

3.1

99.82

113.94

ug/l

0.53

112

864

Shigellosis, including avohilmo

153

1234

1.52

3.02

4.1

3.0

109.64

99.70

ug/l

0.20

144

1169

Migraine with aura, drug-induced

223

1878

1.42

3.01

3.8

3.2

93.33

93.66

ug/l

0.01

212

1772

Caught, crushed, jammed or pinched in or between objects

1080

9971

1.16

3.01

3.4

3.2

98.65

121.87

ug/l

5.36

1023

9437

Preterm labour and delivery

6284

60925

1.07

3.00

3.4

3.2

86.89

84.75

ug/l

0.37

5932

57900

Other papulosquamous disorders

230

1932

1.39

2.99

4.1

3.1

109.51

108.05

ug/l

0.05

212

1815

Occupational exposure to risk-factors

609

5470

1.21

2.99

2.9

3.1

165.58

146.01

ug/l

0.56

569

5127

Horner syndrome

233

1956

1.38

2.99

3.4

3.0

120.12

125.64

ug/l

0.19

217

1838

Monoplegia

295

2530

1.33

2.98

3.8

3.0

108.94

125.99

ug/l

0.60

271

2359

Lumbosacral root disorders, not elsewhere classified

217

1806

1.39

2.97

3.4

2.8

108.69

133.42

ug/l

1.19

208

1677

Nail dystrophy

126

994

1.57

2.94

4.9

2.8

75.63

107.08

ug/l

3.98

119

919

Disorders of other and unspecified cranial nerves

749

1.63

2.93

4.4

2.9

119.96

113.54

ug/l

0.16

701

Exophthalmic conditions

204

1695

1.41

2.92

3.3

3.0

135.00

123.23

ug/l

0.29

194

1584

Motorcycle rider injured in other and unspecified transport accidents

1139

10533

1.14

2.91

3.0

115.72

123.34

ug/l

0.71

1073

10016

Other disorders of thyroid

276

2367

1.35

2.91

4.1

3.1

103.89

101.21

ug/l

0.05

255

2203

Acute inflammation of orbit

133

1057

1.53

2.89

3.9

2.9

153.79

112.49

ug/l

0.65

127

996

Pemphigus

131

1039

1.54

2.88

4.0

3.0

150.03

116.00

ug/l

1.38

123

968

Juvenile osteochondrosis

708

6450

1.20

2.88

3.6

3.2

96.07

93.12

ug/l

0.14

672

6129

Other, unspecified and serous retinal detachments

553

4937

1.21

2.88

3.8

3.1

142.61

150.23

ug/l

0.29

517

4585

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

385

2.07

2.86

4.9

2.9

100.51

95.62

ug/l

0.08

366

Keratoconus

458

4052

1.24

2.86

3.3

3.0

114.84

127.05

ug/l

0.82

422

3837

Biliary cirrhosis, secondary

121

3.93

2.86

7.9

3.0

147.67

126.62

ug/l

0.22

112

Toxic effect of contact with venomous animals

843

7732

1.18

2.86

3.1

3.2

119.34

113.51

ug/l

0.24

784

7292

Mental and behavioural disorders of puerperium, not classified elsewhere

295

2594

1.40

2.86

3.8

3.4

57.85

60.22

ug/l

0.20

281

2485

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

149

1195

1.47

2.85

3.6

3.0

101.35

138.19

ug/l

2.12

136

1104

Gender identity disorders

275

3165

0.76

2.84

2.7

3.3

59.49

58.13

ug/l

0.09

251

3025

Schizoaffective disorder

1598

15013

1.12

2.84

2.9

3.1

103.12

106.92

ug/l

0.40

1510

14285

Acute drug-induced interstitial lung disorder

138

1100

1.50

2.84

3.7

3.0

256.44

131.41

ug/l

1.40

130

1005

Acute bronchiolitis

1408

11893

1.13

2.83

3.8

3.2

82.48

68.01

ug/l

1.57

1337

11256

Complications following abortion and ectopic and molar pregnancy

660

5994

1.20

2.82

3.5

3.1

95.70

96.45

ug/l

0.05

593

5634

Torsion of testis

281

2369

1.28

2.82

2.4

2.8

136.36

159.37

ug/l

1.00

264

2270

Contact with other hot metals

288

2470

1.31

2.81

3.6

3.1

128.92

130.22

ug/l

0.04

273

2315

Rheumatic fever incl heart disease

505

4476

1.21

2.80

4.8

3.0

159.97

137.56

ug/l

0.54

474

4101

Other drug-induced secondary parkinsonism

175

1433

1.42

2.80

3.4

2.8

139.92

140.34

ug/l

0.01

157

1329

Pneumothorax

1213

11241

1.13

2.80

3.5

3.0

197.99

148.84

ug/l

3.27

1120

10431

Other and unspecified injuries of neck

193

1616

1.43

2.79

3.2

3.0

99.53

85.23

ug/l

0.64

187

1541

HSIL lesion of the cervix uteri, vagina or vulva

5785

56219

1.07

2.79

3.3

3.4

73.95

68.66

ug/l

1.94

5492

53920

HSIL lesion of the vagina

303

2641

1.34

2.78

3.4

3.2

98.77

82.47

ug/l

1.10

286

2481

Other congenital malformations of peripheral vascular system

303

2636

1.33

2.78

4.6

3.3

89.43

86.87

ug/l

0.09

283

2499

Maternal care for cervical incompetence

872

8068

1.19

2.78

3.7

3.3

73.53

77.01

ug/l

0.38

819

7590

Acne varioliformis

405

2.02

2.77

4.7

2.9

131.60

91.69

ug/l

0.72

387

Brain meningioma

923

8488

1.16

2.77

3.2

3.1

129.62

108.34

ug/l

1.47

851

7866

Benign neoplasm: Short bones of upper limb

310

2692

1.31

2.77

3.4

3.1

101.08

112.62

ug/l

0.64

282

2548

Exposure to other specified electric current

393

4447

0.81

2.76

3.1

90.21

101.55

ug/l

0.88

379

4240

Puerperal sepsis

2717

25956

1.09

2.75

3.4

3.2

96.44

94.02

ug/l

0.23

2532

24391

Benign neoplasm of other and unspecified female genital organs

848

7807

1.18

2.75

3.3

3.2

92.86

93.53

ug/l

0.05

772

7291

Toxic effect of corrosive substances

110

862

1.59

2.74

3.3

2.9

107.15

101.57

ug/l

0.10

105

824

Disorders of sphingolipid metabolism and other lipid storage disorders

529

1.79

2.74

5.6

2.9

142.90

95.86

ug/l

1.06

491

Simple and mucopurulent chronic bronchitis

678

6115

1.17

2.72

3.9

3.1

137.16

145.49

ug/l

0.25

617

5610

Abscess of external ear

272

2338

1.33

2.72

3.9

3.1

133.47

109.35

ug/l

0.82

252

2210

Congenital stenosis of pulmonary valve

144

1171

1.50

2.71

4.8

3.4

93.61

81.07

ug/l

0.47

139

1118

Cholinergic urticaria

106

831

1.62

2.71

3.3

2.9

143.69

91.32

ug/l

0.54

794

Congenital deformities of hip, including avohilmo

471

4228

1.26

2.70

3.7

3.3

90.14

67.44

ug/l

2.01

447

4031

Deformity of finger(s)

122

968

1.53

2.70

3.4

2.8

130.04

124.80

ug/l

0.08

112

899

Dengue, including avohilmo

306

2.18

2.69

4.4

3.0

68.76

109.83

ug/l

3.00

284

Other specified and unspecified strabismus

245

2094

1.35

2.69

4.3

3.1

118.97

98.80

ug/l

0.56

231

1979

Acquired stenosis of external ear canal

181

1496

1.40

2.69

3.2

3.0

135.31

152.48

ug/l

0.57

165

1397

Evidence of alcohol involvement determined by blood alcohol level

286

2468

1.31

2.67

3.4

3.1

136.81

127.79

ug/l

0.25

261

2342

Primary angle-closure glaucoma

727

6608

1.17

2.67

3.4

3.1

141.83

138.40

ug/l

0.14

653

6045

Contact with sharp glass

818

7515

1.17

2.67

3.3

3.2

104.94

105.09

ug/l

0.01

768

7151

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

679

6184

1.20

2.66

4.3

3.4

110.33

84.30

ug/l

1.48

652

5916

Kela-code for behavioural disturbances in mental retardation

1209

0.67

2.65

2.7

2.9

101.98

127.86

ug/l

0.82

1123

Cysts of oral region, not elsewhere classified

1129

10495

1.14

2.65

3.4

3.1

130.77

125.81

ug/l

0.19

1056

9860

Ankylosis of joint

703

1.57

2.64

3.0

2.7

131.07

113.47

ug/l

0.37

648

Anisometropia and aniseikonia

632

5743

1.20

2.63

3.7

3.1

116.82

108.92

ug/l

0.18

570

5388

Cholesteatoma of external ear

141

1138

1.46

2.63

3.4

3.1

124.65

145.49

ug/l

0.58

131

1058

Nystagmus and other irregular eye movements

288

2499

1.31

2.62

3.7

3.2

149.92

98.59

ug/l

0.92

274

2361

Secondary parkinsonism+Parkinsonism in other disease

463

4110

1.22

2.62

3.3

3.1

133.23

151.46

ug/l

1.35

418

3788

Hyperprolactinaemia, drug-induced

115

920

1.59

2.62

3.8

3.1

87.02

91.43

ug/l

0.13

110

868

Torticollis

340

2978

1.28

2.61

3.8

3.0

103.41

97.13

ug/l

0.29

318

2812

Exposure to other and unspecified animate mechanical forces

707

6479

1.19

2.61

3.7

3.2

101.15

92.46

ug/l

0.34

665

6175

Accidental poisoning by and exposure to alcohol

298

3421

0.79

2.61

3.5

3.2

87.36

99.90

ug/l

0.59

283

3227

Other disorders of central nervous system

243

2076

1.34

2.61

4.4

3.1

104.51

102.06

ug/l

0.08

224

1961

Pervasive developmental disorders excl. Autism + Asperger

274

2334

1.32

2.61

3.4

3.5

60.97

64.35

ug/l

0.20

255

2238

Other degenerative diseases of the basal ganglia

313

2719

1.28

2.61

2.8

3.1

158.26

158.82

ug/l

0.01

287

2500

Asymmetry of jaw

328

2893

1.31

2.60

3.1

3.2

80.52

85.74

ug/l

0.33

319

2751

Mandibular retrognathia AND surgery (BSSO)

576

5241

1.22

2.59

3.2

3.1

77.08

89.96

ug/l

2.07

563

5021

Lack of expected normal physiological development

495

3889

1.23

2.59

4.6

2.9

52.82

46.69

ug/l

0.74

482

3688

Undefined dementia

1784

17525

0.91

2.58

2.9

3.1

164.79

151.48

ug/l

1.17

1568

15647

Respiratory tuberculosis, confirmed, including avohilmo

296

2542

1.27

2.58

4.2

3.0

183.42

154.44

ug/l

0.74

276

2347

Donors of organs and tissues

308

2687

1.29

2.57

3.4

2.8

214.68

98.85

ug/l

3.05

300

2550

Cerebral arteritis

409

1.92

2.57

4.0

2.9

91.02

101.30

ug/l

0.28

381

Other osteochondrodysplasias, including avohilmo

240

2058

1.35

2.57

3.4

3.2

95.72

101.16

ug/l

0.20

226

1945

Colorectal neuroendocrine tumor and carcinoma

271

2340

1.31

2.56

4.0

3.0

103.50

106.39

ug/l

0.11

259

2190

Hip and thigh

401

1.93

2.56

3.2

103.17

112.40

ug/l

0.25

381

LSIL lesion of the cervix uteri

3166

30520

1.09

2.55

3.5

3.4

69.14

68.56

ug/l

0.11

3049

29241

Cicatricial alopecia [scarring hair loss]

168

1395

1.43

2.55

3.9

2.9

151.56

104.45

ug/l

0.84

158

1296

Osteomalacia

165

1367

1.43

2.55

3.5

3.1

119.22

114.16

ug/l

0.11

157

1288

Congenital malformations of nose, including avohilmo

414

1.96

2.53

3.4

3.3

76.68

83.46

ug/l

0.25

395

Exposure to other and unspecified man-made environmental factors

382

3383

1.25

2.53

3.5

3.1

128.58

109.27

ug/l

0.34

363

3202

Birth trauma

136

1114

1.51

2.53

3.7

3.4

50.23

62.39

ug/l

1.76

131

1069

Disorders of puberty

353

3131

1.28

2.52

4.4

3.4

64.58

56.27

ug/l

0.58

331

2971

Injury of blood vessels at hip and thigh level

457

1.78

2.52

2.7

3.1

111.77

139.93

ug/l

0.71

429

Congenital malformations of breast

460

4191

1.28

2.50

3.6

3.3

63.31

57.67

ug/l

0.87

437

4002

Rheumatoid lung disease

584

1.65

2.50

3.4

3.1

355.51

154.53

ug/l

0.78

535

Melanoma in situ of trunk

276

2387

1.30

2.50

3.3

3.1

135.11

156.38

ug/l

0.95

250

2209

Exposure to unspecified smoke, fire and flames

182

1521

1.38

2.48

3.3

3.0

137.77

126.45

ug/l

0.29

172

1441

Convergent concomitant strabismus

1258

11801

1.13

2.47

3.3

3.2

95.61

93.68

ug/l

0.16

1192

11236

Inflammation of lacrimal passages (acute and unspecified)

348

3067

1.26

2.47

3.9

3.0

113.65

112.17

ug/l

0.04

330

2855

Pilonidal cyst

1796

16988

1.10

2.46

3.5

3.1

133.49

115.79

ug/l

0.98

1722

16229

Disorders of male genital organs in diseases classified elsewhere

103

796

1.49

2.46

3.1

2.7

179.77

191.82

ug/l

0.13

755

LSIL lesion of the vulva

610

5581

1.20

2.46

3.8

3.1

102.15

81.91

ug/l

1.76

584

5302

Injury of blood vessels at lower leg level

677

1.61

2.46

5.7

2.9

273.41

130.15

ug/l

0.65

634

conjunctival degenerations and deposits

382

3381

1.24

2.45

3.2

3.0

103.42

128.87

ug/l

2.82

359

3133

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

855

7897

1.16

2.44

3.4

3.1

111.23

121.32

ug/l

0.84

814

7428

Secondary parkinsonism

455

4057

1.21

2.44

3.3

3.1

133.57

151.32

ug/l

1.27

410

3741

Hirsprung

158

2.69

2.43

9.3

3.0

58.98

60.87

ug/l

0.05

151

Acute hepatitis A, including avohilmo

735

1.60

2.42

3.2

3.1

133.20

111.75

ug/l

0.31

690

L01XE Protein kinase inhibitors

903

8354

1.15

2.42

3.5

3.1

313.71

140.11

ug/l

12.89

853

7745

Other operation for atrial fibrillation

651

1.60

2.39

4.5

3.0

179.97

179.43

ug/l

0.01

601

Benign neoplasm: Ill-defined sites within the digestive system

110

876

1.52

2.39

4.1

2.9

123.93

117.75

ug/l

0.15

103

817

Contact with sharp object, undetermined intent

481

4329

1.21

2.39

3.4

3.1

114.16

125.51

ug/l

0.36

452

4113

Carcinoma in situ of vulva

185

1570

1.40

2.39

3.8

3.2

100.58

84.80

ug/l

0.77

171

1478

213

1805

1.32

2.38

3.5

2.9

121.30

135.89

ug/l

0.61

201

1690

Alzheimer’s disease, strict definition

4966

38695

1.06

2.37

2.8

3.2

130.69

157.17

ug/l

13.35

4450

34805

Trichomoniasis, including avohilmo

176

1480

1.39

2.37

3.9

3.0

117.57

96.10

ug/l

0.96

156

1363

Use of entacapone

1023

0.67

2.36

2.6

3.1

143.46

149.28

ug/l

0.06

925

Chronic suppurative otitis media, including avohilmo

1561

14736

1.11

2.36

3.5

3.2

111.87

112.83

ug/l

0.06

1444

13819

Malignant neoplasm of bone and articular cartilage

175

1463

1.37

2.35

4.0

3.0

371.43

114.99

ug/l

1.31

168

1368

Increased muscle tone

153

1278

1.44

2.34

3.8

3.0

92.68

96.87

ug/l

0.15

145

1190

Benign neoplasm: Tonsil

234

2017

1.32

2.32

3.5

2.9

140.44

121.28

ug/l

0.59

221

1888

Benign neoplasm: Pharynx, unspecified

161

1346

1.41

2.32

3.6

3.0

111.45

116.80

ug/l

0.12

146

1256

Oesophagitis, drug-induced

323

1.97

2.31

3.8

3.3

142.50

131.47

ug/l

0.11

302

Degeneration of the brain due to alcohol

350

3082

1.23

2.31

3.2

3.1

239.74

189.20

ug/l

0.49

323

2861

Sleepwalking [somnambulism]

612

1.76

2.30

4.4

3.2

67.93

68.71

ug/l

0.02

591

Actinomycosis

532

1.65

2.30

3.9

2.8

235.18

101.16

ug/l

2.05

497

Disorders of puberty, all

400

3602

1.25

2.29

4.3

3.5

67.01

55.20

ug/l

0.90

375

3427

Delayed puberty

169

1420

1.39

2.29

3.5

3.4

68.57

64.42

ug/l

0.14

158

1360

Cytomegaloviral pneumonitis

267

2.13

2.28

6.2

2.7

333.69

151.44

ug/l

1.85

246

Erosion and ectropion of cervix uteri

513

4640

1.19

2.28

3.4

3.0

142.05

104.29

ug/l

0.57

474

4305

Polyclonal hypergammaglobulinaemia

146

2.75

2.27

7.7

3.4

118.83

144.61

ug/l

0.42

135

Foreign body in genitourinary tract

215

1857

1.35

2.27

3.1

3.2

86.25

87.04

ug/l

0.03

192

1765

Ascorbic acid deficiency

127

3.36

2.26

10.0

2.9

159.00

97.68

ug/l

0.77

120

Other and unspecified disorders of orbit

101

805

1.54

2.26

3.3

3.1

222.08

129.92

ug/l

0.61

745

Foreign body or object entering through skin

1211

11357

1.12

2.26

3.4

3.1

111.42

126.23

ug/l

2.35

1137

10750

Benign neoplasm: Other parts of oropharynx

179

1515

1.37

2.26

3.9

3.0

135.52

120.56

ug/l

0.30

164

1419

Malignant neoplasm of mesothelium and soft tissue

674

6163

1.16

2.25

2.9

3.0

297.27

130.03

ug/l

4.85

637

5691

Congenital malformations of great veins

516

1.76

2.25

4.9

3.6

66.05

77.18

ug/l

0.35

501

Osteolysis

118

2.52

2.24

2.6

2.4

180.52

131.66

ug/l

0.38

110

Chromophobe cell carcinoma of kidney

756

1.53

2.24

4.0

3.0

249.76

137.00

ug/l

1.27

702

Abnormalities of forces of labour

2564

24654

1.09

2.24

3.2

3.3

80.65

75.89

ug/l

0.57

2473

23713

Acute and transient psychotic disorders

2394

22886

1.08

2.24

3.2

3.1

122.77

115.66

ug/l

0.41

2212

21709

Pedal cyclist injured in noncollision transport accidents

2460

23538

1.08

2.24

3.2

3.1

101.19

114.44

ug/l

3.22

2337

22269

Gonococcal infection, including avohilmo

670

6146

1.16

2.23

3.2

2.9

114.03

111.11

ug/l

0.06

616

5800

Osteitis due to dental implant

147

1222

1.41

2.23

4.0

3.0

167.38

124.96

ug/l

0.73

142

1125

Severe visual impairment, monocular

190

1612

1.34

2.22

4.0

3.0

132.96

119.91

ug/l

0.38

166

1493

Drug-induced tremor

128

1049

1.45

2.22

3.6

3.0

137.33

118.17

ug/l

0.49

119

978

Arthropathy in hypersensitivity reactions classified elsewhere

223

2.41

2.22

4.3

2.7

176.68

87.31

ug/l

0.50

208

Congenital dislocation of hip, unilateral

147

1237

1.45

2.20

4.3

3.3

88.59

64.50

ug/l

0.89

140

1176

Carcinoma in situ of other and unspecified genital organs

406

3657

1.23

2.20

3.5

3.1

110.38

89.46

ug/l

1.50

379

3427

Benign neoplasm: Pelvic bones, sacrum and coccyx

712

1.58

2.20

3.4

3.0

155.19

104.96

ug/l

0.73

671

Respiratory tuberculosis, confirmed

286

2485

1.24

2.19

4.3

3.1

186.94

153.62

ug/l

0.86

267

2292

Carcinoma in situ of vagina

132

1100

1.48

2.19

3.7

3.1

110.66

78.13

ug/l

1.35

123

1036

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

117

937

1.42

2.19

3.7

3.0

221.01

144.20

ug/l

1.06

107

857

Certain zoonotic bacterial diseases, including avohilmo

564

5143

1.18

2.18

3.5

3.1

126.02

122.39

ug/l

0.16

530

4808

Burn and corrosion of shoulder and upper limb, except wrist and hand

392

3503

1.22

2.18

3.3

3.1

142.94

131.44

ug/l

0.32

369

3302

Gonococcal infection

601

5492

1.17

2.17

3.2

2.9

117.47

115.53

ug/l

0.04

550

5172

Actinomycosis, including avohilmo

635

1.57

2.17

3.7

2.9

212.19

97.13

ug/l

2.07

590

Malignant neoplasm of ovary, including Hilmo

1061

11332

0.89

2.17

2.9

3.1

181.23

92.73

ug/l

15.90

999

10497

Benign neoplasm: Other/unspecified site

284

2492

1.27

2.16

3.4

3.0

107.60

120.28

ug/l

0.76

258

2325

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

337

2970

1.22

2.16

3.1

3.0

189.06

136.11

ug/l

3.33

321

2724

Bicornuate uterus

182

1584

1.45

2.16

4.4

3.4

62.16

56.76

ug/l

0.35

168

1526

Placental disorders

255

2267

1.35

2.16

4.1

3.3

51.58

58.97

ug/l

0.88

243

2181

Degeneration of nervous system due to alcohol

350

3098

1.22

2.16

3.2

3.1

239.74

186.81

ug/l

0.52

323

2879

Haemorrhagic disorder due to circulating anticoagulants

227

1948

1.29

2.16

4.6

3.1

164.23

155.18

ug/l

0.19

200

1765

Vertical strabismus

664

6111

1.17

2.15

3.5

3.1

98.24

113.47

ug/l

2.00

624

5745

Other specified/unspecified deforming dorsopathies

342

3037

1.24

2.15

3.5

2.9

101.37

107.86

ug/l

0.27

322

2868

Congenital deformities of feet

548

5012

1.19

2.15

3.8

3.2

94.64

93.96

ug/l

0.03

519

4754

Benign neoplasm: Spinal cord

266

2329

1.28

2.14

3.0

98.61

123.68

ug/l

2.62

249

2159

Cytomegaloviral hepatitis

426

1.81

2.14

4.9

2.9

104.56

101.10

ug/l

0.07

403

Other and unspecified injuries of forearm

169

1434

1.37

2.12

3.2

3.1

94.94

100.37

ug/l

0.17

160

1363

Burns and corrosions of multiple and unspecified body regions

416

3737

1.21

2.12

3.5

3.1

116.60

126.44

ug/l

0.51

396

3526

Idiopathic hypercalciuria

109

883

1.48

2.11

3.4

2.9

112.68

123.56

ug/l

0.26

834

Defect, injury or illness of neck

132

1101

1.46

2.11

3.7

3.1

124.20

88.32

ug/l

0.43

124

1036

Other superficial injuries of ankle and foot

142

1189

1.42

2.09

4.2

3.3

100.10

89.33

ug/l

0.45

131

1143

Typhoid and paratyphoid fevers

721

1.53

2.09

3.7

3.0

157.26

118.03

ug/l

0.29

676

Other infestations, including avohilmo

325

2887

1.24

2.07

3.2

3.0

114.82

123.82

ug/l

0.42

311

2683

Benign neoplasm: Long bones of lower limb

648

5974

1.16

2.06

3.2

3.1

115.29

110.78

ug/l

0.22

611

5642

Classical phenylketonuria

3.20

2.05

5.6

2.8

97.01

97.54

ug/l

0.01

Atrophy of thyroid (acquired)

216

2.22

2.04

3.3

2.8

99.74

85.24

ug/l

0.21

201

Melanoma in situ of other and unspecified parts of face

214

1848

1.30

2.04

3.8

3.1

158.25

143.83

ug/l

0.31

186

1683

Other sexually transmitted chlamydial diseases

1683

16066

1.10

2.04

3.4

3.3

73.66

72.06

ug/l

0.21

1588

15414

Chromomycosis and phaeomycotic abscess, including avohilmo

686

1.58

2.04

3.7

3.1

161.71

96.08

ug/l

0.97

649

Congenital deformities of hip

416

3775

1.23

2.04

3.9

3.3

83.26

62.10

ug/l

2.09

394

3596

Contact with blunt object, undetermined intent

127

1051

1.43

2.04

3.3

3.0

88.61

102.78

ug/l

0.83

119

990

Pneumonia due to Haemophilus influenzae

580

1.57

2.02

3.5

2.9

314.68

107.95

ug/l

1.46

551

Disorders of acoustic nerve

482

4379

1.18

2.02

3.1

3.0

124.64

130.79

ug/l

0.16

445

4084

Assault by other specified means

208

1801

1.31

2.01

3.4

3.1

109.25

110.82

ug/l

0.04

198

1728

516

1.66

2.00

6.4

2.9

99.73

100.69

ug/l

0.03

495

Hereditary motor and sensory neuropathy

165

1402

1.35

2.00

3.1

2.9

100.02

112.79

ug/l

0.36

155

1316

Mandibular hypoplasia

142

1202

1.42

1.98

3.5

3.3

68.24

86.14

ug/l

1.70

134

1149

Benign neoplasm: Retina

107

873

1.46

1.98

3.1

3.0

118.15

115.56

ug/l

0.04

102

816

Fatigue fracture of vertebra

771

1.49

1.98

3.5

3.1

107.60

104.96

ug/l

0.06

716

Sequelae of burns, corrosions and frostbite

764

1.49

1.96

3.0

2.9

109.43

116.69

ug/l

0.16

725

Suppurative otitis media, unspecified

527

4828

1.18

1.95

3.8

3.2

101.90

96.94

ug/l

0.13

505

4539

Viral infections of central nervous system, not elsewhere classified/unspecified

207

1792

1.30

1.95

3.5

2.9

101.35

113.87

ug/l

0.66

193

1692

Benign neoplasm: Vulva

405

3673

1.21

1.95

3.5

3.1

86.04

88.56

ug/l

0.15

373

3421

Universal erythroderma, KELA reimbursement

235

2045

1.27

1.94

3.4

2.9

144.04

142.42

ug/l

0.04

211

1920

Lesion of sciatic nerve

690

6357

1.14

1.94

3.3

3.0

136.98

147.88

ug/l

0.50

649

5781

Burn and corrosion of wrist and hand

752

6987

1.14

1.94

3.3

3.2

110.64

111.45

ug/l

0.02

700

6631

Carcinoma in situ of uteri, other/unspecified

1116

0.69

1.94

3.8

3.1

95.62

84.72

ug/l

0.20

1054

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

598

1.58

1.93

3.6

3.1

109.72

95.27

ug/l

0.17

554

Other assisted single delivery

443

4081

1.23

1.93

3.7

3.5

48.27

60.92

ug/l

6.41

417

3929

Tick-borne viral encephalitis, including avohilmo

111

912

1.44

1.92

2.9

3.0

122.42

115.03

ug/l

0.15

101

862

Cyst of Bartholin Gland

881

8278

1.14

1.92

3.3

3.2

77.81

74.53

ug/l

0.31

840

7860

Glycogen storage disease

110

3.06

1.92

9.7

3.5

307.67

119.76

ug/l

0.45

104

Deaf mutism, not elsewhere classified

689

1.48

1.92

4.3

2.9

96.75

117.36

ug/l

0.61

639

Congenital mitral valve regurgitation

299

2.01

1.90

5.0

3.8

69.70

68.91

ug/l

0.02

287

Benign neoplasm: Hypopharynx

649

1.52

1.90

3.6

2.8

159.42

137.14

ug/l

0.45

603

Frostbite

192

1651

1.29

1.89

3.3

2.9

120.01

137.59

ug/l

0.61

178

1555

Toxic effect of ethanol

783

7296

1.14

1.88

3.4

3.2

98.64

111.93

ug/l

1.42

741

6929

Other acute disseminated demyelination

216

1899

1.31

1.87

3.5

3.2

111.00

82.58

ug/l

1.07

205

1816

Benign neoplasm: Lip

366

3291

1.20

1.87

3.4

3.0

141.08

128.54

ug/l

0.26

325

3042

Pustulosis palmaris et plantaris

810

7561

1.13

1.86

3.3

3.0

119.65

112.64

ug/l

0.15

750

7109

Malignant neoplasm of tonsil and base of tongue

320

2846

1.21

1.86

2.9

208.39

145.91

ug/l

2.83

297

2656

Other and unspecified primary disorders of muscles

137

1152

1.37

1.86

4.0

3.1

115.35

107.44

ug/l

0.17

131

1089

Malignant neoplasm of bone and articular cartilage, including Hilmo

315

2803

1.22

1.86

3.7

3.1

303.27

120.71

ug/l

1.69

296

2608

Absence of one kidney, including avohilmo

544

1.64

1.86

7.0

3.2

141.14

94.52

ug/l

1.41

507

Congenital obstruction of the pelviureteric junction

157

1339

1.35

1.86

4.0

3.0

88.35

101.68

ug/l

0.94

151

1257

Unspecified parasitic disease, including avohilmo

145

1223

1.35

1.86

4.8

3.1

207.99

141.50

ug/l

1.06

138

1151

Third [oculomotor] nerve palsy

315

2809

1.22

1.86

4.2

3.1

146.50

137.78

ug/l

0.24

293

2602

Respiratory tuberculosis, bacteriologically and histologically confirmed

293

2585

1.21

1.85

4.2

3.0

186.97

153.42

ug/l

0.90

273

2382

Injury of nerves and spinal cord at thorax level

758

1.46

1.85

3.5

2.9

123.56

140.34

ug/l

0.42

715

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

147

1238

1.34

1.85

3.2

3.0

153.31

134.78

ug/l

0.56

135

1159

Other specified/unspecified diseases of inner ear

748

1.46

1.85

3.2

3.1

164.59

109.50

ug/l

0.54

695

Open bite that required surgery (Lefort1 or BSSO)

231

2052

1.31

1.84

3.4

3.3

60.42

71.65

ug/l

1.33

224

1966

Congenital ptosis, including avohilmo

667

1.53

1.84

3.9

3.1

96.04

91.12

ug/l

0.12

639

Congenital malformations of posterior segment of eye

101

828

1.46

1.82

4.1

3.2

104.18

107.98

ug/l

0.09

781

Dissection of cerebral arteries, nonruptured

145

1228

1.35

1.82

3.9

2.9

121.39

120.51

ug/l

0.01

140

1162

Focal epilepsy

4529

43975

1.05

1.82

3.4

3.2

137.59

125.31

ug/l

1.64

4205

41185

Unequal limb length (acquired)

192

1670

1.31

1.82

3.5

3.0

95.54

74.65

ug/l

0.90

178

1577

Acute hepatitis A

675

1.51

1.81

3.3

3.0

128.41

111.09

ug/l

0.21

633

Malignant neoplasm of palate, including Hilmo

106

866

1.41

1.81

2.5

2.9

205.75

116.77

ug/l

2.80

101

802

Unspecified parasitic disease

139

1171

1.35

1.81

4.7

3.1

216.08

143.86

ug/l

1.13

132

1104

Melanocytic naevi of eyelid, including canthus

179

1548

1.32

1.80

3.2

3.1

148.48

104.94

ug/l

0.33

170

1445

Moderate visual impairment, monocular

757

1.48

1.80

2.7

3.0

137.21

116.52

ug/l

0.43

712

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

1922

18449

1.09

1.80

3.9

3.2

85.68

85.65

ug/l

0.00

1811

17386

Disorders of copper metabolism

146

2.31

1.80

7.1

2.7

108.74

113.65

ug/l

0.06

135

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

210

1844

1.30

1.80

3.8

3.4

70.95

67.45

ug/l

0.19

198

1752

Other specified transport accidents

124

1038

1.39

1.80

3.1

3.2

90.08

106.78

ug/l

0.54

113

990

Focal epilepsy, strict definition

4122

39979

1.05

1.80

3.4

3.2

140.79

125.68

ug/l

2.11

3820

37394

Sequelae of intentional self-harm, assault and events of undetermined intent

142

1209

1.37

1.79

3.4

3.0

105.30

97.81

ug/l

0.19

136

1158

Histrionic personality disorder

806

1.47

1.78

3.4

2.9

95.53

95.62

ug/l

0.00

764

Pustular psoriasis

889

8340

1.12

1.78

3.4

3.1

121.64

115.08

ug/l

0.15

823

7840

218

1922

1.29

1.78

4.5

3.1

81.47

78.88

ug/l

0.08

204

1830

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

294

2669

1.28

1.78

3.3

62.19

62.90

ug/l

0.04

283

2555

Circumscribed brain atrophy

280

3158

0.83

1.77

3.1

128.83

152.99

ug/l

1.35

263

2870

Enterobiasis

815

1.51

1.77

5.3

3.3

75.71

67.41

ug/l

0.25

771

Injury of muscle and tendon at forearm level

338

3038

1.20

1.76

3.5

3.0

115.77

133.74

ug/l

0.82

321

2883

Conduct disorder

462

4234

1.18

1.76

3.5

3.3

74.39

85.75

ug/l

1.07

435

4042

Benign neoplasm: Rectum/anal canal icd-9

135

1124

1.32

1.76

3.7

3.1

182.18

141.24

ug/l

0.96

112

1005

Onycholysis

134

1135

1.37

1.74

3.6

3.1

112.90

99.98

ug/l

0.45

124

1062

Benign neoplasm: Vagina

254

2264

1.26

1.74

2.7

3.1

102.58

84.84

ug/l

0.96

228

2108

Mastocytosis

104

861

1.43

1.73

4.1

3.1

125.69

96.90

ug/l

0.74

813

Human immunodeficiency virus [HIV] disease resulting in other specified diseases, including avohilmo

2.95

1.73

3.1

3.3

129.54

182.23

ug/l

0.43

Digestive system disorders of fetus and newborn

229

2.19

1.73

7.8

3.5

52.97

48.37

ug/l

0.09

222

Failure in dosage during surgical and medical care

217

2.09

1.73

6.6

3.4

104.81

89.17

ug/l

0.30

199

Hydrocephalus

1182

12508

0.91

1.73

3.0

3.1

125.67

143.60

ug/l

2.45

1073

11478

Exposure to smoke, fire and flames

431

3923

1.17

1.73

3.1

132.85

142.62

ug/l

0.44

407

3689

Benign neoplasm: other/unspecified salivary gland

441

4019

1.17

1.72

3.6

3.0

134.52

135.02

ug/l

0.02

404

3707

Otosclerosis

1346

12783

1.09

1.72

3.0

3.1

139.06

126.95

ug/l

0.65

1244

11927

Acute myringitis

150

1288

1.35

1.72

4.0

3.2

108.03

96.07

ug/l

0.16

143

1221

Contact with other sharp object(s)

1454

13855

1.09

1.71

3.2

107.11

107.93

ug/l

0.04

1357

13194

Melanocytic naevi of scalp and neck

495

4562

1.17

1.71

3.6

3.2

87.99

103.97

ug/l

2.16

478

4308

Hereditary retinal dystrophy

255

2260

1.23

1.70

3.2

3.0

110.67

120.79

ug/l

0.46

233

2122

Acromegaly and pituitary gigantism

128

1082

1.37

1.70

3.4

2.9

104.29

108.39

ug/l

0.13

117

1012

Trichomoniasis

139

1181

1.34

1.70

4.1

3.0

130.37

103.84

ug/l

0.97

119

1082

Congenital malformations of eyelid, lacrimal apparatus and orbit

184

1609

1.31

1.69

3.9

3.5

67.09

65.14

ug/l

0.10

176

1527

Abnormal reflex

100

827

1.43

1.68

4.4

3.0

96.15

105.11

ug/l

0.28

784

Benign neoplasm: Prostate

105

862

1.38

1.68

3.1

3.0

185.37

192.13

ug/l

0.09

793

Shigellosis

493

1.57

1.67

3.7

2.9

169.95

105.12

ug/l

0.75

469

Sclerosis of liver

2.93

1.67

6.0

3.5

121.93

103.10

ug/l

0.14

Retained placenta and membranes, without haemorrhage

2773

26847

1.07

1.67

3.4

3.2

87.45

84.30

ug/l

0.44

2619

25438

Benign neoplasm: Spinal meninges

189

1648

1.28

1.66

3.7

3.0

141.98

112.78

ug/l

0.62

176

1513

Chronic mastoiditis

430

3924

1.17

1.66

3.7

3.1

146.61

141.65

ug/l

0.13

375

3617

Other and unspecified degenerative diseases of nervous system

442

4031

1.16

1.66

3.0

3.1

138.26

151.99

ug/l

0.64

406

3664

Malignant neoplasm of tonsil

237

2089

1.23

1.65

2.9

219.00

145.08

ug/l

2.70

222

1945

Fall involving playground equipment

152

1313

1.34

1.65

4.3

3.8

62.01

67.71

ug/l

0.24

147

1263

Accessory breast

158

1386

1.37

1.63

3.5

3.4

66.49

64.41

ug/l

0.13

151

1335

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

420

3841

1.17

1.63

3.3

3.1

125.41

122.57

ug/l

0.11

386

3591

Corneal pigmentations and deposits

591

1.49

1.63

3.6

3.0

113.13

118.18

ug/l

0.13

554

Iodine-deficiency-related thyroid disorders and allied conditions

145

2.33

1.60

4.5

2.6

99.42

114.95

ug/l

0.23

133

Use of fingolimod

166

1884

0.77

1.60

3.0

3.3

77.60

72.00

ug/l

0.17

156

1821

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1440

13733

1.09

1.59

3.2

3.1

144.88

134.64

ug/l

0.91

1392

12919

Primary ovarian failure

459

4259

1.19

1.59

3.5

3.2

74.27

65.63

ug/l

0.88

439

4078

Combined immunodeficiency, unspecified

163

2.28

1.58

4.0

3.3

127.20

85.23

ug/l

0.89

153

Nocardiosis, including avohilmo

135

2.24

1.58

9.7

2.7

288.54

112.47

ug/l

1.05

128

Nocardiosis

135

2.24

1.58

9.7

2.7

288.54

112.47

ug/l

1.05

128

Polymorphous light eruption

169

1483

1.32

1.58

3.7

3.1

90.75

80.36

ug/l

0.51

161

1409

Cerebral amyloid angiopathy

728

1.42

1.58

2.9

3.1

159.15

155.33

ug/l

0.05

662

Proteinuria and renal glomerular damage; focal glomerulonephritis

179

2.14

1.57

9.7

3.0

211.53

111.40

ug/l

1.48

171

Arthropod-borne viral fevers and viral haemorrhagic fevers

1739

16659

1.08

1.57

3.2

3.1

141.75

136.95

ug/l

0.39

1673

15665

Mild mental retardation

411

4483

0.86

1.56

4.1

3.3

99.50

101.48

ug/l

0.10

392

4254

Other and unspecified disorders of binocular movement

122

1043

1.38

1.56

3.5

3.2

93.65

86.05

ug/l

0.16

117

996

Early syphilis

192

1676

1.25

1.56

2.8

144.66

153.19

ug/l

0.20

184

1599

Injury of blood vessels at forearm level

478

1.54

1.56

3.6

3.0

119.05

126.92

ug/l

0.17

453

Malignant neoplasm of tonsil and base of tongue, including Hilmo

374

3395

1.17

1.56

2.9

192.91

144.43

ug/l

2.38

351

3165

Enduring personality changes

671

1.46

1.56

4.0

3.0

88.50

96.21

ug/l

0.16

643

Benign neoplasm: Peripheral nerves and autonomic nervous system

284

2552

1.21

1.56

3.2

3.0

118.62

123.65

ug/l

0.13

262

2377

Mental retardation, wide definition

695

7365

0.89

1.55

3.9

3.4

98.82

101.50

ug/l

0.18

649

6981

Maltreatment syndromes

1167

11109

1.10

1.53

3.5

3.2

107.69

89.93

ug/l

1.60

1090

10626

Malignant neoplasm of trachea, including Hilmo

126

0.38

1.53

9.5

3.0

96.50

155.97

ug/l

—

112

Other and unspecified disorders of globe

260

1.75

1.53

2.9

92.28

102.02

ug/l

0.26

244

Liposarcoma, including Hilmo

163

1410

1.28

1.53

3.3

2.9

228.69

127.90

ug/l

1.51

153

1309

Rheumatic valve diseases

339

3057

1.17

1.53

4.8

3.0

162.97

141.01

ug/l

0.51

315

2788

Burn and corrosion, body region unspecified

111

936

1.37

1.52

3.5

3.1

121.80

104.97

ug/l

0.59

105

889

Malignant neoplasm of pancreas

1030

10912

0.92

1.52

2.7

3.1

240.88

137.74

ug/l

12.13

958

9979

Pituitary-dependent Cushing's disease

552

1.56

1.52

4.2

3.3

120.60

82.10

ug/l

0.57

523

ILD medications: pirfenidone

167

1449

1.27

1.52

2.6

2.9

183.01

164.32

ug/l

0.39

158

1317

Mumps

443

4071

1.16

1.51

2.9

3.0

123.31

134.52

ug/l

0.47

401

3852

Other osteochondrodysplasias

172

1507

1.29

1.51

3.3

3.2

91.05

96.49

ug/l

0.18

163

1428

Chondromalacia

513

4755

1.15

1.51

3.0

3.1

108.46

118.66

ug/l

0.83

484

4499

Systemic atrophies primarily affecting the central nervous system

617

6628

0.89

1.50

3.1

158.73

144.12

ug/l

0.38

564

6121

HSIL lesion of the cervix uteri

5306

51999

1.05

1.50

3.3

3.4

71.53

66.98

ug/l

1.45

5051

49967

Other meningitis

309

2800

1.20

1.50

3.8

3.2

118.36

98.51

ug/l

1.05

294

2641

Divergent concomitant strabismus

1553

14887

1.08

1.48

3.5

3.2

100.66

106.44

ug/l

0.48

1489

14115

Mental and behavioural disorders due to hallucinogens

817

1.38

1.47

3.2

2.9

87.79

112.01

ug/l

0.96

794

Malignant neoplasm of other and unspecified male genital organs, including Hilmo

200

1.78

1.47

4.3

2.9

250.73

166.66

ug/l

0.39

182

LSIL lesion of the vagina

331

3031

1.20

1.47

3.6

3.2

85.70

80.51

ug/l

0.33

310

2871

Type 1 diabetes, definitions combined

2119

20369

1.07

1.46

4.2

3.1

105.33

92.68

ug/l

0.92

2010

19483

Muscle wasting and atrophy, not elsewhere classified

101

842

1.36

1.46

3.5

2.7

147.72

138.18

ug/l

0.17

779

Arteriovenous malformation of peripheral vessels

110

936

1.38

1.46

5.3

3.3

113.59

90.21

ug/l

0.45

890

Human immunodeficiency virus [HIV] disease, including avohilmo

307

2774

1.18

1.45

2.9

3.0

167.73

149.89

ug/l

0.24

299

2657

Benign neoplasm: Connective and other soft tissue of thorax

721

1.42

1.45

3.2

3.1

106.65

109.73

ug/l

0.09

677

Benign neoplasm: Skin of upper limb, including shoulder

371

3398

1.17

1.45

3.6

3.1

134.70

116.71

ug/l

0.79

353

3184

L02BG Aromatase inhibitors

6212

62621

0.96

1.44

2.9

3.1

138.88

107.00

ug/l

12.52

5687

57913

Use of interferon beta-1a

421

4542

0.86

1.43

2.9

3.2

99.44

83.36

ug/l

0.97

398

4363

Melanoma in situ of upper limb, including shoulder

135

1162

1.30

1.43

3.9

3.0

170.94

126.75

ug/l

1.12

121

1071

Beningn neoplasm: Meninges, unspecified

265

2384

1.20

1.42

3.3

3.0

114.30

119.43

ug/l

0.16

242

2198

Meckel's diverticulum

112

951

1.34

1.42

4.2

3.1

131.44

123.01

ug/l

0.11

101

903

Congenital malposition of the kidney

185

2.11

1.42

4.2

3.3

117.12

78.47

ug/l

0.69

174

Malignant neoplasm of oropharynx, including Hilmo

321

2910

1.17

1.41

3.1

2.9

201.26

141.53

ug/l

2.97

301

2710

Malignant neoplasm of other and unspecified parts of biliary tract

240

2138

1.20

1.41

3.0

198.81

134.92

ug/l

2.90

228

1962

Mumps, including avohilmo

454

4192

1.15

1.41

3.1

3.0

124.78

133.84

ug/l

0.36

412

3969

Forearm

168

2.16

1.41

3.7

3.1

179.97

86.54

ug/l

0.61

153

Unspecified human immunodeficiency virus [HIV] disease

164

1431

1.26

1.40

2.8

3.0

214.09

158.16

ug/l

0.49

159

1376

Postpartum haemorrhage due to anatomy

3330

32558

1.07

1.40

3.7

3.6

58.08

55.09

ug/l

0.80

3103

31303

Muscular dystrophy

143

1240

1.29

1.40

3.2

124.36

112.94

ug/l

0.21

134

1155

Relapsing polychondritis

384

1.62

1.40

4.8

3.2

108.49

103.27

ug/l

0.08

364

Benign neoplasm: Endocrine pancreas

112

954

1.34

1.40

3.7

3.0

141.25

138.41

ug/l

0.04

107

881

Filariasis, including avohilmo

175

2.02

1.39

4.5

3.0

64.27

98.50

ug/l

1.58

164

Filariasis

175

2.02

1.39

4.5

3.0

64.27

98.50

ug/l

1.58

164

Burn and corrosion of head and neck

377

3457

1.16

1.38

2.8

3.1

118.39

133.63

ug/l

0.84

350

3268

Assault by blunt object

262

2359

1.20

1.38

3.0

146.74

127.52

ug/l

0.58

236

2259

Knuckle pads

223

1.77

1.37

6.4

3.0

83.54

129.97

ug/l

1.75

210

Pedestrian injured in other and unspecified transport accidents

229

2053

1.22

1.37

3.6

3.1

84.44

119.57

ug/l

3.29

213

1929

Malignant neoplasm of tonsil, including Hilmo

266

2393

1.19

1.37

3.0

207.75

141.59

ug/l

2.68

250

2232

Postpartum haemorrhage due to retained placenta

3661

35796

1.06

1.37

3.5

3.4

64.12

63.98

ug/l

0.03

3483

34406

Impacted maxillary molar

1765

17066

1.08

1.36

3.5

3.3

62.28

60.51

ug/l

0.29

1713

16268

Behavioural disorders

459

4263

1.15

1.36

3.5

3.3

73.92

83.33

ug/l

0.81

432

4079

Lymphangioma, anys site

154

1352

1.29

1.36

3.8

3.0

78.53

90.37

ug/l

0.53

149

1276

Malignant neoplasm of penis, including Hilmo

743

1.34

1.36

3.8

2.8

224.16

187.26

ug/l

0.42

680

Acquired clawhand, clubhand, clawfoot and clubfoot

104

883

1.35

3.7

2.9

160.10

109.88

ug/l

0.67

841

Neuroendocrine tumor and carcinoma of pancreas

113

963

1.32

1.35

3.7

2.9

100.39

120.10

ug/l

0.96

105

898

Mental retardation

663

6992

0.90

1.35

4.0

3.4

99.19

98.47

ug/l

0.04

621

6636

Osteopathy after poliomyelitis

2.50

1.35

5.6

2.4

163.79

82.95

ug/l

0.70

Acute mastoiditis

169

1489

1.26

1.35

4.4

3.1

130.27

116.88

ug/l

0.32

157

1425

Use of galantamine

1340

12796

1.08

1.34

2.6

3.2

131.96

151.46

ug/l

2.38

1165

11495

Certain zoonotic bacterial diseases

323

2949

1.17

1.33

3.6

3.0

136.93

124.61

ug/l

0.41

302

2754

Mucinous and mucinous cystic tumor, including Hilmo

1118

0.75

1.33

3.0

3.1

99.90

82.49

ug/l

0.71

1048

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

200

1776

1.22

1.32

3.7

3.1

361.93

120.25

ug/l

1.31

187

1660

Dyslexia and other symbolic dysfunctions, not elsewhere classified

590

1.43

1.32

3.3

3.1

94.81

106.65

ug/l

0.31

545

Aneurysms, operations, SAH

3153

30632

1.05

1.32

3.5

3.1

131.83

138.58

ug/l

0.83

2937

28389

Guttate psoriasis

280

2549

1.19

1.32

3.8

3.1

106.44

108.28

ug/l

0.06

265

2407

Abnormal findings on diagnostic imaging of breast

286

2607

1.19

1.32

3.3

3.1

97.93

91.34

ug/l

0.45

269

2424

Burn and corrosion of hip and lower limb, except ankle and foot

449

4166

1.15

1.32

3.4

3.2

122.10

118.85

ug/l

0.14

416

3926

Burn and corrosion of other internal organs

483

1.48

1.31

2.9

2.8

113.01

105.33

ug/l

0.16

450

Rhinophyma

103

872

1.33

1.31

3.0

2.8

140.31

171.88

ug/l

1.05

804

Acute otitis externa, noninfective

308

2810

1.18

1.31

4.2

3.0

111.55

117.13

ug/l

0.23

283

2638

Type 1 diabetes, strict (exclude DM2)

2100

20239

1.06

1.30

4.2

3.1

105.39

92.88

ug/l

0.89

1991

19355

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

271

2449

1.18

1.30

2.8

3.0

141.79

151.50

ug/l

0.21

265

2354

Congenital malformations of nose

255

1.74

1.29

3.4

89.30

87.91

ug/l

0.03

247

Other cranial nerve disorders in other disorders

405

1.55

1.29

4.8

2.9

136.75

117.42

ug/l

0.26

381

Secondary malignant neoplasm of other and unspecified sites

239

2656

0.85

1.28

2.0

3.0

505.05

133.37

ug/l

8.17

219

2438

Follicular adenocarcinoma of thyroid gland, including Hilmo

188

1674

1.23

1.28

3.6

3.0

96.47

102.22

ug/l

0.21

177

1563

Tooth agenesis EXCLUDE clefts and syndromes

938

8943

1.10

1.27

4.4

3.4

64.12

66.42

ug/l

0.17

897

8550

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

135

1169

1.26

2.7

3.0

154.77

131.96

ug/l

0.50

124

1070

Benign neoplasm: Brain, supratentorial

293

2677

1.18

1.26

3.5

3.0

107.39

105.52

ug/l

0.07

273

2518

Calcific tendinitis

172

1523

1.24

1.26

3.4

2.8

137.33

132.79

ug/l

0.09

165

1425

Blepharospasm

164

1448

1.25

1.26

3.3

2.9

125.01

118.07

ug/l

0.14

156

1344

Human immunodeficiency virus [HIV] disease resulting in other conditions

269

2435

1.18

1.26

2.8

3.0

142.80

152.03

ug/l

0.20

263

2341

Tick-borne viral encephalitis

722

1.37

1.26

3.0

3.1

139.31

122.92

ug/l

0.28

679

Reduction defects of unspecified limb

104

2.40

1.25

2.8

2.3

83.26

93.84

ug/l

0.21

Human immunodeficiency virus [HIV] disease

299

2723

1.17

1.25

2.9

3.0

170.43

150.45

ug/l

0.27

291

2611

Other fusion of spine

256

1.70

1.24

2.7

108.84

105.35

ug/l

0.04

236

Normal-pressure hydrocephalus

685

7277

0.91

1.24

2.7

3.1

132.36

152.08

ug/l

1.81

619

6605

Bus occupant injured in other and unspecified transport accidents

132

1154

1.29

1.24

4.7

3.1

97.22

96.77

ug/l

0.01

116

1081

Vascular dementia (sudden onset)

408

0.66

1.24

3.0

3.2

100.69

145.08

ug/l

1.02

379

Schizotypal disorder

437

4062

1.14

1.24

3.1

141.53

109.68

ug/l

0.38

407

3878

Primary amenorrhea

203

1862

1.30

1.23

3.9

3.3

50.86

47.16

ug/l

0.40

196

1784

Inflammation of lacrimal passages (chronic)

256

2317

1.18

1.23

3.0

118.92

127.63

ug/l

0.41

239

2118

Flatback syndrome

137

2.07

1.23

3.6

3.2

88.15

119.11

ug/l

0.77

127

Malignant neoplasm of oropharynx

257

2325

1.18

1.22

2.9

3.0

212.74

144.01

ug/l

2.73

242

2170

Accidental poisoning by and exposure to pesticides

383

1.56

1.22

3.4

3.0

104.18

94.57

ug/l

0.17

362

Oral leukoplakia, including avohilmo

467

4347

1.13

1.22

3.2

3.0

132.82

143.28

ug/l

0.39

421

4053

Drug-induced androgenic alopecia

3.11

1.21

5.4

3.0

70.82

88.30

ug/l

0.23

Hereditary ataxia

216

1940

1.20

1.21

3.4

3.0

109.17

135.25

ug/l

1.78

198

1809

Malignant neoplasm of renal pelvis

773

1.31

1.21

3.2

2.9

235.30

141.93

ug/l

1.86

696

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

172

1527

1.22

1.18

2.8

3.0

207.58

157.03

ug/l

0.46

167

1468

Dementia due to Parkinson's disease

396

3662

1.14

1.17

2.6

3.2

159.91

160.75

ug/l

0.02

335

3300

Other and unspecified disorders of lacrimal system

312

1.60

1.17

4.2

2.8

137.99

97.03

ug/l

0.59

296

Tularaemia

228

2063

1.19

1.17

3.6

3.0

139.37

124.40

ug/l

0.38

215

1926

Diseases caused by chlamydiae

220

2000

1.21

1.17

3.3

3.1

93.27

80.68

ug/l

0.83

215

1913

Hydatidiform mole

318

2952

1.18

1.15

3.7

3.2

67.75

69.53

ug/l

0.17

310

2835

Intracerebral haemorrhage

2081

21517

0.95

1.15

3.6

3.1

174.24

157.08

ug/l

1.36

1891

19586

Early syphilis, including avohilmo

226

2043

1.19

1.14

2.9

132.57

139.17

ug/l

0.18

215

1948

Tuberculosis of other organs

319

2927

1.15

1.14

4.1

3.0

156.04

137.52

ug/l

0.65

293

2676

Carcinoma in situ of breast, lobular

133

1172

1.27

1.14

2.7

3.0

138.40

94.18

ug/l

1.00

121

1078

Malignant neoplasm of other and ill-defined sites

349

1.45

1.14

2.6

2.8

219.48

129.02

ug/l

1.60

309

Non-small cell lung cancer, adenocarcinoma

905

9519

0.93

1.13

3.0

3.1

237.57

140.09

ug/l

9.11

831

8691

Specific developmental disorder of motor function

291

2598

1.17

1.13

4.4

3.6

62.17

59.40

ug/l

0.15

281

2483

Nezelof syndrome

621

1.37

1.13

4.5

3.0

119.72

112.84

ug/l

0.10

588

Pterygium

476

4446

1.12

3.0

3.1

148.20

150.47

ug/l

0.05

427

4096

Malignant neoplasm of lip, including Hilmo

152

1334

1.21

1.12

3.4

2.9

237.48

144.68

ug/l

1.20

141

1220

Other congenital malformations of face and neck

594

5614

1.12

3.5

3.2

85.61

96.69

ug/l

1.24

565

5332

Other and unspecified syphilis

390

1.45

1.11

4.1

2.6

127.20

165.89

ug/l

0.52

374

Contact with lifting and transmission devices, not elsewhere classified

293

2690

1.16

1.09

2.9

3.0

132.81

150.34

ug/l

0.77

278

2544

Mesial bite

209

1904

1.21

1.09

3.4

3.3

66.28

73.78

ug/l

0.46

198

1816

Pedestrian injured in collision with car, pick-up truck or van

465

4357

1.12

1.09

3.3

3.1

105.31

112.78

ug/l

0.29

427

4086

Social disorders starting during childhood or adolescence

172

1551

1.23

1.09

4.4

3.6

72.95

61.93

ug/l

0.55

166

1480

Injury of nerves at ankle and foot level

139

1233

1.25

1.09

3.7

3.1

99.46

102.87

ug/l

0.12

133

1172

Assault by sharp object

288

2640

1.15

1.08

3.1

3.0

131.11

135.56

ug/l

0.14

264

2526

Unspecified transport accident

743

1.32

1.08

3.3

3.0

118.47

111.48

ug/l

0.15

700

Burns classified according to extent of body surface involved

172

1540

1.21

1.08

4.1

2.9

122.05

131.22

ug/l

0.26

167

1459

Osteogenesis imperfecta

391

1.52

1.07

3.1

3.6

91.98

87.36

ug/l

0.06

374

Other benign neoplasm of uterus: Cervix uteri

136

1213

1.27

1.07

3.5

3.3

79.26

81.03

ug/l

0.07

129

1140

Other chronic figurate erythema

2.35

1.06

3.0

110.73

68.04

ug/l

0.58

Drowning to ice

148

0.50

1.06

2.7

3.0

63.78

142.57

ug/l

—

137

Operations 1 for CAVS

414

1.44

1.05

4.4

3.4

131.68

114.87

ug/l

0.25

376

Unspecified hairloss

157

1.79

1.05

2.6

2.7

134.41

126.67

ug/l

0.07

146

Benign neoplasm: Skin of lip

228

2077

1.18

1.05

3.8

3.1

131.64

119.65

ug/l

0.38

214

1924

Cicatricial pemphigoid

336

1.53

1.05

2.9

223.68

115.58

ug/l

1.01

310

Malignant neoplasm of larynx, including Hilmo

274

2500

1.15

1.05

3.1

3.0

172.48

159.06

ug/l

0.35

257

2303

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

163

1456

1.21

1.05

3.8

3.0

187.10

105.78

ug/l

2.72

155

1363

Precocious central puberty

135

1207

1.27

1.04

4.7

3.2

80.94

67.22

ug/l

0.44

126

1151

Rickettsioses

264

1.59

1.03

4.4

2.9

159.83

133.38

ug/l

0.32

251

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

208

1900

1.20

1.02

3.7

3.4

75.95

69.92

ug/l

0.34

202

1821

Chronic suppurative otitis media

1260

12126

1.07

1.02

3.6

3.1

115.21

114.97

ug/l

0.01

1164

11354

Tuberculosis, IBD comorbidity

1110

10632

1.07

1.02

3.9

3.1

155.46

148.67

ug/l

0.35

1013

9721

Inhalation and ingestion of other objects causing obstruction of respiratory tract

111

973

1.27

1.01

3.9

3.1

81.35

103.02

ug/l

1.14

100

922

Acute appendicitis, with complications

3969

38854

1.04

1.01

3.3

3.1

139.29

133.42

ug/l

0.70

3741

36500

Other diseases caused by chlamydiae

234

2151

1.18

1.00

3.3

3.0

95.18

86.34

ug/l

0.52

228

2056

Benign neoplasm: Extrahepatic bile ducts

472

1.40

1.00

4.0

2.7

142.91

121.03

ug/l

0.51

434

Reactive perforating collagenosis

2.50

0.99

6.2

3.2

163.91

68.43

ug/l

—

Isolated patent ductus arteriosus

211

1910

1.20

0.99

5.2

3.8

64.03

62.18

ug/l

0.07

204

1823

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

378

3519

1.14

0.99

4.4

3.4

61.44

67.10

ug/l

0.56

364

3333

Ovarian dysfunction, other/unspecified

143

1295

1.27

0.98

4.0

3.2

80.01

63.05

ug/l

0.59

133

1227

Optic atrophy, wide definition

319

2960

1.14

0.98

3.4

3.1

118.48

117.59

ug/l

0.03

289

2778

Malaria

760

1.30

0.98

3.7

3.1

122.70

116.49

ug/l

0.11

719

Benign neoplasm: Cranial nerves

492

4636

1.11

0.98

3.1

3.0

124.38

134.33

ug/l

0.29

453

4310

Complicated migraine, drug-induced

181

1.81

0.98

3.2

90.50

79.89

ug/l

0.26

174

Mixed disorders of conduct and emotions

553

5251

1.11

0.97

3.7

3.4

74.73

61.36

ug/l

1.60

524

5002

Pustulosis subcornealis

2.62

0.97

2.8

2.9

147.05

92.01

ug/l

—

Venous complications and haemorrhoids in the puerperium

230

2122

1.19

0.97

3.4

3.2

87.95

76.67

ug/l

0.53

217

2001

Brain astrocytoma, helper endpoint

723

0.75

0.97

2.5

3.1

89.21

92.79

ug/l

0.09

692

Mandibular prognathia

314

2924

1.15

0.96

3.8

3.3

156.19

86.53

ug/l

0.39

298

2787

Malignant neoplasm of larynx

212

1920

1.16

0.96

3.0

171.64

163.95

ug/l

0.16

197

1772

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

131

1168

1.23

0.95

3.2

3.0

104.25

121.28

ug/l

0.91

121

1089

Benign neoplasm: Testis

534

1.33

0.95

2.8

2.9

177.10

182.43

ug/l

0.06

501

Crushing injury of wrist and hand

244

2238

1.15

0.95

3.7

3.1

154.12

163.45

ug/l

0.25

231

2107

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

111

986

1.28

0.95

4.0

3.6

48.92

49.50

ug/l

0.04

105

936

Contact with nonpowered hand tool

711

6768

1.09

0.94

3.1

3.0

166.70

150.27

ug/l

0.70

652

6389

Tularaemia, including avohilmo

349

3258

1.13

0.94

3.4

3.1

125.96

122.89

ug/l

0.09

333

3067

Diseases caused by chlamydiae, including avohilmo

317

2962

1.15

0.94

3.1

83.09

75.53

ug/l

0.63

309

2837

Other demyelinating diseases of the central nervous system

796

7630

1.09

0.93

3.4

3.2

101.09

89.96

ug/l

0.50

763

7285

Environmental-pollution-related condition

200

1.73

0.93

4.7

3.3

155.15

95.59

ug/l

0.74

190

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

179

1.68

0.93

10.9

3.1

72.25

84.29

ug/l

0.31

169

Juvenile dermatomyositis

181

1.74

0.93

3.2

3.6

68.70

69.37

ug/l

0.01

175

Dementia in Alzheimer disease

3289

26853

1.04

0.93

2.8

3.3

146.63

159.51

ug/l

1.94

2771

24166

Reiter disease

855

1.26

0.93

3.5

2.9

227.56

161.30

ug/l

0.70

806

Scissor bite

586

5518

1.10

0.93

3.8

3.4

95.95

64.72

ug/l

0.42

555

5278

Myelofibrosis

2.08

0.93

3.0

331.45

130.35

ug/l

1.23

Felty syndrome

782

1.27

0.92

4.6

3.1

258.51

115.07

ug/l

0.66

720

Malignant neoplasm of lip

109

951

1.22

0.91

3.5

3.0

265.35

146.39

ug/l

1.09

101

867

Premature separation of placenta [abruptio placentae]

542

5167

1.11

0.91

3.6

3.3

57.10

68.53

ug/l

3.06

516

4981

Rare circulating lymphoid malignancy

704

1.27

0.89

3.1

2.9

601.72

146.70

ug/l

4.14

639

Endometroid carcinoma of ovary, including Hilmo

125

1397

0.83

0.89

3.3

3.0

121.90

90.23

ug/l

1.23

117

1292

Liveborn infants according to place of birth

211

1817

1.20

0.89

3.5

3.4

41.51

44.52

ug/l

0.15

202

1731

Injury of blood vessels at wrist and hand level

116

1029

1.23

0.88

4.0

2.9

229.79

149.28

ug/l

0.48

109

977

Rubella [German measles], including avohilmo

469

4414

1.10

0.88

2.9

2.8

170.44

201.06

ug/l

1.42

450

4226

Optic atrophy

305

2842

1.13

0.87

3.4

3.1

119.70

117.77

ug/l

0.06

275

2670

Benign neoplasm: Connective and other soft tissue of head, face and neck

296

2756

1.13

0.87

3.3

3.0

101.58

114.11

ug/l

0.89

277

2587

Mandibular prognathia AND surgery (LeFortI or BSSO)

100

886

1.27

0.87

3.2

3.1

80.89

93.28

ug/l

0.49

845

Disorders of tyrosine metabolism

118

1.72

0.87

7.8

3.1

235.44

163.01

ug/l

0.28

108

Motor- or nonmotor-vehicle accident in traffic area

138

1243

1.21

0.87

3.8

2.9

96.05

108.12

ug/l

0.52

130

1184

Other congenital malformations of ear

311

2925

1.15

0.86

3.3

3.4

62.65

62.92

ug/l

0.01

297

2794

Aggressive periodontitis

385

3618

1.12

0.86

3.3

3.1

134.99

137.50

ug/l

0.08

357

3380

Foreign body on external eye

2706

26427

1.04

0.86

3.1

144.30

150.95

ug/l

0.59

2546

25066

Phakomatoses, not elsewhere classified

209

1923

1.17

0.86

4.1

3.1

93.23

95.29

ug/l

0.06

195

1824

Acute poliomyelitis, including avohilmo

212

1947

1.16

0.86

3.1

2.9

127.11

121.10

ug/l

0.16

194

1802

Disorders of conjunctiva in diseases classified elsewhere

104

1.88

0.85

3.0

2.9

105.42

117.62

ug/l

0.16

Contact with hot air and gases

106

936

1.23

0.85

3.8

2.9

179.26

140.42

ug/l

0.31

101

882

Acute poliomyelitis

211

1941

1.15

0.83

3.1

2.9

127.58

120.95

ug/l

0.18

193

1797

Malignant neoplasm of floor of mouth

664

1.26

0.83

3.0

2.8

216.62

150.39

ug/l

1.15

606

Other diseases caused by chlamydiae, including avohilmo

333

3133

1.13

0.82

3.1

84.67

80.46

ug/l

0.29

324

2998

Mesothelioma

111

1253

0.84

0.82

2.6

3.0

461.53

156.08

ug/l

2.87

105

1144

Maxillary retrognathism

375

3540

1.12

0.82

3.4

3.3

85.48

80.23

ug/l

0.32

359

3369

Rubella [German measles]

466

4397

1.09

0.82

2.9

2.8

171.08

201.59

ug/l

1.40

447

4210

Hydrocephalus in other diseases

925

0.80

0.82

4.0

3.2

142.20

113.75

ug/l

0.54

868

Motor disorders

291

2699

1.13

0.82

4.4

3.7

62.17

60.39

ug/l

0.09

281

2581

Use of dimethyl fumarate

156

1701

0.84

0.82

2.7

3.3

94.06

69.68

ug/l

0.51

149

1646

Use of selegiline

699

6677

1.08

0.82

3.1

139.56

152.13

ug/l

0.65

617

6105

Tuberculosis, wide, including avohilmo

1158

11168

1.06

0.81

3.8

3.1

155.18

148.81

ug/l

0.34

1058

10199

Disorders of glycine metabolism

2.05

0.81

7.2

2.4

182.33

95.91

ug/l

0.40

Injury of nerves at shoulder and upper arm level

190

1742

1.16

0.81

3.7

3.0

128.05

137.46

ug/l

0.28

180

1642

Thoracic root disorders

246

1.49

0.80

5.2

3.0

97.96

119.07

ug/l

0.50

231

Other benign neoplasms of uterus

911

8775

1.07

0.80

3.4

3.1

104.22

107.26

ug/l

0.22

814

8003

Serous carcinoma of ovary, including Hilmo

519

5456

0.92

0.80

2.8

3.0

225.35

96.70

ug/l

12.16

489

5014

Benign neoplasm: Bronchus and lung

202

1856

1.15

0.79

3.6

3.0

129.15

138.36

ug/l

0.28

194

1729

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

110

984

1.23

0.79

3.6

3.0

174.28

112.97

ug/l

1.25

102

925

Disorders of globe

415

3916

1.10

0.79

4.0

3.0

128.38

131.98

ug/l

0.12

388

3616

Other changes in lacrimal passages

268

1.51

0.79

4.1

3.2

173.13

81.08

ug/l

0.60

251

Superficial frostbite

116

1037

1.21

0.79

4.0

2.8

119.26

124.73

ug/l

0.12

107

978

Respiratory distress of newborn

252

2175

1.14

0.78

4.8

4.0

81.24

47.56

ug/l

0.68

244

2095

Other diseases of appendix

206

1902

1.15

0.78

3.2

3.0

135.32

118.72

ug/l

0.27

189

1762

Malignant neoplasm of retroperitoneum and peritoneum

128

1153

1.20

0.78

2.5

2.9

219.18

108.48

ug/l

3.73

122

1071

Brain astrocytoma

708

0.78

2.5

3.1

89.21

87.91

ug/l

0.03

677

Brain astrocytoma, including Hilmo

708

0.78

2.5

3.1

89.21

87.91

ug/l

0.03

677

Prominent ears

242

2270

1.17

0.78

3.5

3.3

57.46

56.61

ug/l

0.04

229

2161

Abscess of spleen

107

1.87

0.78

8.6

2.8

216.73

120.95

ug/l

0.90

Labyrinthine fistula

450

1.35

0.77

3.5

3.1

191.60

131.78

ug/l

0.38

422

Congenital malformations of anterior segment of eye

155

1418

1.19

0.77

3.8

3.1

112.85

97.26

ug/l

0.49

143

1324

Balanced rearrangements and structural markers, not elsewhere classified

728

1.29

0.77

3.0

3.4

72.18

73.99

ug/l

0.06

703

Contact with other specified venomous animals

128

1160

1.20

0.76

3.7

3.2

106.18

117.30

ug/l

0.25

118

1089

Acquired keratosis [keratoderma] palmaris et plantaris

683

1.26

0.76

3.5

2.9

104.98

122.75

ug/l

0.34

639

Non-neuropathic heredofamilial amyloidosis

177

1.59

0.76

8.1

2.8

187.76

101.88

ug/l

0.71

160

Syndactyly, including avohilmo

642

1.30

0.76

3.4

3.1

77.45

73.22

ug/l

0.12

610

Glaucoma secondary to eye trauma

100

888

1.22

0.75

3.6

3.0

132.82

154.08

ug/l

0.60

828

Benign neoplasm: Female genital organ, unspecified

529

1.33

0.75

3.5

3.2

93.99

77.99

ug/l

0.30

494

Benign neoplasm: Brain, infratentorial

114

1029

1.22

0.75

3.0

3.1

120.47

96.00

ug/l

0.50

103

968

Personality and behavioural disorders due to brain disease, damage and dysfunction

230

2128

1.13

0.75

3.5

3.1

141.85

147.91

ug/l

0.14

204

1987

982

9428

1.06

0.74

3.6

3.0

109.24

125.90

ug/l

2.30

908

8616

Purulent endophthalmitis

101

898

1.21

0.74

4.5

3.1

148.40

142.41

ug/l

0.13

816

Heberden's nodes [with arthropathy]

148

1351

1.18

0.74

3.9

2.9

100.70

112.00

ug/l

0.59

142

1241

Scarlet fever, including avohilmo

176

1623

1.17

0.73

3.8

3.0

117.74

81.50

ug/l

0.66

165

1566

Epidermolysis bullosa

253

1.52

0.73

5.3

3.5

85.80

95.07

ug/l

0.20

242

Bilateral cryptorchidism (undescended testicles)

247

1.42

0.73

6.6

4.4

85.60

94.69

ug/l

0.16

237

Cholesteatoma of middle ear

848

8166

1.07

0.73

3.3

3.1

128.80

140.67

ug/l

0.54

783

7546

Assault by hanging, strangulation and suffocation

533

1.34

0.73

3.9

3.4

69.09

73.33

ug/l

0.13

515

Obstetric embolism

226

1.56

0.73

3.9

3.2

86.31

79.67

ug/l

0.16

216

Polyp of middle ear

232

1.48

0.73

2.3

3.1

82.86

107.06

ug/l

0.53

215

Irritant contact dermatitis due to drugs in contact with skin

103

1.91

0.73

2.1

3.8

173.31

95.93

ug/l

0.36

Crystalline deposits in vitreous body

146

1330

1.17

0.72

4.0

3.0

131.72

143.37

ug/l

0.34

132

1226

Malignant neoplasm of testis

219

2022

1.12

0.72

3.8

2.7

181.56

163.09

ug/l

0.64

200

1899

Burns and corrosions of multiple body regions

151

1379

1.17

0.71

3.0

93.06

137.96

ug/l

3.18

143

1304

Tuberculosis of other organs, strict

353

3324

1.10

0.71

4.0

3.1

163.62

136.89

ug/l

1.11

323

3028

Liposarcoma

115

1034

1.19

0.71

3.3

2.9

194.76

133.13

ug/l

1.13

109

966

Focal epilepsy, mode (most common among epilepsy diagnosis)

3878

38118

1.03

0.71

3.3

3.2

141.62

124.51

ug/l

2.43

3604

35673

Meningococcal infection, including avohilmo

135

1228

1.18

0.71

3.1

2.9

105.34

95.66

ug/l

0.25

127

1163

Ankyloglossia

342

3228

1.11

0.70

4.4

3.5

58.98

60.26

ug/l

0.09

329

3070

Testicular hypofunction, drug-induced

0.00

0.70

0.0

1.9

—

125.09

—

Atypical virus infections of central nervous system

158

1450

1.16

0.70

3.3

2.9

139.98

118.43

ug/l

0.82

145

1354

Tuberculosis, wide

1138

11013

1.05

0.70

3.9

3.1

155.90

149.25

ug/l

0.35

1038

10061

Personal history of allergy to analgesic agent

127

1160

1.20

0.70

3.2

3.1

89.22

89.49

ug/l

0.00

118

1099

Malignant neoplasm of base of tongue, including Hilmo

129

1169

1.17

0.69

2.7

2.8

160.40

146.55

ug/l

0.27

120

1087

Malignant neoplasm of other and unspecified parts of mouth

809

1.21

0.69

2.5

3.0

160.47

121.36

ug/l

0.78

745

Mental retardation, excluding more controls

660

6109

1.07

0.69

4.0

3.1

99.47

102.17

ug/l

0.17

618

5804

Melanocytic naevi of lip

160

1476

1.17

0.68

3.8

3.0

98.80

93.59

ug/l

0.17

153

1391

Cleft palate

209

1952

1.15

0.68

3.4

3.3

69.45

79.46

ug/l

0.81

199

1874

Respiratory tuberculosis, not confirmed

534

5597

0.93

0.67

3.4

3.0

149.73

153.57

ug/l

0.11

482

5082

Delayed milestone in childhood

321

2723

1.11

0.66

5.0

3.9

51.32

55.74

ug/l

0.31

312

2611

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Ferritin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS